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Abstract 
The neural crest is a transient population of cells that forms a diverse range of derivatives 
in vertebrate embryos. Neural crest cells also migrate extensively throughout the embryo. 
The specification of a number of neural crest derivatives, including pigment cells and 
neurons and glia of the peripheral nervous system, is dependent on the transcription 
factor Sox10. In sox10 mutant zebrafish embryos, these neural crest derivatives fail to 
specify and subsequently the cell differentiation and migration fails leading to apoptosis. 
Sox10 mutant embryos also display an ear defect although the precise role of Sox10 in 
the ear is less well defined. Thus Sox10 controls an extensive gene regulatory network 
that drives the development of an important subset of neural crest derivatives and also 
functions during ear development. This gene regulatory network is currently poorly 
defined. 
The aim of this project was to identify genes that are both direct and indirect 
targets of Sox10 to further elucidate this gene regulatory network. To achieve this, a 
microarray approach was adopted. Initially, fluorescence activated cell sorting was 
employed to enrich for sox10 expressing cells from 24 hours post fertilization sox10:GFP 
transgenic embryos. The transcriptomes of WT and sox10 mutant cells were compared by 
microarray analysis to identify differentially regulated genes. A large number of target 
genes were identified by this method and by an unbiased in situ hybridization screen, 28 
genes were validated. Of these, 23 genes were expressed in cells of the neural crest and 
down-regulated in sox10 mutant embryos. The majority of these genes were expressed in 
cells of the melanocyte and xanthophore lineages. 5 genes were expressed in the ear 
(otic vesicle) of which three otic vesicle genes were down-regulated while two otic vesicle 
genes were up-regulated in sox10 mutant embryos. Unfortunately due to time constraints, 
a study into the function of one of these target genes could not be completed. 
The series of validated genes identified during this project has opened new 
opportunities for research and has identified a number of highly expressed marker genes 
that will be useful in future studies. In addition, the microarray data presented will be a 
useful resource to aid the identification of further targets of Sox10. 
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Chapter 1: Introduction 
1.1 Introduction to the Neural Crest 
1.1.1 Overview 
The neural crest (NC) is a critical vertebrate embryonic cell population sometimes referred 
to as the fourth germ layer. Neural crest cells (NCCs) arise at the border between neural 
and non-neural ectoderm and after neurulation lie at the dorsal aspect of the neural tube. 
Subsequently, NCCs undergo an epithelial to mesenchymal transition (EMT) and 
delaminate from the neural tube before migrating to numerous locations within the 
developing embryo. The initially multipotent population of NCCs differentiates into a 
diverse variety of cell types including pigment cells, neurons and glia of the peripheral 
nervous system and craniofacial cartilage. NCCs have thus provided an excellent model 
for the study of cell specification, differentiation and migration. In addition, the properties 
of NCCs have strong parallels with both stem cells and invasive cancerous cells. A 
number of human diseases are also attributed to errors in NC development, such 
diseases are termed neurocristopathies. Therefore study of the NC has been driven by 
both their key developmental importance and their relevance to human disease aetiology. 
1.1.2 Formation and Induction of the Neural Crest 
The neural crest forms at the lateral edges of the neural plate at the boundary with the 
prospective epidermis. As neurulation progresses, NCCs are positioned at the tip of the 
neural folds and are found in the dorsal NT after NT closure. In zebrafish there is no 
folding of the neural plate but instead the neural keel is formed by a thickening of the 
neural plate. The neural keel then separates from the prospective ectoderm and 
subsequently NC mesenchymal cells can be distinguished in the dorsal portion of the 
neural keel (Eisen and Weston, 1993). As with other vertebrate species, the development 
of NCCs occurs in a rostrocaudal progression (Raible et al., 1992). 
Several major signalling pathways converge to induce formation of the NC. In 
accordance with the classical gradient model, the NC is induced from ectoderm at 
intermediate levels of Bone Morphogenic Protein (BMP) signalling, with neural tissue 
induced at high levels of BMP signalling (Marchant et al., 1998). Analysis of zebrafish 
mutants has supported this model; the swirl/bmp2 zebrafish mutant abolishes BMP 
signalling and displays no induced NC while a mutant that has reduced BMP signalling, 
for example somitabun/smad5, displays an expanded zone of induced NC (Nguyen et al., 
1998). However, other studies have identified that an intermediate level of BMP signalling 
is necessary but not sufficient to induce NC. Induction of NCCs from chordin treated 
Xenopus neural plate explants required additional signals, in particular Wnt or Fibroblast 
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Growth Factor (FGF) signalling (LaBonne and Bronner-Fraser, 1998). Such findings have 
led to the development of the double gradient model which stipulates that intermediate 
BMP signalling in conjunction with other signalling molecules including Wnts and FGFs 
from surrounding tissues are required to induce the NC (Aybar and Mayor, 2002). Loss of 
function experiments in zebrafish has also identified a key role for Wnts during NC 
induction. Using a heat inducible transgenic zebrafish embryo, in which canonical Wnt 
signalling could be blocked, the authors identified a key period when inhibition of Wnt 
signalling prevented the induction of NCCs (Lewis et al., 2004). In response to the correct 
combination of signals, a set of transcription factors termed neural plate border specifiers 
(including zic1, msx genes, dlx genes and pax genes) are up-regulated and define the 
embryonic region capable of forming the NC (Sauka-Spengler and Bronner-Fraser, 2008). 
Neural plate border specifier genes include msx1 which is a known target of BMP 
signalling (Tribulo et al., 2003). Msx1 is capable of inducing expression of the NC specifier 
genes slug, snail and foxd3 in Xenopus embryos (Tribulo et al., 2003). MSX1 also up-
regulates and cooperates with PAX3 to induce NC specifier gene expression by mediating 
WNT and FGF signals (Monsoro-Burq et al., 2005). Thus in response to the neural plate 
border specifier genes, early NC genes known as NC specifier genes are up-regulated 
(Sauka-Spengler and Bronner-Fraser, 2008). 
1.1.3 Neural Crest Specification and Differentiation 
The NC specifier genes are a group of transcription factors and are used as early NC 
markers. This set of genes includes snail genes, soxE genes, foxd3, tfap2, twist, c-Myc 
and Id genes (Sauka-Spengler and Bronner-Fraser, 2008). The combination of these 
genes distinguishes NCCs from other neuroepithelial cells and initiates further steps in NC 
development such as epithelial to mesenchymal transition (EMT), delamination, 
specification of NC derivatives, cell migration and cell survival. Evidence so far shows that 
the NC specifier genes display extensive co-ordination and cross-regulation in a gene 
regulatory network. For example, the depletion of Sox10 by morpholino knockdown in 
Xenopus embryos inhibited the expression of snai2 and foxd3 (Honore et al., 2003). 
Although, the expression levels of snai2 and foxd3 are not affected in the early NCCs of 
zebrafish sox10 mutants (Lopes et al., 2008). Over expression of snail, slug and sox9 all 
increased the expression of sox10 (Aoki et al., 2003, Honore et al., 2003). The NC 
specifier gene network ensures that the NCC state is maintained and downstream NC 
effector genes are activated (Meulemans and Bronner-Fraser, 2004). 
The potential of a cell is defined as the fate or fates that can be adopted by that 
cell or its progeny given appropriate environmental conditions. A cell is therefore 
multipotent if it has the potential to generate more than one distinct cell type (Kelsh, 
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2006). It should be noted that the fate a cell actually adopts is not necessarily the same as 
what it could do given appropriate signals. Single cell labelling and subsequent cell 
lineage analysis has identified, in a variety of model organisms, that NCCs are initially 
multipotent (Bronner-Fraser and Fraser, 1989, Collazo et al., 1993, Serbedzija et al., 
1994, Raible and Eisen, 1994). Some NCCs were capable of producing more than one 
type of derivative while some NCCs only produced one derivative. As such, NCCs are not 
only multipotent but the NCC population is heterogeneous. How a wide range of NC 
derivatives are specified from a multipotent precursor population is thus a key question. 
Two options exist for NCCs to achieve this; cells could be directly specified from the 
multipotent precursor population, or cells could undergo progressive fate restriction. 
Currently evidence supports cells progressively losing potential, passing through a series 
of partially restricted precursors before finally specifying and subsequently committing to a 
single fate (Kelsh, 2006). For example, Sox10 mutant embryos only display defects in a 
subset of NC derivatives, the non-skeletogenic (non-ectomesenchymal) derivatives which 
include pigment cells and the neurons and glia of the peripheral nervous system (PNS). 
The skeletogenic derivatives, which include cartilage and fin mesenchyme, are unaffected 
(Southard-Smith et al., 1998, Dutton et al., 2001a). This indicates that the multipotent NC 
has been restricted into skeletogenic and non-skeletogenic precursor populations. A 
restriction between neuronal and pigment cell precursors has also been identified (Henion 
and Weston, 1997). It should also be noted that NC specification and fate choice occurs 
with temporal and spatial differences. Zebrafish trunk NCCs that are specified to a 
neuronal fate appear first while pigment cells appear later (Raible and Eisen, 1994). NCCs 
at different axial levels produce different cell types, for example, only vagal NCCs produce 
smooth muscle that contributes to the heart (Li et al., 2003) while NCCs at all axial levels 
produce neurons, glia and pigment cells. 
A cell becomes specified to a particular fate when it starts to express 
characteristics of a particular cell type or fate, but it should be noted that a specified cell is 
not necessarily committed to a particular fate (Kelsh, 2006). Thus a specified cell will 
express key molecular markers indicative of the future cell type. The earliest marker of 
melanocytes is the transcription factor Mitf (the zebrafish homolog is mitfa). Mitf is 
considered to be the key gene in the switch from a bipotent glial/melanocyte precursor to 
a melanocyte and is the master regulator of melanogenesis (Opdecamp et al., 1997). Mitf 
expression requires co-regulation by SOX10 and PAX3, thus two NC specifier genes 
activate this master switch gene (Potterf et al., 2000, Elworthy et al., 2003). In addition, 
activation of the Wnt signalling pathway by injection of mRNA into single cells promotes 
the formation of melanocytes in zebrafish embryos (Dorsky et al., 1998). During the same 
study, injection of dominant negative Wnt1 mRNA to inhibit Wnt signalling promoted 
neuron formation at the expense of melanocytes. It has been shown that the mitfa 
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promoter contains Wnt signalling responsive binding sites (Dorsky et al., 2000). Thus 
there is a key requirement for both TF expression and signalling by extrinsic instructive 
cues for correct NCC specification. Subsequently Mitf regulates the expression of a 
number of melanocyte specific genes (Murisier and Beermann, 2006). Thus the model of 
NC specification and differentiation presented here involves NC specifier genes activating 
master regulator transcription factor genes, in concert with environmental signals, to 
activate genes responsible for NCC differentiation, migration and survival (Dutton et al., 
2001a). The NC specifier transcription factors therefore activate molecular cascades 
necessary to initiate further NCC development. Examples of master regulator transcription 
factors that are key to the development of a particular NC cell type include, phox2b 
(enteric nervous system) and ngn1 (sensory neurons) in mouse (Pattyn et al., 1999, Perez 
et al., 1999) and zebrafish (Elworthy et al, 2005, Carney et al, 2006). 
1.1.4 Epithelial to Mesenchymal transition and Crest cell migration 
NC specifiers regulate some of the characteristic features of NCCs, namely the epithelial 
to mesenchymal transition (EMT), delamination and migration of NCCs. After 
specification, NCCs are located within the dorsal neural tube and subsequently transform 
from epithelial cells into mesenchymal cells, which have migratory properties. NCCs then 
delaminate from the neural tube. During these events NCCs undergo a series of changes 
including a loss of apico-basal polarity, dissolution of tight junctions, a change in cell 
adhesion and they acquire invasive properties which confers the cells with the ability to 
delaminate and migrate (Sauka-Spengler and Bronner-Fraser, 2008). It should be noted 
that cancer cells also undergo EMT during tumour progression, thus NC biology relates to 
cancer biology in this regard (Thiery and Sleeman, 2006). NCCs then undertake extensive 
migration on stereotypical pathways to various locations within the developing embryo. In 
mammals, melanocytes migrate on the dorsolateral pathway between the epidermis and 
the somites while cells of a neural fate migrate on the ventral pathway through the anterior 
half of the sclerotome (Figure 1). The situation is slightly different in zebrafish embryos. 
Neural fated cells are restricted to the segmentally organized medial (ventral) migration 
pathway while melanocytes can migrate on both the medial and lateral (dorsolateral) 
pathways (Raible and Eisen, 1994, Kelsh, 2004). Xanthophores are restricted to migrating 
on the lateral pathway while iridophores migrate solely on the medial pathway (Figure 1) 
(Kelsh, 2004). Temporal differences in cell migration have also been observed, neural 
fated cells migrating first on the medial pathway (16 - 18 hpf) and melanocyte fated cells 
initiating migration slightly later and continuing for a longer period of time (16.5 – 23.5 hpf) 
(Raible and Eisen, 1994). Migration on the lateral pathway initiates 4-5 hours later than 
migration on the medial pathway (Raible and Eisen, 1994). 
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NCCs are initially part of the epithelial NT and have a typical apical-basal polarity. 
This polarity is lost as cells progress through EMT and gain the ability to migrate. As part 
of this process tight junctions are lost. This is achieved by the down-regulation of 
constituent components of tight junctions. For example, occludin, a major structural 
component of tight junctions, is down-regulated in the dorsal neuroepithelium during NT 
closure (Aaku-Saraste et al., 1996). However, NCCs were not specifically examined 
during this study. Over expression of the NC specifier snail induces EMT in cultured 
mouse epithelial cells; this process occurred with a concurrent down-regulation in the tight 
junction proteins occludin and claudin (Ikenouchi et al., 2003). During NT closure tight 
junctions are lost as part of the EMT and there is a shift to gap junctions (Shook and 
Keller, 2003). Gap junctions are formed when two connexons or hemi-channels in 
neighbouring cell membranes are opposed to allow the passage of small molecules 
between cells. Connexons are constructed of a hexamer of proteins encoded by the 
connexin family of genes. Connexons can consist of one type of connexin or a 
combination of different connexins (Meşe et al., 2007). The function of one connexin, 
Cx43, has been well studied in the NC and is known to modulate the motility and 
migration rate of cardiac NCCs (Huang et al., 1998, Xu et al., 2001). It appears that the 
function of Cx43 is dependent on interactions with the actin cytoskeleton and is 
independent of gap junction function (Xu et al., 2006). Despite the considered importance 
of the transition from tight junctions to gap junctions during EMT in both NC and cancer 
biology, there is little published data regarding the expression of other members of the 
connexin family during this process and therefore little is known about the function of 
connexins during EMT and NC migration. 
A change in cell to cell adhesion presents another key step that occurs during 
EMT to infer NCCs with the capacity to migrate. Cadherins are a family of calcium 
dependent cell adhesion molecules which are split into several groups. The classical 
cadherins are split into two types, type I includes epithelial (E) and neuronal (N) cadherins 
while type II covers cadherin-5 and beyond (Halbleib and Nelson, 2006, Taneyhill, 2008). 
Type I cadherins contain an HAV tri-peptide motif in their extracellular domain that 
mediates strong cell to cell adhesion and are expressed in stable epithelial cell 
assemblies, this adhesion motif is lacking in type II cadherins (Halbleib and Nelson, 2006). 
A switch from the expression of type I cadherins to type II cadherins with the associated 
change in cell adhesion is correlated with the progression of EMT and acquisition of cell 
motility. Type I cadherins are down-regulated during EMT by NC specifier genes such as 
Foxd3 and Snail2 (Cheung et al., 2005, Cano et al., 2000). Conversely, type II cadherins 
are up-regulated in migrating NCCs by NC specifier genes (Cheung et al., 2005). To 
facilitate migration, a cell not only has to modulate cell to cell adhesion but also cell to 
extracellular matrix (ECM) adhesion. The integrin family of receptors, that recognise ECM 
13

molecules like fibronectin, represent a major effector of cell to ECM adhesion. Several 
integrins are expressed by NCCs (Testaz et al., 1999). Loss of function studies has shown 
that integrins are required for NCC migration both in vitro and in vivo (Kil et al., 1996). 
Thus regulation of cell adhesion plays a key role in facilitating the migration of NCCs. 
Proteins called matrix metalloproteases (MMPs), which digest the ECM, have also 
been implicated in both NCC EMT and migration. Interestingly, MMPs are also strongly 
linked with cancer cell invasion (Kuriyama and Mayor, 2008). The NC specifier gene, 
snail, was shown by microarray analysis to regulate the expression of MMP-2 in a 
melanoma cell line. Comparison of cancer cells treated with snail antisense cDNA against 
untreated cells identified a number of important EMT genes including MMP-2 as down-
regulated in treated cells (Kuphal et al., 2005). MMP-2 is expressed in NCCs during EMT 
and cell migration but expression is down-regulated in cells that have reached their final 
destination (Duong and Erickson, 2004). In addition, MMP chemical and MMP-2 
morpholino inhibition prevented EMT and NCC dispersion from the NT in vivo and in vitro 
(Duong and Erickson, 2004). Members of the metalloprotease/disintegrin ADAM family of 
genes have also been implicated in NCC migration. Xenopus NCC grafts of ADAM-13 
protease defective cells did not migrate in WT embryos (Alfandari et al., 2001). Thus 
inhibition of a range of genes that remodel the ECM results in defective NCC migration. 
A NCC must acquire a range of molecular characteristics to confer the cell with the 
ability to migrate. Subsequently, a number of molecules have been identified that 
segregate cells onto the NC migration pathways and direct cells to specific final locations, 
including ephrins, semaphorins, slit/robo signalling and non-canonical Wnt signalling (for a 
review see Kuriyama and Mayor, 2008). Semaphorins are ligands involved in both cranial 
and trunk NCC migration; neuropilins are the receptors of semaphorins. In mice, NCCs 
express Npn2 while migrating through the anterior region of the somite (sclerotome). The 
repulsive ligand of this receptor, Sema3f, is expressed in the posterior region of the 
somite (Gammill et al., 2006). In Npn2 mutant mice NCCs were observed to migrate as a 
single sheet rather than in segmentally arranged streams thus semaphorin/neuropilin 
signalling appears to play a role in excluding migrating NCCs from the posterior area of 
somites (Gammill et al., 2006). Ephrins are also thought play a role in regulating both 
cranial and trunk NCC migration and in restricting NCCs to the anterior of each somite. 
The ligand Ephrin-B1 is expressed in the posterior part of the sclerotome while NCCs 
migrating through the anterior part of the somite express the receptor EphB3 (Krull et al., 
1997). A number of studies have identified similar complementary ephrin ligand and 
receptor expression patterns (Kuriyama and Mayor, 2008). Addition of soluble Ephrin-B1, 
which can occupy the receptor without activating it, to chick whole trunk explants, 
disrupted the segmental migration pattern of NCCs with cells migrating in both anterior 
and posterior segments of the somite (Krull et al., 1997). Ephrins also play a role in 
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restricting the entry of early NCCs to the medial pathway. NCCs specified as neurons or 
glial cells are prevented from entering the dorsolateral pathway, when soluble inactive 
Ephrin-B1 was applied to chick whole trunk explants, again the segmental migration 
pattern was lost but cells normally restricted to the ventromedial pathway were seen 
migrating on the dorsolateral pathway (Santiago and Erickson, 2002). It was noted that 
Ephrin-B receptors were still expressed by melanoblasts during migration on the 
dorsolateral pathway. It was identified that melanoblast migration was actually stimulated 
by Eph receptor activation (Santiago and Erickson, 2002). Thus Eph signalling can inhibit 
the migration of some NCCs while stimulating the migration of other NCCs. Currently no 
work has been performed to examine if this holds true in zebrafish where melanocytes 
migrate on both the lateral and medial pathways (Kelsh et al., 2009). The Robo receptor 
and the Slit secreted ligand represent a third class of molecules involved in NC migration. 
Early migrating NCCs express Robo receptors and Slits are expressed in the 
dermomyotome close to the dorsolateral migration pathway. Slit/Robo signalling was 
observed to repel NCC migration both in vitro and in vivo to prevent NCCs of a neural fate 
migrating on the pigment cell pathway (Jia et al., 2005). Slit/Robo signalling has also been 
implicated in preventing trunk NCCs from migrating into the gut, which is only colonised by 
vagal NCCs that lack a Robo receptor (De Bellard et al., 2003). Only membrane bound 
Slit was capable of inhibiting trunk NCC migration, surprisingly soluble Slit, during in vitro 
experiments, increased the motility of trunk NCCs (De Bellard et al., 2003). Thus, 
Robo/Slit and Ephrin signalling can both have positive and negative effects on NCC 
migration. Generally though, signals identified with roles in NCC migration thus far have 
been inhibitory, denying NCCs access to defined areas. 
While the majority of NCC migratory signals identified thus far tend to restrict 
NCCs from a particular area or route, some positive cues that guide cells to a specific 
location have now been elucidated. The CXCR4-SDF1 signalling system is known to 
guide neurons and primordial germ cells to their correct positions (Knaut et al., 2003, 
Miyasaka et al., 2007). In zebrafish, the chemokine sdf1a marks the path of the posterior 
lateral line primordium (PLL). Cells of the PLL also express the sdf1a receptor cxcr4a 
(cxcl12). Knockdown of expression of either the ligand or the receptor prevents the PLL 
from migrating (David et al., 2002). The chemokine sdf1a has also been shown to be a 
positive attractant for melanocytes in zebrafish (Svetic et al., 2007). The zebrafish choker 
mutant is a you-type muscle mutant; mutant embryos display “u” rather than “v” shaped 
somites (van Eeden et al., 1996). The choker mutant also displays an accumulation of 
melanocytes in an ectopic collar position and an absence of melanocytes in the lateral 
stripe. These pigment phenotypes were shown to be a secondary consequence of the 
muscle phenotype by transplantation experiments (Svetic et al., 2007). Aberrant sdf1a 
expression corresponded to the melanocyte pattern defects; sdf1a expression along the 
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lateral stripe was lost while sdf1a was ectopically expressed in the collar region. In 
addition, human SDF1 soaked beads attached to the epidermis of zebrafish embryos 
acted as a chemo-attractant to melanocytes (Svetic et al., 2007). Expression of the sdf1a 
receptor, cxcr4a, could not be identified in melanocytes, thus the complete molecular 
mechanism of this chemo-attractant system remains to be fully understood. Glial cell line 
derived neurotrophic factor (GDNF) may act as a chemo-attractant of vagal NCCs fated to 
form elements of the enteric nervous system (ENS) (Young et al., 2001, Natarajan et al., 
2002). These cells express the GDNF receptor, RET, and GDNF is expressed in a 
temporal and spatial pattern consistent with a role in guiding ENS cells to appropriate 
locations. Additionally, in vitro experiments demonstrated that ENS neurons grow towards 
a source of GDNF and loss of RET function resulted in ENS NCCs migrating at a reduced 
rate (Young et al., 2001, Natarajan et al., 2002). Despite very few positive migration cues 
having been identified for NCCs thus far, NCCs do migrate in a highly directed fashion to 
precise locations. It seems likely that further positive migration cues will be discovered 
including their corresponding receptors. 
Migrating cells are highly polarised, extending many projections (lamellipodia and 
fillopodia) in the direction of travel (Kuriyama and Mayor, 2008). This cell polarisation may 
play a role in ensuring NCCs migrate in the correct direction. The non-canonical Wnt 
signalling pathway has been implicated as a key player in regulating NCC polarity during 
migration. Wnt11 and Wnt11r have been shown to be expressed adjacent to the NC, cells 
of which express the putative Wnt11 receptor Frz7 at the time of EMT and initiation of cell 
migration (De Calisto et al., 2005, Matthews et al., 2008). Loss of function studies of 
components of the non-canonical Wnt signalling pathway also results in NCCs migration 
failing (De Calisto et al., 2005, Matthews et al., 2008). NCCs were attracted to grafts of 
ectoderm over expressing Wnt11 positioned adjacent to NC migration pathways (De 
Calisto et al., 2005). Analysis of cultured NCCs identified that non-canonical Wnt 
signalling helped to stabilise the lamellipodia that favour the leading edge of a migrating 
cell (De Calisto et al., 2005). Wnt11 and Wnt11r both promote NCC migration but are 
expressed adjacent to but on opposite sides of the NC therefore these molecules are 
unlikely to function simply as a chemo-attractant (Matthews et al., 2008). Thus although 
correct non-canonical Wnt signalling by both molecules is essential for migration, full 
understanding of this process has yet to be deduced. In all of the above studies, non-
canonical Wnt signalling was shown to function non-cell autonomously; NCCs did not 
express Wnt11 or Wnt11r. In contrast, Wnt11r was found to function cell autonomously 
during NCC EMT and was essential for correct formation of the dorsal fin (Garriock and 
Krieg, 2007). In Wnt11r morphant embryos, skeletogenic NCCs and muscle cells that 
contribute to the dorsal fin failed to migrate to this location. Therefore non-canonical Wnt 
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signalling and the role that it plays in NCC migration displays an additional level of 
complication that needs to be examined. 
Figure 1: Zebrafish embryonic pigment cell pattern. 
(A) Lateral view of a 5 dpf zebrafish embryo with anterior left and dorsal top. Note that 
melanocytes (black pigmented cells) are visible in four stripes, DS = dorsal stripe, LS = 
lateral stripe, VS = ventral stripe and YSS = yolk sac stripe. Yellow pigmented 
xanthophores are also visible particularly in the head and the dorsal region of the trunk. 
Reflective iridophores are visible in the eye but cannot be seen in this photo. Iridophores 
are present in the DS, VS and YSS. (B) Images of zebrafish pigment cells. Iridophores are 
reflective cells containing platelets of guanine, melanocytes are black melanin containing 
cells and xanthophores are yellow pteridine containing cells. (C) NCCs migrate on 
stereotypical pathways as shown in schematics of a transverse section through a mouse 
and a zebrafish trunk. In mice, melanoblasts (black stars) only migrate between the skin 
and somites (So) on the dorsolateral (lateral) pathway. Neurons and glia of the PNS 
migrate between the neural tube (NT) and somites (purple arrow) on the ventromedial 
(medial) pathway. In zebrafish embryos, xanthoblasts (yellow stars) are restricted to the 
lateral pathway while iridoblasts are restricted to the medial pathway (light blue star). 
Melanoblasts migrate on both the lateral and medial pathway. Neurons and glia of the 
PNS migrate on the medial pathway. Figure adapted from Kelsh et al., 2004. 
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1.1.5 Zebrafish Neural Crest Mutants 
A large number of zebrafish NC mutants have been generated, mainly through large scale 
chemical mutagenesis and insertion mutant screens (Henion et al., 1996, Haffter et al., 
1996, Driever et al., 1996, Amsterdam et al., 2004). Many pigment mutants were identified 
during these screens. Not only are pigment cells easily visualised but the stereotypical 
embryonic pigment pattern of zebrafish permits differences in cell number, distribution, 
differentiation and specification in mutant embryos to be identified. The zebrafish WT 
pigment pattern is comprised of three pigment cell types, melanocytes (black), 
xanthophores (yellow) and iridophores (reflective or shiny). Melanocytes are organised 
into four stripes, the dorsal stripe, lateral stripe, ventral stripe and yolk-sac stripe. It should 
be noted that the melanised cells of the eye in the retinal pigment epithelium (RPE) are 
not NC derived. Iridophores co-localise with melanocytes in the dorsal, ventral and yolk-
sac stripes and migrate to cover the eye. Xanthophores fill in the gaps between the 
pigment cell stripes but are more concentrated dorsally (Figure 1) (Kelsh, 2004). Pigment 
cell mutants were sorted into several classes as follows (Kelsh et al., 1996): Some 
mutants, for example colourless/sox10, displayed a lack of all pigment cell types (Class 
1). In addition sox10 mutants showed defects in all non-skeletogenic NC derivates 
including neurons and glia and as such this mutant is of particular interest. Class 2 
mutants showed a strong reduction or absence in only one pigment cell type, for example 
pffefer (xanthophores) and shady/ltk (iridophores). Additional mutants that only show 
defects in one pigment cell type have also been identified, for example nacre/mitfa 
(melanocytes) (Lister et al., 1999). Some mutants (Class 3) displayed reduced 
melanocytes, such as sparse/kita, although during the Kelsh et al., 1996 screen no 
mutants lacking melanocytes were identified. Defects in five genes led to pigment pattern 
defects (Class 4), this included choker. The fifth class of mutants (Class 5) showed 
additional pigment cells in ectopic locations, for example parade. The largest class of 
mutants discovered (Class 6) displayed defects in pigment cell pigmentation and was split 
into several subclasses. Examples of genes placed into this category are golden/slc24a5, 
albino and touch-down. It should be noted that a large number of mutations affecting 
xanthophores were identified (Kelsh et al., 1996, Odenthal et al., 1996). The location of 
the lesion of many of these mutants have yet to be identified, thus the defective gene is 
unknown. 
Non-skeletogenic NC derivatives include neurons and glia of the peripheral 
nervous system (PNS). These cells contribute to the enteric nervous system and sensory 
neurons and glia of the dorsal root ganglia (DRGs). Mutants with defects in the PNS have 
been identified. As already mentioned, the colourless/sox10 mutant displays a loss of all 
pigment cell types and defects in the PNS (Dutton et al., 2001a). The sox10baz1 mutant 
allele is unique amongst the sox10 mutant alleles as it has supernumerary DRGs instead 
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of a reduced number (Carney et al., 2006). The mother superior/foxd3 mutant displays a 
depletion of cells in the PNS, pigment cells and craniofacial cartilage (Montero-Balaguer 
et al., 2006). The nosedive mutant shows a lack of DRGs but little effect on other NC 
derivatives although some melanocytes do appear in ectopic locations where DRGs 
normally lie (Henion et al., 1996). PNS defects are harder to identify as molecular markers 
are required to label these NC derivatives. A large number of zebrafish mutants are 
available, particularly as a result of the large scale mutagenesis screens. These mutants 
provide a valuable resource to dissect the processes that occur during NC development. 
1.1.6 Waardenburg syndromes and Hirschprung’s disease 
Defective NC development leads to a number of syndromes collectively known as 
neurocristopathies. The Waardenburg syndromes are a major family of neurocristopathies 
and patients display defects in a number of NC derivatives. The symptoms of these 
defects include varying combinations of hypopigmentation and sensorineural hearing loss. 
Sensorineural deafness results from defects in the inner ear, specifically the cochlea. The 
Waardenburg syndromes are split into four sub-types based on the combination of 
phenotypes presented. A number of mutations that are causative of these diseases have 
been located, all of which identify key factors during neural crest development. 
1.1.6.1 Waardenburg syndrome Type I (WS1) 
WS1 (OMIM #193500) patients display pigment abnormalities such as partial hair albinism 
and heterochromatic irises, subtle facial defects such as dystopia canthorum (inner canthi 
of the eyes are displaced further apart than normal), a broadening of the nose and 
sensorineural deafness. WS1 shows autosomal dominant inheritance and although 
dystopia canthorum is the most consistent feature of this syndrome, the symptoms 
presented and severity of the disorder vary from case to case. WS1 is caused by lesions 
in the PAX3 gene, thus the mouse Pax3/Splotch mutant is a model of this disease 
(Tassabehji et al., 1992). Splotch heterozygous mice show pigment abnormalities but not 
deafness while Splotch homozygous mice show very severe defects and die prior to birth 
(Tachibana et al., 2003). 
1.1.6.2 Waardenburg syndrome type II (WS2) 
WS2 was initially described to classify Waardenburg syndrome cases that did not display 
the characteristic phenotype of WS1, dystopia canthorum. Cases of WS2 typically only 
show eye and skin pigment abnormalities and deafness. WS2 has now been split into a 
number of sub-types: WS2A (OMIM #193510), WS2B (OMIM %600193), WS2C (OMIM 
19

%606662), WS2D (OMIM #608890) and WS2E (OMIM #611584). The loci affected in 
WS2B and WS2C have been mapped but no gene has yet been associated with these 
sub-types. The very rare form of WS2, WS2D, is caused by deletions in the SNAI2 gene. 
The original WS2, WS2A, is caused by lesions in the melanocyte master regulator gene 
MITF (Tassabehji et al., 1994). WS2A follows a pattern of autosomal dominant inheritance 
and is caused by a haploinsufficiency of MITF (Nobukuni et al., 1996). Both the mouse 
mutant Mitf/mi and the zebrafish mutant mitfa/nacre are animal models of this disorder. It 
should be noted that the zebrafish nacre mutant results from mutations in both copies of 
the mitfa gene and not from haploinsufficiency. The pigment and hearing defects 
associated with WS2A can both be explained by a lack of melanocytes. In regard to 
hearing, a loss of melanocytes in the cochlea can result in deafness (Nobukuni et al., 
1996). A recently identified form of WS2 is WS2E and results from a mutation in SOX10 
(Bondurand et al., 2007). 
1.1.6.3 Waardenburg syndrome type III (WS3; Klein-Waardenburg Syndrome) 
As with WS1, WS3 (OMIM #148820) is caused by mutations at the PAX3 locus. WS3 
shares the same defects as observed with cases of WS1 but in addition patients present 
with musculoskeletal defects that result in limb abnormalities. Thus WS3 patients present 
with a more severe phenotype (Hoth et al., 1993). There is evidence that WS3 occurs 
when two defective copies of PAX3 are inherited. Homozygous Splotch mice may 
represent a model for WS3 and these mice do display limb abnormalities along with 
severe neural tube defects which are absent in humans (Zlotogora et al., 1995). 
1.1.6.4 Waardenburg syndrome type IV (WS4; Waardenburg-Shah syndrome) 
WS4 (OMIM #277580) combines the pigmentation defects of WS2 with the enteric 
aganglionosis of Hirschsprung disease (OMIM #142628). Hirschsprung disease patients 
show a congenital absence of ganglion cells along the gut, particularly in the terminal 
portion of the gut. Thus multiple NC derivatives are affected in this neurocristopathy. WS4 
can be inherited in either a recessive or dominant manner depending on the causative 
mutation. The recessive condition typically results from mutations in the G-protein coupled 
receptor EDNRB or the ligand EDN3 (Edery et al., 1996, Hofstra et al., 1996, Syrris et al., 
1999). The recessive WS4 condition presents with a range of severities but always with 
some degree of hypopigmentation and often enteric aganglionosis. Sensorineural 
deafness is seen in recessive WS4 patients but tends to be rare and may be caused by a 
lack of melanocytes in the cochlea (Hofstra et al., 1996). The mouse mutants 
Ednrb/piebald-lethal and Edn3/lethal spotting are models for WS4 (Tachibana et al., 
2003). This disorder and the phenotype of the mouse mutants suggests at a conserved 
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role for EDNRB/EDN3 signalling in both melanocyte and enteric nervous system 
development. The dominant form of WS4 is caused by heterozygosity at the SOX10 locus 
resulting in haploinsufficiency (Pingault et al., 1998). This leads to hypopigmentation 
combined with Hirschsprung disease and is often associated with deafness. Deafness in 
Waardenburg syndromes is usually associated with a loss of melanocytes in the cochlea 
but SOX10 is expressed in the ear thus deafness may result from a direct effect 
(Bondurand et al., 1998). The mouse mutant Sox10/Dominant megacolon and the 
zebrafish mutant sox10/colourless provide models of WS4 and will be examined in more 
detail later. 
1.1.6.5 Waardenburg-Shah syndrome, neurologic variant 
A neurologic variant of Waardenburg-Shah syndrome, also called peripheral 
demyelinating neuropathy, central dysmyelinating leukodystrophy, Waardenburg 
syndrome and Hirschsprung disease (PCWH), has been characterised (OMIM #609136) 
(Inoue et al., 2004). This disease combines the following four disorders that display 
defects in characteristic cell types; peripheral demyelinating neuropathy (Schwann cells), 
central dysmyelinating leukodystrophy (oligodendrocytes), Waardenburg syndrome 
(melanocytes) and Hirschsprung disease (enteric ganglia). PCWH combines the defects 
of WS4 patients with myelin deficiency (Inoue et al., 2002). PCWH is caused by mutations 
in the SOX10 gene (Inoue et al., 2002, Inoue et al., 2004). Mutations resulting in a 
truncated SOX10 protein can cause WS4 or the more severe PCWH. In WS4 cases the 
truncated SOX10 mRNA was degraded, while in PCWH cases truncated mRNA showed 
more stability and was translated into a protein with dominant-negative activity (Inoue et 
al., 2004). 
1.2 Transcription Factors 
1.2.1 What are transcription factors and how do they function? 
Eukaryotic RNA polymerase II cannot initiate transcription without additional factors. 
General transcription factors bind to a gene’s promoter sequence to facilitate the tight 
binding of RNA polymerase thus allowing transcription to commence (Alberts et al., 1998). 
Therefore transcription factors (TFs) are DNA binding proteins that help to initiate the 
transcription of a gene. These TFs recognise common promoter sequences and are 
present in all cells thus do not display any specificity regarding the genes that they 
activate. To achieve specificity in the activation of transcription, genes contain regulatory 
sequences within their promoters that are recognised by specific transcription factors 
(Alberts et al., 1998). Therefore a second key feature of TFs is the ability to recognise and 
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bind tightly to a specific DNA sequence. These TFs regulate a subset of genes as a 
consequence of a particular cellular environment. In this way a transcription factor (TF) 
can regulate the expression of genes required for a unique purpose such as directing a 
cell to specify and differentiate into a particular cell type. It should be noted that some TFs 
activate gene expression while others act as repressors, indeed some transcription factors 
can perform both roles under different regulatory conditions (Latchman, 1997). 
TFs all contain a DNA binding motif but can be separated into different groups 
based on sequence homology and tertiary protein structure. Examples of these include 
helix-loop-helix TFs such as bHLH genes, leucine zipper TFs, zinc finger TFs and helix-
turn-helix TFs such as Hox, Pax and Fox genes. The majority of TF DNA binding motifs 
insert into the major groove of the DNA double helix and form tight associations with a 
number of DNA base pairs (Alberts et al., 1998). To regulate transcription, TFs can 
function through several mechanisms. TFs can stabilize or disrupt the binding of RNA 
polymerase to the gene promoter to increase or inhibit transcription. TFs can regulate the 
accessibility of a promoter region to RNA polymerase by altering the conformation of 
chromatin. For example, TFs can help to regulate histone acetylation. Histone acetylation 
by histone acetyltransferase can enhance the accessibility of DNA to protein complexes 
like RNA polymerase while hypoacetylation by histone deacetylase strengthens the 
association of DNA with histones making it less accessible (Narlikar et al., 2002). TFs can 
also recruit additional activating or repressing proteins to a promoter mediated through a 
protein interacting domain (Latchman, 1997). Indeed many TFs work in concert with a 
number of other TFs and co-activating or co-repressing proteins. These proteins all 
respond to environmental and biological stimuli to ensure that the transcription of a gene 
proceeds at the correct rate. 
1.2.2 Transcription Factors in the Neural Crest 
A network of transcription factors act to induce and specify NCCs during early NC 
development. This includes NC specifier genes such as Foxd3 and Sox10. Subsequently, 
a number of TFs that drive the specification and differentiation of specific cell types are 
activated. Such TFs with roles in NC specification and differentiation, termed master 
switch TFs, which are currently known, will be examined here. 
1.2.2.1 Mitf is required for melanogenesis 
The mammalian melanocyte master regulator TF is a basic helix-loop-helix leucine zipper 
(bHLH-Zip) TF known as Mitf. The mouse Mitf/microphthalmia mutant displays severe 
defects in the NC derived melanocyte lineage (Opdecamp et al., 1997). The zebrafish 
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homologue of Mitf is mitfa and the mitfa/nacre mutant also has an absence of 
melanocytes (Lister et al., 1999). Melanocytes fail to specify correctly in mitfa mutants as 
indicated by the failure of early melanoblast marker expression. In addition, expression of 
WT mitfa in mutant embryos can rescue melanocyte development (Lister et al., 1999). Mitf 
initiates the melanocyte developmental programme by activating differentiation and 
survival genes such as Dct, c-Kit, Ednrb, Tyr and Pmel17 (Thomas and Erickson, 2008). 
Expression of Mitf is mainly driven by the NC specifier TFs Sox10 and Pax3 (Bondurand 
et al., 2000). WNT signalling also plays a key role in driving the differentiation of 
melanoblasts and can up-regulate Mitf expression (Thomas and Erickson, 2008). 
1.2.2.2 Transcription factors involved in xanthophore development 
In mice, Pax3 plays a role in melanocyte development by activating expression of Mitf in 
concert with Sox10. Pax3 is a paired box transcription factor known to be expressed in 
very early NCCs and expression is maintained in pre-migratory NCCs (Lewis et al., 2004, 
Minchin and Hughes, 2008). A recent study has identified a key role for pax3 in zebrafish 
xanthophore development (Minchin and Hughes, 2008). When pax3 expression was 
knocked down using morpholinos, xanthoblast marker gene expression was lost, 
suggesting that pax3 plays a role in xanthophore specification. Given that xanthophore 
specification also fails in sox10 mutant embryos (Dutton et al., 2001a) and PAX3 and 
SOX10 co-operate during mouse melanocyte development (Potterf et al., 2000), it is 
plausible that these two genes also function together in xanthophores. Expression of early 
markers of the NC such as foxd3 and sox10 were not affected by pax3 knockdown 
although at later stages sox10 expression was reduced in pre-migratory and migrating 
NCCs in morphant embryos. It was identified that pax3 was required for sox10 expression 
in developing enteric neurons and that pax3 deficiency resulted in a failure of enteric 
neuron formation. A role for pax7 in xanthophore differentiation, but not specification, was 
also identified. Morpholino knock down of pax7 did not affect the expression of early 
xanthoblast markers, such as xdh. It was identified that Pax7 did not play a role in 
xanthophore specification as these cells could be still be detected but they failed to 
pigment. Thus multiple TFs are required during xanthophore development (Minchin and 
Hughes, 2008). 
1.2.2.3 Transcription factors involved in peripheral nervous system development 
The peripheral nervous system (PNS) consists of NC derivatives and a number of 
transcription factors key to PNS development have been identified. The autonomic 
nervous system (sympathetic, parasympathetic and enteric ganglia) fails to form in the 
mouse mutant of the paired-homeodomain TF Phox2b (Pattyn et al., 1999). In zebrafish, 
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knockdown of phox2b expression using morpholinos resulted in a strong reduction of 
enteric ganglia thus showing a conserved role in ENS development between the two 
organisms (Elworthy et al., 2005). Knockout of the TF Phox2a in mice also leads to some 
autonomic defects but these are not as pronounced as in Phox2b mutant mice (Morin et 
al., 1997, Pattyn et al., 1999). The bHLH TF Mash1 is also important during autonomic 
nervous system development. Mash1 knockout mice display extensive defects in the 
autonomic nervous system (Guillemot et al., 1993). An in vitro study identified a role for 
Mash1 in inducing the expression of neuronal differentiation genes following the 
specification of a neuronal precursor (Sommer et al., 1995). It is thought that Phox2b acts 
upstream of Mash1 as Phox2b knockout mice do not express Mash1 in the autonomic 
nervous system (Pattyn et al., 1999). 
Sensory neurons, whose cell bodies lie in the dorsal root ganglia (DRGs), are also 
derived from the NC. The two neurogenin genes, Ngn1 and Ngn2, are proneural bHLH 
TFs. Neurogenins are expressed in the precursors of sensory neurons although Ngn1 and 
Ngn2 show slightly different temporal and spatial expression patterns. Analysis of mutant 
embryos identified functional redundancy between these two TFs and only in a double 
mutant were all sensory neurons absent (Ma et al., 1999). Forced expression of these 
neurogenins in chick NC biased the cells towards a sensory neuron fate in vivo (Perez et 
al., 1999). This suggested that neurogenins play a role in specifying sensory neurons. 
Similarly, ngn1 has been shown to be essential for sensory neuron specification in 
zebrafish (Carney et al., 2006). Thus a number of TFs play roles in the specification and 
differentiation of elements of the PNS. 
1.3 Introduction to Sox10 
1.3.1 The Sox Family Overview 
Sox proteins comprise a family of approximately 20 transcription factors with a high-
mobility-group (HMG) DNA binding domain (Schepers et al., 2002). The HMG domain was 
first identified in SRY, the sex determining gene on the Y chromosome and Sox genes are 
named to reflect this (SRY-related high-mobility-group box). Sox genes have been 
classified into eight groups (A-H) based on sequence homologies both inside and outside 
of the HMG domain. The HMG domain is almost identical across Sox genes within the 
same group but only approximately 50 % similar between groups (Lefebvre et al., 2007). 
Sox TFs display sequence specific DNA binding but, unlike most TFs, they bind the minor 
groove of the double helix. In addition Sox proteins bend DNA and interact with a range of 
protein partners. Via these mechanisms, Sox TFs play a critical role in the regulation of 
transcription. Sox genes are expressed in a wide range of tissues but also show tightly 
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regulated temporal and spatial expression patterns. This family of genes is known to 
regulate multipotency, specification and differentiation in a range of cell types and play 
key roles during development (Lefebvre et al., 2007). 
The HMG box fulfils the functions of DNA binding, DNA bending and in some Sox 
groups, protein interactions and nuclear import or export. As mentioned previously, unlike 
most TFs, Sox genes interact with the double helix minor groove. All Sox TFs tested 
display an in vitro binding preference for the sequence 5’-A/TA/TCAAA/TG-3’ although 
different Sox proteins display varying preferences for nucleotides flanking this core 
sequence (Mertin et al., 1999). It has been shown that Sox proteins can bind in vivo, 
sequences that are only a partial match for this in vitro consensus sequence (Lefebvre et 
al., 1997). This complicates the search for Sox binding sites through in silico exploration of 
genomic data. Thus experimental approaches may be required to identify regulatory 
targets of Sox genes. 
Sox proteins can influence target transcription by bending the target promoter 
sequence. This manipulates the three dimensional structure of the promoter. It is thought 
that this brings together TFs bound to disparate regulatory sites and other proteins bound 
to the promoter to alter transcription rates. This may occur by altering the arrangement 
and interactions of the components of the enhanceosome (functionally active complexes 
of TFs bound to gene enhancer sequences) (Lefebvre et al., 2007). While solid evidence 
of this process is required, some mutant studies have provided evidence of the important 
role that DNA bending plays. A mutation in the Sox2 HMG box that reduced the bend 
imparted to the DNA by the TF actually increased target transcription in comparison to WT 
protein. In addition, mutation of the target enhancer sequence to render the DNA more 
difficult to bend decreased transcription rates (Scaffidi and Bianchi, 2001). Therefore the 
architecture of the promoter and the enhanceosome plays an important role in regulating 
transcription rates. 
Sox proteins not only bind to a specific DNA sequence but can also bind to and 
interact with other proteins and TFs (Wilson and Koopman, 2002). The TFs Sox2 and 
Oct3 are required to activate transcription of Fgf4 during early embryonic development 
(Yuan et al., 1995). An enhancer on the Fgf4 promoter contains adjacent Sox and Oct TF 
binding sites. These two TFs act in concert to activate the enhancer. These two TFs 
actually synergise when bound to DNA through their DNA binding domains to form a 
heterodimer (Reményi et al., 2003). All interactions between Sox proteins and other TFs 
studied thus far occur through the DNA binding domain. These interactions, while bound 
to DNA, may be facilitated by the fact that Sox proteins bind to the minor groove of DNA 
while most other TFs bind to the major groove. Thus cell specific gene activation by Sox 
proteins often requires additional partners; this may help to increase specificity despite the 
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generality of the Sox DNA recognition sequence. Sox TFs can regulate transcription rates 
both by bending DNA and by regulating the formation of transcriptionally active protein 
complexes. 
In addition to the HMG DNA binding domain, some groups of Sox proteins also 
include protein interacting domains known as transactivating or transrepression domains 
in their C terminal region (Figure 2). For example, during chrondrogenesis, Sox9 binds to 
the transcriptional co-activator CBP/p300 to enhance transcription from the Col2a1 
promoter (Tsuda et al., 2003). Transrepression domains have been identified in members 
of the SoxB group (Uchikawa et al., 1999). Thus Sox proteins are capable of regulating 
the activity of enhanceosomes and therefore transcription through architectural alterations 
and direct protein interactions (Lefebvre et al., 2007). 
1.3.1.1 The SoxE group 
The SoxE group is made up of three Sox genes, Sox8, Sox9 and Sox10 (in zebrafish 
additionally there is sox9b). All three genes are expressed in multiple cell types during 
embryonic development. During mouse development, Sox8 is expressed in a number of 
developing sensory organs including the otic vesicle, the brain, the spinal cord and a 
number of NC derivatives including cranial ganglia, dorsal root ganglia, branchial arches 
and the enteric nervous system (Schepers et al., 2000, Sock et al., 2001). A closer 
examination of expression in the brain identified that Sox8 marks developing glia (Cheng 
et al., 2001). Despite widespread expression of Sox8 and the strong phenotypes 
displayed by Sox9 and Sox10 mutants, a homozygous mutant Sox8 mouse was still 
viable, did not display specific defects in Sox8 expressing tissues and only exhibited 
reduced weight (Sock et al., 2001). As Sox8 expression overlaps with expression of other 
SoxE genes this weak phenotype may result, to some extent, from functional redundancy 
(Stolt et al., 2004). Certainly, Sox8 and Sox9 display functional redundancy during testis 
cord differentiation with Sox9 knockout mice not displaying a phenotype in this tissue but 
Sox9 and Sox8 double mutants displayed a more severe phenotype than Sox8 mutants 
(Barrionuevo and Scherer, 2009). Sox8 is known to function during gliogenesis, male 
gonad development, osteogenesis and neural crest formation in Xenopus (Chaboissier et 
al., 2004, Stolt et al., 2004, Schmidt et al., 2005, O'Donnell et al., 2006). The human 
disorder ATR-16 (OMIM #141750) has been associated with deletions of a chromosomal 
region that includes the area that SOX8 maps to (Pfeifer et al., 2000). No specific human 
disease has been attributed to SOX8 thus this gene has been less well studied than the 
other two members of this group. 
Haploinsufficiency of SOX9 results in the disorder Campomelic Dysplasia (CMPD, 
OMIM #114290) which is characterised by skeletal defects, particularly of the long bones, 
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and many XY individuals also suffer genital defects or develop as females (Wagner et al., 
1994). Consistent with these defects, sites of expression of Sox9 in mouse embryos 
strongly correlate with sites of chondrogenesis and chondrocyte precursor cells. For 
example, at twelve days post coitum most skeletal structures show Sox9 expression 
(Wright et al., 1995). Sox9 was identified as an essential transcription factor in 
chondrocyte specification and differentiation and therefore in the development of cartilage 
and skeletal structures (Bi et al., 1999). Also consistent with the phenotype of CMPD, 
SOX9 is thought to play a role in sex determination. Sox9 has been shown to be essential 
for Sertoli cell differentiation and activates the expression of several Sertoli cell specific 
markers (Chaboissier et al., 2004). Sox9 is also expressed in the early NC and forms part 
of the NC specifier gene network. Forced expression of Sox9 in chick embryos can induce 
the expression of NC markers and the formation of trunk NC neural derivatives fails in 
Sox9 knockout mice. In these mice, NCCs were shown to apoptose after delamination 
(Cheung et al., 2005). 
The third member of the SoxE family is Sox10 and is associated with the human 
disorders WS4 and PCWH. Sox10 contains an HMG DNA binding domain and at the C 
terminus a transactivation domain (Figure 2). Sox10 has been termed a NC specifier 
gene, playing a critical role in the specification of all non-skeletogenic NC derivatives 
(Dutton et al., 2001a). Sox10 also functions during cellular differentiation and in 
maintaining cell multipotentiality, although the later function has yet to be substantiated in 
zebrafish (Britsch et al., 2001, Kim et al., 2003, Carney et al., 2006). In addition, sox10 
plays a role in inner ear formation (Whitfield et al., 1996). This transcription factor will be 
examined in more detail in the next few sections. The SoxE group of TFs regulate a large 
number of important developmental processes and have been associated with a number 
of human developmental disorders. Therefore this group of genes have been and remain 
of tremendous interest. 
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Figure 2: Zebrafish sox10 mutant. 
(A) Lateral image of a 5dpf zebrafish WT embryo (top) and sox10 mutant (bottom) 
embryo. Note the lack of pigmented cells in the mutant embryos, particularly striking is the 
lack of dark melanocytes in the head and trunk. The eye is still pigmented by melanocytes 
as these are not NC derived and are thus not Sox10 dependent. The otic vesicle in both 
embryos is marked by an arrowhead; note the small otoliths in the mutant embryo. (B) 
Schematics of WT Sox10 protein and Sox10 mutant proteins produced by the different 
sox10 mutant alleles. Red box = HMG domain, blue box = transactivation domain. The 
yellow box of the t3 allele protein denotes additional amino acids inserted as part of the 
frame shift mutation prior to protein termination. The positions of the leucine to glutamine 
and valine to methionine substitutions in the m618 allele and baz1 allele proteins 
respectively are shown. The tw2 and tw11 alleles both produce truncated proteins lacking 
the transactivation domain. 
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1.3.2 Expression of Sox10 
The expression pattern for Sox10 has been determined for a number of vertebrate 
species by in situ hybridization and Northern blotting and appears to be conserved across 
species. In humans, SOX10 is expressed in the CNS of adults. During embryonic 
development SOX10 expression was noted in the otic vesicle and trunk NCC derivatives. 
While expression in melanocytes was not directly observed, strong expression in the PNS 
was seen (Bondurand et al., 1998). Sox10 expression has been examined further in a 
range of model organisms including rodents, chick, Xenopus and zebrafish (Southard-
Smith et al., 1998, Kuhlbrodt et al., 1998, Cheng et al., 2000, Dutton et al., 2001a, Aoki et 
al., 2003). The sites of Sox10 expression outside of the NC in the otic vesicle and 
oligodendrocytes, are conserved across all organisms. Sox10 expression is particularly 
strong in the otic vesicle. In the NC Sox10 again displays a conserved expression pattern 
across species, although these expression patterns have not been directly compared. In 
all organisms Sox10 is expressed in pre-migratory NCCs and it seems likely that Sox10 is 
a generic marker of non-skeletogenic NC. Expression has also been seen in migrating 
NCCs on the medial and dorsolateral pathways in the trunk and in ENS precursor cells 
migrating along the developing gut. It has been noted that Sox10 expression is down-
regulated in differentiating NCCs, for example sox10 expression is lost in zebrafish as 
melanocytes pigment (Dutton et al., 2001a, Greenhill 2008). In contrast, Sox10 expression 
persists in differentiating glia even until adulthood (Kuhlbrodt et al., 1998). Thus Sox10 is 
expressed in a range of NC non-skeletogenic derivatives and non-NC derivatives and 
shows dynamic changes in expression as development proceeds. 
The expression of sox10 in zebrafish (Figure 3) has been examined in detail 
(Dutton et al., 2001a). Cells expressing sox10 are first visible at approximately 10 hpf at 
the lateral edge of the neural plate. By 11 hpf cranial NCCs are marked by sox10 
expression and as development progresses, sox10 expression spreads caudally and is 
seen in trunk NCCs at around 16 hpf. Up until this stage all sox10 expressing cells in the 
trunk have yet to begin migrating. The first NCCs to migrate are neural derivatives on the 
medial pathway at approximately 16 hpf (Raible et al., 1992). These cells initially express 
sox10 during migration. At 24 hpf sox10 expression can be seen in pre-migratory NC and 
NCCs migrating on the medial pathway, in the otic vesicle, in two clusters in the head that 
correspond to cranial ganglia and in cells along the posterior lateral line nerve (Figure 3). 
Scattered cells in the head express sox10 in a pattern that bears a striking resemblance to 
markers of pigment cells. Only rarely are sox10 expressing cells seen on the lateral 
pathway, perhaps as a consequence of expression being rapidly down-regulated in 
pigment cells. If in situ hybridizations are pushed hard, these cells can be visualised. 
Precursor cells of the ENS can be seen expressing sox10 at 36 hpf and Sox10 positive 
cells are seen forming the DRGs by 40 hpf (Elworthy et al., 2005, Carney et al., 2006). 
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Figure 3: Whole mount in situ hybridization of Sox10 expression. 
Lateral view of a 24 hpf zebrafish embryos is shown, anterior to left and dorsal top. 
Expression in NCCs migrating at the midbrain-hindbrain boundary (MHB), otic vesicle (ov) 
and glia of the posterior lateral line nerve (PLL) is marked. In addition expression in two 
patches either side of the otic vesicle are marked by asterisks, cells at these locations 
form the cranial ganglia. Arrowheads mark pre-migratory NCCs in the trunk and arrows 
mark NCCs migrating on the medial pathway. 
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1.3.3 Sox10 mutants 
The spontaneous mouse mutant Dominant megacolon (Dom) was mapped to the Sox10 
locus. As a result of a frame shift mutation in which an extra guanine was inserted C 
terminal of the HMG box domain, 99 novel amino acids were added to the protein before 
terminating (Herbarth et al., 1998, Southard-Smith et al., 1998). Functional analysis of this 
mutant protein showed that DNA binding was not affected but transcriptional activation of 
partner proteins mediated by the transactivation domain was abolished (Herbarth et al., 
1998). Heterozygotes of this mutant display pigment abnormalities and megacolon, 
homozygotes are embryonic lethal. In addition, heterozygous animals display behavioural 
defects associated with deafness (Pingault et al., 1998). It is thought that deafness in 
WS4 and the Dom mouse results from a loss of melanocytes in the ear and is a 
secondary consequence of a failure in Sox10 signalling. Analysis of NC markers identified 
defects in a number of NC derivatives in Dom embryos with homozygotes more severely 
affected than heterozygotes. Dom/Dom embryos lack Dct+ melanoblasts and also display 
a lack of Ednrb and Sox10 expressing NCCs. These expression patterns identified defects 
in the PNS, particularly a failure of enteric neurons to colonise the gut alongside pigment 
abnormalities. Cranial ganglia were disrupted and displayed morphological defects in 
Dom/Dom embryos but this was not observed in heterozygous embryos (Herbarth et al., 
1998, Southard-Smith et al., 1998). Significant levels of NCC apoptosis were identified in 
both heterozygous and homozygous Dom mutant embryos (Southard-Smith et al., 1998). 
A targeted Sox10 mouse mutant has also been constructed by knock in of the lacZ 
reporter gene that deleted the entire Sox10 reading frame (Britsch et al., 2001). 
Heterozygous and homozygous Sox10lacZ mice display essentially the same phenotypes 
as heterozygous and homozygous Dom mice respectively. This indicated that the Sox10 
mutant phenotype could be caused by haploinsufficiency and not necessarily as a result 
of possible dominant negative activity of the Dom mutant SOX10 protein. In addition, LacZ 
staining was seen in the same sites as Sox10 expression as detected by in situ 
hybridization. This included sites outside the NC such as in oligodendrocyte precursors in 
the CNS and the otic vesicle and NC derived cell types in the PNS and melanoblasts. The 
generation of this mouse line has facilitated the analysis of Sox10 function in various cell 
types. For example, analysis of melanocyte development using the melanoblast markers 
Mitf, c-Kit and Dct identified a 50 % decrease of melanoblasts in heterozygous embryos 
and an almost total absence of melanoblasts in homozygous mutant embryos (Britsch et 
al., 2001). Analysis of glial differentiation markers in Sox10lacZ embryos indicated that cells 
expressing the reporter gene in DRGs were glial cells and this cell type was reduced in 
homozygous mutant embryos. Within these DRGs, the sensory neurons were seen to 
form and then degenerate. Interestingly the authors concluded that the sensory neuron 
phenotype of Sox10 mutants was an indirect effect resulting from the lack of glial support 
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cells (Britsch et al., 2001). The targeted Sox10 mutant mouse was also used to study the 
role of SOX10 during ENS development (Paratore et al., 2002). This study identified that 
enteric aganglionosis resulted from ENS progenitor cells failing to correctly specify in 
homozygous Sox10 mutant animals, with the defect in NCC migration a secondary effect. 
Both neurons and glia failed to specify in the ENS, in contrast to sensory neurons. A 
second role for SOX10 during ENS development was identified by fate mapping of cells 
expressing β-galactosidase. While these cells migrated to the gut in heterozygous mutant 
embryos they did not migrate along the gut and failed to express the NC progenitor 
markers Sox10 and ErbB3. These cells also failed to adopt appropriate ENS fates. Thus 
these cells seemed unable to maintain a multipotent progenitor state and could not 
respond correctly to environmental cues present in the gut. This resulted in a reduced 
number of progenitor cells available to colonise the gut. The mouse Sox10 mutants 
indicate that Sox10 may play various roles in different NC cell types including cell 
specification, driving cell differentiation, cell survival and maintaining multipotency. 
The zebrafish sox10 mutant, also known as colourless, was initially identified 
during the large scale Tϋbingen mutagenesis screen (Kelsh et al., 1996). Several mutant 
alleles have been identified, the tw2 and tw11 alleles lack the transactivation domain, and 
the t3 allele produces a severely truncated protein that lacks both the HMG and 
transactivation domain. The m618 allele generates a full length Sox10 protein but a single 
base pair substitution has resulted in a non-conservative leucine to glutamine amino acid 
change within the HMG DNA binding domain (Figure 2). This renders the protein 
effectively non-functional, although this has not been explicitly tested (Dutton et al., 
2001a). All of these alleles display a striking phenotype (Figure 2) that bears a strong 
resemblance to the mouse homozygous Dom mutant. All of these alleles are recessive 
and homozygous lethal. All NC derived pigment cells are absent in sox10 mutant embryos 
and there is a strong reduction in the expression of key melanocyte specification genes 
(Dutton et al., 2001a). The pigment defects are combined with PNS defects; enteric 
ganglia are absent in sox10 mutant embryos while DRGs are reduced in number and 
often appear in ectopic positions. Glia are also strongly reduced in mutant embryos 
(Carney et al., 2006). NCCs form in normal numbers, subsequently non-skeletogenic 
NCCs in zebrafish sox10 mutant embryos fail to migrate and die by apoptosis. This cell 
death occurs during a discrete time period that corresponds to cell differentiation in WT 
embryos. These defects appear to be secondary consequences of NCCs failing to 
correctly specify in sox10 mutant embryos, at least in pigment cell precursors (Dutton et 
al., 2001a). Zebrafish sox10 mutants also show a defect in otic vesicle development with a 
small otic vesicle and small otoliths (Whitfield et al., 1996). Key otic vesicle patterning 
genes display de-regulated expression patterns in sox10 mutants thus suggesting sox10 
may play a direct role in ear development beyond the specification of melanocytes within 
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the cochlea (Dutton et al., 2009). Thus the zebrafish and mouse sox10 mutants both 
display strong defects in non-skeletogenic cell types. 
Recently a new sox10 mutant allele was identified in zebrafish, the sox10baz1 allele. 
This allele has a valine to methionine amino acid substitution in the HMG DNA binding 
domain (Figure 2) (Carney et al., 2006). The pigment phenotype of sox10baz1 mutant 
embryos is slightly less severe than for other mutant sox10 alleles with melanocytes 
absent but xanthophores and iridophores mildly reduced. Similar to melanocytes, glia 
were also strongly reduced in the sox10baz1 mutant. Surprisingly the number of sensory 
neurons (DRGs) actually increased in mutant embryos in comparison with WT siblings. 
This strongly suggests that sox10 plays a direct role in regulating the specification of 
sensory neurons, in contrast with evidence gathered from mouse Sox10 mutants. 
Induction of early sensory neuron markers also fails in zebrafish sox10 mutants 
supporting a role for sox10 in specifying sensory neuron fate (Carney et al., 2006). Thus it 
appears that sox10 functions to specify all non-skeletogenic NC derivatives. The function 
of sox10 will be evaluated in more detail in the next section. 
1.3.4 Sox10 Function 
Sox10 has been postulated to function at a number of stages during NC development 
including formation of the NC, maintenance of multipotency and NCSC characteristics, 
cell specification and cell differentiation (for a review see Kelsh 2006). Evidence for the 
role of Sox10 in all of these processes comes from various experiments in different model 
species and from examination of Sox10 mutant animals. In this section the function of 
Sox10 in each of these processes will be examined. 
1.3.4.1 Sox10 and formation of the NC 
Work in frog has indicated that Sox10 plays a role in early NC formation. Morpholino 
mediated knockdown of Sox10 function resulted in a strong reduction of early NC marker 
gene expression (Snai2, Foxd3 and Sox9) (Honore et al., 2003). Over expression of 
Sox10 in Xenopus embryos was also capable of expanding the expression domain of 
Snai2 and Sox9 (Honore et al., 2003, Aoki et al., 2003). Thus Sox10 appears to expand 
the number of early NCCs. These results are difficult to interpret as the complicated gene 
network responsible for NC induction and formation has yet to be fully resolved. The 
genes involved in this network are known to be interdependent thus it is difficult to identify 
the specific functions of each individual gene. For example, another SoxE gene, Sox9, is 
also expressed in early NCCs and over expression of Sox9 can induce expression of early 
NC marker genes including Sox10 (Cheung and Briscoe, 2003). In situ hybridization 
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analysis has also shown that Sox10 expression initiates after that of other early NC 
marker genes, such as Sox9 (Cheung and Briscoe, 2003). It has also been shown during 
an animal cap assay in which NC marker gene expression was induced using noggin and 
Wnt5 that the expression of these marker genes was independent of Sox10 function 
knockdown using morpholinos (Honore et al., 2003). In mouse and zebrafish Sox10 
mutants, NCCs form in normal numbers strongly suggesting that in these vertebrate 
species Sox10 is not required for NC formation (Dutton et al., 2001a, Southard-Smith et 
al., 1998). There could be species specific differences between the function of Sox10. 
Alternatively, species specific variation in the degree of functional redundancy between 
SoxE genes could exist. Thus in mouse and zebrafish the early roles of SoxE genes could 
largely be functionally redundant while in frogs Sox10 has a more pronounced early role. 
In conclusion, early NC formation maybe independent of Sox10 function or the function of 
Sox10 could be redundant with other SoxE genes. However, Sox10 is expressed in early 
NCCs and forms part of this complicated NC specifier gene network. It has been 
hypothesised that Sox10 functions to maintain NC marker gene expression and therefore 
NC characteristics rather than in NC formation (Kelsh, 2006). 
1.3.4.2 Sox10 and Stem Cell maintenance 
Sox10 is expressed in a number of embryonic neural crest stem cells (NCSCs) isolated 
from pre-migratory NC, DRGs and the gut (Paratore et al., 2001, Iwashita et al., 2003, Kim 
et al., 2003) and adult NCSCs termed epidermal NCSCs (EPI-NCSCs) and skin derived 
precursors (SKPs) (Sieber-Blum et al., 2004, Wong et al., 2006). NCSCs can differentiate 
into PNS neurons, glia and smooth muscle in culture (Stemple and Anderson, 1992). The 
differentiation of these cells can be directed by exposure to appropriate growth signals, for 
example BMP2 (bone morphogenic protein) signalling drives neuronal fate choice, glial 
growth factor (GGF) signalling drives glial fate choice and transforming growth factor-β 
(TGF-β) signalling promotes smooth muscle fate (Shah and Anderson, 1997). In 
embryonic NCSCs Sox10 has been shown to play a role in maintaining multipotency (Kim 
et al., 2003). This study identified a correlation between a loss of multipotency and a loss 
of Sox10 expression in response to growth factor signalling. Forced expression of Sox10 
ensured NCSCs in culture retained the ability to differentiate into neurons or glia despite 
exposure to a growth factor that would normally direct cells towards a specific fate choice 
(Kim et al., 2003). In other words, cells maintained multi-potentiality, possibly by ensuring 
the maintenance of growth factor receptor expression. 
To promote sympathetic neuronal differentiation Sox10 induces the expression of 
the proneural genes Mash1 and Phox2b. These TFs activate downstream differentiation 
genes such as Phox2a. Sox10 expression is down-regulated in MASH1+ PHOX2B+ cells 
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and forced expression of Sox10 inhibited neuronal differentiation of these cells. This 
correlated with a repression of the differentiation marker Phox2a (Kim et al., 2003). The 
transient nature of Sox10 expression in other NCC lines (except glia) suggests this role 
may be general and recent work has shown Sox10 has to be down-regulated in 
melanocytes for differentiation to proceed (Greenhill, 2008). However, in adult melanocyte 
stem cells Pax3 has been shown to activate a melanogenic gene cascade while inhibiting 
differentiation by repressing Dct (Lang et al., 2005). The data above has provided strong 
evidence that, at least in NCSCs with neural potential, Sox10 maintains multipotency and 
inhibits differentiation. It would be very interesting if this could be extended to NCSCs that 
have the potency to form other cell types such as pigment cells. The adult EPI-NCSCs 
and SKPs which are Sox10+ may present an opportunity to evaluate this. Indeed, the role 
of Sox10 in these cell types has not yet been examined. 
1.3.4.3 Sox10 and fate specification 
A large body of evidence from both mouse and fish points to a general role for Sox10 in 
the specification of a subset of NC derivatives. Fate specification requires the activation of 
a master switch transcription factor that is both necessary and sufficient to drive the 
development of a specific cell type. The expression of this master switch TF is regulated 
by both intrinsic cellular factors, such as Sox10, and extrinsic factors such as extracellular 
growth factors signalling through receptors. Together these factors activate expression of 
the appropriate master switch TF which activates the cascade of genes necessary for the 
differentiation, migration and survival of a specific cell type (Figure 4). 
The fate specification of melanocytes has been well studied in both zebrafish and 
mouse model systems and in both systems Sox10 plays a very early role in melanocyte 
development (Dutton et al., 2001a, Southard-Smith et al., 1998). Sox10 is also known to 
directly regulate the melanocyte master switch TF, Mitf in mouse (Verastegui et al., 2000) 
and mitfa in zebrafish (Elworthy et al., 2003). Mitf has been well characterised as the 
pivotal gene in melanocyte development (Levy et al., 2006) and in zebrafish mitfa can 
rescue melanocyte development in sox10 mutant embryos (Elworthy et al., 2003). 
Expression of Mitf or mitfa is absent in both mouse and zebrafish sox10 mutant embryos 
(Southard-Smith et al., 1998, Kelsh and Eisen, 2000) and the direct regulation of mitfa by 
sox10 is crucial for the correct expression of this master switch TF (Elworthy et al., 2003). 
Loss of function morpholino experiments in frog has also indicated that Sox10 may specify 
melanocytes but the early role of Sox10 during NC formation in this model organism has 
complicated this analysis (Aoki et al., 2003). 
While strong evidence exists that Sox10 acts in the specification of the melanocyte 
lineage, work has been ongoing to assess if this model can be generalised to other non­
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skeletogenic NCC types. While this body of work is currently less extensive, fate 
specification of sympathetic, enteric and sensory neurons has been shown to be defective 
in Sox10 mutants. Sympathetic neuron specification requires the action of two master 
switch TFs, Mash1 and Phox2b (Lo et al., 1998, Pattyn et al., 1999). Both of these 
transcription factors require Sox10 in vivo for induction (Kim et al., 2003). Phox2b also 
plays a key role in the specification of enteric neurons in both mouse and zebrafish 
(Elworthy et al., 2005, Pattyn et al., 1999). Morpholino knockdown of Phox2b function led 
to a loss of enteric neurons, a phenotype also seen in sox10 mutant embryos. Expression 
of phox2b is defective in sox10 mutant embryos thus sox10 activation of phox2b is 
required for enteric neuron specification. The sensory neuron lineage requires the action 
of the Neurogenin TFs for specification (Ma et al., 1999, Perez et al., 1999). In both 
mouse and zebrafish Sox10 mutants, sensory neuron numbers are reduced although this 
defect is less pronounced than for other NCC derivatives (Southard-Smith et al., 1998, 
Dutton et al., 2001a, Carney et al., 2006). It was hypothesised from work in mouse that 
the defects in sensory neurons were a secondary consequence of the loss of their 
supporting glia. In zebrafish, analysis of ngn1 expression identified that sensory neuron 
specification fails in sox10 mutant embryos. Sox10 can also induce expression of ngn1 in 
vivo (Carney et al., 2006). Interestingly morpholino knock-down of sox9b increased the 
severity of the sox10 mutant sensory neuron phenotype (Carney et al., 2006). The 
neurogenic phenotype of the sox10baz1 mutant that possess additional sensory neurons 
but lacks glia also argued against the sensory neuron defect simply resulting from a loss 
of support cells (Carney et al., 2006). Thus in zebrafish at least, it appears that sox10 
functions during sensory neuron specification. To fully confirm the generalisation of the 
Sox10 specification model this work needs to be replicated in mouse. 
Despite strong evidence supporting a role for Sox10 in the specification of non­
skeletogenic NCCs, the complex phenotype of Sox10 mutants could be explained by 
Sox10 functioning at multiple steps in development. For example, zebrafish sox10 
mutants show defects in cell differentiation, migration and survival. However, if 
specification is defective, it is likely that defects in these processes would be a secondary 
consequence of cells failing to initiate appropriate molecular cascades. For example, in 
chick at least, lateral pathway migration is dependent on melanocyte specification 
(Santiago and Erickson, 2002). It is likely that migration is dependent on specification 
activated pro-migration genes such as receptors for migration cues and cell surface 
proteins that regulate adhesion. The apoptosis of NCCs in Sox10 mutants is also likely to 
be a result of a failure in specification. For example, expression of the zebrafish c-kit 
homologue (kit) which is essential for melanoblast survival is absent in sox10 mutant 
embryos (Parichy et al., 1999, Dutton et al., 2001a). Importantly, NCC death in sox10 
mutant embryos occurs a considerable period of time after mitfa expression fails to be 
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induced thus indicating that the survival defect is a consequence of specification failing 
(Dutton et al., 2001a). The differentiation defect of melanocytes in Sox10 mutants is easily 
explained by the failure of Mitf expression. Mitf is known to activate the expression of a 
large number of enzymes involved in melanogenesis (Levy et al., 2006). However, this 
specification model may not be as clear cut as this. Sox10 is known to directly regulate a 
key gene in melanin synthesis, Dct, at least in mouse cells in vitro (Jiao et al., 2004, 
Potterf et al., 2001). While Mitf plays a key role in activating Dct expression, the action of 
Sox10 can enhance this (Jiao et al., 2004). However, in vivo work in zebrafish suggested 
that mitfa alone is sufficient to drive melanocyte differentiation as mitfa rescued 
melanocytes in sox10 mutant embryos (Elworthy et al., 2003). The expression of sox10, 
while overlapping with that of dct is down-regulated in differentiating melanocytes and 
Sox10 can repress the expression of mitfa target genes in zebrafish (Greenhill, 2008). 
Thus while Sox10 may play a transient role in melanocyte differentiation, this is currently 
unclear. A similar late role for Sox10 has also been identified during neurogenesis. Sox10 
both activates expression of the pro-neural genes Mash1 and Phox2b while inhibiting 
expression of their downstream target gene Phox2a (Kim et al., 2003). It remains to be 
established if Sox10 has a role during differentiation in other NC derivatives. 
According to the model of Sox10 functioning in cell specification, NCC death in 
Sox10 embryos occurs as a result of specification failing. Thus cells cannot develop 
correctly and will not express the appropriate survival factors and subsequently apoptose. 
It is unclear what the molecular characteristics of these unspecified cells will be but it is 
possible they will maintain the expression of early NCC characteristics. These genes will 
fail to be repressed without functional Sox10 and without development proceeding 
correctly. Thus such unspecified cells may express markers of early NCCs, NCSC genes, 
receptors for instructive signals and markers of early pluripotent NCC lineages such as 
the chromatophore precursor. This hypothesis remains to be tested. 
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Figure 4: General model of sox10 and NCC specification. 
(A) A schematic of the general role of Sox10 in NCC development. A multipotent NCC 
(multicoloured shading) becomes specified by an instructive ligand (oval) binding a 
receptor (stick in cell membrane) in combination with Sox10 signalling. This activates a 
key downstream TF and the cell becomes specified (indicated by single colour of 
nucleus). In a sox10 mutant NCCs a lack of Sox10 signalling results in a failure of 
specification leading eventually to cell death. (B) Schematic of the general model applied 
to melanocyte specification. Wnt signalling in combination with Sox10 activates the master 
switch TF Mitfa to specify melanoblasts. Figure adapted from Kelsh 2006. 
1.3.4.4 Sox10 and Glia 
In contrast to other NCCs in which Sox10 expression is transient, Sox10 expression 
persists in differentiated glia even into adulthood (Bondurand et al., 1998). This suggests 
that Sox10 may play a role in both glial fate specification and differentiation. Homozygous 
mouse Sox10 mutants and zebrafish sox10 mutants display strong defects in glial 
development thus indicating that Sox10 is absolutely required by this cell lineage (Britsch 
et al., 2001, Carney et al., 2006). In Sox10 mutants, expression of the Neuregulin receptor 
ErbB3 in glial progenitors is lost (Britsch et al., 2001). This signalling system plays a key 
role in glial specification thus loss of ErbB3 expression in Sox10 mutants may cause the 
failure of glial specification (Britsch et al., 2001). Sox10 mutant NCCs grown in culture 
conditions that promote gliogenesis cannot adopt a glial fate and expressed markers for 
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other fates suggesting that fate specification failed (Paratore et al., 2001). While mouse 
and zebrafish ErbB3 mutants do show defects in glia, the Sox10 mutant glial phenotype is 
more severe (Britsch et al., 2001, Carney et al., 2006). Thus additional mechanisms are 
likely to contribute to the glial Sox10 mutant phenotype. Notch signalling is known to play 
an important role in the fate choice between neurogenesis and gliogenesis with transient 
activation of notch receptors capable of irreversibly driving cells to a glial fate (Morrison et 
al., 2000). Interestingly Notch1 expression is transiently up-regulated in NCCs during early 
DRG development and this up-regulation fails in Sox10 mutant embryos (Britsch et al., 
2001). Thus at least two mechanisms that promote gliogenesis fail in Sox10 mutant 
embryos. Both of these mechanisms promote glial specification through the detection of 
extrinsic factors by receptors. Thus current evidence indicates that Sox10 promotes glial 
specification by regulation of receptors that when lost prevent NCCs adopting a glial fate. 
However, no master switch TF that drives glial specification has been identified. 
Therefore the influence of Sox10 on this gene as per the general model of Sox10 in 
specification cannot be evaluated. 
As glial specification fails in Sox10 mutant embryos, the role of Sox10 in glial 
differentiation is difficult to assess. However, Sox10 is known to directly regulate several 
glial differentiation genes (Table 1). The Schwann cell specific protein, protein zero (P0) is 
involved in myelin compaction while Cx32 is expressed in Schwann cells and allows the 
passage of small molecules through the myelin sheath. Both of these genes are highly 
expressed in Schwann cells, are required for Schwann cell differentiation and are direct 
regulatory targets of Sox10 (Bondurand et al., 2001, Peirano et al., 2000). Indeed, SOX10 
up-regulates the expression of both of these genes. Thus Sox10 has a known function in 
both glial specification and differentiation. With data from melanocytes suggesting that 
Sox10 can regulate Dct expression, it will be interesting to identify direct targets of Sox10 
to examine the role Sox10 has in differentiating NCCs. 
1.3.4.5 Sox10 and otic vesicle development 
Human diseases that result from SOX10 mutations such as WS4 are often associated 
with deafness. While Sox10 heterozygous mouse mutants do display behaviour 
characteristic of hearing problems, the cause and molecular basis of this has yet to be 
properly characterised. It has been assumed that a loss of melanocytes in the ear, which 
are NC derived and therefore Sox10 dependent is the defect that results in hearing 
impairment. Melanocytes in the stria vascularis of the inner ear are required for both the 
development of the stria vascularis and for normal function of the inner ear (Tachibana, 
1999). At least one function of melanocytes in the stria vascularis involves the secretion of 
K+ via ion pumps to help generate the positive potential (endocochlear potential) of the 
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otic vesicle endolymph. Zebrafish sox10 mutant embryos display a small otic vesicle and 
reduced otoliths (Whitfield et al., 1996). Recent work has identified that Sox10 influences 
ear development independent of the loss of melanocytes in sox10 mutant embryos 
(Dutton et al., 2009). Analysis of a number of important otic vesicle patterning genes in 
WT and sox10 mutant embryos identified altered expression patterns. In sox10 mutant 
embryos expression of patterning genes, for example fgf8a, fsta and bmp4, all displayed 
slightly expanded expression domains or ectopic expression (Dutton et al., 2009). Thus 
the loss of Sox10 function in the ear results in a loss of gene regulation. This suggests at 
a model for Sox10 function in the ear that is distinct from NC fate specification through the 
induction of key TFs. 
1.3.5 Target genes of Sox10 
The function of Sox10 is becoming understood in a number of NC derivatives. Sox10 is 
likely to perform these roles by regulating the expression of a number of target genes 
including master switch TFs. A small number of Sox10 direct targets have been 
established (Table 1). Sox10 binding sites have been identified in all the promoter regions 
of these target genes except the β4 subunit of the nicotinic acetylcholine receptor. In 
addition, as is typical for Sox genes, it has been shown that Sox10 acts in synergy with 
other TFs to achieve optimal rates of target gene transcription in the majority of these 
cases. For example, co-transfection of Sox10 and EGR2 expression constructs with the 
Cx32 promoter driving a luciferase reporter gene led to increased activation of the 
promoter than with either TF independently (Bondurand et al., 2001). The only known 
direct target of SOX10 that acts as a master switch TF is Mitf in the melanocyte lineage 
(Verastegui et al., 2000). A number of genes have also been observed to be differentially 
regulated in Sox10 mutant embryos in comparison to WT embryos (Table 2). These 
genes have not been described as direct targets of Sox10. However in many cases the 
relationship between Sox10 and these target genes has not been investigated. Of 
particular interest is whether the TFs in Table 2 such as Phox2b, Mash1 or ngn1 are 
direct targets of Sox10. These genes have been shown to play a role in the specification 
of certain NC derivatives and thus are candidate master switch TFs (Carney et al., 2006, 
Elworthy et al., 2005, Kim et al., 2003). A number of the genes known to be differentially 
regulated in Sox10 mutant embryos are also likely to be indirect targets of Sox10. That is, 
the expression of these genes is perturbed in Sox10 mutant embryos not as a result of a 
lack of Sox10 function directly but via incorrect regulation of a target of Sox10. These 
indirect targets may include genes responsible for cellular differentiation and survival and 
for NCC processes such as migration. 
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Tissue/Cell Type Gene Evidence Reference 
P0 
Transient transfection reporter 
assay and Sox10 binding sites (Peirano et al., 2000) 
Cx32 
Transient co-transfection 
reporter assay and Sox10 
binding sites 
(Bondurand et al., 
2001) 
Mbp 
Transient co-transfection 
reporter assay and Sox10 
binding sites 
(Wei et al., 2004) 
Glia 
Cntf 
Transient co-transfection 
reporter assay and Sox10 
binding sites 
(Ito et al., 2006) 
Plp ChIP and Sox10 binding sites 
(Lee et al., 2008) 
Ptn ChIP and Sox10 binding sites 
Sod3 
ChIP, Sox10 binding sites 
transient co-transfection reporter 
assay and EMSA 
Sox10 ChIP and Sox10 binding sites 
c-Ret 
Transient co-transfection 
reporter assay and Sox10 
binding sites 
(Lang et al., 2000) 
Ednrb Sox10 binding sites and EMSA (Zhu et al., 2004) 
Neurons of PNS 
α3 subunit of nACh 
Transient co-transfection 
reporter assay and Sox10 
binding sites (Liu et al., 1999) 
β4 subunit of nACh Transient co-transfection reporter assay and EMSA 
Mitf 
Transient co-transfection 
reporter assay and Sox10 
binding sites 
(Bondurand et al., 
2000, Elworthy et al., 
2003) 
Melanocytes 
Dct 
Transient co-transfection 
reporter assay, Sox10 binding 
sites and EMSA 
(Ludwig et al., 2004, 
Jiao et al., 2004) 
Tyrp1 
Transient co-transfection 
reporter assay and Sox10 
binding sites 
(Murisier et al., 2006) 
Tyr 
Transient co-transfection 
reporter assay and Sox10 
binding sites 
(Murisier et al., 2007) 
Table 1: Direct Targets of Sox10. 
Abbreviations used: nACh = nicotinic acetylcholine receptor, ChIP = Chromatin 
immunoprecipitation assay, EMSA = Electrophoretic mobility shift assay. 
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Cell/Tissue type Gene Change of expression level in Sox10 mutant embryos Reference 
ngn1 Down (Carney et al., 2006) 
PNS Phox2b Down 
(Elworthy et al., 2005, Kim et 
al., 2003} 
Phox2a Up (Kim et al., 2003) Mash1 Down 
ErbB3 Down 
(Britsch et al., 2001) Glia Hes5 Down Notch1 Down 
foxd3 Down (Kelsh et al., 2000) 
Melanocyte kita Down (Dutton et al., 2001a) c-Kit Down (Britsch et al., 2001) 
Xanthophore pax7 Down (Hammond et al., 2007) gch Down (Pelletier et al., 2001) 
Iridophore 
/chromatoblast ltk Up (Lopes et al., 2008) 
Neural Crest crestin Down (Elworthy et al., 2005) 
Table 2: Table of Genes differentially regulated in Sox10 mutant embryos. 
The genes present in this table have not been tested and described as direct targets of 
Sox10. 
1.4 Project Overview and Aims 
While a number of Sox10 target genes have been identified, this complement of direct and 
indirect targets is not sufficient to ensure the correct development of all non-skeletogenic 
NC derivatives. Targets that remain to be identified include master switch TFs for cell 
lineages such as iridophores and glia, receptors for extracellular instructive cues that drive 
processes such as fate choice and genes involved in cell differentiation, migration and 
survival. The identification of such genes will provide key information to describe the 
molecular process that NCCs are required to undergo during development. As NCCs 
provide models of both cell development and cancer biology the understanding of these 
processes is crucial. In addition, a study to identify key genes in NC development will 
shed light on the underlying causes of a group of human diseases known as 
neurocristopathies. 
The ultimate aim of this study is to identify direct and indirect targets of Sox10. To 
address the paucity of Sox10 target genes, a microarray approach was adopted. This 
approach was designed to compare the expression profiles of sox10 expressing cells from 
both WT and sox10 mutant embryos. Towards this end the initial aims were: 
1.	 To isolate GFP positive cells from both WT and sox10 mutant embryos at 24 hpf 
from sox10:GFP transgenic embryos by fluorescence activated cell sorting 
(FACS). Subsequently RNA needed to be extracted from these cells suitable for 
microarray analysis. 
2.	 Analysis of the microarray data is required to identify genes differentially regulated 
in sox10 mutant embryos, these genes are candidate direct or indirect targets of 
Sox10. 
42

3.	 To validate candidate genes by in situ hybridization. This approach will reveal both 
temporal and spatial information regarding expression of candidate genes in both 
WT and sox10 mutant embryos. 
Genes whose expression is positively regulated by Sox10 will appear to be down-
regulated in sox10 mutant embryos. These genes should include a number of well known 
Sox10 target genes that are expressed at 24 hpf such as mitfa and dct. These down-
regulated genes are required to drive the development of NCCs. While a number of genes 
are known to be down-regulated in sox10 mutant embryos, very few genes are known to 
be up-regulated. It is predicted that genes up-regulated in sox10 mutant embryos will be 
markers of early NCCs and may include markers of NCSCs. 
The targets identified will be limited to the cell types that are defective in sox10 
mutant embryos at 24 hpf such as glia and pigment cells. Specification of other non­
skeletogenic NC derivatives such as the ENS and sensory neurons occurs later than 24 
hpf therefore differentially regulated marker genes of these lineages are unlikely to be 
detected. 
It was also initially hoped that a gene identified by this process as a particularly 
interesting target of Sox10 would be further examined through functional studies. In 
particular it was envisioned that a morpholino study would be utilised to examine the 
effects of knocking out this specific gene of interest. Due to time constraints this was not 
completed. 
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Chapter 2: Materials and Methods 
2.1 Materials 
2.1.1 Chemicals 
General laboratory chemicals were of analytical research grade from a range of 
manufacturers. Most chemicals came from Sigma Chemical Company (St. Louis, MO, 
USA) or Fischer Scientific UK Ltd. (Loughborough, Leicester, UK). Specialist reagents and 
sources are listed below: 
Agarose Invitrogen (Carlsbad, CA, USA)

Ethidium Bromide Sigma Chemical Company (St. Louis, MO, USA)

Luria Broth Sigma Chemical Company (St. Louis, MO, USA)

Luria Agar Sigma Chemical Company (St. Louis, MO, USA)

Carbenicillin Bioline (London, UK)

Fetal Bovine Serum Sigma Chemical Company (St. Louis, MO, USA)

Horse Serum Sigma Chemical Company (St. Louis, MO, USA)

Kanamycin Sigma Chemical Company (St. Louis, MO, USA)

6 x Loading Dye Promega (Madison, WI, USA)

Phenol Red Sigma Chemical Company (St. Louis, MO, USA)

Sheep Serum Sigma Chemical Company (St. Louis, MO, USA)

IPTG Melford Labs Ltd. (Suffolk, UK)

Phenol/chloroform/isoamyl alcohol Sigma Chemical Company (St. Louis, MO, USA)

1-phenyl-2-tiourea (PTU) Sigma Chemical Company (St. Louis, MO, USA)

Tricaine (methylsulfonate) Sigma Chemical Company (St. Louis, MO, USA)

TriReagentTM Sigma Chemical Company (St. Louis, MO, USA)

X-gal Sigma Chemical Company (St. Louis, MO, USA)

DEPC Sigma Chemical Company (St. Louis, MO, USA)

2.1.2 Nucleic Acids 
DIG RNA labelling mix Roche Diagnostics GmbH (Mannheim, Germany)

100 bp DNA ladder Promega (Madison, WI, USA)

1 kb DNA ladder Promega (Madison, WI, USA)

Primers (see Table 3/appendix) Invitrogen (Carlsbad, CA, USA) or

Bioneer (Alameda, CA, USA) 
2.1.3 Enzymes 
Restriction endonucleases and appropriate 10 x restriction buffers were purchased from

Promega (Madison, WI, USA) or New England Biolabs (Beverly, MA, USA). Other

enzymes were obtained from the following sources along with appropriate buffers.

Proteinase K Roche Diagnostics GmbH (Mannheim, Germany)

Trypsin Invitrogen (Carlsbad, CA, USA)

Pronase (Protease Type XIV) Sigma Chemical Company (St. Louis, MO, USA)

RNase Inhibitor Roche Diagnostics GmbH (Mannheim, Germany)

T4 DNA ligase Promega (Madison, WI, USA)

GoTaq DNA polymerase Promega (Madison, WI, USA)

iScript Reverse Transcriptase BioRad (Hercules, CA, USA)

SP6 RNA Polymerase Roche Diagnostics GmbH (Mannheim, Germany)

T7 RNA polymerase Roche Diagnostics GmbH (Mannheim, Germany)
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2.2 Solutions, Buffers and Media 
2.2.1 Solutions and Buffers 
Hybridization mix 
50 % Formamide 
5 x SSC 
0.25 mg Heparine 
2.5 mg TRNA 
0.1 % Tween20

9 mM Citric Acid

In Sterile Water

Holtfreter’s solution 
0.35 % (w/v) NaCl 
0.005 % (w/v) KCl 
0.01 % (w/v) CaCl2 
0.02 % (w/v) NaHC03

In MilliQ Water

In situ blocking buffer 
5 % Sheep serum 
2 mg/ml BSA 
0.1 % Tween

In PBS

NBT/BCIP buffer 
100 mM Tris-HCl pH 9.5 
50 mM MgCl2 
100 mM NaCl 
0.1 % Tween20

In MilliQ Water

PFA 
PBS with 4 % Paraformaldehyde 
PBS 
2.7 mM KCl

137 mM NaCl

0.01 M Phosphate buffer (Na2HPO4 + KH2PO4) pH 7.4 
PBT 
PBS with 0.1 % Tween20 
1 x SSC 
0.15 M Sodium chloride 
0.015 M Sodium citrate

Adjust to pH 7.2 with NaOH

1 x TAE 
40 mM Tris-HCl 
20 mM Sodium acetate 
2 mM EDTA 
Adjust to pH 7.8 with glacial acetic acid 
5 % Fetal Bovine Serum (FBS) 
5 % FBS in PBS 
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2.2.2 Media 
Embryo Medium 
0.50 µM NaCl 
0.17 µM KCl 
0.33 µM CaCl 
0.33 µM MgSO4 
0.1 % methylene blue 
LB 
2.5 % (w/v) Luria broth base 
LB-agar 
3.7 % (w/v) Luria agar base 
2.3 All other Reagents 
2.3.1 Plasmids 
Figure 5: Vector map of pGEM-T® easy. 
Map shows the ampicillin resistance gene, the restriction enzyme cutting sites in the 
multiple cloning region and the transcription initiation sites for SP6 and T7 flanking the 
multiple cloning region. Taken from the Promega pGEM-T® easy manual. Additionally 
plasmids for generating some in situ probes were very kindly sent by the following people: 
Otomp – Tanya Whitfield 
Pax7 – Hitoshi Okamoto 
Wnt11r - Simon Hughes 
Hoxd4a – Victoria Prince 
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2.3.2 Primers 
Custom primers were purchased from Invitrogen (Carlsbad, CA, USA) or Bioneer 
(Alameda, CA, USA). Primers in Table 3 were used to amplify key target genes from 
cDNA, for a full list of primers used to amplify targets identified by microarray analysis see 
appendix. 
Primer 
Name Sequence Expected Band Size (bp) 
ActinF GGTATGGGACAGAAAGACAG 330 
(680 from genomic DNA) ActinR AGAGTCCATCACGATACCAG 
DctF AACTGTGGCGAGTGTAAGTT 697 DctR GACTGTCGAAGTCTCTGAGG 
MitfaF GCTTTCCAGTAGAAGCAGAA 581 MitfaR GTTGTCCATAAGCATGTCCT 
Sox10F 
(S21) AACTACCGAAGTCACCTGTGG 420 Sox10R 
(S22) GATATTGATCCGCCAGTTTCC 
OtompF GTTTTCACAGTCTTTGTATG 355 OtompR AGTCTACGACAAATAACACA 
GFPf ATGGCCAACACTTGTCAC 600 GFPr TGCTAGTTGAACGCTTCC 
Table 3: Primers. 
All primer pairs were designed to amplify a fragment of the named gene from zebrafish 
cDNA. Primer sequences are given in the 5’ to 3’ direction of their respective DNA 
strands. 
2.3.3 Kits 
iScriptTM cDNA synthesis kit Bio-Rad, Hercules, CA, USA 
Plasmid Midi kit Qiagen, Valencia, CA, USA 
RNeasy micro kit Qiagen, Valencia, CA, USA 
Wizard® Plus SV miniprep DNA purification Promega, Madison, WI, USA 
QIAquick® Gel extraction kit Qiagen, Valencia, CA, USA 
DIG RNA labelling kit Roche Diagnostics GmbH, Mannheim, 
Germany 
Ovation Biotin RNA Amplification NuGEN, San Carlos, CA, USA 
and Labelling system. 
2.3.4 Microarray Chips 
Affymetrix GeneChip® Zebrafish Genome Array – Affymetrix, Inc, Santa Clara, CA, USA. 
2.3.5 Software 
PhotoshopTM 7 (Adobe) was used to analyse and enhance captured images and to 
compile and annotate figures. PhotoshopTM CS2 (Adobe) was used to merge images to 
create composite pictures of whole embryos. Microsoft Excel 2003 or 2007 was used to 
record results from analyses of the microarray data and to perform basic statistical tests. 
Microsoft Word 2007 was used for word processing. Initial Microarray assessment and 
initial analysis were performed using the Affymetrix GeneChip Operating Software 
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(GCOS) available freely on www.Affymetrix.com. Array data normalization and 
identification of differential gene expression was performed using the Gene Expression 
Pattern Analysis Suite (GEPAS) freely available on the WWW at www.gepas.org. 
2.4. General Techniques 
2.4.1 Transformation of Competent E. coli 
An appropriate amount of plasmid DNA was introduced into 50 µl of thawed chemical 
competent XL-1 Blue competent cells (Stratagene, Cedar Creek, TX, USA). 
Transformation was performed using a standard heat shock protocol following 
manufacturer’s guidelines. Post transformation, cells were incubated in LB shaking at 37 
ºC for one hour followed by spreading on LB-agar plates containing the appropriate 
antibiotic and incubated at 37 ºC overnight. When required, blue white selection was 
performed by addition of IPTG and X-gal to concentrations of 0.016 mg/ml and 0.04 mg/ml 
respectively. 
2.4.2 Purification of Plasmid DNA 
Plasmid DNA was prepared from bacterial suspensions, inoculated using freshly 
transformed cells, supplemented with the appropriate antibiotic using Promega miniprep 
WizardTM kits as per the manufacturer guidelines. 
2.4.3 Restriction Digests 
Digestion of DNA was performed using conditions specified by the enzyme manufacturer 
for at least one hour at the appropriate incubation temperature. Five units of each 
restriction endonuclease were added per 1 μg of DNA while ensuring the volume of 
enzyme never exceeded 10 % of the total digest volume. 
2.4.4 DNA Sequencing 
DNA sequencing was performed by MWG-Biotech (Ebersberg, Germany). 2-3 μg of DNA 
was precipitated per sequencing reaction using 0.1 volumes of 8 M LiCl and 2.5 volumes 
of ice-cold 100 % ethanol and incubated on ice for 30 minutes. Samples were centrifuged 
at 14,000 rpm in a Techne Genofuge 16M desktop centrifuge, washed in 70 % ethanol 
and air-dried. Alternatively 15 μl of liquid plasmid DNA (concentration 100-150 ng/ μl) was 
sent for sequencing as specified on the MWG-Biotech website (www.mwg-biotech.com). 
Sequencing was performed from the T7 RNA transcription start site of the pGEM-T easy 
vector (Figure 5). Sequence results were analysed using the NCBI BLAST tool on the 
World Wide Web (WWW) to confirm cloning of part of the correct gene and to identify 
insert orientation. The gene fragment cloned was further analysed for restriction enzyme 
sites using NEB cutter v2.0 on the WWW (http://tools.neb.com/NEBcutter2/index.php). 
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2.4.5 Electrophoresis of DNA and RNA 
Size fractionation of DNA was performed by electrophoresis on agarose (1-2 %) gels 
supplemented with ethidium bromide, in TAE running buffer. Samples were loaded with 
1x gel loading buffer, electrophoresed at 90 V and visualised using UV light. Images were 
captured using an AlphaimagerTM 3400. RNA electrophoresis was performed as stipulated 
above under RNase free conditions using RNase free agarose and TAE running buffer 
made using DEPC water. The gel tray, comb and gel tank were soaked in 1 % Hydrogen 
peroxide prior to pouring and running the gel. 
2.4.6 Phenol Chloroform extraction of DNA 
DNA solutions were made up to 100 µl with 1 x TE and 1 volume of 
Phenol:Chloroform:Isoamyl alcohol (Sigma-Aldrich, St. Louis, MO, USA) was then added. 
After vigorous mixing the sample was centrifuged for 5 minutes at 14,000 rpm on a 
desktop centrifuge (Techne Genofuge 16M). The upper, aqueous, layer was collected and 
contaminating phenol was removed by washing with an equal volume of chloroform 
followed by centrifugation as above. DNA was recovered by ethanol precipitation 
2.4.7 Ethanol Precipitation of DNA 
DNA samples were precipitated by addition of sodium acetate pH 5.2 to a final 
concentration of 0.3 M and 2 volumes of ice cold ethanol. To allow the DNA to precipitate 
samples were left on ice for 30 minutes, DNA was recovered by centrifugation, 14,000 
rpm for 15 minutes, on a desktop centrifuge (Techne Genofuge 16M). The pellet was 
washed with ice cold 70 % ethanol, air dried at room temperature and resuspended using 
nuclease free water. 
2.4.8 Polymerase Chain Reaction (PCR) 
PCRs were performed in 25 µl reactions using GoTaq Green PCR master mix (Promega, 
Madison, WI, USA). Appropriate primer concentrations, 0.1-1 µM, and template DNA, 
<250 ng, were used. Amplification was performed in either a Techne Touchgene 
(Cambridge, UK) or a G-Storm (Gene Technologies Ltd, Braintree, Essex, UK) thermal 
cycler. Programs consisted of an initial template denaturation at 95 ºC for 5 minutes, 35­
40 cycles consisting of denaturation at 94 ºC for 30 seconds, 30 second primer annealing 
step at a temperature appropriate for the primers and an extension step at 72 ºC for 30 
seconds. A final extension step of 5 minutes at 72 ºC was included. To determine optimal 
primer annealing temperatures the primer annealing step was sometimes replaced with a 
gradient PCR step thus allowing multiple annealing temperatures to be tested. 
2.4.9 Reverse Transcription 
Reverse transcription was performed using the iScriptTM cDNA synthesis kit (Bio-Rad, 
Hercules, CA, USA) following manufacturer’s guidelines. Briefly, 1 µg of RNA was added 
along with iScript Reverse Transcriptase and reaction mix and then the following heat 
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steps were performed in either a Techne Touchgene (Cambridge, UK) or a G-Storm 
(Gene Technologies Ltd, Braintree, Essex, UK) thermal cycler, 5 minutes at 25 ºC, 30 
minutes at 42 ºC, 5 minutes at 85 ºC. Quality of cDNA was assessed using Actin, Dct and 
Sox10 primers (Table 3). 
2.4.10 PCR product purification 
A PCR reaction was size fractionated by gel electrophoresis on a 1 % agarose gel. The 
gel was visualised under UV lighting wearing appropriate protection on a UV 
transilluminator (UVP, Upland, CA, USA). A glass plate was placed between the gel and 
the UV source and the duration of UV exposure was kept to a minimum. Overexposure of 
DNA to UV light can result in the formation of pyrimidine dimers which can lead to very 
few or no positive ligations occurring. A band at the correct size for the primer pair used 
during PCR was excised using a scalpel blade and DNA was purified from the agarose 
using the QIAquick® Gel extraction kit (Qiagen, Valencia, CA, USA) following 
manufacturer’s guidelines for the microcentrifuge protocol. A small amount of eluted DNA 
was visualized using gel electrophoresis to confirm gel extraction had worked. 
2.4.11 pGEMT®-easy Ligations 
Ligation of purified PCR products into pGEMT®-easy vectors (Promega, Madison, WI, 
USA) was performed as per the manufacturer’s guidelines. Briefly 1 µl of purified PCR 
product was mixed with vector and T4 DNA ligase (Promega, Madison, WI, USA) and 
incubated over night at 4 ºC. Appropriate positive and background controls were 
performed to assess the efficacy of the ligation reaction. Ligations were transformed into 
competent bacteria. 
2.4.12 DNA and RNA quantification by spectrophotometry 
To quantify the concentration of DNA and RNA samples a Beckman DU 530 
spectrophotometer (Beckman Coulter Inc., Fullerton, CA, USA) was used. Samples, 
appropriately diluted, were assayed using light absorbance at a wavelength of 260 nm 
(A260). Typically a sample of DNA purified by miniprep was diluted 1:20 using nuclease 
free water, RNA was diluted with an appropriate amount of DEPC treated water. 
Additionally RNA sample absorbance was assayed at 280 nm (A280) wavelength to 
compare the ratio between A260 and A280, this provided a measure of purity. 
2.4.13 Total RNA extraction from whole embryos 
RNA work must be carried out under RNase free conditions. 150 dechorionated embryos 
at the appropriate developmental stage suspended in 1 ml of TriReagentTM (Sigma 
Chemical Company, St. Louis, MO, USA) were homogenized by repeatedly passing 
through a needle (21Gx37) attached to a syringe. The homogenate was centrifuged for 10 
minutes at 14,000 rpm in a Techne Genofuge 16M desktop centrifuge. The supernatant 
was decanted and 0.2 ml of chloroform was added followed by vigorous mixing and 
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incubated for 15 minutes. After incubation the sample was centrifuged for 15 minutes at 
14,000 rpm in a Techne Genofuge 16M and the RNA containing upper aqueous phase 
was transferred to a new tube. RNA was precipitated by addition of 0.5 ml isopropanol, 
incubation for 5-10 minutes and by centrifugation for 10 minutes at 12,000 rpm on a 
microcentrifuge. The supernatant was then removed and the RNA pellet was washed in 
75 % ethanol. Ethanol was removed and the pellet allowed to air dry quickly. The pellet 
was resuspended in 10 µl of DEPC-treated water. 1 µl of RNA was visualized by gel 
electrophoresis and 1µl was quantified by spectrophotometry. Remaining RNA was stored 
at -20 ºC short term or -80 ºC long term. 
2.5 Zebrafish Techniques 
2.5.1 Fish Husbandry 
Embryos were obtained through appropriate crosses of wild type, mutant and transgenic 
fish stocks maintained in the University of Bath zebrafish facility. Embryos were raised in 
embryo medium and staged according to Kimmel et al., 1995. Dechorionation was 
performed using Dumontstar number 5 biological forceps or by incubation in 2 mg/ml 
pronase (Protease Type XIV, Sigma Chemical Company St. Louis, MO, USA) dissolved in 
embryo medium for appropriate time periods, typically 10-15 minutes. Embryos were 
anaesthetised with tricane (Sigma Chemical Company St. Louis, MO, USA) diluted to 
approximately 0.2 % final volume prior to manipulation, live mounting or fixation when 
appropriate. Fixation was performed in 4 % PFA overnight at 4 °C. Embryos older than 18 
somites were dechorionated prior to fixation. To inhibit melanisation embryo medium was 
supplemented with 0.003 % 1-phenyl-2-thiourea (PTU) when required. Sections were 
taken of resin embedded embryos (see Appendix for protocol). 
2.5.2 Injection of zebrafish embryos 
Injection needles were made by pulling Bores Oocyte Inj 90 mm flared glass capillaries 
(Drummond Scientific Company, Broomall, PA, USA) on a Micropipette puller (Sutter 
Instrument Company, Novato, CA, USA). Embryos were pipetted onto a 2 % agarose 
plate and held in a groove in the agarose. Injections were performed under a dissecting 
microscope using a Drummond Nanoinject II apparatus (Drummond Scientific Company, 
Broomall, PA, USA). Phenol Red was added to the injection solution and dispensed from 
needles backfilled with mineral oil. 
2.5.3 Embryo mounting and microscope techniques 
Low power microscopic analysis and general embryo manipulation was performed on 
dissecting microscopes, either a Leica MZ7.5 or a Leica MZFLIII for fluorescence work. 
For detailed analysis fixed embryos were mounted between No. 1 cover slips in 50 % 
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glycerol and examined on an Eclipse E800 (Nikon) microscope using Nomarski optics. 
Images of embryos were captured on a Digital Sight DS-5M camera with U1 Controller 
(Nikon). Cell counts were performed using a haemocytometer and examined on an 
Eclipse E800, dead cells were stained fluorescently using 7-Amino-actinomycin D (7­
AAD). 
2.5.4 In situ Hybridization of whole mount embryos 
In situ probes were synthesized under sterile RNase free conditions. 10 µg of DNA was 
linearized by digesting 5' of the probe sequence with an appropriate restriction enzyme. 
The reaction was stopped and DNA purified by phenol:chloroform extraction followed by 
ethanol precipitation. DIG labelled probes were synthesized using a DIG RNA labelling kit 
(Roche GmbH, Mannheim, Germany) following manufacturer’s guidelines. Briefly, 
approximately 1 µg linearized DNA was added to 1 µl DIG labelled NTP mix, 2µl 
transcription buffer, 1µl RNase Inhibitor and made up to a total volume of 18 µl with DEPC 
treated MilliQ water. Finally 2µl of the appropriate RNA polymerase was added and the 
reaction was incubated at 37 ºC for 2 hours. RNA was purified by adding 2.5 µl 4 M LiCl 
and 70 µl 70 % cold ethanol and incubated overnight at -20 ºC. RNA was pelleted by 
centrifugation at 14,000 rpm for 15 minutes on a desktop centrifuge (Techne Genofuge 
16M). The pellet was washed with 70 % cold ethanol then briefly air dried and dissolved in 
10 µl RNase free water. The probe was visualised by electrophoresis of 1 µl on an 
agarose gel. The rest of the probe was made up to 100 µl using hybridization mix. 
Fixed embryos were dehydrated by washing three times in 100 % methanol 
(MeOH) followed by incubation at -20 ºC for a minimum of 30 minutes. Embryos were 
rehydrated by washing in 75 % MeOH 25 % PBS, then 50 % MeOH 50 % PBS, then 25 % 
MeOH 75 % PBS followed by four PBT washes for 5 minutes each, all PBT washes were 
5 minutes unless otherwise stated. Embryos older than 18 somites were digested with 
Proteinase K, 1:1,000 or 1,10,000 dilution, for an appropriate period of time. Embryos 
were washed quickly in PBT and refixed for 20 minutes in 4 % PFA followed by 4 PBT 
washes. 
The following steps were performed typically at 65 ºC or occasionally at 68 ºC to 
improve hybridization specificity if appropriate for the probe. Embryos were washed in 
hybridization mix (HM) at 65 ºC for 15 minutes and then incubated in HM for 2-5 hours. 
Embryos were incubated overnight in 200 µl of diluted DIG labelled probe, typically 1:100 
or 1:200 in HM, to hybridize the probe. Subsequently embryos were washed quickly in HM 
followed by 10 minute washes in 75 % HM 25 % 2 x SSC, 50 % HM 50 % 2 x SSC, 25 % 
HM 75 % 2 x SSC and 2 x SSC. Embryos were then washed in 0.2 x SSC twice for 30 
minutes at 65 ºC. All further washes were performed at room temperature. Embryos were 
washed for 5 minutes in 75 % 0.2 x SSC 25 % PBT, 50 % 0.2 x SSC 50 % PBT, 25 % 0.2 
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x SSC 75 % PBT then PBT. Hybridized embryos were blocked by incubation in situ 
blocking buffer for 2-4 hours. Blocked embryos were incubated with anti-DIG alkaline 
phosphatase conjugated Fab fragment (Roche GmbH, Mannheim, Germany) diluted 
1:5,000 with in situ blocking buffer at 4 ºC overnight with gentle agitation. 
The antibody was removed and embryos were washed once quickly in PBT 
followed by 6 PBT washes then three 5 minute washes in NBT/BCIP buffer. Embryos 
were transferred to glass nine well plates and incubated in NBT/BCIP blue staining stock 
solution (Roche GmbH, Mannheim, Germany) diluted 1:50 in NBT/BCIP buffer. Staining 
reaction was stopped by a fast PBT wash followed by a 5 minute PBT wash. Alternatively 
to reduce non-specific staining embryos were washed quickly in PBT followed by a wash 
in 100 % EtOH for an appropriate time period then washed in PBT. Embryos were stored 
at 4 ºC in 50 % glycerol. 
2.5.5 FACS sorting of zebrafish embryos 
To generate sox10 mutant embryos expressing GFP under the control of the sox10 
promoter (Tg(-7.2sox10:EGFP);sox10m618/m618 embryos), heterozygous sox10+/m618 fish 
were crossed with Tg(-7.2sox10:EGFP);sox10+/m618 fish. This cross generated sox10 
mutant and wild type embryos in a normal Mendelian ratio (1:3) and 50 % of the embryos 
expressed GFP. At 20 hpf embryos were sorted for GFP expression under a dissecting 
microscope. Approximately 500 GFP positive embryos were then dechorionated. Removal 
of the chorion reduced the number of GFP negative events that were counted during cell 
sorting. Embryos were then lightly anaesthetized and sorted into sox10 mutant and WT 
GFP positive groups. 500 GFP positive embryos were selected to ensure that at least 100 
mutant embryos could be sorted based on normal Mendelian genetics. Tg(­
7.2sox10:EGFP);sox10m618/m618 embryos were identified from non-mutant transgenic 
embryos by visualizing differences in GFP expression at 22 hpf. At this time point Tg(­
7.2sox10:EGFP);sox10m618/m618 embryos showed reduced GFP expression in the ear 
compared to WT embryos. Mutant embryos also displayed a clumping of GFP expression 
in the head close to the midbrain/hindbrain boundary, in WT embryos GFP expression 
was more evenly spread. 100 Tg(-7.2sox10:EGFP);sox10m618/m618 embryos and 100 WT 
embryos in separate 1.5 ml eppendorf tubes were washed three times in 1x Holtfreter’s 
solution and then disaggregated at 24 hpf with a micropestle (Eppendorf, Hamburg, 
Germany) by firmly inserting the micropestle into the tube 5 or 6 times. Disaggregated 
embryos were pelleted at 3,000 rpm for 5 minutes in a desktop centrifuge (Techne 
Genofuge 16M), this helped to separate cells from yolk material. The supernatant was 
removed and the pellet was resuspended in 1 ml 0.05 % trypsin plus 53 mM EDTA 
(Invitrogen, USA) then incubated at 33 ºC for 35 minutes with gentle mixing by pipetting 
with a P1000 Gilson pipette every 5 minutes. Mixing helped to break up large clumps of 
cells and enabled small clumps to be broken down into single cells. Cells were pelleted by 
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spinning at 4,000 rpm, 4 ºC for 5 minutes in a desktop centrifuge (Jencons-PLS 
Spectrafuge 24D). The pellet was washed three times in PBS to remove the trypsin and 
then resuspended in 500 µl of ice cold 5 % FBS in PBS and filtered using 40 µm cell 
strainer (BD Biosciences, NJ, USA) into a 5 % FBS coated chilled 50 ml falcon tube (BD 
Bioscience, NJ, USA). The addition of 5 % FBS helped to prevent cells sticking to the 
plastic equipment. 500 µl of 5 % FBS was used to rinse out the falcon tube and then 
passed through the filter. The filter was rinsed through with another 500 µl of 5 % FBS. 
The samples were filtered to ensure that only single cells were taken for FACS. 
To enrich for GFP positive cells, cells from both sox10m618/m618 and WT embryos 
were sorted independently for GFP and collected in RLT buffer (Qiagen Ltd, West Sussex, 
UK) containing 0.1 % β-Mercaptoethanol on a BD FACSVantageTM SE cell sorter system 
(BD Bioscience, NJ, USA) into FACS tubes (BD Bioscience, NJ, USA). Samples were 
transferred into FACS 5ml polypropylene round bottom tubes (BD Bioscience, NJ, USA) 
coated with 5 % FBS for loading onto the FACS machine. The FACS machine detector 
amp was set as follows, FSC-H typically to 8, SSC-H set to log and FL1-H set to 700. The 
laser used was an argon 488 nm laser capable of exciting GFP. Gates identifying the cell 
populations to be sorted were set on a 50,000 event run using FACStationTM software. 
500,000 events were subsequently collected 4 times, with each run taking between 8-10 
minutes. Between each run the collected samples were mixed by pipetting to ensure all 
sorted cells were mixed with RLT. Collected samples were stored at -80 ºC prior to RNA 
extraction. 
To enrich for NCCs from Tg(-4.9sox10:EGFP) fish the protocol above was 
followed except for the identification of WT from mutant fish using the pattern of GFP 
expression at 24 hpf. Tg(-4.9sox10:EGFP) embryos only displayed weak ear expression 
so the embryos were genotyped using the pattern of GFP positive cells in the head only, 
WT fish displayed an even spread of GFP positive cells over much of the head while 
mutant embryos displayed an obvious clumping of GFP expressing cells. 
2.6 Preparing Samples for Microarray analysis 
2.6.1 RNA Extraction and cDNA synthesis 
RNA was extracted from FACS sorted samples using an RNeasy Micro kit (Qiagen Ltd. 
West Sussex, UK), one column was used per sample. 12 µl of sample was eluted per 
column; each sample was made up to 50 µl with DEPC water. 10µl was utilised as a 
template to generate cDNA with an iScriptTM cDNA synthesis kit (Bio-Rad, Hercules, CA, 
USA) following the manufacturer’s guidelines. WT samples versus sox10m618/m618 samples 
were checked for differential gene expression by PCR using actin, sox10, dct, mitfa and 
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otomp primers. RNA samples were sent on dry ice to the University of California, Irvine 
(UCI), DNA and Protein Microarray Facility for processing and hybridization to an 
Affymetrix Genechip Zebrafish Genome Array. 
2.6.2 RNA Sample Preparation and hybridization to the array 
Eluted total RNAs were quantified with a portion of the recovered total RNA adjusted to a 
final concentration of 5-10 ng/µl. All starting total RNA samples were quality assessed 
prior to beginning target preparation/processing steps by running out a small amount of 
each sample onto a RNA Lab-on-A-Chip (Caliper Technologies Corp. Mountain View, CA) 
that was evaluated on an Agilent bioanalyzer 2100 (Agilent Technologies, Palo Alto, CA). 
Single-Stranded, then double-stranded cDNA was synthesized from the poly(A) + mRNA 
present in the isolated total RNA followed by linear amplification, fragmentation and 
labelling using the Ovation™ Biotin Pico RNA Amplification and Labelling system and the 
FL - Ovation™ cDNA Biotin Module (NuGEN, San Carlos, CA) as per manufacturer's 
guidelines. 3.75 µg of the resulting single-stranded cDNA generated during the 
amplification process was fragmented and labelled to an average strand length of 85 
bases (range 80-100 bases) following prescribed protocols (NuGEN, San Carlos, CA). 
Subsequently, 3.4µg of this fragmented target cDNA was hybridized at 45°C with rotation 
for 18 hours (Affymetrix GeneChip® Hybridization Oven 640) to probe sets present on an 
Affymetrix Zebrafish array. The GeneChip® arrays were washed and then stained 
(SAPE, streptavidin-phycoerythrin) on an Affymetrix Fluidics Station 450, followed by 
scanning on a GeneChip® Scanner 3000. The results were quantified and initially 
analyzed, including checking all appropriate control probes on each array, using GCOS 
v1.4 software (Affymetrix Inc.) using default values (Scaling, Target Signal Intensity = 500; 
Normalization, All probe Sets; Parameters, all set at default values). 
2.6.3 Analysis of Array data 
Analysis of differential gene expression between WT versus sox10-/- arrays was 
performed using the web based free software Gene Expression Pattern Analysis Suite 
(GEPAS) v3.1 (http://gepas3.bioinfo.cipf.es/). Affymetrix Cell Intensity Files (.cel files) 
provided by the UCI DNA and Protein Microarray Facility were uploaded in a compressed 
.zip file format to the Expresso tool on GEPAS for pre-processing. The default settings of 
Background correction = rma, normalization = quantiles, PM correction = pmonly and 
summary = medianpolish were used. The output file from Expresso was copied and 
pasted into a Microsoft notepad file and class information was added to identify the 
columns of wild type and mutant data. This file was uploaded to the GEPAS T-Rex tool for 
analysis of differential gene expression using both the T-test and a CLEAR test 
(significance level = 0.05) tools. The m value output from the CLEAR test equals the 
signal log ratio; this can be used to calculate fold change as follows: 
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If Signal Log Ratio ≥ 0 then Fold Change = 2Signal Log Ratio 
If Signal Log Ratio ˂ 0 then Fold Change = (-1)*(2-(Signal Log Ratio)) 
The output file from the T-Rex analysis was copied and pasted into a Microsoft Excel 
spreadsheet and additional annotation was added. Gene name and GO term information 
was taken mostly from the Netaffx™ Analysis Centre 
(http://www.affymetrix.com/analysis/index.affx). When additional information could be 
found from the following sources; Zebrafish Information Network (ZFIN) website 
(http://zfin.org) or the Danio rerio Genome build 7 (Zv7) on the Ensembl website 
(http://www.ensembl.org/index.html), it was added to existing annotation. The Ensembl 
website included information on both Affymetrix probe identifiers and links to genes on the 
ZFIN website in a single location and thus provided a useful tool to connect both these 
resources. If a conflict in annotation was identified, the information provided by Affymetrix 
was preferred. 
2.6.4 Searching microarray data for GO terms of interest. 
The web based tool Babelomics v3.1 (http://babelomics.bioinfo.cipf.es) was used to 
perform functional analysis of the microarray data. This tool was developed by the same 
group as the GEPAS tool used previously to analyse the microarray data. Affymetrix 
identifiers of interest were uploaded to the Babelomics FatiGO search tool. The search 
tool was run using default options except duplicates were never removed. All analyses 
were performed by examining lists of genes for GO biological process and GO molecular 
function terms of interest. Affymetrix identifiers associated with a GO term of interest were 
annotated by uploading the Affymetrix identifiers to a NetAffx batch query. 
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Chapter 3: Towards an Initial Validation of a Microarray Analysis 
of Sox10 targets 
3.1 Introduction 
In this chapter, the series of experiments that were pursued to generate microarray data 
for comparing gene expression between wild type (WT) and sox10-/- neural crest cells 
(NCCs) will be presented. It is hoped that the generation of such data will lead to the 
identification of novel targets of Sox10. Initially Green Fluorescent Protein (GFP) 
expressing cells were purified from two different zebrafish transgenic lines at 
approximately 24 hours post fertilization (hpf) by fluorescent activated cell sorting (FACS). 
Chronologically, the Tg(-7.2sox10:EGFP) cells were purified first and RNA was extracted 
from them. The RNA was sent to the Microarray Facility at the University of California, 
Irvine, for hybridization to Affymetrix zebrafish GeneChips. The resulting data was then 
analysed for differential gene expression, the quality of this was assessed using some key 
NC genes and an otic epithelium expressed gene as markers. Cells from the Tg(­
4.9sox10:EGFP) were also purified and subjected to the same process, proceeding a few 
months later. 
3.1.1 Zebrafish Transgenic Lines Utilised in this Project 
In this project, two stable zebrafish transgenic lines have been employed that were 
previously generated in the lab. Both lines express GFP under the control of DNA directly 
upstream from the ATG start site of the Sox10 coding region. The Tg(-7.2sox10:EGFP) 
(Dutton et al., 2008) contains 7.2 kb of the sox10 promoter region driving GFP while the 
Tg(-4.9sox10:EGFP) (Carney, 2003, Carney et al., 2006) line contains 4.9 kb of the sox10 
promoter region driving GFP. The Tg(-7.2sox10:EGFP) has been published under this 
nomenclature (Hoffman et al., 2007) and as Tg(-4725sox10:GFP)ba4 (Dutton et al., 2008). 
For consistency the two lines will be distinguished by the length of the promoter sequence 
driving GFP and shortened to 7.2sox10:GFP and 4.9sox10:GFP. In both lines, GFP 
expression marking NCCs is first seen around the one somite stage (approximately 11 
hpf) and by 24 hpf both lines display strong GFP expression that replicates endogenous 
sox10 expression as determined by in situ hybridization (Carney, 2003, Carney et al., 
2006, Dutton et al., 2008). This includes GFP expression in trunk pre-migratory NCCs, 
NCCs migrating on the medial and lateral pathways as well as migratory cranial NCCs 
and glial precursor cells in the head (Carney et al., 2006, Dutton et al., 2008, Carney, 
2003). The two lines display a striking difference; 7.2sox10:GFP embryos display strong 
GFP expression in the otic epithelium, a site of strong sox10 expression, while the 
4.9sox10:GFP line displays markedly weaker otic epithelium expression (Carney et al., 
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2006, Dutton et al., 2008, Carney, 2003). The expectation when using FACS is that NCCs 
from both lines will be purified but otic epithelium cells will be strongly reduced in samples 
from the 4.9sox10:GFP line compared to the 7.2sox10:GFP line. Thus microarray data 
from the 4.9sox10:GFP line may not identify otic vesicle expressed genes as differentially 
regulated. By comparing the data from both lines it might be possible to identify otic 
vesicle expressed genes. Additionally both lines show strong ectopic GFP expression in 
the most anterior somites (Carney et al., 2006, Carney, 2003) The GFP expression 
patterns displayed by both these lines is summarised in Table 4. 
7.2sox10:GFP 4.9sox10:GFP 
sox10 in situ 
hybridization 
Pre-migratory NC    
Migrating NC    
Otic Epithelium   (weak)  
Cranial NC    
Olfactory Neurons    
Branchial Arches    
CNS Brain    
CNS Neural Tube    
Glial Precursors nd   
Schwann Cells nd   
Muscle    
Table 4: Summary of the sites of GFP expression in the sox10 reporter transgenic 
lines at 24 hpf. 
Sites where expression has been identified are indicated by a tick, sites where expression 
has not been noted are identified by a cross. Sites where no information is available 
regarding expression are identified by nd for not defined. Information collated from 
(Carney et al., 2006, Dutton et al., 2008, Carney, 2003). 
3.1.2 Fluorescence Activated Cell Sorting 
Cell sorting by flow cytometry enables the enrichment of a heterogeneous population of 
cells into defined populations based on detectable cellular properties. A commonly used 
criterion for cell sorting is cellular fluorescence, either emitted from an expressed 
fluorescent molecule or from a fluorophore bound to a cell by a specific antibody; this is 
known as fluorescence activated cell sorting (FACS). For a comprehensive review of flow 
cytometry and FACS see Practical Flow Cytometry, 4th Ed by H. M. Shapiro which is free 
to view on the Invitrogen Website. Briefly, a stream of single cells is passed through a 
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beam of laser light and the character of interest is measured, in the case of this project, 
GFP expression. The stream is broken into droplets containing a single cell by a vibrating 
mechanism. If a GFP positive cell is detected voltage is then applied to impart an electric 
charge to the droplet. The droplet stream subsequently passes through an electric field 
generated between two deflecting plates with strongly polarized charges. Droplets to be 
sorted are deflected out of the stream towards the plate with the opposite charge and 
collected. Uncharged cells are not deflected out of the stream and pass into a waste 
collector (Shapiro, 2003). The precise nature of the cells to be sorted can be defined with 
user-selected gates on the software operating the FACS machine. FACS provides a 
powerful tool to enrich for living cells of a defined population that can then be subjected to 
further study. 
The NC consists of a wide diversity of different cell types, which express a range 
of cell markers and migrate to many locations within an embryo; they are therefore a 
difficult cell population to purify by dissection. Flow cytometry has the potential to be a 
useful tool for sorting NCCs from a disaggregated embryo yet very few examples of this 
appear in the literature. Indeed when this work commenced there were no examples 
although FACS has now been employed to enrich for populations of NCCs. Recently 
cranial neural crest multipotent progenitor cells have been enriched by FACS from a 
culture of human embryonic stem cells (Zhou and Snead, 2008). Melanocytes expressing 
GFP under the control of the Fugu tyrp1 promoter have also been enriched by FACS from 
transgenic zebrafish embryos (Zou et al., 2006). The zebrafish provides a powerful model 
organism for the generation of transgenic embryos (Grabher and Wittbrodt, 2008, Kwan et 
al., 2007, Villefranc et al., 2007) and therefore has the potential to work effectively with 
FACS to purify cell populations of interest from an in vivo source. Indeed there are several 
recent examples where this has been achieved including enrichment of melanocytes (Zou 
et al., 2006), lmo2 positive hematopoietic and endothelial cells (Zhu et al., 2005), fli1 
positive hematopoietic, endothelial and pharyngeal arch cells (Covassin et al., 2006), vasa 
positive primordial germ cells (Fan et al., 2008) and both pax2a positive CiA interneurons 
and elav13 positive neurons (Cerda et al., 2009). Thus zebrafish transgenesis and FACS 
are two techniques that complement each other. 
3.1.3 Microarray Technology 
While FACS sorting provides a powerful tool to enrich for a cell population of interest, it is 
rarely an endpoint. Sorted cells could be characterised by reverse transcription 
polymerase chain reaction (RT-PCR) or immunohistochemical analysis. Sorted cells could 
also be cultured to enable in vitro examination and manipulation. The entire transcriptome 
of a specific cell population or cell type is of great interest and can be elucidated through 
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the use of expression microarrays. Indeed FACS has been used successfully to isolate a 
cell population of interest for microarray analysis (Reeves and Posakony, 2005, Covassin 
et al., 2006, Cerda et al., 2009). Expression microarrays consist of a solid substrate on 
which a large number of DNA sequences (probes) are placed in a defined order 
(Stoughton, 2005). Arrays enable the expression level of thousands of genes to be 
measured simultaneously, that is, the entire transcriptome of an organism can be 
interrogated with a biological sample of interest. This has the potential to generate vast 
amounts of data and to identify a role for genes never before associated with the sample 
being tested. 
In this project gene expression levels are being compared between two different 
biological conditions; GFP positive cells from sox10:GFP transgenic lines from WT 
embryos versus GFP positive cells from sox10-/- embryos utilising the Affymetrix zebrafish 
GeneChip® platform. The zebrafish GeneChip® is made up of probes (25-mer 
oligonucleotides) that are organized into a square containing thousands of perfect match 
(PM) probes of a single and unique sequence, these squares are probe cells. Every probe 
cell has a corresponding mis-match (MM) probe cell consisting of the identical 25-mer 
oligonucleotide with a mis-match base in the middle. Each transcript on the array is 
recognized by 16 different probe cells, known as a probe set. The zebrafish GeneChip® 
has 15,509 probe sets on it and these probe sets detect approximately 14,900 different 
transcripts (Affymetrix, 2008). 
To generate material for hybridization to an array, RNA isolated from the sample of 
interest is used to generate cDNA by reverse transcription using oligo-dT primers. This is 
followed, if required, by an amplification step to increase the amount of cDNA. The 
resulting cDNA is then fragmented and labelled with biotin; this generates the target 
material which is hybridized to the array. After hybridization the array is washed leaving 
biotin labelled target cDNA specifically bound to probes on the array. After washing, the 
array is stained using Streptavidin-phycoerythin, a fluorescent dye that binds biotin and is 
then scanned with a laser to detect fluorescence. This is recorded, processed and is 
utilised to produce a readout measuring transcript abundance (signal) for each probe cell. 
The signal readings are then summarised, this combines data from all the probe cells in a 
set to give a measure of transcript levels. Subsequently microarray data can be analysed 
using specialist software to compare the two groups and identify differential gene 
expression. 
Affymetrix arrays differ from the two colour array format, where two different 
fluorescently labelled samples are hybridized to one array for comparison. With the 
Affymetrix system, each independent sample is hybridized to an array and then 
comparisons are made between arrays (WT arrays versus mutant arrays for example). 
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This requires the Affymetrix arrays to be normalized for noise and background as part of 
the analysis process (Harrington et al., 2000). 
Microarray technology has been applied in a wide variety of organisms and 
contexts to elucidate biological information. The aim of this experiment was to identify 
genes whose expression has been perturbed in sox10 mutant embryos to aid the 
discovery of genes important in the development of the NC and otic vesicle. This 
application of microarray technology has been successfully utilised to identify genes 
affected in zebrafish mutant embryos such as the cloche mutant (Qian et al., 2005, 
Sumanas et al., 2005). However both of these studies used RNA extracted from whole 
embryos; this has the potential to mask real changes in gene expression in the tissue of 
interest behind signal detected from unaffected tissues or cell types. A study of young 
mutant embryos (Leung et al., 2008) circumvented this problem by isolating the tissue of 
interest, the retina. There are currently no published cases of FACS being used to isolate 
mutant and WT zebrafish cells for examination by microarray analysis. 
Microarray analysis is a tool that has already been applied to investigate key 
genes in the development of the neural crest. Melanocytes transfected with various 
isoforms of PAX3 were interrogated using microarrays to identify downstream target 
genes (Wang et al., 2007). Novel targets of MITF have been identified through a 
combination of various microarray analyses from melanomas and melanocyte cultures 
(Hoek et al., 2008). These studies have identified genes involved in the development of 
only one neural crest cell type. A macroarray approach was adopted to identify the gene 
expression profile of NCCs induced from chick neural tissue in an in vitro setting (Adams 
et al., 2008, Gammill and Bronner-Fraser, 2002). A large number of microarray 
experiments are performed on cultured tissue as it is easy to generate the tissue or cell 
type of interest in the quantities required for microarray analysis. Often these cultures are 
subjected to additional manipulations such as transfection of a gene to induce over 
expression or siRNA treatment to knock expression down. Thus these experiments may 
not recapitulate the gene expression profile present in an in vivo context. This problem 
should be resolved by isolating cells from live embryos to generate gene expression data 
that is as faithful to the situation in developing in vivo cells as possible. 
Microarray studies have the potential to elucidate a genome wide gene expression 
profile and reveal unexpected results. However the success of this type of experiment is 
dependent on the quality of biological material prepared for microarray analysis. Samples 
need to be independent biological replicates, which are for example, carefully stage 
matched to limit the biological variation of factors that are not being tested. The 
preparation of material for array hybridization, especially, if an amplification step is 
included, can also introduce biases that are independent of the variable being examined. 
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If noise generated by biological and technological variations is too great then detecting 
real changes in gene expression levels could be problematic. It is also a concern that a 
sufficient number of arrays are compared to produce statistically significant results; this is 
often offset against the high cost of array experiments. The statistical analysis of 
microarray data will generate false positives and it is important to correctly control for 
these to minimise their presence. Due to the identification of false positives, candidate 
genes revealed by microarray data usually require validation by an independent 
technique. 
3.1.4 Introduction to Key Marker Genes down-regulated in sox10 mutants. 
The transcription factor sox10 is expressed in non-skeletogenic neural crest cells in the 
head and trunk of WT embryos (Figure 3 and Figure 6). This includes, at 24 hpf, 
expression in pre-migratory NCCs, pigment cells migrating in the head and on the medial 
and lateral pathways and expression in the neurons and glia of the PNS migrating on the 
medial pathway and the cranial ganglia (Dutton et al., 2001a). In sox10-/- embryos the 
expression pattern of sox10 is altered (Figure 6). There is a reduction in the number of 
migrating sox10 positive cells on both pathways (Dutton et al., 2001a). Essentially 
pigment cells fail to specify correctly and do not migrate. As a result of this, the number of 
sox10 positive pre-migratory cells is markedly increased. Another noticeable difference is 
the clumping of sox10 positive cells in the head in mutant embryos, in WT embryos these 
cells are more evenly spread over a greater area of the head (Dutton et al., 2001a). There 
is also a reduction in the number of sox10 positive cranial ganglia cells. Expression in the 
otic epithelium is strong in WT embryos and does not appear to be affected in sox10-/­
embryos. It should be noted that the sox10m618 allele generates a full length transcript but 
it is essentially non-functional as a result of an amino acid substitution. To summarise, the 
expression pattern of sox10 is altered in sox10 mutants but the number of cells and 
transcript levels of sox10 positive cells appears to be unchanged at 24 hpf. 
There are a number of well characterised NC expressed genes that are known or 
expected to be down-regulated in sox10-/- embryos. The key melanocyte transcription 
factor mitfa is expressed in pre-migratory and migrating melanoblasts at 24 hpf in WT 
embryos. Expression of mitfa is very strongly reduced in sox10-/- embryos (Figure 6). 
Similarly, dct is strongly expressed in some melanoblasts at 24 hpf and expression is 
strongly reduced although not absent in NCCs of sox10 mutant embryos (Figure 6). The 
expression of dct seen in the retinal pigmented epithelium is unaffected in sox10 mutants. 
The xanthoblast and xanthophore marker xdh (also known as aox3) is expressed in pre­
migratory and lateral pathway migrating NCCs (Figure 6). The expression of xdh is 
reduced in sox10-/- embryos but some pre-migratory cells and some clumped cells in the 
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head remain (Figure 6). The expression pattern of another xanthoblast and xanthophore 
marker, gch2, is very similar to xdh in WT and sox10-/- embryos (data not shown). The 
marker gch2 should be used with caution though as it is also expressed in melanoblasts 
(Pelletier et al., 2001). 
Crestin is widely used as a NC marker and is expressed in skeletogenic and non­
skeletogenic NCCs including pre-migratory NC, NCCs migrating on the medial pathway 
and NCCs in the branchial arch streams (Elworthy et al., 2005). There are considerable 
defects in crestin expression in sox10-/- embryos with non-skeletogenic derivatives 
showing strongly reduced expression (Elworthy et al., 2005). The transcription factor 
foxd3 is a marker of early crest (Odenthal and Nüsslein-Volhard, 1998) but foxd3 
expression in this early pre-migratory crest is not perturbed in sox10 mutant embryos 
(Lopes et al., 2008). Foxd3 is also expressed in the neural crest derived PNS glia 
surrounding cranial ganglia and posterior lateral line neurons. There is a reduction in 
foxd3 positive cells at these locations in sox10-/- embryos (Kelsh et al., 2000). 
Sox10 is strongly expressed in the otic epithelium of WT embryos at 24 hpf and 
this expression is not noticeably altered in sox10-/- embryos (Figure 6). A strong marker of 
the otic epithelium is otomp (Thisse et al., 2004, Murayama et al., 2005) and this gene is 
strongly down-regulated in sox10-/- embryos (Kelsh R, personal communication and see 
Chapter 4). In summary, the above NC and ear marker genes are all down-regulated to 
some extent in sox10 mutant embryos and will provide useful marker genes during the 
establishment and validation of the sox10 targets microarray screen. 
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Figure 6: Whole mount in situ hybridizations comparing the expression patterns of 
four key marker genes between WT and sox10 mutant embryos. 
All images are composites of lateral views of 24 hpf embryos. The expression pattern of 
sox10 is altered in mutant embryos, which display obvious clumping of sox10 positive 
cells in the head and a reduced number of migrating NCCs. There is an increased density 
of NCCs expressing sox10 in a dorsal position. There is no obvious difference in sox10 
expression levels in the otic epithelium of mutant embryos. Expression of mitfa and dct in 
the melanoblasts of WT embryos is absent in sox10-/- embryos although dct is still 
expressed in cells of the retinal pigmented epithelium. Xdh is expressed in pre-migratory 
NC and cells on the lateral pathway; this gene is a marker of xanthoblasts. Expression of 
xdh is reduced in mutant embryos and remaining xdh positive cells show an altered 
distribution. Xdh positive cells are clumped in the head and stuck in pre-migratory 
positions in mutant embryos. 
64

3.1.5 Aims 
The ultimate goal of this section of work was to generate microarray data from 24 hpf WT 
and sox10-/- zebrafish embryos for comparison. This was to enable the identification of 
genes differentially expressed in mutant embryos. The 24 hpf stage was chosen because 
sox10 is extensively expressed in the NC and otic epithelium at this time point, but more 
importantly NCCs are undergoing and expressing key genes for specification, 
differentiation and migration. The goal of this project is to identify genes that are important 
for these processes in the gene regulatory network of sox10. To achieve this, the following 
aims had to be fulfilled: 
 A method had to be established to identify sox10-/- from WT embryos at a stage 
prior to 24 hpf, preferably as early as possible. 
 A reliable protocol to enrich for GFP positive cells of interest from transgenic 
zebrafish embryos by FACS had to be established. 
 RNA had to be extracted from these groups of cells that was of suitable quality and 
quantity for Microarray analysis on 10 chips (5 mutant and 5 WT) at the DNA and 
Protein Microarray Facility of the University of California, Irvine. 
 Analysis of the Microarray data to generate a list of differentially regulated targets 
for further validation had to be performed. 
3.2 Results and Conclusions 
3.2.1 Identification of sox10 mutant embryos during early development 
To enable the sorting of both WT and sox10-/- NCCs for microarray analysis, transgenic 
embryos from both these genotypes had to be identified to a high degree of accuracy at 
an early stage, around 20 hpf or late segmentation stage. With the aim being to generate 
a gene expression profile of cells at approximately 24 hpf, embryos had to be identified at 
least two hours prior to this time point to ensure that embryos could be disaggregated and 
the resulting single cells processed by FACS. Zebrafish embryo pigmentation 
(melanisation) is first visible at 28 hpf and provides an excellent visual marker for 
genotyping WT and sox10 mutant embryos but these embryos needed to be genotyped 
earlier in development using visible GFP reporter expression. Initially this was achieved 
with the 7.2sox10:GFP line and subsequently with the 4.9sox10:GFP line. It should be 
noted that throughout this thesis, the non-mutant transgenic embryos are referred to as 
WT embryos for brevity. 
When examining 7.2sox10:GFP embryos at 20-22 hpf, from a cross where 25 % of 
the progeny were sox10-/- it was noted that a subset of embryos displayed a clumping of 
GFP expressing cells in the head and reduced GFP expression in the otic vesicle. From 3 
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pairs of adult fish 26.5%, 30.5% and 22.8% of embryos showed clumping of GFP positive 
cells. It was postulated that these were sox10-/- embryos. This hypothesis was tested by 
allowing embryos to develop; embryos sorted by these characteristics did not develop 
melanophores or other types of pigment cell. Using these criteria for genotyping, embryos 
were sorted into WT (non-mutant) or sox10-/- groups without any contamination. Examples 
of GFP expression in these two genotypes at 27 and 30 hpf are shown in Figure 7. 
Arrows in Figure 7B and D mark the clumping of GFP positive cells in the head. In WT 
embryos the GFP positive cells are evenly distributed over the majority of the head 
(Figure 7A and C). Asterisks highlight the otic vesicle; note the reduced level of GFP in 
Figure 7B and D compared to Figure 7A and C. Additionally, clumping of cells in the 
heads of sox10-/- embryos at 24 hpf was also noted when performing in situ hybridizations 
for key NC marker genes such as sox10, mitfa, and xdh (Figure 6) as well as numerous 
genes identified during the in situ hybridization microarray validation screen (see Chapter 
4). 
Having successfully identified how to genotype embryos from the 7.2sox10:GFP 
line, this exercise was repeated with the 4.9sox10:GFP line. As the otic epithelium 
expression is much weaker in this line it did not provide a suitable marker for genotyping 
WT from sox10-/- embryos. The pattern of clumped GFP positive cells in the head however 
appeared to be the same as observed with the 7.2sox10:GFP line and again provided a 
suitable marker for genotyping (Data not shown). Mutant embryos could be distinguished 
from WT embryos without cross contaminating the two genotypes. 
Differences were identified in the pattern of GFP expression between WT and 
mutant embryos for both transgenic lines. WT and mutant embryos could be distinguished 
at stages sufficiently early (approximately 22 hpf) to enable sorting of NCCs from 24 hpf 
embryos, the time point of interest. Also by sorting the embryos with one hundred percent 
accuracy pure batches of WT and mutant embryos could be isolated that would generate 
GFP positive cells whose expression profile could be resolved and compared. 
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Figure 7: Genotyping WT and sox10-/- embryos during early stages of development. 
All images show 7.2sox10:GFP embryos, GFP visualised under UV light on a dissecting 
microscope with embryos in the same orientation, dorsal top, ventral bottom, anterior left 
and posterior right. Embryos visualised at 27 hpf (A and B) and at 30 hpf (C and D). Note 
the clumping of GFP positive cells in B and D indicated by arrows that are absent in A and 
C where GFP positive cells are evenly distributed over the entire head of the embryo. Also 
note the reduced expression of GFP in the otic vesicle (*) when comparing B to A and D 
to C. In C melanophores can be seen starting to melanise thus confirming the embryo is 
WT. 
67

3.2.2 FACS sorting of NCCs 
Having genotyped WT from sox10-/- embryos at a suitably early stage, GFP positive cells 
from both populations of embryos (mutant and WT) could be purified by FACS. From a 
cross of adult zebrafish heterozygous for the sox10m618 allele and in which one parent was 
heterozygous for a sox10:GFP transgene, 500 GFP positive embryos were selected and 
then dechorionated using forceps. This occurred at approximately 20 hpf when GFP was 
clearly visible. These dechorionated embryos were lightly anaesthetised with tricaine and 
sorted by GFP pattern. To sort embryos for GFP and then to sort for WT and sox10-/­
embryos took 3 to 4 hours thus embryos were disaggregated at approximately 24 hpf. 100 
embryos of each genotype heavily anaesthetised with tricaine were placed into separate 
Eppendorf tubes and disaggregated with a micropestle. Cellular clumps generated by this 
were then broken down to single cells for FACS using a 35 minute trypsin digest at 33°C. 
Approximately 24 hpf embryos were disaggregated, a process which took an hour, single 
cells were therefore approximately 25 hpf when FACS was initiated. 
At the start of each FACS session 50,000 WT cells were run to visualise GFP 
positive and GFP negative cells (Figure 8). Using this run the gates were then set to 
determine the GFP positive and the GFP negative cells to be collected in RLT buffer. 
Typically, for the mutant sample four runs of 500,000 cells were then carried out and the 
sorted cells were pooled together. Each run took between 8 and 10 minutes to complete 
and the cells were mixed with RLT buffer by pipetting. Only 2 million events were run to 
minimise the period of time it took to sort cells. This was then repeated to collect the GFP 
positive WT cells. One clutch of embryos provided a mutant sample and a WT sample for 
RNA extraction. No two mutant samples came from the same clutch of embryos thus 
making them independent biological replicates with the same true of the WT samples. 
Total numbers of cells sorted are shown in Table 5 for the 7.2sox10:GFP line and Table 6 
for the 4.9sox10:GFP line. From the 7.2sox10:GFP line 6 mutant samples (7.2_M1 to M6) 
and 6 wild type samples (7.2_WT1 to WT6) were generated. From the 4.9sox10:GFP line 
4 mutant samples (4.9_M1 to M4) and 4 wild type samples (4.9_WT1 to WT4) were 
produced. 
Running two million cells from the 7.2sox10:GFP line through the FACS machine 
collected between 40,000 and 60,000 GFP positive cells (Table 5). This data shows that 
2-3 % of the cells from these transgenic embryos express GFP. Sorted cells are predicted 
to include GFP positive NCCs and cells from the otic epithelium (Figure 7). The number 
of cells collected appears to be lower from WT embryos than from mutant embryos. The 
mean number of GFP positive events ± standard deviation sorted during a 500,000 event 
run from mutant samples equalled 13815 ± 1205 while for WT samples it equalled 11933 
± 1583. A two tailed Student’s t-Test gave a p-value of less than 0.0001, where the null 
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hypothesis was no difference, demonstrating that there is a significant statistical difference 
between the mutant and WT samples. 
While sorting cells during run 4 (marked by an asterisk in Table 6) to generate 
sample 4.9_WT1 the sample tubes that collect cells were removed to refocus the liquid 
streams mid-run. As part of this process the system is flushed with Becton Dickinson 
FACSRinse solution to clear any blocks. This sorting run was not paused during the 
flushing process and thus registered a large number of additional events that were not 
collected. In fact fewer cells would have been collected during this run than normal as the 
500,000 event limit would have been reached with a short period during which nothing 
was collected. This data set has been ignored in the following analyses but is shown in 
the table to be comprehensive. 
The number of cells collected by FACS from the 4.9sox10:GFP line (Table 6) from 
a 500,000 event run appeared to be less than sorted previously from the 7.2sox10:GFP 
line (Table 5). This was noted after gathering the M1, M2, WT1 and WT2 samples and the 
difference was significant (two tailed Student’s t-Test p˂0.0001). Cells from an additional 
500,000 event run (five runs or 2.5 million events each in total) were collected to generate 
samples M3, M4, WT3 and WT4 in an attempt to compensate for this. The mean number 
of GFP positive cells sorted from the 7.2sox10:GFP line ± standard deviation equalled 
12874 ± 1686 and for the 4.9sox10:GFP line equalled 9828 ± 2386. Between 30,000 and 
60,000 GFP positive cells were sorted to make up each 4.9sox10:GFP sample. For most 
samples, 1.5 – 2 % of cells from this transgenic line were GFP positive, again this seemed 
to be a lower percentage than collected from the 7.2sox10:GFP line and tallied with the t-
Test result. The 4.9sox10:GFP line does not express GFP strongly in the otic epithelium 
therefore these cells may not be selected by FACS. As seen when sorting cells from the 
7.2sox10:GFP line, it appeared that the WT samples generated fewer GFP positive cells 
than the mutant samples. This was tested using a two tailed Student’s t-Test (p-value = 
0.054), therefore the null hypothesis of no difference could not be rejected. The mean 
number of GFP positive cells collected from a 500,000 event run ± standard deviation was 
10578 ± 2273 for mutant samples and 8530± 2302 for wild type samples. 
In conclusion, GFP positive cells from two transgenic lines have been sorted using 
FACS on WT and sox10-/- backgrounds. As such, a small population of cells from 
disaggregated whole transgenic embryos have been enriched, a population of cells that 
accounts for only 1.5 - 3% of an embryo. 
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Figure 8: Dot plot visualizing a 50,000 cell FACS run. 
This dot plot shows 50,000 events (single cells) recorded during a FACS run. The gates 
set for collecting cells using this data are also shown by boxes. The upper gate defines 
the GFP positive population of cells sorted while the lower gate marks the GFP negative 
cells collected. Note that the gates are set around obvious concentrations of events. The 
x-axis shows FSC or forward scatter, this is roughly proportional to cell size. The y-axis 
displays detected fluorescence. 
Run Number 7.2_M1 7.2_M2 7.2_M3 7.2_M4 7.2_M5 7.2_M6 
1 14061 14919 13614 15419 11245 14817 
2 13790 14018 14466 15106 11862 14984 
3 13840 13735 14028 14801 11203 14349 
4 13374 12996 14211 14214 11731 14782 
Total 
55065 
(2.75 %) 
55668 
(2.78 %) 
56319 
(2.82 %) 
59540 
(2.98 %) 
46041 
(2.30 %) 
58932 
(2.95 %) 
Run Number 7.2_WT1 7.2_WT2 7.2_WT3 7.2_WT4 7.2_WT5 7.2_WT6 
1 12577 14027 10759 14691 10342 13981 
2 9808 12816 10641 14265 10721 12822 
3 9714 12443 10853 13315 10880 12842 
4 9818 10760 10973 13366 10677 13309 
Total 
41917 
(2.10 %) 
50046 
(2.50 %) 
43226 
(2.16 %) 
55637 
(2.78 %) 
42620 
(2.13 %) 
52954 
(2.65 %) 
Table 5: Numbers of events sorted from 7.2sox10:GFP embryos. 
The number of GFP positive events (cells) sorted from individual 500,000 event runs are 
shown. Runs that were pooled together are in columns and total numbers of cells pooled 
are shown. The percentage shown next to total counts is the percentage of cells sorted as 
GFP positive from all events detected. The mean ± standard deviation for all mutant runs 
= 13815±1205 and for all WT runs = 11933±1583. 
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Run Number 4.9_M1 4.9_M2 4.9_M3 4.9_M4 
14469 9521 10164 9566 
14475 9590 9605 9114 
15050 9331 10047 8970 
14553 9323 10052 8677 
- - 9245 8653 
Total 58547 (2.93 %) 37765 (1.89 %) 49113 (1.96 %) 44980 (1.80 %) 
Run Number 4.9_WT1 4.9_WT2 4.9_WT3 4.9_WT4 
1 12796 8980 9677 9136 
2 12832 8225 7777 8946 
3 13490 8456 8359 8388 
4 57740* 8010 8395 8142 
5 - - 3570 8402 
Total 96853 (4.84 %) 33671 (1.68 %) 37778 (1.51%) 43014 (1.72 %) 
Table 6: Number of events sorted from 4.9sox10:GFP embryos. 
The number of GFP positive events (cells) sorted from individual 500,000 event runs are 
shown. Presented as per Table 5. For sample WT1 a counting error has erroneously 
generated a very high number of sorted GFP positive cells (*) (see text).The mean ± 
standard deviation for all mutant runs = 10578± 2274 and for all WT runs = 8530± 2302. 
3.2.3 RT-PCR analysis of sorted GFP positive cells 
To determine if key NC and otic epithelium marker genes were being enriched in GFP 
positive samples when compared to GFP negative cells, an RT-PCR approach was 
adopted. Total RNA was extracted from the sorted cells using the Qiagen RNeasy® Micro 
kit and used to generate cDNA. The cDNA samples were amplified by polymerase chain 
reaction (PCR) using primers that target key marker genes (Table 3). The same PCR 
program (see Chapter 2), with a 58 °C annealing step, was used to amplify cDNA from 
both the 7.2sox10:GFP and the 4.9 sox10:GFP lines using the same primers. The otomp 
primers were used to amplify cDNA in a separate PCR reaction identical but for an 
annealing temperature of 48°C. DNA samples amplified by PCR were visualised by gel 
electrophoresis (Figure 9). Amplified actin bands from both lines appear to be slightly 
more intense in GFP positive samples thus the differences in the key marker gene band 
intensities should be viewed in this context. Despite this, a clear difference is visible for all 
marker genes, with stronger band intensities visible in GFP positive samples when 
compared to GFP negative samples. This holds true for sorted cells from both transgenic 
lines. The GFP positive and negative dct bands displayed the least striking difference in 
intensity. The reason for this is likely to be that dct is also expressed in cells of the retinal 
pigmented epithelium and is thus not restricted solely to the NC. Surprisingly GFP and 
sox10 was amplified from GFP negative samples suggesting that there was some 
incorrect sorting leading to GFP positive cells contaminating the GFP negative sample. In 
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conclusion, FACS has enabled the strong enrichment of the cell types of interest from 
whole zebrafish embryos. 
To assess if the sorted GFP positive cells from WT and sox10-/- displayed 
differential gene expression an RT-PCR approach was employed as described above. 
DNA samples amplified by PCR were visualised by gel electrophoresis (Figure 10 and 
Figure 11). Amplified sox10 and actin cDNA maintained relatively consistent levels of 
expression across all samples. As expected we observed that dct and mitfa had reduced 
transcript levels in the mutant samples compared to the WT samples. This demonstrated 
that the expression of two key NC genes involved in the development of melanophores 
and known to be affected in sox10 mutants were reduced (Kelsh and Eisen, 2000) This 
result matches the reduced expression of both dct and mitfa seen by in situ hybridization 
in sox10-/- embryos compared to WT siblings. The confirmation of differential gene 
expression between WT and mutant samples demonstrated that WT and mutant 
genotypes had been successfully separated. It was concluded that the total RNA 
extracted from the FACS samples could be sent for microarray analysis. 
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Figure 9: RT-PCR Validation of Key Marker Gene Enrichment in GFP positive cells. 
GFP positive and GFP negative cells were sorted by FACS from both the 7.2sox10:GFP 
(top row of gels) and 4.9sox10:GFP (bottom row of gels) lines. RNA was extracted from 
these samples and used to generate cDNA. This cDNA was amplified using primers that 
target key NC marker genes (dct, mitfa and sox10), a marker of the otic epithelium 
(otomp) and GFP. Actin primers were used as a positive control and samples lacking 
cDNA were used as a negative control. Amplified DNA was visualised by gel 
electrophoresis. A 100 bp ladder (Promega) was used as reference for band sizes; the 
500 bp band is highlighted (yellow arrowhead). Lanes 1-4 for each primer pair were 
identical, containing samples as follows, 1 = GFP+ cDNA+, 2 = GFP+ cDNA-, 3 = GFP­
CDNA+ and 4 = GFP- cDNA-. The expected band sizes amplified from cDNA were as 
follows: dct 697 bp, mitfa 581 bp, sox10 420 bp, otomp 355 bp, GFP 600bp and actin 330 
bp. All bands appear to be of the expected size. Actin was amplified from the GFP positive 
and GFP negative samples of both lines, the band intensity of GFP positive samples was 
slightly greater suggesting that the amount of cDNA starting material was slightly 
overestimated. Band intensity from GFP positive cDNA was considerably stronger than 
from GFP negative cDNA for all key marker genes. GFP and sox10 display the most 
striking differences in band intensity while the difference between the dct bands was less 
distinct. No bands for mitfa or otomp were detectable when amplified from the GFP 
negative samples but weak bands were visible in the GFP positive samples. 
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Figure 10: RT-PCR validation of differential gene expression in 7.2sox10:GFP RNA 
samples. 
Key NC marker genes were amplified from mutant and WT template cDNA generated 
using RNA extracted from FACS samples. The identifier of each sample matches that 
shown previously with the FACS data. Actin primers were used as a positive control and 
to show consistent amplification across all samples. A water control lacking cDNA was 
performed as a negative control. A 100 bp ladder (Promega) was loaded on the gel for 
referencing band sizes. The expected band sizes amplified from cDNA were as follows: 
dct 697 bp, mitfa 581 bp, sox10 420 bp and actin 330 bp. All bands appear to be of the 
expected size. If genomic DNA is amplified with the actin primers a 680 bp band is 
generated, this is not detected here. This provides a simple method to detect for genomic 
DNA contamination. Amplification of actin and sox10 was reasonably consistent across all 
samples. Mitfa was not detected in any of the mutant samples but weak bands were 
present in all WT samples. Dct bands from WT samples showed very strong intensity but 
were much weaker in mutant samples. 
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Figure 11: RT-PCR validation of differential gene expression in 4.9sox10:GFP RNA 
samples. 
Key NC marker genes were amplified using mutant and WT template cDNA generated 
from RNA extracted from FACS samples. Presented as per Figure 10. 
3.2.4 Analysis of Extracted RNA 
The RNA extracted from FACS samples was sent on dry ice to the UCI DNA and Protein 
Microarray Facility at the University of California, Irvine. Here they initially analysed RNA 
quality using an Agilent 2100 Bioanalyser and quantity of RNA using a Nanodrop 
Spectrophotometer to assess the suitability of samples for microarray analysis. The data 
from these analyses are shown here for completeness but demonstrate that some 
samples were of sufficient quality and quantity to undergo processing for microarray 
analysis. 
The quantity of RNA that had been extracted from the 7.2sox10:GFP samples was 
very small, between 15 to 60 ng (Table 7), so an amplification step was required to 
generate enough cDNA for subsequent labelling and hybridization to the arrays. The UCI 
Microarray Facility had tested the WT - Ovation™ Pico RNA Amplification System from 
NuGEN and found it capable of generating enough cDNA for hybridization to Affymetrix 
GeneChips from 10 ng of RNA (C. Selby, personal communication). As such all of the 
samples contained enough RNA for amplification, the decision as to which samples to use 
was therefore based on the quality of RNA extracted. Analysis of the electropherograms 
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generated by the Agilent 2100 Bioanalyser was used to assess RNA quality (Figure 12 
and Figure 13). This assay uses fluorescence to detect the RNA sample and measures 
this against time. Small molecules such as degraded RNA appear quickly on the left of the 
electropherogram while large molecules such as genomic DNA appear to the right. A 
typical electropherogram of a high quality RNA sample shows two clear peaks of 
fluorescence corresponding to the 28s and 18s ribosomal RNA subunits, low noise 
between peaks and minimal low molecular weight contamination. All of the 7.2sox10:GFP 
RNA samples show a good RNA profile however samples M2, M4, WT1 and WT5 show a 
large peak on the far right (particularly clear in sample WT1), representing genomic DNA 
contamination (Figure 12). The electropherogram for M3 is not shown but also displayed 
strong genomic DNA contamination. Based on this, samples M1, M5, M6, WT2, WT4 and 
WT6 were selected for further processing for microarray analysis. 
Sample (1:3 
dilution) A260 
ng/µl 
undiluted Total ng 
M1 0.019 2.28 20.52 
M2 0.015 1.83 16.47 
M3 0.013 1.62 14.58 
M4 0.058 6.93 62.37 
M5 0.033 3.96 35.64 
M6 0.047 5.64 50.76 
WT1 0.036 4.32 38.88 
WT2 0.037 4.44 39.96 
WT3 0.022 2.64 23.76 
WT4 0.033 3.96 35.64 
WT5 0.018 2.13 19.17 
WT6 0.043 5.19 46.71 
Table 7: Nanodrop Spectrophotometer analysis of the 7.2sox10:GFP RNA samples. 
Figure 12: Electropherograms for assessing the quality of the 7.2sox10:GFP 
samples. 
Electropherograms display time on the x axis and fluorescence on the y axis. Molecules 
are eluted at different times dependent on size with small molecules eluting first and large 
molecules later. RNA 18S and 28S peaks as well as genomic DNA peaks are labelled. 
LMW noise = Low molecular weight noise, M = Size Marker. (See next page). 
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RNA extracted from the 4.9sox10:GFP samples was also assessed for quantity 
(data not shown) and quality (Figure 13). The M1 electropherogram shows a profile of 
badly degraded RNA while that of M2 shows the profile of a marginally degraded RNA 
sample. The RNA profiles for both M3 and M4 appeared to be good. For the WT samples, 
WT3 and WT4 appeared to have the highest quality RNA with distinct single peaks 
corresponding to 18s and 28s ribosomal RNA. Consequently the samples M3, M4, WT3 
and WT4 were chosen for further processing. 
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Figure 13: Electropherograms for assessing the quality of the 4.9sox10:GFP 
samples. 
Electropherograms display time on the x axis and fluorescence on the y axis. Molecules 
are eluted at different times dependent on size with small molecules eluting early and 
large molecules later. RNA 18S and 28S peaks and genomic DNA peaks are labelled. 
LMW noise = Low molecular weight noise, M = Size Marker. 
The best quality RNA samples were selected to be processed for hybridization to 
the microarrays. The samples were used as a template to generate cDNA followed by an 
amplification step. The cDNA was then fragmented, labelled with biotin and hybridized to 
the Affymetrix zebrafish GeneChips. Initially the UCI DNA Microarray Facility was asked to 
process two samples, M6 and WT6 for a first analysis. Once the results from this were 
determined and appeared to be promising, the remaining 7.2sox10:GFP samples were 
processed. The 4.9sox10:GFP samples were generated after the 7.2sox10:GFP samples 
and were processed subsequently in a single batch. 
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3.2.5 Initial Analysis of Microarray Data 
Initial assessment and analysis of the array data provided by the UCI Microarray facility 
was performed with the Affymetrix GeneChip® Operating Software (GCOS) using 
guidance presented in the Affymetrix Data Analysis Fundamentals handbook (Affymetrix, 
2008). The data from the 7.2sox10:GFP line consisted of three WT versus three mutant 
arrays, the data from the 4.9sox10:GFP line consisted of two WT versus two mutant 
arrays. 
3.2.5.1 Assessing GeneChip® Quality Control Data 
The array data received from the UCI Microarray Facility was assessed using the quality 
control guidelines specified in the Affymetrix Data Analysis Fundamentals handbook. 
Poly – A RNA controls, lys, phe, thr and dap are polyadenylated prokaryotic 
controls that are spiked into the RNA sample mix and can be used to monitor the entire 
target labelling process. They serve as a positive control for target preparation and 
labelling, independent of the quality of the extracted RNA sent for microarray analysis. All 
were present on all of the scanned arrays as expected (Table 8 and Table 9). 
The hybridization controls are a mix of biotin labelled cRNA controls that are 
spiked into the hybridization mix and are used to assess the efficiency of hybridization 
independently of the sample preparation stages. BioB should be detected as present at 
least 50 % of the time. The remaining hybridization controls should always be present. All 
of the control hybridizations are present on all of the chips (Table 8 and Table 9). 
The Internal control genes β-actin and GAPDH are used to assess RNA sample 
and assay quality. The signal values from the 3’ probe sets of these genes are compared 
with the corresponding 5’ probe sets to produce a ratio of 3’/5’. Typically the ratio of 3’ to 
5’ is no more than 3 but rounds of amplification can increase this (Affymetrix, 2008). A 
high ratio of 3’/5’ can be an indication of RNA degradation or inefficiencies in the in vitro 
transcription reaction that generates double stranded cDNA. The 3’/5’ ratio for GAPDH on 
all of the arrays was between 1 and 1.55. The 3’/5’ ratio was consistently much higher 
than 3 on all of the arrays for actin (Table 8 and Table 9). 
The number of probes identified as present, based on signal values, relative to the 
total number of probe sets on the entire array is represented as a percentage. This value 
is dependent on the biological sample being tested but should be roughly consistent for 
replicate samples. A very low percentage can be an indication of poor sample quality. All 
of the arrays except 4.9_WT3 displayed 50 % or more of probes as present, 4.9_WT3 had 
only 45 % of probes present (Table 8 and Table 9). Across these 10 samples, derived 
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from similar biological sources, the percentage of probes present ranged from 45 – 60 % 
but was typically similar with 4.9_WT3 a slight outlier. 
Average background is reported as a signal value detected from across the entire 
array. Typically background should be between 20 -100 (Affymetrix, 2008). All of the 
arrays displayed background within this range with values of roughly 50 to 75. Arrays 
being compared should have similar background values. Noise (RawQ) is a measure of 
pixel to pixel variation of probe cells on a chip, the main contribution to noise comes from 
the electrical noise of the scanner. Arrays that are being compared should have similar 
noise values. The values detected here were between 1.59 and 3.06. For the 
7.2sox10:GFP samples most RawQ values were similar, ranging from 1.59 to 1.95 with 
the WT6 sample a slight outlier with a value of 2.65. For the 4.9sox10:GFP arrays RawQ 
values ranged from 1.96 to 3.06 and were typically slightly higher than seen with the 
7.2sox10:GFP arrays (Table 8 and Table 9). 
The majority of quality control measures examined here displayed good 
characteristics. It was concluded that the sample preparation and hybridization protocols 
had been successful. This data gives confidence that meaningful results can be obtained 
from analyzing and comparing the array data that has been generated. 
Quality 
control 
Parameters 
M1 M5 M6 WT2 WT4 WT6 
Hybridization 
Controls 
bioB P P P P P P 
bioC P P P P P P 
(Present or bioD P P P P P P 
Absent) cre P P P P P P 
Poly-A 
controls 
lys P P P P P P 
phe P P P P P P 
(Present or thr P P P P P P 
Absent) dap P P P P P P 
3’/5’ Ratio β-actin 7.59 7.48 5.80 5.94 5.69 5.24 GAPDH 1.48 1.20 1.21 1.47 1.55 1.21 
% Present 52.5 59.7 56.8 54.7 57.0 52.6 
Background 
Signal 
Average 
Background 73.94 48.63 54.08 55.64 49.98 76.39 
Noise RawQ 1.95 1.59 1.97 1.88 1.68 2.65 
Table 8 : Summary of Quality control parameters for Arrays hybridized with 
7.2sox10:GFP derived samples. 
Hybridization and Poly A controls are given a detection identifier based on signal values 
detected at 3’ probes, P = Present. β-actin and GAPDH display a ratio of signal values of 
the 3’ probe sets against the 5’ probe sets. The percentage present shows the percentage 
of probes on the array detected as being present based on signal values. Average 
Background is a signal value (measure of intensity) for the average background detected 
across the whole array. RawQ is an Affymetrix measure of noise. 
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Quality 
control 
Parameters 
M3 M4 WT3 WT4 
Hybridization bioB P P P P 
Controls bioC P P P P 
(Present or bioD P P P P 
Absent) cre P P P P 
Poly-A lys P P P P 
controls phe P P P P 
(Present or thr P P P P 
Absent) dap P P P P 
3’/5’ Ratio 
β-actin 6.76 8.77 9.57 8.84 
GAPDH 1.21 1.39 1.36 1.00 
% Present 59.5 54.0 45.4 52.0 
Background Average Background 55.4 89.45 58.29 74.85 
Noise RawQ 2.00 3.06 1.96 2.63 
Table 9: Summary of Quality control parameters for Arrays hybridized with 
4.9sox10:GFP derived samples. 
Presented as per Table 8. 
3.2.5.2 Raw Array Data for Key Genes. 
To assess whether differential gene expression could be detected from the array data, two 
samples (M6 and WT6) from the 7.2sox10:GFP line were initially hybridized to the arrays. 
The results for several key genes from this WT versus mutant comparison were analysed 
(Table 10) prior to the remaining 7.2sox10:GFP samples being hybridized to arrays. 
GCOS was used to generate a change call based on programmed statistical tests to 
compare these two arrays. Sox10 and foxd3 transcripts registered as unchanged when 
comparing these two arrays, for sox10 this was expected but a decrease in foxd3 
expression was expected. The expected result may not have been detected because the 
sample size being examined was very small. The remaining key genes all displayed 
decreased expression in mutant samples as predicted. Mitfa registered as not expressed 
at all (Absent) in the mutant sample (Table 10). As the expected results for differential 
gene expression were detected the remaining samples were processed and hybridized to 
microarrays. 
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Affymetrix 
Identifier Gene Name WT6 signal M6 signal Change 
Dr.12604.1.S1_at sox10 3967.4 (P) 2940.3 (P) NC 
Dr.8080.1.S1_at mitfa 115.4 (P) 34.5 (A) D 
Dr.10336.1.S1_at dct 1454 (P) 386 (P) D 
Dr.19416.1.S1_at otomp 326.7 (P) 154 (P) D 
Dr.590.1.S1_at foxd3 198.2 (P) 165.9 (P) NC 
Dr.8124.1.S1_at crestin 9940.8 (P) 4383.2 (P) D 
Dr.14668.1.S1_at gch 1093.1 (P) 653.5 (P) D 
Dr.14668.2.S1_at gch 2859.6 (P) 1456.6 (P) D 
Dr.9225.1.A1_at aox3 (xdh) 3824.9 (P) 3028 (P) D 
Table 10: Comparison of the raw microarray data for samples WT6 versus M6. 
Affymetrix identifiers were annotated using the NetAffx tool on the Affymetrix website to 
identify correct gene names. Raw data (signal values and detection calls) were then found 
for these genes from data analysed with GCOS. Comparison analysis was performed 
using GCOS following guidelines in the Affymetrix Data Analysis Fundamentals Handbook 
using default settings to generate change calls. The WT sample was set as the baseline 
array and the mutant array as the experimental sample. Detection calls, P = Present, A = 
Absent. Change calls, NC = No Change, D = Down. 
Once all the 7.2sox10:GFP samples had been hybridized to the arrays and the raw 
data received from the UCI Microarray Facility, it was examined. To confirm that 
decreases in transcript level for key genes was likely, signal intensity values for mutant 
samples versus WT samples were assessed (Table 11). All mutant samples had 
consistently lower mean transcript levels detected for all key genes examined. Particularly 
strong examples included crestin and dct. Both sox10 and foxd3 had lower average signal 
intensities in mutant samples, in contrast to the previous two array analysis, but this 
analysis did not include a statistical test so it cannot indicate if differences were significant 
or not. This analysis provided a simple inspection of the raw data and suggested that key 
marker genes for neural crest and ear development were down-regulated in sox10 
mutants. This result was similar to that seen when comparing the samples WT6 and M6 
The same raw data shown in Table 11 was compiled for the arrays hybridized with 
the 4.9sox10:GFP samples (Table 12). Again the majority of key genes showed a 
reduction in transcript levels in the mutant samples, crestin and dct were strong examples 
of this. Transcript levels for sox10 were actually slightly higher in mutant samples for this 
data set. This was in contrast to the 7.2sox10:GFP analysis (Table 11) suggesting that 
sox10 was not significantly changed. This was in agreement with the two array 
comparison shown in Table 10. Once again, examining the raw data suggested that key 
neural crest and ear genes were detected as down-regulated in sox10 mutant embryos. 
The microarray data obtained fits with predicted results and should be analysed further to 
identify transcripts not previously associated with sox10 biology. 
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Gene 
Name WT2 WT4 WT6 
Mean ± 
sd M1 M5 M6 
Mean 
± sd 
sox10 3425.9 3327.3 3967.4 3573.5 ± 344.6 2001.6 1949.7 2940.3 
2297.2 
557.5 
mitfa 161.8 158.3 115.4 145.2 ± 25.8 44.9 32.2 34.5 
37.2 
± 6.8 
dct 1374.6 2553.7 1454 1794.1 ± 659.0 128.3 112.1 386 
208.8 
± 153.7 
otomp 218.2 387.8 326.7 310.9 ± 86.0 106.8 142.7 154 
134.5 
± 24.6 
foxd3 238.8 192.6 198.2 209.9 ± 25.2 190 164.1 165.9 
173.3 
± 14.5 
crestin 9227.4 8703 9940.8 9290.4 ± 621.3 2720.3 3339.5 4383.2 
3481 
± 840.4 
gch 1118.9 479.5 1093.1 897.2 ± 361.9 493.1 476.7 653.5 
541.1 
± 97.7 
gch 2505.3 1399.8 2859.6 2254.9 ± 761.4 1083.8 1159 1456.6 
1233.1 
± 197.1 
aox3 3803.6 3331.1 3824.9 3653.2 ± 279.2 2093.6 2386.5 3028 
2502.7 
± 477.9 
Table 11: Signal Intensities for key genes from the 7.2sox10:GFP arrays compared 
between WT and mutant samples. 
Signal intensities were generated using GCOS for each array and then the mean 
calculated for WT samples and mutant samples for each gene. Mean results are given ± 
standard deviation. 
Gene 
Name WT3 WT4 
Mean ± 
sd M3 M4 
Mean ± 
sd 
sox10 1897.9 2009.3 1953.6 ± 78.8 2457.5 1939.3 
2198.4 
± 366.4 
mitfa 134.7 156.6 145.65 ± 15.5 17.5 46.3 
31.9 
± 20.4 
dct 2891.3 2417.7 2654.5 ± 334.9 49.1 251.5 
150.3 
± 143.1 
otomp 155 128.5 141.75 ± 18.7 23.8 63.1 
43.45 
± 27.8 
foxd3 216.9 280.6 248.75 ± 45.0 118.5 150.2 
134.35 
± 22.4 
crestin 5178.2 6507.1 5842.65 ± 939.7 1646.6 2253.3 
1949.95 
± 429.0 
gch 1141.4 1143.0 1142.2 ± 1.1 380.1 471.5 
425.8 
± 64.6 
gch 2900 3170.9 3035.45 ± 191.6 1089.4 1620.6 
1355 
± 375.6 
aox3 3206.5 3870.8 3538.65 ± 469.7 1814.9 2368.6 
2091.75 
± 391.5 
Table 12: Signal Intensities for key genes from the 4.9sox10:GFP arrays compared 
between WT and mutant samples. 
Signal intensities were generated using GCOS for each array and then the mean ± 
standard deviation calculated for WT samples and mutant samples for each gene. 
84

3.2.6 Normalization of Microarray data using GEPAS 
To perform both the normalization of all the array data and to identify differential gene 
expression, tools freely available on the Gene Expression Profile Analysis Suite (GEPAS) 
website (www.gepas.org) were used (Montaner et al., 2006). 
When dealing with multiple arrays, variation between arrays as a result of non-
biological factors such as differences in sample preparation or array processing need to 
be eliminated. Such variation can obscure differential gene expression resulting from the 
biological factor being tested. Despite the quality control array parameters all being within 
acceptable limits, the arrays all had varying levels of background signal intensity (Figure 
14) and it is elements such as this that must be normalized across all arrays being 
compared. To normalize the data, the expresso module on the GEPAS website was used. 
This module is based on the affy Bioconductor package (Gautier et al., 2004, Gentleman 
et al., 2004). It allows multiple different combinations of tools for correcting background, 
normalizing data, correcting perfect match (PM) probe intensities against mis-match (MM) 
probe intensities and summarization methods to be combined easily. At the end of this 
process two box plots were generated, one displaying the processed probe intensities and 
one showing probe intensities prior to processing (Figure 14). These can be used to 
facilitate the selection of the best combination of normalization tools. Based on this 
criterion the default GEPAS settings were selected that process the data as per the 
Robust multi-array analysis (RMA) expression measure (Irizarry et al., 2003b, Irizarry et 
al., 2003a). The settings used were as follows; Background correction = rma, 
Normalization = quantiles, PM correct methods = pmonly and the Summarization method 
= median polish. The data set generated from the 7.2sox10:GFP samples and the 
4.9sox10:GFP samples were normalized individually and then combined and normalized 
to give a data set of five WT arrays versus five mutant arrays. The pre-normalization box 
plots show that the PM probe intensities of each set of arrays were not centred on the 
same point and did not have identical distributions. Post-normalization, each set of arrays 
became centred on the same point and showed very similar distributions of PM probe 
intensities (Figure 14). In conclusion, arrays were calibrated to the same scale and 
therefore comparisons between mutant and WT arrays in a set can be made successfully. 
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Figure 14: Box plots of probe intensities for raw and normalized array data. 
Box plots on the left show the distribution of PM probe intensities for groups of array data, 
the top row shows 7.2sox10:GFP data, the middle row shows 4.9sox10:GFP data and the 
bottom row shows both these data sets combined as one. The box plots on the right side 
show the same PM probe intensity distribution after normalization by the RMA method. 
Probe intensities are shown in a log2 scale. 
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3.2.6 Analysis of Differential Gene Expression using GEPAS 
To analyse the data normalized using expresso, another GEPAS tool was employed, T-
rex. Output data from expresso can easily be entered into T-rex, but class identifiers 
needed to be added to distinguish mutant from WT data sets. The three normalized data 
sets (one set from each group of arrays and a set with both groups combined) were all 
analysed using the two class analysis package in T-rex primarily with the t-Test option. In 
addition the CLEAR test (Valls et al., 2008) option was also used with a significance level 
of 0.05. The t-Test generated a list of genes ranked by t-statistic with genes down-
regulated in mutant embryos at the bottom of the list and genes up-regulated in mutant 
embryos at the top of the list. A p-value for the t-statistic was also reported. The p-value is 
a measure of the evidence against the null hypothesis, it is the probability of the test 
statistic being equal or greater than the observed result under the assumption that the null 
hypothesis is true (Cui and Churchill, 2003). If the p-value is smaller or equal to the 
defined significance level then the null hypothesis of no difference between the two 
classes can be rejected. The CLEAR test combines a z-test to identify large gene 
expression changes and a Chi squared test to evaluate variability (Valls et al., 2008). The 
CLEAR test was applied as it generated a value for mean difference between the two 
groups (m), when working with log intensities this is known as signal log ratio (D. 
Montaner personal communication), an output the t-test did not supply. A simple 
calculation can change the signal log ratio value into a fold change value (See Chapter 2). 
Additionally the CLEAR test in GEPAS identified the outcome of the test by text, for 
example whether a gene is differentially expressed (diff expr) or not changed (non. 
significant). This provides a clear and convenient readout of the test result. 
All three sets of normalized data were analysed by t-Test and CLEAR test to 
identify genes differentially expressed in mutant embryos, both up-regulated and down-
regulated genes. The total number of genes identified by each test is shown in Table 13. 
Using the t-test, large numbers of genes were identified as differentially expressed in all 
data sets at two different significance levels. GEPAS generated a graphical output of the 
most up-regulated and most down-regulated genes identified by the t-Test. Each gene 
was represented by a row and each array was represented by a column. The data for a 
gene on each array was represented by a coloured square to depict normalized 
expression data around a mean of zero. Red shows increased expression for a gene 
compared to the other sample group, blue shows decreased expression. As such a gene 
down-regulated in mutants will appear blue in the mutant sample and red in the WT 
sample. The more intense the colour the greater the expression difference based on the 
standardized scale displayed in sigma units in the output file. Each output file generated 
by the T-rex analyses is shown in Figure 15 with key marker genes annotated. These grid 
images display the 50 most up-regulated genes in mutant samples at the top and the 50 
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most down-regulated genes at the bottom. The colours on the grid showed that the 
analyses have identified genes that are consistently differentially regulated in mutant 
samples across all arrays, red and blue colours were rarely mixed between mutant and 
WT classes for a gene. Mixing of colours was most common in the up-regulated gene list 
of the combined analysis dataset, showing that differential gene expression was not 
consistent across all arrays for some genes. 
When correction methods for multiple testing were applied only a small number of 
genes in the combined dataset were significant, no significantly differentially regulated 
genes were identified in either single dataset at a significance level of p≤0.05 (Table 13). 
The Family Wise Error Rate (FWER) is a control on the probability of accumulating one or 
more false-positive (Type I) errors over a number of statistical tests. FWER criteria are 
very stringent to prevent false positives being identified and this can reduce the power of 
the test (probability that a real effect can be identified by a statistical test) (Cui and 
Churchill, 2003). In practice this will exclude a large number of true positives (Type II 
errors). The False Discovery Rate (FDR) defines the proportion of false positives among 
all of the genes identified as being differentially expressed (Cui and Churchill, 2003). At a 
defined FDR significance level a known proportion of genes will be false positives, this 
allows for a higher rate of false positives than the FWER correction and therefore can 
achieve more power than with FWER correction (Cui and Churchill, 2003). The q-value is 
similar to the p-value but is an extension of the FDR (Storey and Tibshirani, 2003), and 
hence it is not surprising that both FDR methods give identical results with the datasets. 
The CLEAR test also identified a large number of differentially regulated genes in 
all data sets. The number of down-regulated genes identified in the separate 7.2 and 4.9 
datasets by the CLEAR test was very similar in both cases to the number of genes 
identified by the t-Test at the p≤0.05 significance level. For the combined 7.2 + 4.9 dataset 
the CLEAR test identified 410 differentially regulated genes, over two hundred fewer 
genes than the t-Test at the p≤0.05 significance level. The CLEAR test also identified 
much larger numbers of up-regulated genes than the t-Test at the p≤0.05 significance 
level. 
Having generated lists of differentially expressed genes, they were examined to 
see how the key marker genes performed (Table 14). Neither statistical test identified 
sox10 as differentially regulated in sox10 mutant embryos, the expected result. All other 
marker genes in every dataset were identified as down-regulated by the CLEAR test. The 
t-Test for the 7.2 samples generally performed well but neither gch probe was identified as 
being differentially regulated, perhaps due to the high variability identified by the CLEAR 
test. The t-Test produced mixed results for the 4.9 samples failing to declare mitfa, foxd3 
or crestin as being differentially regulated but successfully identifying both gch probe sets 
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as being down-regulated. The t-Test on the combined 7.2 and 4.9 analysis performed well 
identifying all marker genes other than sox10 as being down-regulated. Differential gene 
expression between mutant and WT samples was successfully identified by microarray 
analysis by both statistical tests. 
t-Test CLEAR Test 
Down p≤0.05 p≤0.01 FWER (p≤0.05) 
FDR 
(p≤0.05) 
q-value 
(q≤0.05) 
Diff 
Expr 
Diff Expr 
High Var Total 
7.2 694 200 0 0 0 496 109 605 
4.9 502 121 0 0 0 354 154 508 
7.2+4.9 640 238 6 32 32 308 102 410 
Up p≤0.05 p≤0.01 FWER (p≤0.05) 
FDR 
(p≤0.05) 
q-value 
(q≤0.05) 
Diff 
Expr 
Diff Expr 
High 
Variability 
Total 
7.2 577 121 0 0 0 566 308 874 
4.9 455 91 0 0 0 578 222 800 
7.2+4.9 494 133 2 7 7 359 351 710 
Table 13: Summary of the number of genes identified as differentially expressed. 
For all three datasets the number of differentially regulated genes, either up or down, 
identified have been summarised from the t-Test and the CLEAR test. The t-Test shows 
the results for two different significant levels and the FWER, FDR and q-value corrections 
for multiple testing that were applied. The CLEAR test shows genes identified as 
differentially expressed (Diff Expr) and differentially expressed but with a high variability 
(Diff Expr High Var) and the total for these when combined. 
Figure 15: Grid image output files representing T-rex differential gene expression t-
Test analyses. 
All grid images are organised with arrays in columns and genes in rows, mutant sample 
arrays are on the left and WT sample arrays are on the right. Red = high intensity gene 
expression, blue = low intensity gene expression with darker shades indicating increasing 
extremes of high or low expression when compared to the other class. The 50 most up-
regulated genes are shown in the top half of the grid, the 50 most down-regulated genes 
in the bottom half of the grid. (A) Shows the 7.2 sample array data, (B) shows the 4.9 
sample array data and (C) shows the combined 7.2 + 4.9 samples array data. The data is 
shown on a standardized scale in sigma units. Key marker genes are indicated. (See next 
page) 
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Gene Data Set p-value CLEAR result Fold Change 
sox10 
Dr.12604.1.S1_at 
7.2 0.1320938021 non.significant -1.16 
4.9 0.5171018839 non.significant 1.07 
7.2 + 4.9 0.3415146768 non.significant -1.07 
mitfa 
Dr.8080.1.S1_at 
7.2 0.0013052389 diff.expr -2.14 
4.9 0.0613204651 diff.expr -1.65 
7.2 + 4.9 0.0001868201 diff.expr -1.89 
dct 
Dr.10336.1.S1_at 
7.2 0.0022070811 diff.expr.high.var -9.59 
4.9 0.0318133533 diff.expr.high.var -26.94 
7.2 + 4.9 0.0000556806 diff.expr.high.var -14.58 
otomp 
Dr.19416.1.S1_at 
7.2 0.0026735307 diff.expr -1.86 
4.9 0.0119594019 diff.expr -1.49 
7.2 + 4.9 0.0160892177 diff.expr.high.var -1.96 
foxd3 
Dr.590.1.S1_at 
7.2 0.0010371582 diff.expr -1.32 
4.9 0.1877090707 diff.expr -1.50 
7.2 + 4.9 0.0126530966 diff.expr -1.32 
crestin 
Dr.8124.1.S1_at 
7.2 0.0015099111 diff.expr -2.49 
4.9 0.0867269561 diff.expr -2.57 
7.2 + 4.9 0.0018713886 diff.expr.high.var -2.53 
gch 
Dr.14668.1.S1_at 
7.2 0.0916629434 diff.expr.high.var -1.87 
4.9 0.0202664994 diff.expr -2.41 
7.2 + 4.9 0.0032915222 diff.expr.high.var -2.11 
gch 
Dr.14668.2.S1_at 
7.2 0.1258791536 diff.expr.high.var -1.69 
4.9 0.0314634927 diff.expr -2.54 
7.2 + 4.9 0.0044618039 diff.expr -1.97 
aox3 (xdh) 
Dr.9225.1.A1_at 
7.2 0.0139850015 diff.expr -1.52 
4.9 0.0016299261 diff.expr -1.59 
7.2 + 4.9 0.0010224523 diff.expr -1.50 
Table 14: Summary of T-rex differential gene expression analysis for key marker 
genes. 
Both the t-Test p-value and the CLEAR test results for all three datasets are shown. The 
fold change readout generated from the CLEAR test m value is also presented. Results 
identifying a gene as differentially regulated are highlighted in green, results identifying a 
gene as not differentially regulated are highlighted in red. For the t-Test a p-value 
significance level of p ≤0.05 was selected. CLEAR test results indicate the following 
outcomes: Non significant (not differentially expressed), diff expr (differentially expressed) 
and diff expr high variability (differentially expressed with high variability). 
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3.3 Discussion 
3.3.1 On FACS of zebrafish GFP positive cells 
The use of FACS to enrich for GFP positive cells from the transgenic embryos resulted in 
selecting approximately between 1.5 % and 3 % (Table 5 and Table 6) of the total 
number of disaggregated cells. As expected, a very small number of cells were purified 
from the total number derived from disaggregated embryos. Importantly, key NC and ear 
marker genes were enriched in GFP positive FACS samples when compared to GFP 
negative samples by RT-PCR (Figure 9). Thus FACS in conjunction with the 
7.2sox10:GFP and 4.9sox10:GFP transgenic lines proved to be capable of enriching for 
the cell types of interest. 
Whereas NCCs were expected to be enriched from both transgenic lines, otic 
epithelium cells were only expected to be enriched from the 7.2sox10:GFP line. Thus the 
percentage of GFP positive cells purified from WT embryos of the 4.9sox10:GFP line 
should provide the most accurate measure of the percentage of NCCs in an embryo. The 
results show this to be approximately 1.5 % to 1.75 % cells in an embryo (Table 6). This is 
likely to be an overestimate as some otic epithelium cells and muscle cells expressing 
GFP (Table 4) would also be purified. In fact otomp was enriched in GFP positive 
samples from both transgenic lines when compared to GFP negative samples (Figure 9). 
Therefore GFP positive otic epithelium cells were sorted from the 4.9sox10:GFP line. It 
was expected that due to reduced fluorescence in the otic epithelium of the 4.9sox10:GFP 
line, considerably fewer of these cells would be selected. In line with this, a t-Test to 
compare the number of cells purified from each transgenic line demonstrated that there 
were significantly fewer cells purified per 500,000 cell FACS run from the 4.9sox10:GFP 
line. In addition otomp appeared to be less enriched from GFP positive 4.9sox10:GFP 
cells than from 7.2sox10:GFP cells as shown by RT-PCR (Figure 9). Comparison of 
otomp expression between WT and mutant 4.9sox10:GFP samples still identified the 
expected down-regulation in sox10 mutant samples (Figure 11). This demonstrates that 
otic epithelium cells have been purified from the 4.9sox10:GFP line and that ear marker 
genes can still be identified from this data set. It will be interesting to observe how any 
other otic epithelium expressed genes behave when compared between 7.2sox10:GFP 
and 4.9sox10:GFP data sets. This data does suggest that it will be difficult to select for 
sox10 regulated ear specific genes by comparing microarray results generated from the 
two transgenic lines. 
It was noticed when purifying GFP positive cells from mutant samples that more 
cells were selected per 500,000 cells than from WT samples. For the 7.2sox10:GFP line 
this difference was statistically significant as determined by a t-Test. For the 
4.9sox10:GFP line this proposed difference was very close to being significant with the t­
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Test generating a p-value of 0.054. These results hint that there could be proportionately 
more GFP positive cells in mutant embryos than in WT embryos. This could have 
occurred as a result of passing WT samples through the FACS machine after mutant 
samples, the increased time spent on ice after embryonic disaggregation may have 
affected GFP positive cell number. There may have been some cell death occurring with 
time after disaggregation, but cell death was not quantified in either WT or mutant 
samples or over a time course. Additionally the expectation would be for cell death to 
affect GFP positive and GFP negative cells equally. Alternatively some sox10-/- cells could 
be maintaining GFP expression as a result of failing to specify correctly. It has been noted 
that sox10 is required for neural crest multipotentiality (Kim et al., 2003) and that down-
regulation of sox10 occurs during melanophore differentiation (Greenhill, 2008) and 
sensory neuron differentiation (Carney et al., 2006). Thus in sox10 mutants, where 
differentiation does not occur due to NCCs failing to become specified (Dutton et al., 
2001a) sox10 expression may persist. This could result in a number of additional GFP 
positive cells being present in mutant embryos compared to WT embryos. However sox10 
expression is being visualised indirectly by the presence of GFP protein which can persist 
beyond active transcription thus this may not explain the possible difference in GFP 
positive cell number between WT and sox10 mutant embryos. 
Enrichment of fluorescent cells by FACS presents a powerful tool to generate a 
pure population of cells for gene expression analysis. However if the process of embryo 
disaggregation and passage through a FACS machine alters the gene expression profile 
of cells then aberrant results may be obtained. Examination of signal intensities from raw 
microarray data (Table 11 and Table 12) showed that key NC marker genes were all 
detected as present in WT samples suggesting that the expression profile of NCCs was 
intact. Additionally, down-regulation of key marker genes between WT and sox10 mutant 
samples (Table 10 and Table 14) was observed as expected thus further suggesting that 
cells retained their endogenous gene expression profile. Having only examined one ear 
specific gene, otomp, there is not enough information to gauge if the gene expression 
profile of otic epithelium cells has been affected. However otomp was detected as 
expressed in the sorted samples and appeared to be down-regulated in mutant samples 
thus behaving as expected. If the gene expression profile of NCCs is unaffected by FACS 
then that of otic epithelium cells would be expected to be normal as well. 
Thus far all results suggested that GFP positive cells of interest have been 
successfully enriched by FACS and that the purified cells have normal gene expression 
profiles. This included expected differences in gene expression when compared between 
WT and mutant cells. However refinements to an experiment are always possible. Only 
two parameters, size (FSC) and fluorescence were used characterise the cell population 
of interest during cell sorting. While GFP expression faithfully marks the cell types of 
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interest, additional parameters could have been examined. Side scatter (SSC) provides a 
measure of cell complexity (granularity) and could have been employed to further define 
the cellular population of interest. However the granularity of our cell types of interest has 
not been examined and could therefore be misleading. Parameters such as FSC and 
fluorescence can be combined with a measure of pulse width which helps to define single 
cells (Cerda et al., 2009). Thus a population of fluorescent single cells could be enriched. 
A wide range of GFP positive events were sorted based on FSC (Figure 8). It is possible 
that clumps of cells could have been sorted as GFP positive based on the fluorescence of 
one cell thus contaminating the sample with GFP negative cells. Additionally a stain such 
as propidium iodide could be added to a sample. Propidium iodide is a fluorescent dye 
that binds DNA however it is excluded from live cells thus it marks dead cells for 
elimination from FACS (Cerda et al., 2009, Zhu et al., 2005). Cerda et al., 2009 
demonstrated that only 1 % of their single cell population was constituted of dead cells. 
This is a very small percentage and thus FACS seems to be a reasonably gentle 
procedure. The number of dead cells in the samples presented here was not quantified to 
confirm it is true for this protocol. It is also possible to run a sample of cells from non-
transgenic embryos through a FACS machine to evaluate background fluorescence and 
thus clearly define GFP negative cells for exclusion (Reeves and Posakony, 2005, Cerda 
et al., 2009). Having sorted a population of interest it is possible to re-run a sample of 
sorted fluorescent cells through a FACS machine to demonstrate the efficacy of the 
sorting process (Covassin et al., 2006). This can identify the number of GFP negative 
cells incorrectly sorted during the initial run. These additional measures help to build 
confidence that the cell sorting protocol being followed is effective, certainly it would be 
sensible to incorporate some of these controls in future experiments. The efficacy of the 
sorting protocol can at least partly be judged by the results of RT-PCR of sorted GFP 
positive versus GFP negative RNA samples (Figure 9). For the key marker genes 
assessed so far results indicate that the sorting protocol has been effective. To ensure the 
purity of sorted material a second sort can be performed (Zou et al., 2006) however in this 
case the cells collected were not processed for gene expression analysis. It would need to 
be demonstrated that cells sorted twice were not detrimentally affected by this leading to 
an altered gene expression profile. The protocol presented in this report was designed so 
that cells were exposed to minimal manipulation and that this manipulation was performed 
as quickly as possible to ensure that the gene expression profile of the cells of interest 
was maintained. Examination of gene expression by both RT-PCR (Figure 9, Figure 10 
and Figure 11) and during initial microarray analysis steps (Table 11, Table 12 and Table 
14) all indicate to some extent that this has been achieved. A considerable number of real 
targets of sox10 were identified from the microarray screen by in situ hybridization (see 
Chapter 4) thus indicating the effectiveness of the experiments performed to prepare 
samples for microarray analysis. 
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3.3.2 Regarding the quantification and validation of extracted RNA 
RNA was extracted from the sorted cell samples using the Qiagen RNeasy small sample 
extraction kit but due to the low concentration and small amount of RNA extracted in each 
sample they could not be accurately quantified using a spectrophotometer. Samples had 
to be sent to collaborators at the UCI DNA protein and microarray facility to accurately 
assess the quantity and quality of the extracted RNA using an Agilent Bioanalyser. As a 
result of this, some degraded RNA samples such as 4.9_M1 and 4.9 _M2 (Figure 13) 
were sent to the USA that were unsuitable for microarray analysis. RT-PCR analysis of 
the extracted RNA samples gave no indication of degradation, both 4.9_M1 and 4.9_M2 
samples show successful amplification of both sox10 and actin transcripts. Of course it is 
possible that degradation occurred during transport on dry ice to the USA after RT-PCR 
analysis was performed. It should also be noted that the actin primers used are positioned 
around an intron and therefore should amplify a larger band from genomic DNA than from 
cDNA. No genomic contamination was detected in any of the samples however several 
samples, especially 7.2_M3 and 4.9_WT1, had high levels of genomic contamination as 
determined by the Bioanalyser. This inability to accurately check the RNA samples 
hindered the progression of the project. Indeed samples from 48 hpf embryos were sorted 
from both WT and mutant embryos by FACS and RNA was extracted for microarray 
analysis. These samples were sent to the USA only to discover that the samples were 
badly degraded. While RT-PCR has proved suitable to give an indication of differential 
gene expression, it appears to be an unsuitable guide to other quality issues. Certainly 
access to an Agilent Bioanalyser for accurate RNA assessment would have been 
beneficial. 
RT-PCR analysis of the extracted RNA gave an indication that RNA from WT and 
mutant samples displayed differential gene expression for two key NC genes, mitfa and 
dct. However this difference could only be judged semi-quantitatively, a quantitative 
approach such as Quantitative RT-PCR (QRT-PCR) would have defined the difference in 
transcript levels between the samples more accurately. A QRT-PCR approach was not 
pursued as this technique is not established in the lab and a simple RT-PCR approach 
enabled the project to proceed more rapidly. 
3.3.3 Examining the Affymetrix Quality Control and raw data. 
Guidelines for assessing Affymetrix GeneChips were followed as per the Affymetrix Data 
Analysis Fundamentals Handbook (Affymetrix, 2008) and results are shown in (Table 8 
and Table 9). The poly-A RNA and hybridization controls were all detected as present, the 
expected result. The trp poly-A control was not spiked into the samples by the UCI DNA 
and Protein Microarray facility and therefore was not detected (data not shown). The 
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average background results were all within the normal range defined by Affymetrix and 
thus were acceptable. The noise or RawQ values detected varied from array to array 
however these were normalised subsequent to this analysis using the GEPAS expresso 
tool. The percentage present analysis consistently showed 50 – 60 % of probes on each 
array to be called present, this seems to be relatively consistent for sets of data examining 
gene expression for the same population of GFP positive cells regardless of mutant or WT 
genetic status (Table 8 and Table 9). The majority of genes that these cells express, such 
as key metabolic and housekeeping genes, should be the same and detected as present. 
The 4.9_WT3 array only showed 45 % of probes as present, while this appears to be a 
slight outlier it is not vastly different from the other arrays. The use of percent present as a 
measure for assessing array quality control should be used in conjunction with other 
parameters (Affymetrix, 2008). With other parameters performing well for the 4.9_WT3 
array this slightly lower percent present value does not indicate a problem. For all arrays a 
high 3’/5’ value was detected for the actin probes while the GAPDH probes showed ratios 
below the maximum of three specified by Affymetrix. A high 3’/5’ ratio can indicate that 
that RNA sample was degraded or that the in vitro transcription reaction steps were 
inefficient. The 3’/5’ ratio can be increased by rounds of amplification (Affymetrix, 2008) 
and the samples have undergone linear amplification, but this might be expected to affect 
both internal control genes. The high actin 3’/5’ ratio may result from use of the NuGen 
Ovation™ Biotin Pico RNA Amplification and Labelling system kits to perform the RNA 
amplification and labelling steps rather than Affymetrix supplied kits. Indeed the 3’/5’ ratios 
for actin and GAPDH observed here are very similar to other studies using NuGen kits 
including the actin ratios being high (Clément-Ziza et al., 2009). Additionally some 
experimental parameters have been altered at the UCI DNA and Protein Microarray 
Facility. A combination of these changes may cause different numbers for some quality 
control measures to be registered (Seung-Ah Chung, personal communication). Despite 
some abnormal quality control measures being detected, the majority were acceptable 
thus giving confidence that the array sample processing and hybridization steps have 
performed well. 
The true test of array performance comes from deriving biologically relevant 
results from the data. The performances of several key NC genes and an otic epithelium 
marker gene were assessed to validate the raw array data (Table 10, Table 11 and Table 
12). Raw signal values for all marker genes displayed a reduction in mutant samples thus 
recapitulating results seen from in situ hybridization patterns (Figure 6). As expected 
sox10 expression levels remained unchanged. The majority of these key marker genes 
were also significantly down-regulated when the 7.2_M6 and 7.2_WT6 arrays were 
compared using GCOS, the only exception being foxd3. These results indicate that 
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biologically significant results can be derived from the data and therefore further analysis 
of the data to identify new sox10 targets will be valuable. 
3.3.4 Regarding the normalization and analysis of microarray data using GEPAS. 
Based on trials using various combinations of options available in the GEPAS tool 
expresso and reading of the literature, the RMA expression measure was selected for 
processing the data sets. The RMA expression measure has been compared favourably 
to other normalization methods, such as those employed by Affymetrix, including a greater 
sensitivity in detection of differential gene expression (Irizarry et al., 2003a) and a higher 
correlation with real time RT-PCR data used to validate differential gene expression 
(Millenaar et al., 2006). The RMA expression measure uses a global model of probe 
intensity distribution based on all the array data sets to correct PM probes only (Irizarry et 
al., 2003b). The background correction calibrates the scales of all the arrays to bring them 
all to the same base level. As such this tries to eliminate non-biological factors, for 
example differences in the surface of the array that affect probe intensities on each 
individual array (www.gepas.org). Subsequently quantile normalization was performed in 
order to convert the distribution of probe intensities for each array in a set to the same 
scale (Bolstad et al., 2003). This step removes non-biological variation across a group of 
arrays by calibrating them to the same scale. Quantile normalization attempts to remove 
variation resulting from different scanner settings or laboratory conditions 
(www.gepas.org). As only PM probes are adjusted by the RMA method, no PM correction 
method based on MM probe intensity was applied. Millenaar et. al. 2006 showed that MM 
probe intensities often correlate with PM probe intensities and thus do not solely represent 
non-specific signal and their use can therefore lead to an underestimate of the true 
expression signal. Finally medianpolish summarization generates expression values in a 
log2 scale (Irizarry et al., 2003b). Summarization combines all the probe intensities that 
interrogate a single transcript (a probe set), into a single value to reflect the expression of 
that transcript (www.gepas.org). It is appropriate to log transform expression values as 
“hybridized probe intensities tend to be distributed over exponential space due to 
hybridization behaviour that is governed by exponential functions of sequence-dependent 
base pairing energetic” (Affymetrix, 2008). If signal values are plotted on a linear scale, 
high or intense data points mask the variation in less intense low values. Log transforming 
this data enables variations in both high and low value data points to be seen (Affymetrix, 
2008). Despite the advantages discussed above it would be interesting to compare 
different normalization methods available on GEPAS using key marker genes to discover 
the process which most successfully identifies differentially expressed genes when 
subsequently analysed using the T-rex tool. The additional marker genes identified during 
the validation screen in Chapter 4 would make such analyses more comprehensive. 
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Having normalized the microarray data sets with the RMA method in expresso, the 
T-rex tool was utilised to identify differential gene expression using both the t-Test and the 
CLEAR test statistical test options. Both performed well when checking the results using 
the genes known to be down-regulated in sox10-/- embryos. The sox10 mutant m618 allele 
used for this screen expresses a full length sox10 transcript but a single amino acid 
change renders the protein effectively non-functional (Dutton et al., 2001a). However, as a 
transcript that will hybridize to a microarray is still produced; no difference in sox10 
expression was expected. In fact, the CLEAR test outperformed the t-Test (Table 14). 
However it was the t-Test statistic that was used to generate the list of potential sox10 
targets for validation. The t-Test was preferred as it is in common use and microarray 
results using the t-Test have been published (Tanaka et al., 2000, Callow et al., 2000, 
Covassin et al., 2006). The t-Test can identify genes with very small differences in gene 
expression levels; however the test can suffer from low power if each gene only has a few 
replicates (Baldi and Long, 2001, Cui and Churchill, 2003). When only a few tests are 
performed, a gene with a very small difference in gene expression may appear to be a 
very significant hit if variance is also low thus generating false positives (Valls et al., 2008, 
Cui and Churchill, 2003). The t-Test performed best when applied to the combined data 
set where each gene is represented by 5 arrays, by increasing the number of replicates 
the power of the test increases. Another common method to identify differentially 
expressed genes is to evaluate fold change. This technique does not generate any 
statistical test to indicate a level of confidence in the classification of a gene as 
differentially regulated and can be biased towards identifying genes with low intensities as 
differentially expressed (Cui and Churchill, 2003). No information on the CLEAR test had 
been published at the time the data analysis was performed (Valls et al., 2008). 
Consequently not enough information was available to select the test as the primary tool 
to identify differential gene expression. A recent paper suggests the CLEAR test has more 
power to detect large changes in differential expression, but can fail to identify genes that 
display small changes in expression (Valls et al., 2008). This may disadvantage the 
CLEAR test in terms of identifying transcription factor genes which often have low 
expression levels. Nevertheless the CLEAR test did successfully identify mitfa and foxd3, 
two transcription factors, as differentially expressed (Table 14). There are additional 
statistical tests available in the T-rex tool to identify differential gene expression that could 
be applied to the data (Montaner et al., 2006, Tárraga et al., 2008). The success of the 
analysis will have to be judged on the number of targets that are successfully validated. 
Once an increased set of known differentially regulated genes is established it will provide 
an excellent tool to reassess the best route for data normalization and differential gene 
expression analysis. Identifying the best pipeline for these processes may aid in 
generating a list of highly probable sox10 targets for data mining. 
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The GEPAS t-Test generates a t-statistic and then computes a p-value; genes 
falling below a defined p-value level are regarded as significant. When performing 
microarray data analysis thousands of tests (one for each gene on the array) are 
conducted leading to an accumulation of false positives. To address this, methods to 
correct for multiple testing can be applied. When applying either the FWER, FDR or q-
value correction methods the majority of the genes were no longer considered to be 
significantly differentially expressed. This includes genes demonstrated by in situ 
hybridization to be down-regulated in sox10 mutant embryos. The genes identified as not 
differentially expressed when multiple testing correction methods were applied contains 
biologically relevant results. As such the multiple testing correction methods have been 
ignored for the purposes of the microarray experiments. This increases the probability that 
in the list of genes significant by p-value alone, a number of false positive results are 
present. Additionally it is interesting to note that the only genes found to be significant 
after corrections for multiple testing are applied are within the combined dataset, the data 
set with the largest number of replicate experiments per gene. This suggests that 
comparing three WT versus three mutant arrays is not a large enough sample size to 
eliminate or at least to reduce the probability of false positive errors. Again this relates to 
the performance of the t-Test which improves with increasing replicate experiments for 
each gene. The genes considered to be significantly differentially expressed after applying 
a multiple testing correction method would be worth examining as it would be predicted 
that this list of genes contains very few false positives (see Chapter 5). This analysis 
highlights the issue of the sample size required in microarray experiments to generate 
statistically significant results. This is likely to be dependent on the biological sample 
being studied. However this project has also shown that some biologically significant 
results can be identified by only comparing 2 WT and 2 mutant arrays (Table 14) but by 
increasing sample size results more consistent with the true biological situation are 
generated (Table 14). A larger sample size is likely to reduce false positive results and 
improve the quality of generated data; this in turn will result in easier downstream analysis 
and more true positives being validated. 
3.3.5 Alternative Strategies for Identifying Sox10 targets. 
The microarray approach adopted in this project was designed to identify any gene 
differentially expressed in sox10 mutant embryos in comparison to WT embryos, including 
direct and indirect targets of Sox10. An alternative strategy that could be employed to 
identify sox10 targets is a chromatin immunoprecipitation (ChIP) assay. This approach 
could be applied to whole embryos or GFP positive cells purified by FACS from transgenic 
lines. This technique uses an antibody specific to the protein of interest (in this case 
Sox10) to precipitate out the protein while bound to its native target DNA sequences. 
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These DNA sequences can then be hybridized to a microarray of genomic DNA or 
promoter sequence probes enabling the identification of the promoter sequences enriched 
by the precipitation step; together this approach is known as ChIP-on-chip. ChIP has been 
used as part of a pipeline to validate direct targets of Sox10 that were identified through 
addition of a small interfering RNA (siRNA) specific for Sox10 to a Schwannoma cell line 
(Lee et al., 2008). Microarray analysis was used to identify down-regulated genes and four 
genes were then validated as novel direct targets using ChIP (Lee et al., 2008). To 
successfully apply this technique for the identification of Sox10 targets, a high affinity 
antibody that recognises Sox10 would be required, something unavailable at present for 
zebrafish. Until recently suitable microarrays were not commercially available for zebrafish 
but this technique has recently been applied to zebrafish (Wardle et al., 2006) and the 
promoter chips designed for this paper are now available through Agilent Technologies. 
This technique can identify direct targets of the protein of interest while the microarray 
approach will identify both direct and indirect targets of Sox10. So while an extremely 
interesting and valuable technology, ChIP-on-chip was technologically too challenging to 
perform and did not have the same potential to identify a range of genes key to neural 
crest and ear development as the microarray approach presented in this chapter. 
Another strategy that can be applied to identify the gene expression profile of a cell 
type and compare it to other expression profiles is Serial Analysis of Gene Expression 
(SAGE) and longSAGE. LongSAGE has been used to identify a molecular signature for 
Epidermal Neural Crest Stem Cells (EPI-NCSCs) (Hu et al., 2006). SAGE requires unique 
sequence identifiers (tags) from every mRNA molecule to be isolated, these are 
concatenated and sequenced. The number of times that a tag for a specific transcript 
appears is assumed to be relative to the abundance of that transcript and can therefore be 
used as a measure for gene expression. The relative abundance of transcripts can be 
compared between samples to identify differentially expressed genes. Again this 
technique could be applied to samples of cells sorted from transgenic embryos by FACS. 
A microarray approach was preferred to a SAGE approach as it is a more widely applied 
technique with many resources to support and facilitate data processing and analysis. 
The microarray experiment presented here could be extended by extracting RNA 
from FACS purified GFP negative cells and comparing the gene expression profile 
generated from these cells to that generated from GFP positive cells (Covassin et al., 
2006, Reeves and Posakony, 2005). This strategy can identify genes preferentially 
expressed in a cellular population of interest and is commonly used in combination with 
transgenic embryos. This is the first work we are aware of that combines FACS and 
microarray analysis to examine a mutant genotype. Using the multi class analysis option 
on GEPAS an analysis of variance test (ANOVA) or a CLEAR test could be applied to 
identify genes differentially regulated across WT GFP positive, sox10-/- GFP positive and 
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GFP negative cells from zebrafish embryos. It is possible that such an approach would 
facilitate the removal of false positives from the list of differentially regulated genes thus 
improving the hit rate. This approach was not pursued as the cost of Affymetrix 
GeneChips was a limiting factor. Collaborators are working on a similar project to examine 
differentially regulated genes in mitfa-/- embryos. This data could then be used to expand 
the project to include a comparison of two different mutants. This approach may facilitate 
the identification of melanocyte specific genes. 
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Chapter 4: Validation of sox10 targets identified by Microarray 
analysis 
4.1 Introduction 
Lists of statistically significant differentially expressed genes between WT and sox10-/­
embryos were generated from microarray data in the previous chapter. To validate the 
results from the microarray analysis a whole mount in situ hybridization approach was 
adopted. The 7.2sox10:GFP data was gathered before the 4.9sox10:GFP data and was 
therefore used to identify targets of sox10 for validation. An unbiased approach was 
adopted to assess the microarray results; the most down-regulated genes and the most 
up-regulated genes ranked by t-statistic were cloned and in situ hybridization probes were 
generated. Gene expression was examined in WT and sox10-/- embryos at both 24 hpf 
and 30 hpf time points to facilitate identification of differentially regulated genes. A total of 
136 genes (89 down-regulated genes and 47 up-regulated genes) were examined by in 
situ hybridization for NC or otic vesicle expression that was differentially regulated in 
sox10 mutant embryos compared to WT embryos. Of the down-regulated targets, 25/89 
(28 %) individual genes (30/89 or 34 % including duplicate probe sets) were validated, of 
the up-regulated genes 2 were validated (4 %) giving a total of 27 (20 %) validated 
differentially-regulated genes. 
4.1.1 Methods that can be applied to validate Microarray Data 
Microarray experiments generate a large amount of data regardless of the array type used 
or biological question being examined. The data presented in Chapter 3 indicates that 
hundreds of genes are differentially regulated in sox10-/- embryos. In fact the data sets 
generated will include results that are not biologically relevant as a consequence of mRNA 
levels varying between WT and mutant samples by chance alone and as a result of 
transcript to transcript variations in the efficacy of various technical steps. Additionally 
genes will have been determined incorrectly as differentially regulated as a result of 
weaknesses in the t-test, including a tendency to report genes as significant due to low 
variance or as a consequence of not controlling for multiple testing (Cui and Churchill, 
2003). As such it is vital to confirm the biological significance of targets identified in a 
microarray screen. Two methods are typically utilised to validate microarray targets, real 
time quantitative or semi-quantitative RT-PCR and in situ hybridization. These methods 
are often used to screen a list of transcripts generated from microarray data for genes of 
interest not previously associated with the biological variable under scrutiny, novel genes 
of interest. 
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Semi-quantitative RT-PCR determines the ratio between the abundance of a target 
transcript relative to the amount of a control transcript, typically a house keeping gene. 
The expression level of this house keeping gene does not vary under the experimental 
conditions being tested. Microarray analysis was performed to identify genes differentially 
regulated in the zebrafish cloche mutants and semi-quantitative RT-PCR was performed 
to validate 19 novel potential down-regulated targets. Of the 19 targets tested, 13 showed 
clear down-regulation (Qian et al., 2005). In a similar study, again examining the cloche 
mutant, 24 genes of interest were examined by semi-quantitative RT-PCR and 13 were 
validated by this method (Sumanas et al., 2005). Quantitative RT-PCR enables the 
absolute amount of a transcript to be determined, typically expressed as a copy number or 
a concentration value. This is achieved using an external standard that has the same 
amplification efficiency as the target sequence of interest. Various different amounts of 
this standard are amplified and a standard curve of crossing point (point at which 
fluorescence and therefore cDNA levels are detectable above background) against log of 
the amount of standard is generated. The sample of interest can be amplified and by 
comparison to the standard curve the amount of starting material can be quantified. This 
technique was used to validate four genes identified as differentially expressed in the eye 
of mouse Mitfvitiligo mutants by microarray analysis (Gelineau-van Waes et al., 2008). Both 
techniques are very sensitive and enable the quantification of mRNA levels using specific 
primers and this can corroborate data from microarray analysis. Additionally RT-PCR 
experiments can be performed in large batches enabling rapid high-throughput validation. 
Real time RT-PCR is a powerful and sensitive quantitative technique but it is 
difficult to generate comprehensive data on spatial gene expression patterns using this 
method. Whole mount in situ hybridization is a qualitative technique that addresses these 
patterns of gene expression. Therefore genes identified by microarray analysis and 
validated by RT-PCR are often further validated and examined using in situ hybridization. 
Qian et al., 2005 examined the 13 genes previously validated by RT-PCR as differentially 
regulated in cloche mutants by in situ hybridization. Eight of these target genes showed 
expression in cell types of interest. The remaining five genes did not display a specific 
expression pattern. Sumanas et al., 2005 also examined eight of the validated genes by in 
situ hybridization. Seven of these genes were expressed in vascular endothelial cells. 
Other microarray studies have employed in situ hybridization alone to validate target 
genes. A microarray comparison of drosophila proneural cluster cells versus non­
proneural cluster cells identified 204 genes preferentially expressed in the cells of interest. 
Subsequently 43 genes were analysed by in situ hybridization. 27 novel candidates were 
validated in this way which showed specific expression patterns in the cell types of 
interest (Reeves and Posakony, 2005). Typically validation and characterisation of genes 
by in situ hybridization only focuses on a handful of genes. Rarely, microarray studies 
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have been validated by more comprehensive in situ hybridization screens. A microarray 
study undertook an analysis of differential gene expression between two populations of 
Xenopus ectodermal cells, superficial polarised epithelial cells and deep non-epithelial 
cells. This study identified 98 differentially expressed genes, all of which were examined 
by in situ hybridization. From this second screen 32 differentially regulated genes were 
positively validated (Chalmers et al., 2006). Such large scale in situ hybridization screens 
are rare due to the labour intensive nature of generating a substantial number of in situ 
hybridization probes. Standalone large scale in situ hybridization screens have been 
performed, particularly in zebrafish (Thisse et al., 2004). Such screens have been collated 
on the zebrafish information network (ZFIN) website (www.zfin.org) (Sprague et al., 2006). 
These databases and other published data have been used where available to validate 
microarray data (Covassin et al., 2006, Cerda et al., 2009). This use of published data 
represents an easy way to examine the expression patterns of genes identified by 
microarray analysis. However these screens are not comprehensive and will not enable 
differential expression between WT and mutant embryos to be determined. 
The methods described above can detect differential gene expression between 
two biological situations. Both real time RT-PCR and in situ hybridization are capable of 
being used in a high throughput manner to screen and validate a large number of genes 
that can, for example, be generated from microarray data. Real time RT-PCR presents a 
rapid method to validate candidate genes. However when applied to cells of interest 
purified by FACS, this technique would not add additional information, it would only 
corroborate the microarray data. Indeed RT-PCR would not help in differentiating between 
otic vesicle expressed genes and NC expressed genes. In contrast the less sensitive 
technique of whole mount in situ hybridization is capable of revealing information on both 
spatial and temporal gene expression patterns. In the case of NCCs, in which different cell 
types migrate on stereotypical pathways, this method would help to elucidate the cell 
types that novel candidate genes are expressed in. 
4.1.2 Screening for Genes Important in Neural Crest and Otic Development 
Chemical mutagenesis screens carried out in zebrafish have identified a large number of 
mutants with critical roles in vertebrate development (Haffter et al., 1996, Driever et al., 
1996). Point mutations were induced in the germ cells of adult male zebrafish using N-
ethyl N-nitrosourea (ENU), a chemical mutagen. Treated male zebrafish were crossed 
with untreated females to transmit the mutation and generate the F1 generation. F2 
families were produced by crossing F1 siblings, progeny from crosses between F2 siblings 
were then examined for homozygous mutant embryos. Nearly 100 mutants from separate 
complementation groups affecting NC pigment cell development were phenotypically 
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characterised (Kelsh et al., 1996, Odenthal et al., 1996). Two studies focused on mutants 
that affected the development of the zebrafish ear, one study identified 39 mutants in 
separate complementation groups (Whitfield et al., 1996) while the second study identified 
13 mutants (Malicki et al., 1996) although complementation tests were not performed. 
Therefore these screens identified a large number of mutants and provided insights into 
the biological processes underpinning the development of the NC (Kelsh, 2004) and the 
otic vesicle. Subsequently the cloning of some of these genes has been successful, for 
example the colourless mutant was successfully identified as a lesion in the zebrafish 
sox10 gene (Dutton et al., 2001a). However the positional cloning of genes is a laborious 
process and many genes corresponding to characterised mutants have remained elusive. 
Regardless of this weakness, these chemical mutagenesis screens remain an important 
resource in vertebrate biology. 
To address the difficulty of cloning a gene altered in a mutant of interest an 
insertional mutagenesis screen was undertaken in zebrafish to identify genes important in 
early development (Amsterdam et al., 2004). Insertional mutagenesis was performed 
using exogenous DNA as a mutagen, the DNA also acts as a molecular tag to facilitate 
the identification and cloning of the gene at the locus of the insertion event (Pickart et al., 
2004). The insertional mutagenesis screen identified approximately 390 separate mutants 
and from these, 315 corresponding genes were identified and cloned (Amsterdam et al., 
2004). This screen did not focus on genes important in NC or otic vesicle development but 
it included 11 mutants in which melanocyte pigmentation was altered, 9 of these 11 genes 
encoded subunits of Vacuolar-ATPase (V-ATPase) ion transporters, V-ATPase 
associated proteins or proteins associated with intracellular vesicles (Amsterdam et al., 
2004). Thus while this resource did not focus on genes important in the NC, some were 
identified. 
A combination of chick embryological techniques and array technology was 
applied to identify genes expressed in recently induced NC tissue (Gammill and Bronner-
Fraser, 2002). Pre-migratory NCCs were induced in vitro by juxtaposing pieces of non-
neural ectoderm and intermediate neural plate. Subsequently, cDNA was generated from 
induced NC tissue and from individual non-neural ectoderm and neural plate tissue 
samples for comparison using a macroarray. The macroarray was prepared using a cDNA 
library generated from 4 to 12 somite chick embryos, a period that covers early events in 
chick NC development and strong NC expression of sox10 (Cheng et al., 2000). Genes 
that were up-regulated on the macroarray in induced NCCs in comparison to the non-NC 
tissue samples were identified. This highlighted the 97 genes with the greatest fold 
changes as being expressed as a result of NC induction; all of these genes were then 
examined by in situ hybridization and 83 genes were validated (Gammill and Bronner-
Fraser, 2002). A follow up examination of the data generated from the study by Gammill 
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and Bronner-Fraser, 2002 selected all remaining up-regulated genes for in situ 
hybridization analysis (Adams et al., 2008). This additional analysis was performed to 
identify weakly expressed genes with the aim of finding key NC transcription factors. Over 
300 genes were identified and 112 genes were examined by in situ hybridization leading 
to the validation of 101 NC genes including 14 transcription factors (Adams et al., 2008). 
The transcription factor sox10 was not identified as up-regulated in NC compared to non-
NC tissue by either of these studies. With the NC being a difficult tissue to dissect from 
embryos this in vitro approach has helped to identify a large number of NC expressed 
genes but may not fully recapitulate the true in vivo expression profile of recently induced 
NCCs. 
Multiple types of neural crest stem cell (NCSC) have been discovered both in 
developing embryos and adult organisms (Delfino-Machín et al., 2007). The different 
types of NCSC studied display a wide range of different markers and these have been 
reviewed by Delfino-Machín et al., 2007. While a common NCSC molecular signature has 
not been identified, a molecular signature for embryonic NCSCs and epidermal NCSCs 
(EPI-NCSCs) has been characterised (Hu et al., 2006). The transcriptome of NCSCs, EPI-
NCSCs and differentiated NCCs were captured by LongSAGE analysis and then 
compared. Genes abundant in NCSCs and in EPI-NCSCs but not in differentiated NC 
progeny were identified giving a characteristic gene expression profile of 91 genes. To 
generate the NCSC molecular signature, genes also expressed in bulge epidermal cells of 
the hair follicle were eliminated leaving a profile of 19 genes (Hu et al., 2006). Melanocyte 
stem cells (MSCs) have also been characterised molecularly in their niche, the lower 
permanent portion of the hair follicle (Osawa et al., 2005). MSCs were characterised by 
PCR based gene expression profiling of individual genetically labelled microdissected 
cells. Strikingly MSCs were mainly characterised by the genes that they did not express 
but conversely were highly expressed by melanocytes and to a lesser extent melanoblasts 
(Osawa et al., 2005). 
A further set of screens that have identified a large number of NC expressed 
genes have already been alluded to, the in situ hybridization screens performed on whole 
mount zebrafish that are collected on the ZFIN website. Additionally published zebrafish 
expression patterns are also collated into the ZFIN database giving an extensive 
searchable resource. A search of the gene expression database on ZFIN at the time of 
writing using the anatomical term neural crest returned 219 genes with expression 
patterns (Sprague et al., 2006). 
Most approaches have attempted to identify the entire transcriptome for the cell 
type of interest. Complimentary to this would be the identification of the proteome of a cell 
type of interest. One study has endeavoured to elucidate the proteome of early 
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melanosomes purified from pigmented human MNT1 cells (Basrur et al., 2003). A total of 
68 proteins were identified from early melanosomes including 6 known proteins that are 
specific to melanosomes. By focusing on a melanocyte specific organelle this study has 
unearthed a sizeable number of genes likely to play a key role in melanosome and 
therefore melanocyte biology. 
4.1.3 Aims 
This chapter aims to validate the genes identified from the 7.2sox10:GFP microarray 
analysis as differentially regulated in sox10-/- embryos when compared to WT embryos. 
Genes were validated by performing an in situ hybridization screen. Validated genes were 
expressed in the NC or otic vesicle of zebrafish and were differentially expressed in 
mutant embryos compared to WT embryos. This approach was designed to generate 
information on both the spatial and temporal expression patterns of these genes. 
4.2 Results and Conclusions 
4.2.1 Description of the in situ Hybridization Screen 
An in situ hybridization screen approach was selected to validate the candidate transcripts 
of interest identified in the sox10 mutant 7.2sox10:GFP microarray screen. A blind screen 
was initiated to validate the most differentially regulated genes, with the aim being to 
screen as many genes as possible. Genes were screened from the 100 most down-
regulated and 50 most up-regulated candidates as ranked by t-statistic. Affymetrix 
Identifiers were annotated with available gene symbol information as supplied on the 
NetAffxTM Analysis Centre website (www.affymetrix.com/analysis/index.affx). To generate 
in situ hybridization probes complimentary to each candidate transcript, the following 
pipeline was employed. 
Sequence data was obtained for every candidate as a preliminary step to in situ 
hybridization probe design. Sequence data for a well characterised transcript was taken 
from the NCBI website (www.ncbi.nlm.nih.gov) Entrez Nucleotide database by referring to 
the transcript assignment provided by Affymetrix. In the majority of cases sequence data 
was obtained in this way. When annotation was poorly defined, with multiple transcript 
assignments or given an Affymetrix determined poor annotation grade (grade E or R), 
target sequence data supplied on the NetAffxTM Analysis Centre website was utilised. On 
occasions a BLAST search on either the ZFIN website or the NCBI website using the 
Affymetrix supplied target sequence data yielded additional sequence data. Primers were 
then designed to amplify candidate sequences from 24 hpf zebrafish cDNA. Typically 
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primers were designed to amplify a 500 to 600 bp fragment of the transcript of interest. In 
circumstances when annotation was poor and only a short fragment of sequence data 
was available the largest possible fragment of sequence was targeted for amplification. 
Amplified PCR fragments were gel extracted, if purified DNA fragments were of a 
very low concentration a second identical PCR step was implemented to amplify the 
amount of purified DNA and then gel extraction was repeated. All candidates were then 
cloned into a pGEMT®-Easy vector. After transformation using competent E. coli, 
blue/white colony selection was performed on X-gal supplemented agar plates to identify 
bacteria containing plasmid with an insert. Plasmid DNA was purified from liquid bacteria 
cultures by miniprep. A diagnostic restriction enzyme digest using EcoRI was performed 
to check for the presence and the size of the DNA inserted into the plasmid. Plasmids 
were then sequenced to check that the correct fragment had been ligated into the vector 
and in what orientation. This information was exploited to determine which RNA 
transcription start site present in the pGEMT®-Easy vector (T7 or SP6) should be used for 
generating a labelled anti-sense in situ hybridization probe. After synthesising probes, the 
expression pattern of each candidate was determined using fixed 24 hpf and 30 hpf WT 
and sox10-/- embryos. Embryos at 24 hpf were used as this was the time point of interest, 
30 hpf embryos were used as pigmentation is visible at this stage to facilitate the 
genotyping of embryos. The embryos were examined to identify NC and otic vesicle 
expression and any differences between WT and mutant embryos were determined. 
4.2.2 Generating an in situ hybridization probe for Dr.13165.1.A1_at 
Results from the steps performed to synthesise the in situ hybridization probe for 
candidate Dr.13165.1.A1_at are presented in this section to demonstrate the pipeline that 
was followed. Dr.13165.1.A1_at was annotated on the NetAffxTM Analysis Centre website 
as si:dkey-199l1.2 and sequence data was obtained from the NCBI website. Originally this 
candidate was annotated as npr3 however this annotation was removed but the sequence 
corresponding to this candidate did not change. A left primer 
(ACGAGAGTTTTTCCGGCTAT) and right primer (TACTATGTCCGCCTTTGAGC) were 
designed to amplify a 570 bp fragment of the si:dkey-199l1.2 transcript. PCR was 
performed to amplify the transcript of interest from 24 hpf zebrafish cDNA (Figure 16A). 
The DNA fragment subsequently purified from this gel by gel extraction is shown in Figure 
16B. After ligating the fragment into a pGEMT®-Easy vector and transforming the plasmid 
into bacterial cells, plasmid DNA was purified by miniprep (Figure 16C). Confirmation that 
purified plasmid DNA contained an insert of the correct size was obtained through a 
restriction enzyme digest, an insert of approximately 570 bp was released from the 
plasmid DNA (Figure 16D). 
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Once the presence of insert was confirmed, plasmid DNA was sent for sequencing 
using T7 sequencing primers and the results analysed (Figure 17). Both primers were 
identified within the sequence data demarcating a region of 570 bp. A BLAST search with 
this sequence returned a result of 99 % similarity with si:dkey-199l1.2. Note that the 
BLAST search indentified the sequence data as being in the reverse compliment (strand 
minus/plus) orientation. Thus the correct gene sequence has been cloned in a 3’ to 5’ 
prime direction from the T7 site, or in the 5’ to 3’ direction from the SP6 site. To generate 
an anti-sense in situ hybridization probe, transcription must start from the 3’ end thus T7 
polymerase was used for probe synthesis. The SalI (Sal1) restriction enzyme site 5’ of the 
insert, towards the SP6 site, a site not present within the insert sequence, was selected to 
linearise the plasmid. 
An antisense in situ hybridization probe was synthesised as shown above and 
whole mount in situ hybridization was performed on 24 hpf and 30 hpf zebrafish embryos 
(Figure 18) from a cross that generated 25 % homozygous sox10 mutants. According to 
ZFIN, si:dkey-199l1.2 is an old name for the gene npr3 and directly submitted gene 
expression images show expression in the floor plate, hypochord, neural tube and 
pronephric ducts (Thisse et al., 2004). These results show strong similarities to the 
expression pattern shown in Figure 18. In addition to the published sites of expression it 
is noted that scattered neural tube cells positioned just above the floor plate also express 
npr3 (Figure 18A). No obvious expression was detected in the NC or otic vesicle and no 
differences were detected between the expression pattern of npr3 at 24 hpf and 30 hpf or 
between WT and sox10-/- embryos (data not shown). Therefore, npr3 is a false positive 
result. These results show that the pipeline adopted to generate the in situ hybridization 
probes for the screen can produce probes with very strong and specific signals that 
perform at least as well as published probes and which allow testing of the validity of the 
microarray data. 
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Figure 16: Early Steps during in situ Hybridization probe synthesis. 
All images are of ethidium bromide stained agarose gels. The size marker used in gels A, 
B and D was a 100 bp ladder (Promega), the 500 bp size marker is indicated by a yellow 
arrowhead. The size marker used in gel C was a 1 Kb ladder (Promega) with the 1,000 bp 
size marker indicated by a yellow arrowhead. Bands pertaining to the transcript of interest 
(si:dkey-199l1.2) are indicated with an asterisk (*), unlabelled bands are from other 
samples at the same stage in the pipeline. The expected band size of si:dkey-199l1.2 was 
570 bp. (A) A band of approximately the expected size for si:dkey-199l1.2 was amplified 
by PCR. (B) The same band of amplified DNA in A is shown after gel purification. (C) Two 
purified plasmid DNA samples that should contain the si:dkey-199l1.2 fragment have been 
visualised. (D) An EcoRI restriction digest was performed on the plasmid DNA samples 
shown in C, asterisks highlight the inserts released from the plasmid DNA that are 
approximately 570 bp in size. The lane on the far right of (D) shows undigested plasmid 
DNA while the bright band at the top of the gel picture in all other lanes represents linear 
plasmid DNA. 
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> Dr.13165.1.A1_at 
ATGCTCCGGCCGCCATGGCGGCCGCGGGAATTCGATTTACTATGTCCGCCTTTGAG 
CACATGATGACCACTTCGCTCCCGTAGACGGAGGTGATGATCCCGTCGGGGTCTAC 
CCTCTCCTCGTTGGAGTTCAACACGGCAAAGTCTGTTGAGATGTGGTACTCAGAGAG 
CACCGTAAAAACTCCCTCCATCGTAAAGTAACAGTTTCTCTCATCTTTATCATCGTCG 
TAAATCAAATACGCGGTTCTCCAGCCGAAATGTCCAAATATCGCCTGAAAGGTCTCA 
GCCATCTTCAGGTATGTTGGTGCGATTCGTGTCAGATGAGAGTACTCGGGGGTTTTG 
CTGTTGAAGCCGGTGGCCAGAGCACCTGCCGAGATCACCGGGATGTTCCAGTGCGA 
TGCCACCCTCGTGACCGACGAAGCCGCGTACTCGCACACCGGACCGAGGACCAGG 
TCGGGACGCTCGTCTTTCTGCCGGTCCACGAGCGCGTAGAGAGCGTCCATCCCGCA 
CGCGGAGTTCTCAAAGCGCACATTGAATCTCAGTCCCGCATACGCGTCTGCTTCTCT 
GAGGGCTTTTTTCGCGTACTCAATAGCCGGAAAAACTCTCGTAATCACTAGTGAATTC 
GCGGCCGCCTGCAGGTCGACCATATGGGAGAGCTCCCAACGCGTTGGATGCATAGC 
TTGAGTATTCTATAGTGTCACCTAAATAGCTTGGCGTAATCATGGTCATAGCTGTTTC 
CTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAA 
GTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTC 
ACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCA 
ACGCGCGGGGAGAGGCGGTTTGCGTAT 
BLAST search results: Identities = 567/570 (99%), Positives = 567/570 (99%), Strand = 
Minus / Plus to Danio rerio si:dkey-199l1.2, mRNA 
Figure 17: Dr.13165.1.A1_at Sequence Data. 
Both primers were located in the returned sequence data, the right primer appears first 
and the reverse compliment of the left primer appears second, both highlighted in green. 
The results of a ZFIN BLAST search against RNA and cDNA sequences using the 
sequence between both primers was performed with the sequence data returning a hit of 
99 % similarity to si:dkey-199l1.2. 
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Figure 18: Whole mount in situ hybridization pattern of npr3 expression. 
Lateral views of 30 hpf zebrafish trunks are shown oriented, dorsal top, ventral bottom, 
anterior left and posterior right. An image of mid-trunk (A) and an image of a more 
posterior trunk region towards the end of the yolk sac extension (B) are shown. 
Expression of npr3 occurs in distinct stripes stretching the entire length of the trunk, rp = 
roof plate, fp = floor plate hc = hypochord and pd = pronephric duct. Pronephric duct 
expression is stronger posteriorly (B). In addition to expression in the labelled structures, 
npr3 is also expressed in scattered cells in the ventral neural tube indicated by an asterisk 
(*) in A. 
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4.2.3 Summary of the Down-Regulated Genes Selected for Validation 
The aim was to validate as many genes as possible from the 100 most down-regulated 
candidates, ranked by t-statistic (Table 15). Seven transcripts were not examined as a 
result of time constraints, these are summarised in Table 16. Of the seven candidates not 
examined, five could not be amplified from 24 hpf cDNA, one repeatedly failed to ligate 
successfully into a vector and for one, primers were not designed. From the remaining 93 
candidates there were three pairs of probe sets that corresponded to the same genes 
(Table 17). Thus when duplicates were ignored, 90 separate genes were investigated. 
Initial annotation identified the probe Dr.24498.1.A1_at as sox11a and as such sequence 
data pertaining to this gene was used to generate an in situ hybridization probe. 
Subsequent to the screen being completed this annotation was removed and as such the 
wrong gene was cloned and examined. Therefore 89 separate candidates were 
successfully examined, included within this list were five marker genes that were expected 
to be down-regulated (crestin, dct, foxD3, mitfa and otomp). Plasmids used for the 
transcription of in situ hybridization probes to detect mRNA transcribed from these genes 
were already available in the laboratory and as such were not cloned. The otomp probe 
was obtained from Dr. Tanya Whitfield. The pax7 probe was obtained courtesy of Dr. 
Hitoshi Okamoto. Thus for the in situ hybridization screen 83 candidates were cloned and 
89 gene expression patterns examined in WT and sox10-/- embryos at two separate time 
points. Whole mount in situ hybridization expression patterns are shown for the validated 
genes. These are ordered into sections based on the cell type they are likely to be 
expressed in. 
Affymetrix ID t-statistic p-value Fold Change Gene Symbol 
Dr.991.2.A1_s_at -6.173 0.003497 -1.15 ggps1 
Dr.22144.1.A1_at -6.185 0.003473 -1.25 zgc:113142 
Dr.7154.1.A1_at -6.227 0.003386 -1.19 slc25a26 
Dr.19421.1.A1_at -6.231 0.003378 -1.24 phf8 
Dr.1251.1.S1_at -6.27 0.003303 -1.58 degs1 
Dr.7955.1.A1_at -6.274 0.003295 -1.5 
Dr.10151.1.A1_a_at -6.282 0.003279 -1.37 
Dr.24473.1.A1_at -6.296 0.003252 -1.11 si:ch211-218c6.1 
Dr.14787.1.A1_at -6.307 0.003231 -2.85 s100b 
Dr.9236.2.A1_at -6.365 0.003124 -1.45 si:ch211-243g18.2 
Dr.11740.1.A1_at -6.4 0.00306 -1.08 wu:fb74h01 
Dr.1242.1.S1_at -6.401 0.003059 -1.38 cotl1 
Dr.5325.1.A1_at -6.428 0.003011 -2.27 zgc:65870 
Dr.21407.1.A1_at -6.482 0.00292 -1.16 
Dr.13966.1.S1_at -6.522 0.002854 -1.29 zgc:63767 
Dr.6142.1.A1_at -6.633 0.002681 -2.85 si:dkey-180p18.9 
Dr.19416.1.S1_at -6.638 0.002674 -1.86 otomp 
Dr.7966.1.S1_at -6.639 0.002672 -1.84 atp6v1e1 
Dr.7250.1.A1_at -6.676 0.002617 -1.41 zgc:110239 
Dr.3991.1.A1_at -6.692 0.002594 -2.53 wu:fd02h10 
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Dr.20271.1.S1_at -6.705 0.002575 -1.14 zgc:162119 
Dr.4599.1.A1_at -6.854 0.002373 -1.29 zgc:112247 
Dr.16013.1.A1_at -6.873 0.002348 -1.29 wu:fj65e12 LOC100004591 
Dr.4751.2.A1_at -6.883 0.002335 -2.48 aldh2b 
Dr.7215.1.S1_at -6.947 0.002256 -1.25 mtch2 
Dr.4615.2.S1_at -6.975 0.002222 -1.06 
Dr.22212.1.A1_at -6.98 0.002216 -1.24 cyp3c1l2 
Dr.10336.1.S1_at -6.987 0.002207 -9.59 dct 
Dr.1920.1.S1_at -7.018 0.002171 1.07 derl1 
Dr.13359.1.S1_at -7.087 0.002093 -1.84 adsl 
Dr.9157.1.S1_at -7.126 0.00205 -1.3 mkks 
Dr.17743.1.A1_at -7.173 0.002 -1.94 zgc:66482 
Dr.13642.1.S1_at -7.181 0.001992 -1.91 
Dr.14845.1.S1_at -7.359 0.001816 -1.1 
Dr.20896.1.S1_at -7.372 0.001805 -1.99 slc2a15b 
Dr.4171.1.A1_at -7.446 0.001738 -3.7 pah 
Dr.7590.1.A1_at -7.478 0.00171 -2.02 wu:fj68b05 
Dr.4248.1.A1_at -7.673 0.001551 -1.52 wu:fa98e08 
Dr.10624.2.S1_a_at -7.705 0.001527 -2.84 zgc:110343 
Dr.18158.1.A1_at -7.71 0.001523 -1.53 
Dr.8124.1.S1_at -7.728 0.00151 -2.49 crestin 
Dr.4751.1.S1_a_at -7.748 0.001495 -2.34 aldh2a aldh2b 
Dr.983.1.S1_at -7.758 0.001488 -1.56 paics 
Dr.26101.1.A1_at -7.819 0.001444 -3.26 
Dr.4629.1.A1_at -7.83 0.001436 -1.53 pi4k2a 
Dr.22990.1.A1_at -7.88 0.001402 -3.05 wu:fj82h06 
Dr.1691.3.S1_at -7.89 0.001396 -1.4 cct5 
Dr.18052.1.S1_at -7.898 0.00139 -1.4 znf593 
Dr.8594.1.S1_at -7.945 0.001359 -1.81 zgc:100919 
Dr.3237.1.A1_at -7.946 0.001358 -1.57 wu:fc08b04 
Dr.13244.1.A1_at -7.965 0.001346 -1.57 zgc:152987 
Dr.26323.1.A1_at -7.965 0.001346 -1.35 wu:fb95f11 
Dr.8080.1.S1_at -8.03 0.001305 -2.14 mitfa 
Dr.6806.1.S1_at -8.161 0.001227 -2.8 keap1 
Dr.10624.2.S1_at -8.217 0.001195 -2.08 zgc:110343 
Dr.3972.1.S1_at -8.302 0.00115 -3.2 
Dr.2155.2.S1_at -8.385 0.001107 -1.22 ppa1 
Dr.590.1.S1_at -8.529 0.001037 -1.32 foxd3 
Dr.25954.1.A1_at -8.543 0.001031 -1.2 
Dr.8251.1.A1_at -8.556 0.001025 -1.6 wu:fi05a09 
Dr.481.1.S1_at -8.667 0.000975 -1.85 atic 
Dr.12707.1.A1_at -8.672 0.000973 -2.16 zgc:112072 
DrAffx.1.65.S1_at -8.688 0.000966 -1.54 cx33.8 
Dr.2606.1.A1_at -8.689 0.000966 -1.26 LOC568088 
Dr.2788.1.S1_at -8.714 0.000955 -2.63 si:dkeyp-86b9.2 
Dr.2393.1.S1_at -8.766 0.000934 -1.14 dohh 
Dr.14798.1.A1_at -8.793 0.000923 -1.19 zgc:110718 
Dr.2729.1.A1_at -8.801 0.000919 -1.57 wu:fc54b10 
Dr.4873.1.A1_at -8.871 0.000892 -1.16 wu:fi46h04 
Dr.2901.1.S1_at -9.323 0.000737 -1.45 coro1c 
Dr.646.1.S1_at -9.401 0.000713 -1.26 mg:cb01g09 
Dr.15700.1.A1_at -9.492 0.000687 -1.31 ell 
Dr.4568.1.A1_a_at -9.55 0.000672 -1.19 wu:fc17h11 
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Dr.3180.1.A1_at -9.713 0.000629 -1.96 bhlhb2 
Dr.20850.1.S1_at -9.913 0.000581 -1.69 fabp7a 
Dr.18800.1.S1_at -9.97 0.000569 -1.27 ccbl2 
Dr.14747.1.A1_at -9.988 0.000565 -3.03 slc2a15b 
Dr.7249.1.A1_at -10.191 0.000522 -1.14 zgc:110397 
Dr.5963.1.A1_at -10.548 0.000457 -1.62 wu:fj38e08 
Dr.23456.1.S1_at -10.592 0.00045 -1.25 pax7 
Dr.22614.1.A1_at -10.704 0.000432 -3.22 
Dr.24498.1.A1_at -10.723 0.000429 -1.28 
Dr.4838.1.A1_at -10.73 0.000428 -3.36 wu:fb51g06, zgc:158673 
Dr.13012.1.S1_at -10.857 0.000408 -1.66 nfkb2 
Dr.3933.1.A1_at -11.345 0.000344 -3.58 wu:fc46b01, zgc:100933 
Dr.25879.1.A1_at -11.355 0.000343 -1.13 
Dr.18194.1.A1_at -11.487 0.000328 -2.62 pik3c3 
Dr.2900.1.A1_at -11.918 0.000284 -1.46 ift88 
Dr.3154.1.A1_at -12.091 0.000268 -1.29 LOC564527 zgc:154036 
Dr.12107.1.A1_at -12.15 0.000263 -2.14 ndrg1 
Dr.25257.1.A1_at -14.48 0.000132 -7.41 bhlhb3l 
Dr.9611.1.A1_at -14.789 0.000122 -3.11 si:ch211-241e15.2 wu:fj94a03 
Dr.518.1.A1_at -15.54 0.0001 -4.59 sb:cb319 
Dr.10292.1.S1_at -16.037 0.000088 -7.77 rbp4l 
Dr.8680.1.S1_at -16.124 0.000087 -2.71 cldnj 
Dr.2855.1.A1_a_at -16.267 0.000084 -1.86 
LOC564804 similar to 
ATPase, H+ 
transporting, lysosomal 
70kDa, V1 subunit A, like 
Dr.9560.1.A1_at -16.778 0.000074 -1.52 wu:fj87g04 LOC565706 
Dr.13919.1.S1_at -17.892 0.000057 -3.8 
Dr.4612.1.A1_at -18.127 0.000054 -2.83 wu:fc31e04 
Dr.16789.1.A1_at -25.393 0.000014 -1.96 
Affymetrix ID t-statistic p-value Fold Change Gene Symbol 
Table 15: Table of the 100 most down-regulated genes in sox10 mutant embryos, 
ranked by t-statistic. 
The 100 most down-regulated genes as identified from the 7.2sox10:GFP microarray data 
analysed in Chapter 3 and evaluated using a t-Test are shown. Genes are ranked by t-
statistic; the p-value generated by the t-Test is also shown. The fold change for each gene 
is also shown as determined from the CLEAR test. Each gene was annotated with a gene 
symbol using the NetAffx website. 
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Affymetrix 
Identifier Gene Symbol 
Reason That Gene Expression Pattern 
Was Not Obtained 
Dr.9560.1.A1_at wu:fj87g04, LOC565706 PCR failed 
Dr.22614.1.A1_at PCR failed 
Dr.4568.1.A1_a_at wu:fc17h11 Ligation failed 
Dr.4615.2.S1_at PCR failed 
Dr.6142.1.A1_at si:dkey-180p18.9 Primers not designed 
Dr.21407.1.A1_at PCR failed 
Dr.14787.1.A1_at s100b PCR failed 
Table 16: Summary of the down-regulated candidate genes for which assessment 
by in situ hybridization was not completed. 
Candidates are identified by both Affymetrix identifier and gene symbol as annotated on 
the NetAffxTM Analysis Centre website. PCR failed indicates that the gene could not be 
amplified from 24 hpf zebrafish cDNA using the designed primers. 
Affymetrix Identifier Gene Symbol 
Dr.14747.1.A1_at slc2a15b 
Dr.20896.1.S1_at slc2a15b 
Dr.10624.2.S1_a_at zgc:110343 
Dr.10624.2.S1_at zgc:110343 
Dr.4751.1.S1_a_at aldh2a aldh2b 
Dr.4751.2.A1_at aldh2b 
Table 17: Duplicate Down-Regulated Genes. 
4.2.4 Summary of the Up-Regulated Genes Selected for Validation 
It was attempted to clone and identify a gene expression pattern for as many of the up-
regulated genes as determined by microarray analysis as possible. The 50 most up-
regulated genes as ranked by t-test from the 7.2sox10:GFP microarray data were 
examined (Table 18). From these 50 genes, 47 were successfully cloned and a gene 
expression pattern obtained, 3 genes were not cloned (Table 19). Within the 50 most up-
regulated genes an Affymetrix control probe (AFFX-r2-Bs-lys-3_at) was present, this 
transcript was excluded thus the candidates that were screened actually comprised of 50 
of the top 51 up-regulated genes. Although 47 of the up-regulated genes were cloned, the 
following probes were also obtained from other laboratories, hoxd4a with thanks to Dr. 
Victoria Prince and wnt11r with thanks to Dr. Simon Hughes. 
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Affymetrix ID t-statistic p-value Fold Change Gene Symbol 
Dr.16.1.S1_at 14.94 0.00012 1.38 nr2f1 
Dr.22087.1.A1_at 13.055 0.0002 1.47 wu:fd12f01 
Dr.26266.1.A1_at 12.811 0.00021 1.2 
Dr.597.1.S2_at 11.376 0.00034 1.4 vegfaa 
Dr.2967.1.A1_at 9.233 0.00076 1.95 hoxc8a 
Dr.11268.1.A1_at 8.818 0.00091 1.71 
Dr.18334.1.A1_at 8.794 0.00092 1.25 cars 
Dr.6063.1.A1_at 8.624 0.00099 1.58 si:dkey-73n10.1 
Dr.21429.1.S1_at 8.527 0.00104 1.31 zgc:85683 
Dr.23153.1.S1_at 8.394 0.0011 1.36 LOC100000500 
Dr.17602.1.A1_at 8.277 0.00116 1.11 
Dr.4119.2.S1_at 8.189 0.00121 1.44 hoxd4a 
Dr.22671.1.A1_at 8.166 0.00122 1.41 si:dkey-174n20.1 
Dr.14080.1.A1_at 7.987 0.00133 1.28 wu:fq26c12 
Dr.18932.1.A1_at 7.962 0.00135 1.08 zgc:153973 
Dr.8297.1.S1_at 7.61 0.0016 1.59 wnt11r 
Dr.4978.1.A1_at 7.513 0.00168 1.31 zgc:85829 
Dr.1094.1.A1_at 7.334 0.00184 2.04 wu:fk49e12 
Dr.11996.1.A1_at 7.316 0.00186 1.25 LOC100000439 
Dr.12764.1.A1_at 7.288 0.00188 1.42 sb:cb54 
Dr.3936.1.A1_at 7.177 0.002 1.43 zgc:162730 
Dr.12263.1.A1_at 7.156 0.00202 1.39 LOC556968 
Dr.20715.1.S1_at 7.143 0.00203 1.23 ssr1 
Dr.10232.1.A1_at 7.1 0.00208 1.54 meis2.2 
Dr.23461.1.A1_at 7.036 0.00215 1.53 stanniocalcin 2 (stc2) zgc:136650 
Dr.1837.1.A1_at 6.988 0.00221 1.16 wu:fc83f05 
Dr.17738.1.S1_at 6.915 0.00229 1.15 tnfaip6 
Dr.14522.1.S1_at 6.862 0.00236 1.92 pvalb7 
Dr.11252.1.A1_at 6.833 0.0024 1.1 zgc:56085 
Dr.10119.1.A1_at 6.713 0.00256 1.16 zgc:92480 
Dr.38.1.A1_at 6.7 0.00258 1.43 sb:cb307 
Dr.18513.2.S1_at 6.617 0.0027 1.33 sccpdhb 
Dr.7908.1.S2_at 6.589 0.00275 1.22 
calm1a 
calm1b 
calm2a 
calm2b 
calm3a 
calm3b 
zgc:55813 
Dr.21012.1.A1_at 6.478 0.00293 1.38 sfrp5 
Dr.14529.1.S1_at 6.458 0.00296 1.19 zgc:91935, LOC792266 
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Dr.6496.1.S1_at 6.452 0.00297 1.18 fth1 
AFFX-r2-Bs-lys-3_at 6.445 0.00298 2.63 
Dr.3336.1.S1_at 6.435 0.003 1.31 meis1 
Dr.10254.1.A1_at 6.413 0.00304 1.37 lin7b 
Dr.18367.1.A1_at 6.393 0.00307 1.19 
Dr.25500.1.S1_at 6.359 0.00314 1.27 vamp1 
Dr.8093.1.S1_at 6.345 0.00316 1.25 par1 
Dr.2615.1.S1_at 6.334 0.00318 1.34 appb 
Dr.15532.1.A1_at 6.306 0.00323 1.13 LOC100148646 
Dr.13165.1.A1_at 6.02 0.00384 2.01 si:dkey-199l1.2 
Dr.18374.1.A1_at 5.961 0.00398 1.72 
Dr.16719.1.A1_at 5.957 0.00399 1.37 
Dr.1911.1.A1_at 5.927 0.00406 1.17 LOC564069 
Dr.15347.1.S1_at 5.919 0.00408 1.42 LOC562530 
Dr.10524.1.S1_at 5.903 0.00412 1.18 zgc:85694 
Dr.4649.1.A1_a_at 5.777 0.00446 1.31 phc2 
Dr.16431.1.S1_at 5.679 0.00474 1.24 wu:fj63d08 
Affymetrix ID t-statistic p-value Fold Change Gene Symbol 
Table 18: Table of the 50 most up-regulated genes in sox10 mutant embryos, 
ranked by t-statistic. 
The 50 most up-regulated genes as identified from the 7.2sox10:GFP microarray data 
analysed in Chapter 3 and evaluated using a t-Test are shown. Genes are ranked by t-
statistic; the p-value generated by the t-Test is also shown. The fold change for each gene 
is also shown as determined from the CLEAR test. Each gene was annotated with a gene 
symbol using the NetAffx website. 
Affymetrix 
Identifier Gene Symbol 
Reason That Gene 
Expression Pattern Was Not 
Obtained 
Dr.11996.1.A1_at LOC100000439 PCR Failed 
Dr.12764.1.A1_at sb:cb54 Ligation Failed 
Dr.18367.1.A1_at PCR Failed 
Table 19: Summary of the Up-Regulated Candidate Genes Not Examined during the 
in situ hybridization screen. 
Candidates are identified by both Affymetrix identifier and gene symbol as annotated on 
the NetAffxTM Analysis Centre website. PCR failed indicates that the gene could not be 
amplified from 24 hpf zebrafish cDNA using the designed primers. 
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4.2.5 Validated Genes Down-Regulated in sox10 mutant embryos. 
4.2.5.1 Known down-regulated genes 
The TF mitfa and the differentiation gene dct are both expressed in melanocytes and are 
known to be down-regulated in sox10 mutant embryos (Dutton et al., 2001a, Kelsh and 
Eisen, 2000). In fact, evidence exists showing that both genes are direct targets of Sox10 
(Bondurand et al., 2000, Ludwig et al., 2004). Thus the results from the microarray data 
and the in situ hybridization screen that both these genes were strongly down-regulated in 
NC derived melanoblasts at 24 hpf embryos were expected (Figure 19 and Table 20). 
Occasional dct expressing cells can be seen in sox10 mutant embryos thus expression of 
this differentiation gene is not completely abolished (Kelsh et al., 2000b). 
The Affymetrix probe set Dr.8124.1.S1_at corresponds to the pan-NC marker gene 
crestin (Luo et al., 2001, Rubinstein et al., 2000). Crestin is a widely used NC marker but 
this gene has been poorly characterised. It has been hypothesised that crestin is a 
member of a family of retroelements in the zebrafish genome (Rubinstein et al., 2000). It 
has been shown previously that crestin is down-regulated in sox10 mutant embryos 
(Elworthy et al., 2005). Note that in contrast to dct and mitfa, crestin expression is only 
reduced not absent. For example, a small number of cells expressing crestin can still be 
detected migrating on the medial pathway in mutant embryos (Figure 19 and Table 20). 
These cells are likely to be of a neural fate and can be visualised by sox10 in situ 
hybridization in sox10 mutant embryos (Dutton et al., 2001a). Thus the results from the 
microarray data and the in situ hybridization screen that crestin is strongly down-regulated 
in 24 hpf embryos was expected (Figure 19). 
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Affymetrix Probe Identifier Dr.8080.1.S1_at Dr.10336.1.S1_at Dr.8124.1.S1_at 
Affymetrix Gene Symbol mitfa dct crestin 
ZFIN Gene Symbol mitfa dct crestin 
Full Name 
microphthalmia-
associated 
transcription factor a 
dopachrome 
tautomerase crestin 
Orthology MITF DCT N/A 
Biological Process GO Term 
transcription, DNA-
dependent 
melanocyte 
differentiation 
regulation of 
transcription 
metabolic process N/A 
Molecular Function GO Term 
transcription activator 
activity 
protein dimerization 
activity 
oxidoreductase 
activity 
metal ion binding 
N/A 
7.2sox10:GFP array 
results 
t-
statistic -8.0299043655 -6.9873137474 -7.7277312279 
p-value 0.0013052389 0.0022070811 0.0015099111 
CLEAR 
result diff.expr diff.expr.high.var diff.expr 
Fold 
Change -2.14 -9.59 -2.49 
4.9sox10:GFP array 
results 
t-
statistic -3.85014081 -5.4718756676 -3.1706631184 
p-value 0.0613204651 0.0318133533 0.0867269561 
CLEAR 
result diff.expr diff.expr.high.var diff.expr 
Fold 
Change -1.65 -26.94 -2.57 
7.2+4.9sox10:GFP 
array results 
t-
statistic -6.5065011978 -7.7335410118 -4.5512132645 
p-value 0.0001868201 0.0000556806 0.0018713886 
CLEAR 
result diff.expr diff.expr.high.var diff.expr 
Fold 
Change -1.89 -14.58 -2.53 
Table 20: Summary of information for mitfa, dct and crestin. 
All tables summarising the information for each validated probe are presented in the same 
format. Affymetrix gene symbol and GO terms were taken from the NetAffx website. The 
ZFIN symbol was identified by searching ZFIN with the Affymetrix gene symbol or through 
a BLAST search using sequence data taken from NetAffx. Orthology to a human gene 
was determined from either the Ensembl website or the ZFIN website. All array data was 
taken from the appropriate microarray data set. 
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Figure 19: Whole mount in situ hybridization expression patterns of mitfa, dct and 
crestin. 
All images are lateral views of 24 hpf zebrafish embryos oriented anterior left and dorsal 
top. Images labelled with a letter alone are of WT embryos, images labelled with a letter 
and an apostrophe are corresponding images of sox10 mutant embryos. Images C and C’ 
are of dct expressing melanoblasts in the head, all remaining images are of the trunk. 
Arrowheads in A, E and E’ indicate pre-migratory NCCs. Arrows indicate cells migrating 
on the medial pathway (A, D and D’) and on the lateral pathway (B). Scale bars = 50 µm. 
4.2.5.2 Melanocyte Expressed Genes 
The following section contains genes that displayed an expression pattern consistent with 
the melanocyte lineage and were down-regulated in sox10 mutant embryos. Melanocytes 
migrate on both the lateral and medial pathways, unlike other NC derivatives that are 
restricted to migration on a single pathway. Thus gene expression on both pathways is 
suggestive of expression in the melanocyte lineage. Cells of the melanocyte lineage can 
also be visualised, using known marker genes, migrating in the midbrain-hindbrain 
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boundary and over the head. Melanocytes fail to migrate in sox10 mutant embryos; this is 
in contrast to neural derivatives as some of these cells still migrate in mutants. The mitfa 
expression pattern typifies a melanocyte expression pattern thus any gene with a similar 
expression pattern showing the features mentioned above are likely to be expressed in 
the melanocyte lineage. By 30 hpf, melanoblasts have begun to pigment thus co­
localisation of in situ hybridization stain with melanin also indicates that the gene is 
expressed in the melanocyte lineage. While the above characteristics strongly suggest at 
gene expression in the melanocyte lineage they do not exclude expression in other NCC 
types; it would require expression of the target gene to be evaluated in zebrafish mutant 
embryos that specifically lack cells of the melanocyte lineage to confirm this. This would 
help to distinguish between a melanocyte expressed gene and a gene expressed in two 
cell types, such as xanthophores and iridophores, that migrate on the lateral and medial 
pathway respectively. 
4.2.5.2.1 Melanocyte expressed V-ATPase genes 
Affymetrix Probe Identifier Dr.2855.1.A1_a_at Dr.7966.1.S1_at 
Affymetrix Gene Symbol 
LOC564804 similar to ATPase, 
H+ transporting, lysosomal 
70kDa, V1 subunit A, like 
atp6v1e1 
ZFIN Gene Symbol atp6v1a atp6v1e1 
Full Name ATPase, H+ transporting, lysosomal V1 subunit A 
ATPase, H+ transporting, 
lysosomal, V1 subunit E 
isoform 1 
Orthology ATP6V1A ATP6V1E1 
Biological Process GO Term N/A retina development in camera-type eye 
Molecular Function GO Term N/A 
hydrogen ion transporting 
ATPase activity, rotational 
mechanism 
7.2sox10:GFP 
array results 
t-statistic -16.2673625946 -6.6389508247 
p-value 0.0000835642 0.0026715409 
CLEAR 
result diff.expr diff.expr 
Fold 
Change -1.86 -1.84 
4.9sox10:GFP 
array results 
t-statistic -48.0081 -5.532494545 
p-value 0.0004335995 0.0311520807 
CLEAR 
result diff.expr diff.expr 
Fold 
Change -2.33 -2.22 
7.2+4.9sox10:GFP 
array results 
t-statistic -13.7012033463 -9.7082853317 
p-value 0.000000776 0.0000105832 
CLEAR 
result diff.expr diff.expr 
Fold 
Change -1.96 -1.97 
Table 21: Summary of Dr.2855.1.A1_a_at and atp6v1e1 information. 
124 
The Affymetrix probe set Dr.2855.1.A1_a_at corresponds to LOC564804 (similar to 
ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A, like). This transcript has a 95 % 
sequence homology with the ZFIN gene atp6v1a as identified by a BLAST search on the 
ZFIN website. This search was performed using the NetAffx sequence data for 
Dr.2855.1.A1_a_at to interrogate the database of ZFIN RNA and cDNA sequences. 
Atp6v1a was the only hit returned from this BLAST search. It seems likely that probe 
Dr.2855.1.A1_a_at corresponds to the ZFIN gene atp6v1a. This gene has been identified 
as down-regulated in all three of the microarray data sets by both t-Test and CLEAR test 
(Table 21). The Affymetrix probe set Dr.7966.1.S1_at detects transcripts from the 
atp6v1e1 gene. This probe set has been identified as down-regulated in all three of the 
microarray data sets by both the t-Test and the CLEAR test (Table 21). Thus based on 
nomenclature, both of these genes encode subunits of the V-ATPase ion transporter. 
Cells that express atp6v1a were present in a typical pre-migratory NC position 
along the anterior two thirds of the trunk in 24 hpf WT embryos (Figure 20A), expression 
in this position was reduced in mutant embryos (Figure 20A’). Pre-migratory NCCs 
towards the posterior of the embryo at 30 hpf also expressed atp6v1a (data not shown) 
suggesting that this gene is transiently expressed in early NCCs. In addition atp6v1a was 
expressed in migrating NCCs on both the medial pathway (Figure 20B and E) and lateral 
pathway (Figure 20C and D). In sox10-/- embryos no migrating cells expressing atp6v1a 
were detected (Figure 20B’, C’, D’ and E’). Additionally, some cells expressing atp6v1a 
were also observed to be melanising (Figure 20D and E). Cranial NCCs expressing 
atp6v1a were also observed in WT embryos in a pattern consistent with a pigment cell 
fate and again this expression was reduced in mutant embryos (Figure 20F, F’ and data 
not shown). The expression pattern for atp6v1e1 (Figure 21) was weaker than but very 
similar to atp6v1a. Atp6v1e1 was expressed in pre-migratory NC at both 24 hpf and 30 
hpf stages (Figure 21A and D), this expression was strongly reduced in sox10-/- embryos 
(Figure 21A’ and D’). Atp6v1e1 was also expressed in migrating cranial NCCs in the 
region of the MHB (Figure 21C), on the medial pathway (Figure 21B and E) and on the 
lateral pathway (Figure 21F). Expression in migrating cells particularly in the trunk was 
weak and hard to visualise. In mutant embryos no expression was detected in migrating 
cells (Figure 21B’, C’, E’ and F’) Thus it seems likely that both genes are expressed in 
melanoblasts and pigmenting melanocytes. Mucus secreting cells also expressed both of 
these V-ATPase genes, these cells can be distinguished from NCCs by their more ventral 
position, more rounded (not dendritic) morphology and qualitatively higher levels of V-
ATPase expression (data not shown). Mucus secreting cells did not display any change in 
expression level in sox10-/- embryos (data not shown). 
There is no embryonic expression pattern for atp6v1a or atp6v1e1 published on 
the ZFIN website for comparison. An insertion mutant (hi577a) has generated a lesion in 
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atp6ve1e, this mutant has a phenotype of severely reduced body pigment at 2 dpf and by 
3 dpf abnormal spotty pigment, a small head and small otoliths (Amsterdam et al., 2004). 
As this gene is likely to be expressed in melanoblasts and melanocytes, this mutant 
pigment phenotype fits with the observed pattern. In summary, atp6v1a and atp6v1e1 are 
both likely to be expressed in the melanocyte lineage and are both down-regulated in 
sox10 mutant embryos. Atp6v1a and atp6v1e1 both represent novel NC expressed 
genes. 
The protein product of atp6v1a and atp6v1e1 are subunits of the V1 sector of the 
vacuolar-H+ ATPase (V-ATPase). V-ATPase is a complex multi-subunit enzyme that 
couples proton pumping to ATP hydrolysis; the V0 sector is responsible for proton 
translocation across membranes while the V1 sector contains the catalytic sites necessary 
for ATP hydrolysis (Pietrement et al., 2006, Tabata et al., 2008). V-ATPases are 
responsible for the acidification of intracellular vesicles such as lysosomes. With atp6v1a 
and atp6v1e1 expressed in melanoblasts and melanocytes, this protein complex may play 
a role in the acidification of melanosomes. With two genes that encode subunits of the 
same proton pump validated during the in situ hybridization screen, the microarray data 
was examined for further examples of V-ATPase genes down-regulated in sox10-/­
embryos (Table 22). A further seven V-ATPase genes were indicated as differentially 
regulated in one or more of the microarray data sets by t-Test or CLEAR test. Thus a total 
of nine V-ATPase genes have been identified as differentially regulated in sox10-/­
embryos. As all these genes are subunits in the same proton pump, it is the function of 
this proton pump in melanocyte development that is of interest. As stated previously, the 
V-ATPase proton pump might play a role in regulating the acidity of melanosomes. The 
prevalence of V-ATPase genes in the microarray data and their possible function in the 
NC is examined further in the discussion. 
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Figure 20: Whole mount in situ hybridization pattern of Dr.2855.1.A1_a_at 
expression. 
All images are lateral views of embryos oriented anterior to the left, dorsal top, posterior to 
the right and ventral bottom. Images A-C’ are of 24 hpf embryos and images D-F’ are of 
30 hpf embryos, A-F are of WT embryos, A’-F’ are corresponding images of sox10-/­
embryos. A and A’ are images of dorsal mid-trunk, (A) arrow indicates pre-migratory NC 
expressing atp6v1a. Expression of atp6v1a is strongly reduced in mutant embryos. 
Images B, B’, C and C’ are of anterior trunk, in B and B’ focus is on the interior of the 
embryo, cells migrating on the medial pathway (arrows in B) express atp6v1a. (C) Cells 
expressing atp6v1a are visible just underneath the epidermis and are migrating on the 
lateral pathway. Atp6v1a expression cannot be detected in migrating NCCs in mutant 
embryos. Images D, D’, E and E’ are of mid-trunk, (D) arrow indicates a cell migrating on 
the lateral pathway expressing atp6v1a co-localised with melanin. (E) Arrow points to a 
cell on the medial pathway expressing atp6v1a co-localised with melanin. Images F and F’ 
are of the posterior head immediately behind the otic vesicle, cells in F expressing 
atp6v1a are becoming pigmented with melanin. Scale bars in D and E = 25 µm, all other 
scale bars = 50 µm. 
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Figure 21: Whole mount in situ hybridization pattern of atp6v1e1 expression. 
All images are presented as per Figure 20. Images C and C’ are of the head at the 
midbrain-hindbrain boundary (MHB), images F and F’ are of posterior head and anterior 
trunk, all other images are of trunk. Images A and D show expression of atp6v1e1 in a 
pre-migratory NC position (arrowheads), images A’ and D’ are of mutant embryos in the 
same position showing reduced levels of expression. Image C shows expression in NCCs 
in the region of the MHB (*), expression was reduced in mutant embryos (C’). Images B 
and E show cells expressing atp6v1e1 on the medial pathway (arrows), in E expression 
co-localises with melanin. Images B’ and E’ show that no cells expressing atp6v1e1 were 
migrating on the medial pathway in mutant embryos. Image F shows a cell expressing 
atp6v1e1 co-localised with melanin (arrow) migrating just under the epidermis. Scale bars 
in E and F = 25 µm, all other scale bars = 50 µm. 
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Affymetrix 
Identifier 
Gene 
Symbol 
7.2 Array Data 4.9 Array data 7.2+4.9 Array Data 
p-
value 
CLEAR 
p-
value 
CLEAR p-value CLEAR 
Dr.14783.1.S1_at atp6v1c1 0.044 diff.expr 0.020 diff.expr 0.032 diff.expr 
Dr.186.1.S1_at atp6v1ba 0.042 diff.expr 0.009 non.sig 0.001 diff.expr 
Dr.14072.1.S1_at atp6v1d 0.011 diff.expr 0.136 non.sig 0.002 diff.expr 
Dr.1971.1.A1_at atp6v0c 0.009 diff.expr 0.136 non.sig 0.0003 non.sig 
Dr.370.1.S1_at atp6v1g1 0.005 diff.expr 0.005 diff.expr 0.00005 diff.expr 
Dr.13658.1.S1_at atp6v1f 0.063 diff.expr 0.035 diff.expr 0.001 diff.expr 
Dr.14847.1.A1_at atp6v1c1l 0.066 diff.expr.high.var 0.135 diff.expr 0.004 diff.expr 
Table 22: Summary of Differentially Expressed V-ATPase genes. 
Genes named as V-ATPases by Affymetrix that were identified as differentially regulated 
in one or more microarray data sets are summarised. Results from all three microarray 
data sets are given for the t-Test (p-value) and CLEAR test. Statistically significant results 
(differentially regulated) are highlighted in green; results that are not significant are 
highlighted in red. 
4.2.5.2.2 Dr.8594.1.S1_at 
Affymetrix Probe Identifier Dr.8594.1.S1_at 
Affymetrix Gene Symbol zgc:100919 
ZFIN Gene Symbol zgc:100919 
Full Name zgc:100919 
Orthology N/A 
Biological Process GO Term transport 
Molecular Function GO Term transporter activity, lipid binding 
7.2sox10:GFP array 
results 
t-statistic -7.944715023 
p-value 0.0013592674 
CLEAR result diff.expr 
Fold Change -1.81 
4.9sox10:GFP array 
results 
t-statistic -4.4917368889 
p-value 0.0461597666 
CLEAR result diff.expr 
Fold Change -2.00 
7.2+4.9sox10:GFP 
array results 
t-statistic -11.8869142532 
p-value 0.0000023042 
CLEAR result diff.expr 
Fold Change -1.89 
Table 23: Summary of Dr.8594.1.S1_at information 
The Affymetrix probe set Dr.8594.1.S1_at corresponds to the gene zgc:100919. Currently 
this gene is only known by a Zebrafish Gene Collection code and has yet to be identified 
with a gene name. According to the NetAffx website and the Entrez Gene entry for 
zgc:100919, this gene may be a member of the tetraspanin superfamily and specifically 
has similarity to the subfamily of vertebrate transmembrane 4 superfamily 8 (TM4SF8) like 
genes. Dr.8594.1.S1_at was consistently detected as down-regulated in all three 
microarray data sets (Table 23). This gene is expressed in a sub-set of pre-migratory 
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NCCs along most of the trunk at 24 hpf (Figure 22A). By 30 hpf pre-migratory expression 
was restricted to the posterior trunk only (data not shown). Cells migrating on the medial 
pathway at 24 hpf (Figure 22A) and at 30 hpf (data not shown) also expressed 
zgc:100919. Cells expressing zgc:100919 were also detected migrating on the lateral 
pathway at both time points (data not shown). Expression in pre-migratory and migrating 
cells was absent in sox10-/- embryos (Figure 22A’ and B’). At 30 hpf zgc:100919 
expression overlapped with cells that were beginning to pigment with melanin (Figure 
22B and C). Zgc:100919 thus appeared to be expressed in early NCCs, specifically, 
melanoblasts and melanocytes and was down-regulated in sox10 mutant embryos. An 
expression pattern for zgc:100919 has been published on the ZFIN website and this 
shows expression in melanoblasts at 24 hpf with expression continuing in melanocytes, at 
least until 48 hpf (Thisse et al., 2004). The probe used to detect zgc:100919 mRNA in this 
project has generated a strong signal with very little background expression. The 
expression pattern generated appears to mark a large number of melanoblasts, a similar 
number as marked by a mitfa in situ hybridization probe. These two facts make this an 
attractive marker gene for the melanocyte lineage. 
Tetraspanins are a family of transmembrane proteins that have been associated 
with the regulation of a number of cellular processes including cell proliferation, motility 
and cell death (Hemler, 2005). These are all processes important during NC development 
but despite this tetraspanins have not been strongly linked to NC biology. A study has 
identified that a number of tetraspanins localise to the end of projections that extend from 
cultured melanocytes. This includes at the end of projections that connect to other 
melanocytes and at the tip of dendrites that act during cell migration (García-López et al., 
2005). Knockdown of tetraspanins reduced the ability of these melanocytes to migrate. It 
would be of interest to assess the knockdown of zgc:100919 in zebrafish embryos, 
perhaps focusing on defects in melanocyte migration. Such a study would be particularly 
important given the context that very little study of tetraspanins in zebrafish has been 
undertaken (Hemler, 2005). 
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Figure 22: Whole mount in situ hybridization expression pattern of zgc:100919. 
All images presented as per Figure 20. Images A and A’ are of the trunk of 24 hpf 
embryos while B, B’ and C are images of 30 hpf embryos. B and B’ are images of the 
posterior head just behind the otic vesicle (ov). C is a magnified image of two melanised 
cells in the trunk. Zgc:100919 was expressed in a subset of pre-migratory NCCs 
(asterisks in A) and cells migrating on the medial pathway (arrows in A). At 30 hpf 
zgc:100919 expression overlapped with melanising cells (arrowheads in B and C). 
Expression of zgc:100919 was strongly reduced in sox10 mutant embryos (A’ and B’). 
Scale bars in A and B = 50 µm, scale bar in C = 10 µm. 
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4.2.5.2.3 pah 
Affymetrix Probe Identifier Dr.4171.1.A1_at 
Affymetrix Gene Symbol pah 
ZFIN Gene Symbol pah 
Full Name phenylalanine hydroxylase 
Orthology PAH 
Biological Process GO Term 
L-phenylalanine catabolic process, 
metabolic process, 
aromatic amino acid family metabolic 
process 
Molecular Function GO Term 
monooxygenase activity 
phenylalanine 4-monooxygenase activity, 
iron ion binding, 
amino acid binding 
7.2sox10:GFP array 
results 
t-statistic -7.4460177422 
p-value 0.0017376344 
CLEAR result diff.expr 
Fold Change -3.70 
4.9sox10:GFP array 
results 
t-statistic -14.469004631 
p-value 0.0047426876 
CLEAR result diff.expr 
Fold Change -3.07 
7.2+4.9sox10:GFP 
array results 
t-statistic -8.8098163605 
p-value 0.0000216759 
CLEAR result diff.expr 
Fold Change -3.30 
Table 24: Summary of pah Information 
The Affymetrix probe set Dr.4171.1.A1_at has been annotated as pah, analysis of all 
three microarray data sets has shown that this gene is down-regulated (Table 24). 
Analysis by in situ hybridization showed that pah is expressed in pre-migratory NCCs 
(Figure 23B). A sox10 in situ hybridization at the same stage would label more NCCs 
therefore only a subset of pre-migratory NCCs is labelled. Migrating cells on both the 
medial pathway (Figure 23B and D) and on the lateral pathway (Figure 23C) also 
express pah. Expression in all NCCs was strongly reduced in sox10-/- embryos although 
some pre-migratory cells still expressed pah (Figure 23B’ and C’). At 30 hpf pah 
expression overlapped with lightly melanised melanocytes (Figure 23E and F). Thus pah 
appears to be expressed in both melanoblasts and melanocytes. Interestingly, in contrast 
with most other melanocyte expressed genes, pah expression is still detectable in some 
pre-migratory mutant NCCs (Figure 23B’ and C’). This is a unique result among the 
melanocyte expressed genes assessed during this screen. It might be that pah expression 
does not solely rely on Sox10 induction of mitfa expression. Alternatively, evidence in 
zebrafish suggests that Sox10 can repress expression of some melanocyte markers that 
are down stream of mitfa (Greenhill, 2008). Continued expression of pah in sox10 mutant 
embryos may result from a loss of Sox10 depression although expression levels are 
actually reduced as mitfa expression is not induced. The level of pah expression seen in 
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sox10 mutant embryos is much higher than seen with residual dct expression (Figure 19). 
Pah has been annotated as expressed in pre-migratory and migrating NCCs and pigment 
cells (Thisse et al., 2004) in a pattern that suggests this gene is a marker of the 
melanocyte lineage. Pah codes for an enzyme, phenylalanine hydroxylase, which plays 
an important role in melanogenesis. PAH catalyses the conversion of L-phenylalanine to 
L-tyrosine which is the substrate for the key melanogenic enzyme tyrosinase (Schallreuter 
et al., 2008). The expression pattern of pah observed was to be expected based on 
previous in situ hybridization patterns and the role of PAH in melanin synthesis. In 
summary, pah was expressed in cells of the melanocyte lineage of WT embryos and 
strongly down-regulated in sox10 mutant embryos thus validating this microarray result. 
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Figure 23: Whole mount in situ hybridization pattern of pah expression. 
Figure is presented as per Figure 20. A, A’ and D-E’ show anterior trunk with pre­
migratory NCCs indicated by asterisks (*), cells migrating on the medial pathway are 
shown using arrows and a lightly melanised cell on the lateral pathway highlighted with an 
arrowhead. Images B and B’ are of mid-trunk, pre-migratory NCCs are indicated with an 
asterisk. Images C and C’ show posterior head and anterior trunk with NCCs migrating on 
the lateral pathway. F shows lightly melanised cells co-expressing pah (arrowheads) in 
the region of the most anterior somites. Scale bar in F = 25 µm, scale bars in all other 
images = 50 µm. 
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4.2.5.2.4 degs1 
Affymetrix Probe Identifier Dr.1251.1.S1_at 
Affymetrix Gene Symbol degs1 
ZFIN Gene Symbol degs1 
Full Name degenerative spermatocyte homolog, lipid desaturase 
Orthology DEGS1 
Biological Process GO Term lipid metabolic process oxidation reduction 
Molecular Function GO Term oxidoreductase activity 
7.2sox10:GFP array 
results 
t-statistic -6.2696032524 
p-value 0.0033029604 
CLEAR result diff.expr 
Fold Change -1.58 
4.9sox10:GFP array 
results 
t-statistic -2.097016573 
p-value 0.1709180772 
CLEAR result diff.expr 
Fold Change -1.50 
7.2+4.9sox10:GFP 
array results 
t-statistic -2.9583206177 
p-value 0.0181928389 
CLEAR result diff.expr 
Fold Change -1.54 
Table 25: Summary of degs1 information 
The Affymetrix probe Dr.1251.1.S1_at corresponds to the zebrafish gene degs1. The 
CLEAR test identified degs1 as differentially regulated in all three data sets while the t-
Test identified differential regulation in two data sets but not the 4.9 data set (Table 25). 
Whole mount in situ hybridization identified degs1 expression in cells migrating on the 
medial pathway (Figure 24A and C) and lateral pathway (Figure 24B). Expression in 
these migrating cells was absent in sox10-/- embryos (Figure 24A’, B’ and C’). Weak 
degs1 expression was also detected in a few pre-migratory NCCs which also displayed 
reduced levels of degs1 expression in mutant embryos (data not shown). Degs1 
expression co-localised with cells that were pigmenting with melanin (Figure 24C). In 
general, degs1 expression was weak but it appears to be expressed in melanoblasts and 
pigmenting melanocytes at least until 30 hpf. An expression pattern for degs1 displaying 
expression in migrating NCCs which shows strong similarities to the pattern shown in 
Figure 24 has been submitted to the ZFIN website (Thisse et al., 2004). This expression 
pattern also identified degs1 expression in the otic vesicle at around 24 hpf. Otic vesicle 
expression was not observed during the current study but this could have been a result of 
weak staining. In conclusion, degs1 appears to be expressed in cells of the melanocyte 
lineage and is down-regulated in sox10 mutant embryos. 
Very little literature is available regarding degs1 however the gene was first cloned 
and named as MLD, a membrane fatty acid (lipid) desaturase (Cadena et al., 1997). 
When transfecting a human embryonic kidney cell line with MLD cDNA the authors noted 
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that epidermal growth factor (EGF) receptor expression was inhibited by MLD. A study of 
the in vitro effects of DEGS1 expression in human cancer cell lines identified a role in 
progression of the cell cycle from G1 to S phase. This role was dependent on NF-κB 
activation of cyclin-D1 expression (Zhou et al., 2009). Over expression of DEGS1 also 
promoted the migration of Eca109 oesophageal carcinoma cells (Zhou et al., 2009). Thus 
while a role for degs1 in neural crest biology has yet to be established, this gene is known 
to play a role in cell proliferation and migration, two important processes that NCCs are 
actively involved in. 
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Figure 24: Whole mount in situ hybridization pattern of degs1 expression. 
Images are presented as per Figure 20. Degs1 expression was detected in cells migrating 
on the medial pathway in anterior trunk (arrows in A and C), this expression was absent in 
mutant embryos (A’ and C’). Expression was also detected in WT embryos on the lateral 
pathway in cells migrating at the posterior head/anterior trunk axial level (* in B), this 
expression was absent in sox10-/- embryos (B’). Expression of degs1 co-localised with 
cells synthesising melanin (C). Scale bars = 50 µm. 
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4.2.5.2.5 zgc:110239 
Affymetrix Probe Identifier Dr.7250.1.A1_at 
Affymetrix Gene Symbol zgc:110239 
ZFIN Gene Symbol zgc:110239 
Full Name zgc:110239 
Orthology N/A 
Biological Process GO Term proteolysis 
Molecular Function GO Term cysteine-type endopeptidase activity cysteine-type peptidase activity 
7.2sox10:GFP array 
results 
t-statistic -6.6761045456 
p-value 0.002616606 
CLEAR result diff.expr 
Fold Change -1.41 
4.9sox10:GFP array 
results 
t-statistic -0.569756031 
p-value 0.626308918 
CLEAR result non.significant 
Fold Change -1.09 
7.2+4.9sox10:GFP 
array results 
t-statistic -1.1016930342 
p-value 0.302633673 
CLEAR result non.significant 
Fold Change -1.21 
Table 26: Summary of Information for zgc:110239 
The Affymetrix probe set Dr.7250.1.A1_at corresponds to the gene zgc:110239. Both 
statistical tests identified this gene as differentially regulated in the 7.2 data set. However 
this gene was not identified as differentially regulated in the 4.9 or the 7.2+4.9 data sets 
(Table 26). To validate if zgc:110239 was down-regulated, in situ hybridization was 
performed (Figure 25). In 24 hpf WT embryos zgc:110239 was expressed in positions 
typical of cranial NCCs at the midbrain-hindbrain boundary (data not shown) and near the 
border between posterior head and anterior trunk (Figure 25A). Zgc:110239 expression 
was also observed in a few pre-migratory NCCs in the trunk (Figure 25B). Expression 
was absent from these sites in sox10-/- embryos (Figure 25A’, B’ and data not shown). In 
30 hpf embryos, zgc:110239 was expressed in pre-migratory NC positions in WT 
embryos, this expression was reduced but not absent in mutant embryos (Figure 25D and 
D’). Zgc:110239 expression also overlapped with melanising cells migrating in WT 
embryos (Figure 25C and E), this expression was absent in sox10 mutant embryos 
(Figure 25C’ and E’). The expression pattern examined here was weak and therefore 
hard to interpret but clear NCC expression was observed that was reduced in mutant 
embryos. The expression pattern of zgc:110239 has also been determined and published 
on the ZFIN website (Thisse et al., 2004). This pattern shows extensive zgc:110239 
expression in pre-migratory NCCs and migrating NCCs. While not explicitly annotated as 
such, it appears that the cells are migrating on both the medial and lateral pathways. The 
in situ hybridization pattern from Thisse et al., 2004 is stronger and clearer than the 
pattern shown in Figure 25. There is currently no work that hints at a possible functional 
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role for this gene in the NC. In summary, zgc:110239 is expressed in NCCs of the 
melanocyte lineage and is down-regulated in sox10 mutant embryos. 
Figure 25: Whole mount in situ hybridization pattern of zgc:110239 expression. 
All images are lateral views of zebrafish embryos presented as per Figure 20. Images A, 
A’, C and C’ are of posterior head and anterior trunk; all other images are of mid-trunk. 
Expression of zgc:110239 in 24 hpf WT embryos was observed in a NC like position in the 
head (asterisk in A) and pre-migratory NCCs in the trunk (arrowheads in B). Expression 
was absent from these sites in mutant embryos (A’ and B’). At 30 hpf, zgc:110239 was 
expressed in pre-migratory NCCs (D), this expression was seen in sox10 mutant embryos 
(D’). Zgc:110239 expression also overlapped with migrating melanising cells at 30 hpf in 
WT embryos (arrows in C and E). No migrating cells expressed zgc:110239 in mutant 
embryos (C’ and E’). Scale bars in C and E = 10 µm, all other scale bars = 50 µm. 
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4.2.5.3 Xanthophore Expressed Genes 
Xanthophores are yellow pigment cells which become pigmented from around 42 hpf, 
considerably later than melanocytes which are visibly pigmented from 28 hpf. Despite this, 
expression of early xanthophore lineage markers such as gch and xdh can be visualised 
at 24 hpf, when early melanocyte genes such as mitfa and dct are expressed in 
melanoblasts. Xanthoblasts can be visualised in pre-migratory NC positions and then 
migrating on the lateral pathway only. In addition xanthoblasts can be detected migrating 
over the head of zebrafish embryos. This cannot exclude that a gene might be expressed 
in a sub-set of melanocytes that are restricted to migrating on the lateral pathway, 
although there is currently no precedent for such a gene. In order to examine this, a 
xanthophore marker should not show extensive overlap with melanising cells at 30 hpf. 
Expression of early xanthophore markers is strongly reduced but still detectable in sox10-/­
embryos. In particular, xanthoblast markers are expressed in a reduced number of NCCs 
stuck in clusters in pre-migratory positions in the trunk and head. The above criteria, 
particularly expression of the target gene in cells migrating on the lateral pathway only are 
indicative of the xanthophore lineage and will be used during this study. 
4.2.5.3.1 rbp4l 
Affymetrix Probe Identifier Dr.10292.1.S1_at 
Affymetrix Gene Symbol rbp4l 
ZFIN Gene Symbol rbp4l (purpurin) 
Full Name retinol binding protein 4, like 
Orthology None available 
Biological Process GO Term Transport 
Molecular Function GO Term transporter activity, retinoid binding 
7.2sox10:GFP array 
results 
t-statistic -16.037355423 
p-value 0.0000883988 
CLEAR result diff.expr 
Fold Change -7.77 
4.9sox10:GFP array 
results 
t-statistic -41.8679580688 
p-value 0.0005699871 
CLEAR result diff.expr 
Fold Change -18.65 
7.2+4.9sox10:GFP 
array results 
t-statistic -12.7175235748 
p-value 0.0000013756 
CLEAR result diff.expr.high.var 
Fold Change -11.03 
Table 27: Summary of rbp4l information. 
The Affymetrix probe Dr.10292.1.S1_at detects transcripts from the rbp4l gene, which has 
been known previously as purpurin (Tanaka et al., 2007). This transcript was detected as 
down-regulated in all three microarray data sets by both statistical tests (Table 27). The 
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fold change values for this transcript were some of the highest detected suggesting a very 
strong reduction in expression. Surprisingly then, whole mount in situ hybridization did not 
show any detectable expression at 24 hpf but strong expression was detected at 30 hpf 
(Figure 26). With strong down-regulation of this gene recorded by microarray analysis this 
suggested that the FACS enriched cells were slightly older than 24 hpf, from a time point 
when rbp4l was highly expressed. Rbp4l expression was detected in cells migrating on 
the lateral pathway (Figure 26A and E) but not on the medial pathway (Figure 26C). 
Expression was also detected in a sub-set of pre-migratory NCCs (Figure 26C) and some 
cranial NCCs (data not shown). No NCC expression was detected in sox10-/- embryos 
(Figure 26B and D). Rbp4l was also expressed strongly in the epiphysis of WT and 
mutant embryos equally at both time points (data not shown). The expression pattern for 
rbp4l has already been described (Thisse et al., 2004) and shows strong similarities to the 
pattern presented here. The data suggests that rbp4l is expressed in the xanthophore 
lineage prior to these cells becoming visibly pigmented with detectable expression first 
occurring at a time point between 24 and 30 hpf. Rbp4l expression is strongly reduced in 
sox10 mutant embryos in comparison to WT embryos thus validating this microarray 
result. 
The zebrafish rbp4l gene has been identified as an orthologue of the chick and 
goldfish purpurin gene (Tanaka et al., 2007). Purpurin is a secreted molecule that has 
been shown to promote both cell adhesion and survival of neural retinal cells in culture 
(Schubert and LaCorbiere, 1985, Schubert et al., 1986). Purpurin is expressed in the 
developing retina of zebrafish and also in adult fish photoreceptor cells during 
regeneration after optic nerve transection (Matsukawa et al., 2004, Tanaka et al., 2007). 
Neurite outgrowth from retinal explants was promoted by simultaneous addition of retinol 
and Purpurin (Matsukawa et al., 2004). Thus while the role of purpurin or rbp4l is now 
becoming understood in adult retinas, no biological function has been attributed to this 
gene during the development of the NC. As rbp4l is expressed later than early xanthoblast 
markers this suggests that rbp4l does not play a role in xanthoblast specification. As rbp4l 
is strongly expressed in migrating cells this gene may play a role in cell migration, possibly 
by mediating cell to cell adhesion. Alternatively rbp4l may promote xanthoblast survival. A 
morpholino mediated knock down of rpb4l expression may help to elucidate a function for 
this gene in the NC. 
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Figure 26: Whole mount in situ hybridization pattern of rbp4l expression. 
Images are presented as per Figure 20. All images are of 30 hpf embryos in the mid-trunk 
region. Cells expressing rbp4l were visible migrating on the lateral pathway (arrows in A 
and C) in WT embryos but no expression was detected in mutant embryos (A’). Rbp4l was 
also expressed in WT pre-migratory NCCs (arrowheads in B) but absent in mutant 
embryos (A’ and B’). No cells expressing rbp4l were detected migrating on the medial 
pathway (B) and no melanising cells expressed rbp4l (asterisks in A, B and C). Scale bars 
= 50 µm. 
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4.2.5.3.2 pax7 
Affymetrix Probe Identifier Dr.23456.1.S1_at 
Affymetrix Gene Symbol pax7 
ZFIN Gene Symbol pax7a 
Full Name paired box gene 7a 
Orthology PAX7 
Biological Process GO Term 
transcription 
transcription termination 
regulation of transcription, DNA-dependent 
multicellular organismal development 
transcription antitermination 
regulation of transcription 
Molecular Function GO Term 
DNA binding 
transcription factor activity 
sequence-specific DNA binding 
7.2sox10:GFP array 
results 
t-statistic -10.5922355652 
p-value 0.0004495994 
CLEAR result non.significant 
Fold Change -1.25 
4.9sox10:GFP array 
results 
t-statistic -0.4997960031 
p-value 0.6667875648 
CLEAR result non.significant 
Fold Change -1.02 
7.2+4.9sox10:GFP 
array results 
t-statistic -4.6060390472 
p-value 0.001741653 
CLEAR result non.significant 
Fold Change -1.22 
Table 28: Summary of pax7 information. 
The Affymetrix probe set Dr.23456.1.S1_at corresponds to the transcription factor pax7. 
This gene was identified as differentially regulated in the 7.2 and 7.2+4.9 data sets by the 
t-Test, this gene was not identified as differentially regulated by the CLEAR test (Table 
28). Pax7 was expressed in pre-migratory NCCs dorsal of the neural tube in 24 hpf and 
30 hpf WT embryos and sox10-/- embryos (Figure 27A, A’ and D). Expression in WT 
embryos was stronger than seen in mutant embryos; additionally in 24 hpf WT embryos 
this stripe of expression was fairly continuous along the length of the zebrafish trunk but in 
mutants was punctuated with more gaps. In 30 hpf embryos the pattern of pax7 
expression was consistent with that observed in 24 hpf embryos but was restricted to a 
more posterior trunk region (data not shown). Expression of pax7 was also seen in cranial 
NCCs of WT 24 hpf embryos (data not shown). In 30 hpf embryos, pax7 expression was 
identified in NCCs migrating solely on the lateral pathway (Figure 27B and D) but not in 
mutant embryos (Figure 27B’). Pax7 expressing cells never appeared to be melanising 
(data not shown). Thus it appears that pax7 mRNA marks early NCCs of the xanthophore 
lineage. Pax7 expression was also detected in dorsal NT (Figure 27A, A’ and D) and was 
weakly expressed in the somites (data not shown). It has been demonstrated that Pax7 
positive cells are present on the lateral somite surface and these cells are distinct from NC 
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derived Pax7 positive cells (Hammond et al., 2007). These non NC sites of expression did 
not show obvious down-regulation of pax7 mRNA between WT and sox10-/- embryos. 
Pax7 has been proposed to be a marker of the long-sought common chromatoblast 
precursor cell (Lacosta et al., 2007); however no conclusive evidence of pax7 expression 
overlapping with chromatoblast markers was provided. A careful study of pax7 expression 
in conjunction with markers for the melanocyte and xanthophore lineage concluded that 
this gene is a marker of xanthoblasts (Minchin and Hughes, 2008). In summary, both the 
data presented here and published data has established that pax7 is expressed in 
xanthoblasts and is down-regulated in sox10 mutant embryos. 
A study of pax7 expression in chick embryos identified this gene as a very early 
marker of the NC (Basch et al., 2006). Morpholino mediated inhibition of pax7 translation 
resulted in down-regulation of the early NC marker genes slug, sox9 and sox10 
suggesting a role in early NC formation. In addition the number of migrating cranial NCCs 
was also strongly reduced (Basch et al., 2006). The mouse null pax7 mutant also shows 
defects in cranial NC derivatives (Mansouri et al., 1996). Studies in zebrafish have shown 
that at least some NCCs express pax7 mRNA and protein (Hammond et al., 2007) and 
this was later refined to identify pax7 as a marker of the xanthophore lineage (Minchin and 
Hughes, 2008). Having conclusively shown that pax7 marks xanthoblasts, a temporal 
analysis of pax7 expression and xdh identified that pax7 expression initiates after xdh 
expression (Minchin and Hughes, 2008). This temporal analysis was suggestive of a role 
for pax7 in xanthophore differentiation and a morpholino mediated knockdown approach 
was applied. Pax7 morphants displayed a dose dependent reduction in yellow 
pigmentation but not a reduction in xanthophore cell number confirming a role in 
differentiation (Minchin and Hughes, 2008). In summary, pax7 has both clear expression 
in and a functional role during the development of a NC derivative and is thus a well 
validated target identified in the sox10 mutant microarray screen. 
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Figure 27: Whole mount in situ hybridization pattern of pax7 expression. 
Images are of zebrafish trunk and presented as per Figure 20 except image D which is a 
transverse section through the trunk of a WT 30 hpf embryo with dorsal oriented to the 
top. Pre-migratory NCCs were strongly labelled in WT 24 hpf (arrowheads in A) and 30 
hpf (asterisks in D) embryos, expression in these cells was reduced in mutant embryos 
(arrowheads in A’). A stripe of expression below the pre-migratory NCCs in the dorsal 
neural tube appears to be unchanged between WT and sox10 mutant embryos. In WT 30 
hpf embryos cells migrating on the lateral pathway (arrows in B and D) expressed pax7, 
these cells were not detectable in sox10-/- embryos (B’). No cells migrating on the medial 
pathway expressed pax7 (C). Nt = Neural Tube, Nc = Notochord. Scale bar in D = 25 µm, 
all other scale bars = 50 µm. 
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4.2.5.3.3 slc2a15b 
Affymetrix Probe Identifier Dr.14747.1.A1_at Dr.20896.1.S1_at 
Affymetrix Gene Symbol slc2a15b slc2a15b 
ZFIN Gene Symbol slc2a15b slc2a15b 
Full Name 
solute carrier family 2 
(facilitated glucose 
transporter), member 15b 
solute carrier family 2 
(facilitated glucose 
transporter), member 15b 
Orthology N/A N/A 
Biological Process GO Term transport transmembrane transport 
transport 
transmembrane transport 
Molecular Function GO Term 
transporter activity 
substrate-specific 
transmembrane transporter 
activity 
transporter activity 
substrate-specific 
transmembrane transporter 
activity 
7.2sox10:GFP array 
results 
t-statistic -9.9877481461 -7.371524334 
p-value 0.0005646773 0.0018048198 
CLEAR 
result diff.expr diff.expr 
Fold 
Change -3.03 -1.99 
4.9sox10:GFP array 
results 
t-statistic -4.6440958977 -6.865673542 
p-value 0.0433716364 0.0205624737 
CLEAR 
result diff.expr diff.expr 
Fold 
Change -3.77 -1.56 
7.2+4.9sox10:GFP 
array results 
t-statistic -8.9376220703 -7.8423748016 
p-value 0.0000195028 0.0000503794 
CLEAR 
result diff.expr diff.expr 
Fold 
Change -3.46 -1.81 
Table 29: Summary of slc2a15b information 
The Affymetrix probe sets Dr.14747.1.A1_at and Dr.20896.1.S1_at detect transcript levels 
for the same gene, slc2a15b. This gene was identified as down-regulated in all data sets 
by both statistical tests for both probe sets (Table 29). This provided two independent 
confirmations of differential regulation. Expression of slc2a15b was readily detected by in 
situ hybridization in both cranial and trunk NCCs (Figure 28). At 24 hpf cranial NCCs 
migrating just under the epidermis (Figure 28A and B) and a sub-set of pre-migratory 
NCCs cells (Figure 28C) expressed slc2a15b strongly. This expression was strongly 
reduced, but not absent, in sox10-/- embryos which displayed some stained cells in pre­
migratory positions (Figure 28A’ and C’). At 30 hpf, some pre-migratory NCCs in the 
posterior trunk still expressed slc2a15b (data not shown). At this stage slc2a15b positive 
cells were migrating extensively over the anterior trunk on the lateral pathway only 
(Figure 28D, E and F) showing no co-localisation with melanising cells. An expression 
pattern for this gene has been directly submitted to the ZFIN website (Thisse et al., 2004) 
but in contrast to Figure 28, shows no spatial restriction. The expression patterns 
revealed here provide strong evidence that slc2a15b marks xanthoblasts and is down­
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regulated in sox10 mutants. This gene is extensively expressed in cells of the 
xanthophore lineage and is likely to prove a useful marker gene. 
The gene slc2a15b is in the Entrez Gene Database under the ID number 552924. 
This database shows that slc2a15b is part of the major facilitator superfamily, a large and 
diverse family of transporters. Very little published data exists relating to slc2a15b. The 
slc2a15b probe set Dr.14747.1.A1_at was identified by microarray analysis as being over 
expressed, along with the NC genes dct, gch and crestin, in the retinal pigmented 
epithelium when compared to the retina at 52 hpf (Leung et al., 2008). Thus this gene has 
been the subject of little study and has yet to be assigned a function in NC biology. Based 
on the nomenclature of this gene it functions as a glucose or sugar transporter, it would be 
interesting to determine the importance of such a function in NC development. Slc2a15b 
provides an example of a novel gene identified by this screen. 
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Figure 28: Whole mount in situ hybridization pattern of slc2a15b expression. 
Images are presented as per Figure 20. Migrating cells are indicated by arrows, cells in 
pre-migratory positions are indicated by arrowheads. Images A and A’ are of the head at 
the midbrain-hindbrain boundary, images B, B’, D and D’ are of posterior head and 
anterior trunk. Remaining images are of mid-trunk. Migrating NCCs are indicated with 
arrows, pre-migratory NCCs are indicated by arrowheads. Scale bars = 50 µm. 
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4.2.5.3.4 cx33.8 
Affymetrix Probe Identifier DrAffx.1.65.S1_at 
Affymetrix Gene Symbol cx33.8 
ZFIN Gene Symbol cx33.8 
Full Name connexin 33.8 
Orthology GJB2 (CX26) and GJB6 (CX30) 
Biological Process GO Term cell communication 
Molecular Function GO Term N/A 
7.2sox10:GFP array 
results 
t-statistic -8.6883687973 
p-value 0.0009660177 
CLEAR result diff.expr 
Fold Change -1.54 
4.9sox10:GFP array 
results 
t-statistic -3.7531321049 
p-value 0.0642285049 
CLEAR result diff.expr 
Fold Change -1.64 
7.2+4.9sox10:GFP 
array results 
t-statistic -5.5526852608 
p-value 0.0005392728 
CLEAR result diff.expr 
Fold Change -1.56 
Table 30: Summary of cx33.8 information. 
The Affymetrix probe set DrAffx.1.65.S1_at corresponds to the gene cx33.8. This gene 
was detected as differentially regulated by both statistical tests in all the data sets except 
by the t-Test on the 4.9 data set (Table 30). A strong NC gene expression pattern was 
identified by in situ hybridization for cx33.8 (Figure 29). At 24 hpf strong pre-migratory NC 
expression was observed (arrowheads in Figure 29A and B) and some cells migrating on 
the lateral pathway at the anterior-trunk axial level were also noted (arrow Figure 29A). 
These sites of expression were strongly reduced in mutant embryos although some 
clustered pre-migratory cells continued to express cx33.8 (arrow heads in Figure 29A’ 
and B’). Composites showing the expression pattern of cx33.8 in both WT and sox10 
mutant 24 hpf embryos are also shown for comparison displaying the features noted 
above (Figure 29F and F’). At 30 hpf, in WT embryos, cx33.8 expression remained in pre­
migratory NCCs in the posterior trunk (data not shown). Cells weakly expressing cx33.8 
were visible migrating on the lateral pathway in WT embryos but not in mutant embryos 
(Figure 29C and C’). Rarely cx33.8 expressing cells were seen migrating on the medial 
pathway; in approximately 50 % of the WT embryos a single cell was typically observed. 
(Figure 29E). Cx33.8 expressing cells did not appear to melanise (Figure 29D). Cx33.8 
expression was strongest at 24 hpf and therefore is likely to be expressed in early cells of 
the xanthophore lineage. The pattern of cx33.8 expression at 24 hpf closely matches that 
of xdh and gch (see Chapter 3 and Pelletier et al., 2001). Cx33.8 has also been shown to 
be expressed in the otic vesicle of zebrafish embryos at 3 dpf and is down-regulated at 
this site in sox10-/- embryos (Dutton et al., 2009). In summary cx33.8 appears to be 
expressed chiefly in xanthoblasts during early embryonic development with expression in 
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unidentified occasional medial pathway migrating cells also observed. Thus for the first 
time, cx33.8 has been identified as a marker of a sub-set of NCCs including xanthoblasts 
and this expression is reduced in sox10 mutant embryos. 
The zebrafish gene cx33.8 is an orthologue of two human genes, GJB2 (CX26) 
and GJB6 (CX30) (Cruciani and Mikalsen, 2006). Mutations in these two genes that result 
in deafness have been characterised in a number of populations (Rabionet et al., 2002). 
Thus cx33.8 expression in the zebrafish ear suggests at a conserved role in ear 
development. However the data presented here provides the first evidence for a role in 
neural crest biology. Little is known about the cx33.8 gene in zebrafish thus making this 
target an attractive one to investigate further to elucidate a function in neural crest and 
xanthophore biology (see discussion). 
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Figure 29: Whole mount in situ hybridization pattern of cx33.8 expression. 
All images are presented as per Figure 20 except images F and F’ which are composite 
images in the same orientation. Images A and A’ are of anterior trunk, images B-C’ and E 
are of mid-trunk and images D and D’ are of posterior head including the otic vesicle (ov). 
Pre-migratory NCCs are marked by arrowheads (A-B’) and migratory NCCs are 
highlighted with arrows (A, C and E). Scale bars in F and F’ = 100 µm, all other scale bars 
= 50 µm. 
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4.2.5.3.5 Validation of three genes in the IMP biosynthesis pathway 
Affymetrix Probe 
Identifier Dr.481.1.S1_at Dr.983.1.S1_at 
Dr.13359.1.S1 
_at 
Affymetrix Gene Symbol atic paics adsl 
ZFIN Gene Symbol atic paics adsl 
Full Name 
5-aminoimidazole-4­
carboxamide 
ribonucleotide 
formyltransferase/IMP 
cyclohydrolase 
phosphoribosylaminoimi 
dazole carboxylase, 
phosphoribosylaminoimi 
dazole 
succinocarboxamide 
synthetase 
adenylosuccin 
ate lyase 
Orthology ATIC PAICS ADSL 
Biological Process 
GO Term 
purine nucleotide 
biosynthetic process 
IMP biosynthetic 
process 
purine nucleotide 
biosynthesis 
'de novo' IMP 
biosynthesis 
purine 
ribonucleotide 
biosynthetic 
process 
Molecular Function 
GO Term 
catalytic activity 
IMP cyclohydrolase 
activity 
phosphoribosylaminoimi 
dazolecarboxamide 
formyltransferase 
activity 
transferase activity 
hydrolase activity 
DNA binding 
catalytic activity 
phosphoribosylaminoimi 
dazole carboxylase 
activity 
phosphoribosylaminoimi 
dazolesuccinocarboxami 
de synthase activity 
ATP binding 
catalytic 
activity 
adenylosuccin 
ate lyase 
activity 
lyase activity 
7.2sox10:GF 
P array 
results 
t-statistic -8.6674394608 -7.7576050758 -7.0870451927 
p-value 0.0009749859 0.0014879868 0.0020928441 
CLEAR 
result diff.expr diff.expr diff.expr 
Fold 
Change -1.85 -1.56 -1.84 
4.9sox10:GF 
P array 
results 
t-statistic -3.0787854195 -6.7212591171 -2.9042654037 
p-value 0.0912824571 0.0214270819 0.10092666 
CLEAR 
result diff.expr diff.expr diff.expr 
Fold 
Change -1.80 -2.11 -1.71 
7.2+4.9sox1 
0:GFP array 
results 
t-statistic -7.9875617027 -8.1890239716 -5.87099123 
p-value 0.00004416 0.000036897 0.0003737883 
CLEAR 
result diff.expr diff.expr diff.expr 
Fold 
Change -1.88 -1.76 -1.82 
Table 31: Summary of information for atic, paics and adsl. 
The Affymetrix probe sets Dr.481.1.S1_at, Dr.983.1.S1_at and Dr.13359.1.S1_at 
correspond to the genes atic, paics and adsl respectively (Table 31). All three genes 
encode for enzymes that function in the IMP biosynthesis pathway (Figure 33). These 
genes were all identified as down-regulated in the 7.2sox10:GFP microarray data set by 
the t-Test and the CLEAR test. Whole mount in situ hybridization was used to validate the 
microarray results for paics (Figure 30) atic (Figure 31) and adsl (Figure 32). 
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Whole mount in situ hybridization revealed that paics had a strong NC expression 
pattern (Figure 30). At 24 hpf paics was expressed in a sub-set of pre-migratory NCCs 
along much of the trunk and in cells migrating on the lateral pathway in anterior trunk 
(Figure 30A, B and C). Expression at pre-migratory NC sites was strongly reduced in 
sox10-/- embryos and no cells were observed migrating on the lateral pathway (Figure 
30A’ and B’). Paics expression was also observed in cranial NCCs and this was reduced 
in mutant embryos (data not shown). A similar expression pattern was noted at 30 hpf 
although pre-migratory NCCs were restricted to a more posterior region and lateral 
pathway migrating cells had extended into the mid-trunk region (Figure 30D, E and F). 
Again pre-migratory NCC expression was reduced and migratory cells were absent in 
mutant embryos (Figure 30D’, E’ and F’). Expression of paics did not overlap with 
melanising cells (Figure 30D). The NC expression pattern of paics, including cells 
migrating on the lateral pathway, has already been published on the ZFIN website (Thisse 
et al., 2004). Thus this gene appears to be expressed in early cells of the xanthophore 
lineage, is down-regulated in sox10 mutant embryos and with a strong expression pattern 
may prove to be a useful marker. Consistent with this, an insertion mutant (paicshi2688) has 
been characterised for this gene. This mutant has a lack of pigmentation, although it is 
unclear if this is due to a loss of xanthophores or a failure in pigmentation. Melanocytes 
appear to be grossly normal (Amsterdam et al., 2004). Thus the evidence presented here 
(Figure 30) and other published evidence suggests that paics is expressed in 
xanthoblasts, is down-regulated in sox10 mutant embryos and plays an important role in 
xanthophore development. 
The expression patterns of atic (Figure 31) and adsl (Figure 32) were both 
weaker than, but displayed many similarities to, the expression of paics. Essentially, 
expression of both genes was noted in typical NC positions and in cells migrating on the 
lateral pathway; these patterns of expression were absent in sox10 mutant embryos. 
However, some differences were noticed and these will be explored here. The expression 
pattern of atic was very weak and therefore difficult to interpret. Only a few cells were 
noted migrating on the lateral pathway (Figure 31F), but no cells were observed migrating 
on the medial pathway (data not shown). Atic expression also appeared to mark fewer 
cells than paics. Adsl expression was also less readily detected than paics expression and 
thus fewer cells appeared to be marked. This may be a result of the decreased sensitivity 
of detecting atic or adsl expression or a result of a more restricted temporal period of 
expression for these genes. Rare adsl positive cells were observed migrating on the 
medial pathway in WT 24 hpf embryos but not sox10 mutant embryos (Figure 32C and 
C’). Adsl expression in medial pathway migrating cells was only observed in one or two 
cells per embryos. While these cells appear to be NCCs, it is unknown what cell type they 
are. At 30 hpf in both WT and sox10 mutant embryos displayed strong adsl expression in 
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the somites (Figure 32E and E’). This made it very difficult to identify if expression in 
medial pathway migrating NCCs was maintained at this stage. The atic expression pattern 
has also been published on the ZFIN website showing expression in NCCs migrating on 
the lateral pathway at 24 hpf (Thisse et al., 2004). No embryonic expression pattern has 
been published for adsl in zebrafish. Despite the reduced number of cells displaying 
expression of these two genes, the expression patterns shown here are consistent with 
expression in cells of the xanthophore lineage. These gene expression patterns also show 
strong similarities to the expression pattern of paics, a gene in the same metabolic 
pathway (Figure 33). 
While examining the published expression patterns of both paics and atic, it was 
observed that expression was visible in a subset of NCCs at 2 dpf (Thisse et al., 2004). 
These cells were located in the dorsal stripe and in part of the ventral stripe. The location 
of these cells and their interspersed distribution are consistent with the iridophores 
lineage. As no embryonic pattern of adsl expression has been published it would be worth 
examining 2 dpf embryos for a similar expression pattern. 
The enzyme encoded by the paics gene is a bifunctional enzyme that catalyses 
steps 6 and 7 in the de novo purine biosynthesis pathway (Figure 33) (Li et al., 2007). 
This enzyme has both 5-aminoimidazole ribonucleotide (AIR) carboxylase (AIRC) and 4­
(N-succinylcarboxamide)-5-aminoimidazole ribonucleotide (SAICAR) synthetase 
(SAICARs) activities (Li et al., 2007). Adsl encodes the third enzyme in the de novo IMP 
biosynthesis pathway that was validated during the in situ hybridization screen. This 
enzyme catalyses step 8 and performs the conversion of succinylaminoimidazole 
carboxamide ribotide (SAICAR) into aminoimidazole carboxamide ribotide (AICAR). This 
is the step between those catalysed by paics and atic (Figure 33). The ATIC gene is also 
known as PURH, AICAR, AICARFT, and IMPCHASE. This gene encodes a bifunctional 
enzyme that has both Aminoimidazole ribonucleotide formyltransferase (AICARFT) and 
IMP cyclohydrolase activity. As a result of this, ATIC catalyses the final two steps in the de 
novo purine biosynthetic pathway (Rayl et al., 1996). The results presented in this section 
suggest that IMP biosynthesis is involved in xanthophore development. This pathway 
produces inosine monophosphate (IMP) (Figure 33) and other purine nucleotides are 
then synthesised from this intermediate. The possible significance of this pathway is 
examined in more detail in the discussion. 
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Figure 30: Whole mount in situ hybridization pattern of paics expression. 
All images are presented as per Figure 20. Images are of the following axial levels; A, A’, 
C, D and D’ are of anterior trunk, images B, B’, E and E’ are of mid-trunk and F and F’ are 
of posterior trunk. Arrows indicate migratory cells on the lateral pathway, arrowheads 
indicate pre-migratory cells. All scale bars = 50 µm. 
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Figure 31: Whole mount in situ hybridization pattern of atic expression. 
All images are presented as per Figure 20. NCC cells expressing atic were observed 
migrating in the midbrain-hindbrain boundary region (* A and D), but not in mutant 
embryos (A’ and D’). Atic positive cells migrating on the lateral pathway in anterior trunk 
(arrows in B and F) were detected in WT embryos but were absent in mutant embryos (B’ 
and F’). Expression in NCCs was also detected in the anterior trunk (C) of WT embryos 
but not in mutants (C’). Atic expressing cells did not overlap with melanising cells (E and 
F). Ov = otic vesicle, all scale bars = 50 µm. 
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Figure 32: Whole mount in situ hybridization pattern of adsl expression. 
All images are lateral views presented as per Figure 20. Anterior trunk is shown in images 
A, A’, D and D’; images B-C’, E and E’ show mid-trunk. Adsl expression was detected in 
lateral pathway migrating cells at 24 hpf (arrows in A) and 30 hpf (arrows in D), no 
expression was detected at these sites in mutant embryos (A’ and D’). Rare cells were 
observed expressing adsl migrating on the medial pathway in WT embryos (C) but not 
mutant embryos (C’) at 24 hpf. Expression was also detected in WT pre-migratory NCCs 
(arrowheads in B) but not in mutant embryos (B’). A strong somite expression pattern was 
identified at 30hpf (D and D’). All scale bars = 50 µm. 
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identified as down-regulated by both statistical tests in all three data sets. Ppat and gart 
are expressed in NCCs migrating on the lateral pathway at 24 hpf (Thisse et al., 2004). 
Additionally gart is expressed in a putative iridophore position at 2 dpf while no ppat 
expression was detected in an iridophore location (Thisse et al., 2004). An insertional 
mutant for gart has been characterised (garthi3526b) that displays a defect in yellow 
pigmentation and has a strong similarity to the paics insertion mutant. No Affymetrix probe 
set has been attributed to the pfas gene and there is no published expression pattern for 
this gene currently so it could not be examined. In summary, this evidence indicates that 
the majority of genes in the de novo IMP biosynthesis pathway are likely to be down-
regulated in sox10 mutant embryos and are likely to play a role in xanthophore biology 
during early embryo development. 
prps1a 
Dr.2896.1.S1 
_at 
prps1b 
Dr.7674.1.S1_ 
at 
ppat 
Dr.26358.1.A1_ 
at 
gart 
Dr.4801.1.S1 
_at 
7.2sox10 
t-statistic -1.56 -0.23 -5.03 -5.27 
p-value 0.19 0.83 0.0073 0.0062 
:GFP 
array 
CLEAR 
result non.sig non.sig diff.expr diff.expr 
results Fold 
Change -1.04 -1.03 -1.62 -2.07 
t-statistic -4.33 -2.09 -5.46 -11.39 
4.9sox10 p-value 0.049 0.17 0.032 0.0076 
:GFP 
array 
CLEAR 
result non.sig non.sig diff.expr diff.expr 
results Fold 
Change -1.06 -1.39 -1.54 -1.77 
7.2+4.9 
sox10 
:GFP 
array 
results 
t-statistic -3.016 -1.20 -5.39 -5.16 
p-value 0.017 0.26 0.00066 0.00086 
CLEAR 
result non.sig non.sig diff.expr diff.expr 
Fold 
Change -1.05 -1.14 -1.60 -1.91 
Table 32: Microarray Results for the remaining de novo purine biosynthesis 
pathway genes. 
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4.2.5.3.8 Dr.10624 (zgc:110343) 
Affymetrix Probe Identifier Dr.10624.2.S1_a_at Dr.10624.2.S1_at 
Affymetrix Gene Symbol zgc:110343 zgc:110343 
ZFIN Gene Symbol zgc:110343 zgc:110343 
Full Name zgc:110343 zgc:110343 
Orthology PRDX2 PRDX2 
Biological Process GO Term cell redox homeostasis cell redox homeostasis 
Molecular Function GO Term antioxidant activity oxidoreductase activity 
antioxidant activity 
oxidoreductase activity 
7.2sox10:GFP 
array results 
t-statistic -7.7046275139 -8.217423439 
p-value 0.0015271413 0.0011953737 
CLEAR result diff.expr diff.expr 
Fold Change -2.84 -2.08 
4.9sox10:GFP 
array results 
t-statistic -20.3884429932 -15.4375991821 
p-value 0.0023970008 0.0041698213 
CLEAR result diff.expr diff.expr 
Fold Change -3.59 -3.10 
7.2+4.9sox10: 
GFP array 
results 
t-statistic -8.1723003387 -6.6160578728 
p-value 0.0000374464 0.0001665774 
CLEAR result diff.expr diff.expr 
Fold Change -3.18 -2.48 
Table 33: Summary of information for zgc:110343. 
Both the Affymetrix probe sets Dr.10624.2.S1_a_at and Dr.10624.2.S1_at correspond to 
the gene zgc:110343. Both probe sets were identified as down-regulated in all three data 
sets by both statistical sets, furthermore a third probe set that also corresponds to this 
gene showed similar results but was outside the bottom 100 most down-regulated genes. 
Whole mount in situ hybridization was performed to identify the expression pattern of this 
gene (Figure 34). Strong zgc:110343 expression was seen at 24 hpf in WT cranial NCCs, 
in a subset of pre-migratory trunk NCCs and in NCCs migrating on the lateral pathway in 
anterior trunk (Figure 34A, B and C). Expression at these sites was strongly reduced in 
sox10 mutant embryos and cells failed to migrate in mutants resulting in clumps of cells 
remaining in pre-migratory positions (Figure 34A’, B’ and C’). In 30 hpf WT embryos a 
similar expression pattern was observed with more extensive migration on the lateral 
pathway (Figure 34D). No migration on the medial pathway was observed (Figure 34E). 
In 30 hpf sox10 mutant embryos a few cells still expressed zgc:110343 in pre-migratory 
positions similar to 24 hpf (Figure 34D’). The expression pattern of zgc:110343 shows the 
features of an early xanthophore lineage marker with cells only migrating on the lateral 
pathway, not overlapping with melanocytes and some expression remaining in pre­
migratory clumps of cells in sox10-/- embryos. This gene has an expression pattern 
published on ZFIN which shows a very similar pattern as shown in Figure 34 although this 
published pattern does show more extensive zgc:110343 expression (Thisse et al., 2004). 
In summary, this gene shows strong expression in xanthoblasts at both 24 hpf and 30 hpf, 
161

is likely to be an excellent marker for this cell type and is down-regulated in sox10 
mutants. 
The human orthologue of zgc:110343 was annotated as Peroxiredoxin 2 
(PRDX2), although a prdx2 gene has already been identified in zebrafish. The zebrafish 
prdx2 gene is not expressed in the NC (Thisse et al., 2004) and has also been identified 
as an orthologue of the human PRDX2 gene. This suggests that prdx2 has been 
duplicated in zebrafish. Peroxiredoxin genes play an antioxidant protective role in both 
normal cells types and cancerous cells (Shen and Nathan, 2002, Manandhar et al., 2009). 
A major role of peroxiredoxins is the enzymatic degradation of hydrogen peroxide to 
prevent it being converted into reactive oxygen species (Immenschuh and Baumgart-Vogt, 
2005). Hydrogen peroxide can also act as an intracellular messenger and thus 
peroxiredoxins can also mediate this signalling pathway (Kang et al., 1998, Kang et al., 
2004). High levels of peroxiredoxins mediating hydrogen peroxide signalling have been 
associated with both cell proliferation and inhibition of apoptosis (Immenschuh and 
Baumgart-Vogt, 2005). Thus a peroxiredoxin gene such as zgc:110343 may play a role in 
preventing oxidative stress in NCCs or in the regulation of proliferation or cell survival. 
However no definitive role for prdx2 or zgc:110343 has been characterised during NC 
development thus making this an interesting gene for further study. 
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Figure 34: Whole mount in situ hybridization pattern of zgc:110343 expression. 
All images are presented as per Figure 20. Zgc:110343 was expressed in cranial NCCs 
(A) migrating around the midbrain-hindbrain boundary (*) and in cells migrating on the 
lateral pathway (arrows) in anterior trunk at both 24 hpf (B) and 30 hpf (D). In mid trunk at 
24 hpf cells expressing zgc:110343 were present in pre-migratory positions (arrowhead in 
C). At all these sites in sox10 mutant embryos expression was strongly reduced although 
some cells expressing zgc:110343 remained in pre-migratory positions (arrowheads in A’, 
B’, C’ and D’). Zgc:110343 expression did not overlap with melanocytes (D) or appear on 
the medial pathway (E). Scale bars in A-C = 50 µm, scale bars in D and E = 25 µm. 
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4.2.5.3.9 aldh2 
Affymetrix Probe Identifier Dr.4751.1.S1_a_at Dr.4751.2.A1_at 
Affymetrix Gene Symbol aldh2a, aldh2b aldh2b 
ZFIN Gene Symbol aldh2a, aldh2b aldh2b 
Full Name aldehyde dehydrogenase 2a/b 
aldehyde 
dehydrogenase 2b 
Orthology ALDH2 ALDH2 
Biological Process GO Term 
cellular aldehyde 
metabolic process 
metabolic process 
cellular aldehyde 
metabolic process 
metabolic process 
Molecular Function GO Term 
nucleic acid binding 
3-chloroallyl aldehyde 
dehydrogenase activity 
zinc ion binding 
oxidoreductase activity 
metal ion binding 
nucleic acid binding 
3-chloroallyl aldehyde 
dehydrogenase activity 
zinc ion binding 
oxidoreductase activity 
metal ion binding 
7.2sox10:GFP 
array results 
t-statistic -7.7480130196 -6.883207798 
p-value 0.0014949832 0.0023346485 
CLEAR 
result diff.expr diff.expr 
Fold Change -2.34 -2.48 
4.9sox10:GFP 
array results 
t-statistic -5.3127570152 -9.3952064514 
p-value 0.0336509645 0.0111399386 
CLEAR 
result diff.expr diff.expr 
Fold Change -2.80 -5.07 
7.2+4.9sox10:GFP 
array results 
t-statistic -8.8155965805 -7.1221790314 
p-value 0.000021572 0.0000997859 
CLEAR 
result diff.expr diff.expr 
Fold Change -2.34 -3.15 
Table 34: Summary of aldh2a/b information 
The Affymetrix probe set Dr.4751.1.S1_a_at corresponds to transcripts from two related 
genes, aldh2a and aldh2b. The probe set Dr.4751.2.A1_at corresponds to aldh2b only. 
Both probe sets were detected as differentially regulated in all three data sets by both 
statistical tests (Table 34). It seems likely that the differentially expressed gene being 
detected was aldh2b as both probe sets correspond to this gene; it cannot be excluded 
that aldh2a is also differentially regulated. The in situ probe used to validate these probe 
sets was designed to recognise aldh2b mRNA (Figure 35). At both 24 hpf and 30 hpf, 
numerous cells expressing aldh2b were scattered over the head and anterior trunk of WT 
embryos (Figure 35A and D) and cells were visible migrating on the lateral pathway in the 
trunk at both stages (arrows in Figure 35A, B, D and E). No cells migrating on the medial 
pathway were seen at 24 or 30 hpf (data not shown and Figure 35F). A subset of pre­
migratory NCCs expressing aldh2b was also visible in the trunk at both time points in WT 
embryos (Figure 35B, C and F). Aldh2b expression did not overlap with melanocytes. 
Aldh2b expression was mostly absent in sox10-/- embryos (Figure 35A’, C’, D’, E’ and F’) 
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although some cells in pre-migratory positions were weakly marked (Figure 35B’). Thus 
this gene appears to be expressed in early cells of the xanthophore lineage. The 
expression pattern for aldh2b shown here mostly matched the pattern published on the 
ZFIN website; aldh2b was noted as being expressed in the NC and in cells on the lateral 
pathway but in addition weak expression was noted in the otic vesicle (Thisse et al., 
2004). Aldh2a expression in developing zebrafish embryos has been examined by RT­
PCR but NC expression was not assessed (Song et al., 2006). In summary, aldh2b is 
expressed in xanthoblasts and is strongly reduced in sox10 mutant embryos. 
In humans, ALDH2 is responsible for metabolising aldehydes such as 
acetaldehyde, the oxidative metabolite of alcohol. This intermediate in the breakdown of 
alcohol is more toxic than alcohol and is thus responsible for many of the symptoms of a 
hangover. Zebrafish have two orthologues (aldh2a and aldh2b) of the ALDH2 gene, a 
member of the aldehyde dehydrogenase superfamily (Lassen et al., 2005, Song et al., 
2006). No link between ALDH2 and NC biology has been established. Therefore the 
function of aldh2b in zebrafish NC is of great interest. There appears to be no immediately 
obvious link between alcohol metabolism and NC biology therefore this is a surprising 
result. 
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Figure 35: Whole mount in situ hybridization pattern of aldh2b expression. 
All images are presented as per Figure 20. Images A, A’, D and D’ are of posterior head 
and anterior trunk showing aldh2b expressing cells scattered over this region in WT 
embryos and migrating on the lateral pathway (arrows). Images B, B’, E and E’ are of 
anterior trunk, at 24 hpf and 30 hpf pre-migratory NCCs expressing aldh2b were visible 
(arrowheads) and at 30 hpf cells were migrating on the lateral pathway (arrows). Images 
C, C’, F, and F’ are of mid-trunk showing pre-migratory NCCs expressing aldh2b at both 
24 and 30 hpf (arrowheads). No cells expressing aldh2b were visible on the medial 
pathway (F). Expression of aldh2b was mostly absent in sox10 mutant embryos at both 
time points (A’, B’, C’, D’, E’ and F’). All scale bars = 50 µm. 
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4.2.5.4 Otic Vesicle Expressed Genes 
This section contains genes that were expressed in the otic vesicle of zebrafish embryos. 
It was predicted that these genes would be identified as differentially regulated in the 
7.2sox10:GFP line data but not the 4.9sox10:GFP data. This is because the otic vesicle is 
only weakly marked by GFP in the 4.9sox10:GFP transgenic line (Figure 7). 
4.2.5.4.1 cldnj 
Affymetrix Probe Identifier Dr.8680.1.S1_at 
Affymetrix Gene Symbol cldnj 
ZFIN Gene Symbol cldnj 
Full Name claudin j 
Orthology N/A 
Biological Process GO Term lifelong otolith mineralization 
Molecular Function GO Term structural molecule activity 
7.2sox10:GFP array 
results 
t-statistic -16.1235923767 
p-value 0.0000865462 
CLEAR result diff.expr 
Fold Change -2.71 
4.9sox10:GFP array 
results 
t-statistic -2.44237113 
p-value 0.1346058547 
CLEAR result diff.expr 
Fold Change -1.51 
7.2+4.9sox10:GFP 
array results 
t-statistic -2.0496237278 
p-value 0.0745517164 
CLEAR result diff.expr.high.var 
Fold Change -2.35 
Table 35: Summary of cldnj information. 
The Affymetrix probe set Dr.8680.1.S1_at corresponds to the gene cldnj. The t-Test 
declared this gene as differentially regulated in the 7.2 data set only; the CLEAR test 
indicated that this gene is differentially regulated in all three data sets. The gene 
expression pattern of cldnj was determined by in situ hybridization (Figure 36). Cldnj was 
strongly expressed in the otic epithelium of WT 24 hpf and 30 hpf embryos (Figure 36A 
and B). Expression in the otic epithelium was not uniform; expression in the anterior of the 
otic vesicle was reduced in comparison with the posterior. This expression pattern has 
been previously characterised and matches the pattern shown here (Hardison et al., 
2005). Cldnj expression was strongly reduced in 24 hpf and 30 hpf sox10-/- embryos 
(Figure 36A’ and B’). The distribution of cldnj expression was thoroughly examined by 
Hardison et al., 2005, they concluded that cldnj was expressed in the dorso-lateral areas 
of the otic epithelium. Thus cldnj is strongly expressed in the otic epithelium and for the 
first time has been shown to be down-regulated in sox10 mutant embryos. It is likely the 
down-regulation of cldnj in sox10 mutant embryos contributes to the small otoliths 
phenotype of these embryos. 
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The zebrafish cldnj mutant was generated from a large scale insertional mutant 
screen and subsequently characterised (Amsterdam et al., 2004, Hardison et al., 2005). 
The cldnj mutant had reduced otoliths apparently as a result of failing to properly 
incorporate otolith material. The mechanism by which cldnj functions was not elucidated. 
The cldnj mutant displays reduced hearing and vestibular function (balance and spatial 
orientation). In vertebrates, otoliths respond to changes in the direction of gravity as a 
result of head movements. This distorts the hairs on sensory cells in the macula to detect 
the movement. It is therefore not surprising that cldnj mutants display vestibular problems. 
In lower vertebrates the otoliths also function to detect sound thus the zebrafish hearing 
defect fits with a defect in otoliths formation (Finn and Kapoor, 2008). Sox10-/- embryos 
display a small otic vesicle and small otolith phenotype (Whitfield et al., 1996) and thus 
the cldnj mutant displays an element of the sox10 mutant phenotype. It would be 
interesting to assess how sox10 mutant embryos perform in the tapping (hearing) test and 
startle response test used to assess cldnj mutants. There is no clear human orthologue for 
the zebrafish cldnj gene (Hardison et al., 2005). However mutations in the gene CLDN14 
result in human deafness (Wilcox et al., 2001) thus there is a precedent for this gene 
family to function in human hearing. In summary, cldnj is a relatively well characterised 
gene known to be expressed in the otic epithelium and the phenotype of a cldnj mutant 
has been characterised. 
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Figure 36: Whole mount in situ hybridization pattern of cldnj expression. 
All images are dorsal views of embryos oriented anterior left and posterior right. Images A 
and A’ are of 24 hpf embryos and images B and B’ are of 30 hpf embryos. Images A and 
B are of WT embryos, images A’ and B’ are of sox10 mutant embryos. At both 24 hpf and 
30 hpf the otic epithelium strongly expressed cldnj (arrows in A and B), the presence of 
melanocytes is indicated (*). At these time points cldnj expression in the otic epithelium 
was strongly reduced in sox10 mutants (arrows in A’ and B’). Scale bar = 75 µm. 
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4.2.5.4.2 otomp 
Affymetrix Probe Identifier Dr.19416.1.S1_at 
Affymetrix Gene Symbol otomp 
ZFIN Gene Symbol otomp 
Full Name otolith matrix protein 
Orthology N/A 
Biological Process GO Term 
iron ion transport 
cellular iron ion homeostasis 
negative regulation of signal transduction 
otolith development 
otolith development 
Molecular Function GO Term ferric iron binding 
7.2sox10:GFP array 
results 
t-statistic -6.6376228333 
p-value 0.0026735307 
CLEAR result diff.expr 
Fold Change -1.86 
4.9sox10:GFP array 
results 
t-statistic -9.0619659424 
p-value 0.0119594019 
CLEAR result diff.expr 
Fold Change -1.50 
7.2+4.9sox10:GFP 
array results 
t-statistic -3.0389389992 
p-value 0.0160892177 
CLEAR result diff.expr 
Fold Change -1.96 
Table 36: Summary of information for otomp. 
The Affymetrix probe set Dr.19416.1.S1_at corresponds to the gene otomp. Otomp is a 
strongly expressed marker of the otic epithelium (Thisse et al., 2004, Murayama et al., 
2005) and is down-regulated in sox10-/- embryos (R. Kelsh, personal communication). 
Thus this gene has served as the only ear specific marker gene throughout this project. 
Otomp was identified as differentially expressed in all three data sets by both statistical 
tests (Table 36). Validation of otomp down-regulation in sox10 mutant embryos was 
performed by in situ hybridization (Figure 37). As previously reported, otomp was 
specifically expressed throughout the otic epithelium with expression more intense in a 
ventro-posterior area (Figure 37A, B, C and D) (Murayama et al., 2005). This was true at 
both 24 hpf and 30 hpf. In sox10-/- embryos otomp expression persisted at both 24 and 30 
hpf but in a more restricted ventro-posterior region (Figure 37A’, B’, C’ and D’). Thus 
otomp was expressed in the otic epithelium and was down-regulated in sox10 mutant 
embryos. 
The function of otomp in zebrafish has been studied by morpholino mediated gene 
knockdown (Murayama et al., 2005). Otomp morphants displayed otoliths that were 
reduced in size compared to control embryos and also displayed behavioural defects 
consistent with impaired vestibular functions. Otoliths in morphant embryos initially formed 
correctly (seeded) but grew at a reduced rate in comparison with WT embryos. This otolith 
170

phenotype therefore shares similarities with the sox10 mutant small otoliths phenotype 
and the reduction of otomp expression in these embryos is likely to contribute to the small 
otolith phenotype. 
Lateral View Dorsal View 
Figure 37: Whole mount in situ hybridization pattern of otomp expression. 
All images are of zebrafish otic vesicles. Images A, A’, C and C’ are lateral views oriented 
anterior down and ventro-posterior right. Images B, B’, D and D’ are dorsal views oriented 
anterior left. In WT embryos otomp was expressed throughout the otic epithelium but was 
strongly expressed in a ventro-posterior region (arrows in A, B, C and D). In mutant 
embryos expression was limited to a more restricted ventro-posterior region (arrows in A’, 
B’, C’ and D’). Melanocytes in WT 30 hpf embryos are indicated (*). Scale bars = 60 µm. 
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4.2.5.4.3 Dr.18158 
Affymetrix Probe Identifier Dr.18158.1.A1_at 
Affymetrix Gene Symbol N/A 
ZFIN Gene Symbol N/A 
Full Name N/A 
Orthology N/A 
Biological Process GO Term N/A 
Molecular Function GO Term N/A 
7.2sox10:GFP array 
results 
t-statistic -7.7104620934 
p-value 0.0015227671 
CLEAR result diff.expr 
Fold Change -1.53 
4.9sox10:GFP array 
results 
t-statistic -2.5671079159 
p-value 0.1241162792 
CLEAR result diff.expr 
Fold Change -1.45 
7.2+4.9sox10:GFP 
array results 
t-statistic -1.4548796415 
p-value 0.1837879419 
CLEAR result diff.expr.high.var 
Fold Change -1.73 
Table 37:Summary of Results for Dr.18158.1.A1_at. 
The Affymetrix probe set Dr.18158.1.A1_at has no associated annotation on NetAffx. In a 
similar pattern of results to cldnj, the CLEAR test identified this gene as differentially 
regulated in all three data sets while the t-Test only identified this gene as differentially 
regulated in the 7.2 data set (Table 37). To validate these results an in situ hybridization 
probe was designed using the Dr.18158.1.A1_at sequence on NetAffx (Figure 38). 
Dr.18158 was expressed mainly in a ventro-medial region of the otic epithelium in 24 and 
30 hpf WT embryos but expression was also observed in a ventro-lateral region in the 
posterior of the otic vesicle (Figure 38A, B, C and D). In sox10 mutant embryos the same 
expression pattern was observed but expression was noticeably reduced (Figure 38A’, 
B’, C’ and D’). Thus the gene that Dr.18158.1.A1_at corresponds to is expressed in the 
otic epithelium and is down-regulated in sox10 mutant embryos. 
The Dr.18158.1.A1_at probe set has not been annotated so no information 
regarding the gene that this probe set corresponds to is available. Performing BLAST 
searches on the NCBI and ZFIN websites does not show any strong similarity between 
the Affymetrix sequence for the probe set Dr.18158.1.A1_at and any mRNA or cDNA 
sequences. The sequence of Dr.18158.1.A1_at is contained within the GenBank genomic 
DNA sequence BX530036. As such this is a completely novel target to have been 
detected and validated as part of this microarray project. Functional knock down for this 
gene using a morpholino approach to uncover the role of this gene would be very 
interesting. Such an approach could help to unravel another aspect of the complex ear 
phenotype of sox10 mutant embryos. 
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Lateral View Dorsal View 
Figure 38: Whole mount in situ hybridization pattern of Dr.18158.1.A1_at 
expression. 
All images are of zebrafish otic vesicles presented as per Figure 37. In WT embryos at 
both 24 hpf and 30 hpf Dr.18158 was expressed mainly in a ventro-medial region but also 
in a ventro-lateral position in the posterior of the otic vesicle (A, B, C and D). In mutant 
embryos the same expression pattern was observed but expression was comparatively 
weaker (A’, B’, C’ and D’). Melanocytes in WT 30 hpf embryos are indicated (*). Scale 
bars = 60 µm. 
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4.2.5.5 foxD3 is down-regulated in the peripheral nervous system. 
Affymetrix Probe Identifier Dr.590.1.S1_at 
Affymetrix Gene Symbol foxd3 
ZFIN Gene Symbol foxd3 
Full Name forkhead box D3 
Orthology FOXD3 
Biological Process GO Term 
neural crest cell migration 
regulation of transcription, DNA-dependent 
peripheral nervous system development 
neural crest cell development 
melanocyte differentiation 
enteric nervous system development 
sympathetic nervous system development 
lateral line nerve glial cell development 
pigment cell differentiation 
iridophore differentiation 
cartilage development 
Molecular Function GO Term 
DNA binding 
transcription factor activity 
transcription activator activity 
sequence-specific DNA binding 
7.2sox10:GFP array 
results 
t-statistic -8.5286149979 
p-value 0.0010371582 
CLEAR result diff.expr 
Fold Change -1.32 
4.9sox10:GFP array 
results 
t-statistic -3.1133506298 
p-value 0.0895293579 
CLEAR result diff.expr 
Fold Change -1.50 
7.2+4.9sox10:GFP 
array results 
t-statistic -3.1978538036 
p-value 0.0126530966 
CLEAR result diff.expr 
Fold Change -1.32 
Table 38: Summary of information for foxd3. 
The Affymetrix probe set Dr.590.1.S1_at corresponds to the transcription factor foxd3. 
This gene was determined as differentially regulated by both statistical tests on all data 
sets except the t-Test on the 4.9 data set (Table 38). To determine if foxd3 was 
differentially regulated in sox10 mutant embryos, in situ hybridization was performed 
(Figure 39). Foxd3 is a well known early NC marker and was expressed in NCCs in the 
posterior trunk of WT 24 hpf embryos (Figure 39D) (Kelsh et al., 2000, Odenthal and 
Nüsslein-Volhard, 1998). Expression in early pre-migratory NCCs appeared to be identical 
in WT and sox10-/- embryos at 24 hpf and 30 hpf (Figure 39D, D’ and data not shown) 
(Lopes et al., 2008). Foxd3 was also expressed in clumps of cells anterior of the otic 
vesicle (Figure 39A), posterior of the otic vesicle (Figure 39B) and in cells along the 
posterior lateral line nerve (Figure 39B). These sites showed a reduction in foxd3 
expression in sox10 mutant embryos (Figure 39A’ and B’). Previous studies have also 
identified that foxd3 is down-regulated at these sites in sox10 mutant embryos and 
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postulated that these cells are of the glia lineage (Kelsh et al., 2000, Lister et al., 2006). 
Foxd3 expression was also noted in cells migrating on the medial pathway (Figure 39C). 
These cells are in a position consistent with dorsal root ganglia (DRG) and are likely again 
to be of the glia lineage (Kelsh et al., 2000). Obvious down-regulation of foxd3 expression 
in DRG associated cells was not detected in sox10-/- embryos (Figure 39C’). FoxD3 
expression in somites was also observed; this site displayed no difference in expression 
between WT and mutant embryos (Figure 39D and D’). It has been shown that foxd3 is 
expressed in somites and regulates the muscle differentiation gene myf5 during 
somitogenesis (Lee et al., 2006). The expression pattern of foxd3 in 30 hpf WT and 
mutant embryos had strong similarities with the expression patterns identified at 24 hpf 
(data not shown). Thus the expression pattern of foxd3 in early NCCs and NC derived glia 
of the peripheral nervous system shown here (Figure 39) matches previously published 
reports. Down-regulation of foxd3 expression in sox10 mutant embryos was observed in 
glia but not early NCCs. The identification of a gene expressed in the PNS as down-
regulated in this screen shows that it is possible to detect PNS genes by this approach at 
this time point. 
Defects in foxd3 expression in sox10 mutant embryos appear to be restricted to 
the glial cell lineage of the peripheral nervous system (Figure 39) (Kelsh et al., 2000). 
Glial cell differentiation fails in sox10 mutant embryos (Carney et al., 2006) thus a 
reduction in foxd3 positive glial cells was expected. The number of peripheral glia is also 
reduced in foxd3 mutant embryos (Montero-Balaguer et al., 2006, Stewart et al., 2006). A 
sub-population of NCCs in the hindbrain region die by apoptosis in the foxd3sym1 mutant 
(Stewart et al., 2006). The position of these cells is consistent with a glial, neuronal and 
craniofacial cartilage fate. Thus foxd3 may play a role in the survival of glia but this 
requires further investigation. In addition it remains to be seen if this role can be generally 
extended to trunk NC derived glia associated with the posterior lateral line nerve and the 
DRGs. It is interesting to note that clear down-regulation of foxd3 was observed in cells 
associated with the posterior lateral line nerve but not in cells associated with the DRGs. 
As sox10 functions in glial differentiation but not glial specification it is possible that 
expression of foxd3 is only defective in differentiated glia and not glia precursor cells. 
Thus glia precursor cells might still be visualised using foxd3 as a marker. These DRG 
associated glia do fail to differentiate in sox10 mutants by 5 dpf (Carney et al., 2006). 
Characterisation of the role foxd3 plays in the development of this NC derivative has been 
complicated by an early role in pre-migratory NCCs. For example, analysis of foxd3 
mutants identified a down-regulation of important early NC transcription factors including 
sox10 (Montero-Balaguer et al., 2006, Stewart et al., 2006). Thus it appears that foxd3 is 
expressed and functioning both upstream and downstream of sox10. It is likely that these 
two roles, the role in early NC development and the role in glia are distinct. 
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Figure 39: Whole mount in situ hybridization pattern of foxD3 expression in NC 
derivatives. 
All images are lateral views of 24 hpf embryos oriented anterior left and dorsal top except 
A and A’ oriented anterior bottom and dorsal left. Image A and B are of the head, C of 
anterior mid-trunk and D of posterior trunk (WT embryos), images labelled by a letter with 
an apostrophe are corresponding images of sox10 mutant embryos. In WT embryos 
foxD3 was expressed in cells anterior of the otic vesicle (A), posterior of the otic vesicle 
(B) and surrounding the posterior lateral line nerve (B). Expression at these sites was 
reduced in mutant embryos (A’ and B’). In the trunk of WT embryos putative dorsal root 
ganglion cells were visible in both WT and mutant embryos (arrows in C and C’). FoxD3 
was strongly expressed in early pre-migratory crest in both WT and sox10 mutant 
embryos in posterior trunk (arrowheads in D and D’). Labels: g = glia, PLL = posterior 
lateral line nerve and ov = otic vesicle. Scale bars = 50 µm. 
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4.2.5.6 Miscellaneous validated down-regulated genes. 
Gene placed in to this section show expression in NCCs that is reduced in sox10 mutant 
embryos. For some of these genes, the weakness of the expression pattern obtained has 
made it difficult to accurately predict which cell type the gene is expressed. For the 
remaining genes, the gene expression pattern does not neatly fit with the expected 
expression pattern for one NC cell type. 
4.2.5.6.1 Dr.4612 
Affymetrix Probe Identifier Dr.4612.1.A1_at 
Affymetrix Gene Symbol wu:fc31e04 
ZFIN Gene Symbol wu:fc31e04 
Full Name wu:fc31e04 
Orthology N/A 
Biological Process GO Term N/A 
Molecular Function GO Term N/A 
7.2sox10:GFP array 
results 
t-statistic -18.1266307831 
p-value 0.0000544656 
CLEAR result diff.expr 
Fold Change -2.83 
4.9sox10:GFP array 
results 
t-statistic -6.9993152618 
p-value 0.0198077019 
CLEAR result diff.expr 
Fold Change -4.61 
7.2+4.9sox10:GFP 
array results 
t-statistic -10.1082744598 
p-value 0.000007832 
CLEAR result diff.expr 
Fold Change -3.41 
Table 39: Summary of information for Dr.4612.1.A1_at. 
The Affymetrix probe set Dr.4612.1.A1_at corresponds to the expressed sequence 
wu:fc31e04. This probe set was identified as differentially regulated in all three data sets 
by both statistical tests (Table 39). In situ hybridization was performed to visualise the 
expression pattern of this target in WT and sox10 mutant embryos (Figure 40). Dr.4612 
was expressed in cranial NCCs at the midbrain-hindbrain boundary, no expression was 
detected in mutant embryos (Figure 40A and A’). In the trunk, expression was detected in 
pre-migratory NCCs (Figure 40B) and in cells migrating on the lateral pathway (Figure 
40C). In addition, Dr.4612 expression was detected in rare cells on the medial pathway, 
one cell in approximately half of the embryos assessed (Figure 40C). No expression was 
detected at these sites in mutant embryos (Figure 40B’, C’ and D’). No expression 
patterns have been published for this gene. The expression pattern of Dr.4612 
(wu:fc31e04) has been assessed for the first time here and shown to mark NCCs, 
particularly cranial NCCs. The expression of this gene was down-regulated in sox10-/­
embryos. 
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As a result of the staining being very weak, this pattern proved difficult to interpret. 
The pattern does show similarities to markers of the xanthophore lineage. For example, 
most migratory cells expressing Dr.4612 were on the lateral pathway with only rare cells 
observed on the medial pathway. Other markers of the xanthophore lineage also marked 
rare medial pathway cells such as cx33.8 (Figure 29). Thus a tentative prediction is that 
Dr.4612 is expressed in the xanthophore cell lineage. This prediction requires further 
testing to be validated, for example optimisation of the in situ hybridization protocol to 
improve the signal strength and comparison of Dr.4612 expression in xanthophore and 
melanocyte pigment mutants. A BLAST search for RNA sequences on the NCBI website 
using the ZFIN sequence for wu:fc31e04 did not identify any hits with similarities. 
Therefore it is impossible to formulate a hypothesis regarding the function of this gene. In 
summary, although the cell lineage that this gene is expressed in has not been definitively 
determined, this gene is clearly NC expressed and down-regulated in sox10 mutant 
embryos when compared to WT embryos. This target represents a novel NC expressed 
gene. 
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Figure 40: Whole mount in situ hybridization pattern for the probe set 
Dr.4612.1.A1_at. 
All images are lateral views of 24 hpf embryos oriented anterior left and dorsal top. 
Images labelled by a letter alone are of WT embryos; corresponding images of sox10 
mutant embryos are labelled with a letter and apostrophe. Image A and A’ are of the head 
in the region of the midbrain-hindbrain boundary, all other images are of trunk regions. 
Dr.4612 expressing cells were detected at and migrating near the midbrain hindbrain 
boundary (asterisk in A). Pre-migratory NCCs expressed Dr.4612 (B) as did migratory 
cells on the lateral pathway (C) and rare cells on the medial pathway (D). Expression was 
absent in mutant embryos (A’, B’, C’ and D’). Scale bars = 50 µm. 
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4.2.5.6.2 coro1c 
Affymetrix Probe Identifier Dr.2901.1.S1_at 
Affymetrix Gene Symbol coro1c 
ZFIN Gene Symbol coro1c 
Full Name coronin, actin binding protein, 1c 
Orthology CORO1C (CORO3) 
Biological Process GO Term N/A 
Molecular Function GO Term N/A 
7.2sox10:GFP array 
results 
t-statistic -9.323184967 
p-value 0.0007367123 
CLEAR result diff.expr 
Fold Change -1.45 
4.9sox10:GFP array 
results 
t-statistic -1.8859200478 
p-value 0.1999538839 
CLEAR result non.significant 
Fold Change -1.15 
7.2+4.9sox10:GFP 
array results 
t-statistic -3.5967919827 
p-value 0.0070149088 
CLEAR result diff.expr 
Fold Change -1.31 
Table 40: Summary of information for coro1c. 
The Affymetrix probe set Dr.2901.1.S1_at corresponds to the gene coro1c, also known as 
coronin 3. This gene was detected as differentially regulated by both statistical tests in the 
7.2 and 7.2+4.9 data sets but was not identified as differentially regulated in the 4.9 data 
set (Table 40). To validate differential gene expression in sox10 mutant embryos, in situ 
hybridization was performed (Figure 41). Coro1c was expressed in WT 24 hpf embryos in 
pre-migratory NCC positions (Figure 41A) and in cells migrating on the medial pathway 
(Figure 41B). No coro1c expression was observed in cells migrating on the lateral 
pathway (Figure 41C). Expression was strongly reduced in pre-migratory NCCs of mutant 
embryos (Figure 41A’) and fewer cells expressing coro1c were observed on the medial 
pathway (Figure 41B’). This pattern and location of cells suggested that coro1c could be 
expressed in cells of a neural lineage as these cells only migrate on the medial pathway 
and, unlike pigment cells which fail to migrate in sox10 mutant embryos, these cell types 
are only reduced in number. At 30 hpf a different pattern of gene expression was 
identified. Coro1c expression was detected in cells migrating on the medial (Figure 41D 
and E) and lateral (Figure 41F) pathways. Expression of a gene on the lateral pathway is 
strongly indicative of a pigment cell fate. Often coro1c expression overlapped with 
melanising cells (arrows in Figure 41D and E) although not always (arrow and asterisk in 
Figure 41E). Expression in migrating cells was absent in mutant embryos (Figure 41D’). 
The expression pattern of coro1c at 30 hpf is more consistent with a melanocyte pattern, 
albeit a restricted pattern when compared to more commonly used markers like dct. At 
both time points the expression of coro1c was difficult to interpret as the in situ 
hybridization stain was very weak, especially in the trunk and only a few cells were 
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labelled. For example, expression of coro1c may not be absent in lateral pathway 
migrating cells in 24 hpf embryos but below obviously detectable levels. In addition to this, 
strong staining in the head of the CNS was observed (data not shown). This made it 
difficult to assess for NC coro1c expression in the head. If coro1c is expressed in cells of 
a glial lineage then expression would be expected in patches anterior and posterior of the 
otic vesicle as observed with foxd3 (Figure 39). If coro1c is expressed in peripheral 
neurons the gene expression pattern would be expected to reflect neurogenin 1 
expression. Examination of coro1c expression in the sox10baz1 mutant which has 
supernumerary DRGs would help to ascertain if this gene is a neuronal marker (Carney et 
al., 2006). An expression pattern for coro1c has been published on the ZFIN website 
showing strong expression in the CNS particularly the hindbrain but no NC expression 
was detected (Thisse et al., 2004). In summary, coro1c is a novel gene expressed in 
zebrafish NC that is down-regulated in sox10 mutant embryos. The cell lineage this gene 
is expressed in could not be comprehensively identified but it may mark NC derivatives of 
the PNS or melanocytes. There is a paucity of PNS cell lineage markers therefore it is 
important to determine if coro1c is a PNS marker. 
The family of coronin genes are known regulators of the actin cytoskeleton and 
have been implicated in actin dependent processes including cell migration, reviewed in 
(Uetrecht and Bear, 2006). CORO1C was cloned in 2000 and immunocytochemical 
staining identified that CORO1C co-localised with F-actin indicating possible roles in 
cytokinesis, cell motility and signal transduction (Iizaka et al., 2000). Functional studies in 
vitro indicated that absence of functional CORO1C inhibited cell migration possibly 
through a participation in the formation of cellular protrusions (Rosentreter et al., 2007). 
Expression of CORO1C was also correlated with brain tumour malignancy, highly 
malignant tumours contained more CORO1C positive cells (Thal et al., 2008). In addition, 
CORO1C knockdown reduced proliferation, cell motility and invasion of cancer cells in 
vitro (Thal et al., 2008). Thus CORO1C has been implicated in several processes that are 
common to NCCs and cancerous cells. Zebrafish have the potential to provide an in vivo 
model for coro1c functional studies and therefore to complement the in vitro studies 
performed so far. No link between coro1c and NC biology other than demonstrated here 
exists. 
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Figure 41: Whole mount in situ hybridization pattern of coro1c expression. 
All images are lateral views of embryonic trunk presented as per Figure 20. Expression of 
coro1c at 24 hpf in WT embryos was detected in pre-migratory NCCs (arrowheads A), 
NCCs migrating on the medial pathway (arrows in B) but not in cells migrating on the 
lateral pathway (C). In sox10 mutant embryos, expression was strongly reduced in pre­
migratory NCCs (A’) however rare coro1c positive cells were detected on the medial 
pathway (arrow in B’). In 30 hpf WT embryos coro1c expression was detected in cells 
migrating on the medial and lateral pathways (arrows in D, E and F). Melanising cells 
expressing coro1c are indicated with an arrow, a cell expressing coro1c but not melanin is 
marked with an arrow and an asterisk (E). Expression in migratory cells was absent at 30 
hpf in sox10-/- embryos (D’). Scale bars in D-F = 25 µm, all other scale bars = 50 µm. 
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4.2.5.6.3 Dr.3972 
Affymetrix Probe Identifier Dr.3972.1.S1_at 
Affymetrix Gene Symbol N/A 
ZFIN Gene Symbol si:dkey-226k3.4 
Full Name si:dkey-226k3.4 
Orthology N/A 
Biological Process GO Term N/A 
Molecular Function GO Term N/A 
7.2sox10:GFP array 
results 
t-statistic -8.3018627167 
p-value 0.0011496505 
CLEAR result diff.expr 
Fold Change -3.20 
4.9sox10:GFP array 
results 
t-statistic -10.5303659439 
p-value 0.0088978764 
CLEAR result diff.expr 
Fold Change -3.25 
7.2+4.9sox10:GFP 
array results 
t-statistic -12.9263210297 
p-value 0.0000012141 
CLEAR result diff.expr 
Fold Change -3.36 
Table 41: Summary information for the Affymetrix probe set Dr.3972.1.S1_at. 
The probe set Dr.3972.1.S1_at has not been annotated with a gene name by Affymetrix, a 
BLAST search of the probe target sequence on ZFIN identified very strong homology 
(99%) to si:dkey-226k3.4. This gene was identified as differentially regulated in all three 
data sets by both statistical tests (Table 41). To validate this, in situ hybridization was 
performed (Figure 42). Expression of Dr.3972.1.S1_at was strongly detected in cranial 
NCCs at the midbrain-hindbrain boundary (Figure 42A) and in cells in a NC position in the 
posterior head and anterior trunk region (Figure 42B). Weak expression of 
Dr.3972.1.S1_at was seen in pre-migratory trunk NCCs and in some cells migrating on 
the medial pathway (Figure 42C and D). No expression was detected in cells migrating on 
the lateral pathway (data not shown). Expression at all these sites was absent in sox10 
mutant embryos (Figure 42A’, B’, C’ and D’). Expression of Dr.3972.1.S1_at was 
detected in WT 30 hpf embryos in some cells migrating on the medial pathway (Figure 
42E) but not on the lateral pathway (data not shown). Occasionally Dr.3972.1.S1_at 
expression overlapped with melanising cells but this was not the case for the majority of 
cells. As seen at 24 hpf, no Dr.3972.1.S1_at expression was detected in 30 hpf mutant 
embryos (Figure 42E’). 
This expression pattern is hard to interpret as only a few migrating NCCs weakly 
expressed Dr.3972.1.S1_at. The pattern of Dr.3972.1.S1_at expression in the head had 
similarities to a marker of pigment cells. Dr.3972.1.S1_at expressing cells were only 
observed to migrate on the medial pathway. Both cells of the iridophores lineage and 
neural lineage cells migrate solely on the medial pathway. Cells expressing 
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Dr.3972.1.S1_at were observed in positions consistent with that occupied by DRGs 
(Carney et al., 2006). Neural cell fates are only reduced and still migrate in sox10 mutants 
while pigment cell fates fail to migrate in mutant embryos. Thus an absence of expression 
of Dr.3972.1.S1_at in mutants argues that Dr.3972.1.S1_at marks iridophores. The other 
cell type that migrates on the medial pathway is melanocytes, these also migrate on the 
lateral pathway, which was not observed for Dr.3972.1.S1_at expressing cells, and 
Dr.3972.1.S1_at did not typically mark melanising cells. Thus the expression pattern is not 
consistent with the melanocyte lineage. Dr.3972.1.S1_at expression does mark NCCs, 
particularly cranial NCCs, is down-regulated in sox10 mutant embryos. Most likely, this 
gene marks cells of the iridophore lineage but it cannot be excluded that this gene marks 
neural cells. Both of these lineages have a dearth of markers and thus it could prove 
useful to optimise the in situ hybridization protocol for this gene and to further characterise 
the expression pattern obtained here. To test which cell lineage is marked, in situ 
hybridization could be performed in the ltk/shady mutant that lacks iridophores or in the 
sox10baz1 mutant, which has additional sensory neurons. Alternatively to assess for 
expression in neural cells in situ hybridization could be performed in ngn1 morphant 
embryos. 
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Figure 42: Whole mount in situ hybridization visualised expression pattern for 
Affymetrix probe set Dr.3972.1.S1_at. 
All images are lateral views of embryos presented as per Figure 20. Images A and A’ are 
of the head at the midbrain-hindbrain boundary, images B and B’ are of posterior head 
and anterior trunk, all remaining images are of trunk regions. At 24 hpf in WT embryos, 
expression of Dr.3972.1.S1_at was detected in NCC positions at the midbrain-hindbrain 
boundary (* in A), in the posterior head (B) and in pre-migratory NCCs in the trunk 
(arrowheads in C). Expression was also observed in cells migrating on the medial 
pathway (arrows in D). Expression of Dr.3972.1.S1_at was absent in mutant embryos. In 
30 hpf WT embryos, Dr.3972.1.S1_at expressing cells were observed migrating on the 
medial pathway (arrow in E). This expression was absent in mutant embryos (E’). All scale 
bars = 50 µm. 
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4.2.6 Validated Genes Up-Regulated in sox10 mutant embryos. 
4.2.6.1 stc2 
Affymetrix Probe Identifier Dr.23461.1.A1_at 
Affymetrix Gene Symbol stc2 
ZFIN Gene Symbol stc2 
Full Name stanniocalcin 2 
Orthology STC2 
Biological Process GO Term N/A 
Molecular Function GO Term hormone activity 
7.2sox10:GFP array 
results 
t-statistic 7.0355191231 
p-value 0.0021509288 
CLEAR result diff.expr 
Fold Change 1.53 
4.9sox10:GFP array 
results 
t-statistic 1.5754812956 
p-value 0.2558328807 
CLEAR result diff.expr.high.var 
Fold Change 1.66 
7.2+4.9sox10:GFP 
array results 
t-statistic 3.9415335655 
p-value 0.0042866552 
CLEAR result diff.expr 
Fold Change 1.59 
Table 42: Summary of information for stc2. 
The Affymetrix probe set Dr.23461.1.A1_at corresponds to the gene stc2. This gene was 
identified as differentially regulated in all three data sets by both statistical tests except the 
t-Test on the 4.9 data set (Table 42). To validate that stc2 was up-regulated in sox10 
mutant embryos, in situ hybridization was performed (Figure 43). Expression of stc2 was 
identified in two ventro-medial patches in the otic vesicle at both 24 hpf and 30 hpf in WT 
embryos (arrowheads in Figure 43A and D). One patch appears to be more anterior while 
the other patch is more posterior. These patches correspond to the position at which the 
hair cells of the anterior and posterior sensory maculae develop (Dutton et al., 2009). In 
sox10 mutant embryos at 24 hpf the same patches of stc2 expression were visible 
(Figure 43A’ and D’) although one of the patches is out of focus in Figure 43A’. In 
addition to this, the domain of stc2 expression had expanded to include an ectopic ventral 
region of the otic vesicle in between the two previously described patches (Figure 43A’). 
In 30 hpf mutant embryos expression of stc2 was observed in the same two patches seen 
in WT embryos but expression typically appeared to be stronger (Figure 43D’). 
Expression in these two patches was very variable in WT embryos at 30 hpf, ranging from 
weak to strong expression, while in mutant embryos stc2 expression was consistently 
strong. Stc2 expression was also observed in rare cells with a pigment cell like 
morphology in WT 24 hpf embryos including cells migrating on the medial and lateral 
pathways (arrows in Figure 43A, B and C). At 30 hpf, stc2 expression overlapped with 
some migratory melanising cells on the medial (Figure 43E) and lateral pathways (data 
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not shown). The position of these cells was consistent with a melanocyte fate although 
only a few cells (approximately 3-5) were marked in each embryo. Stc2 expression was 
not detected in these cells in sox10 mutant embryos (Figure 43B’ and E’). An expression 
pattern for stc2 has been published on the ZFIN website showing otic vesicle expression 
but not NCC expression (Thisse et al., 2004). In summary, stc2 expression was up-
regulated in the otic vesicle of sox10-/- embryos thus validating the microarray data. 
Surprisingly, stc2 was also down-regulated in rare NCCs, a previously unknown site of 
expression. The specific pattern of stc2 expression in two patches within the otic vesicle, 
possibly corresponding to the positions at which the sensory hairs form, makes this a 
potentially useful marker gene. 
Stanniocalcin (stc1) regulates calcium uptake in the gills and small intestine and is 
the major antihypercalcemic hormone in bony fish (Ishibashi and Imai, 2002). A second 
stanniocalcin gene (stc2) has now been cloned in fish (Luo et al., 2005). A functional role 
for stc2 has not been identified in fish but this study has identified stc2 expression in the 
otic vesicle and a restricted number of NCCs for the first time. Thus the role of stc2 in 
these tissues is of interest and could be examined through a morpholino approach. As 
stc2 appears to be specifically expressed in two patches that correspond to the anterior 
and posterior maculae it is possible that this gene contributes to the development of the 
sensory hair cells at these sites. Indeed, these hair cell patches are expanded in sox10 
mutant otic vesicles (Dutton et al., 2009) and this corresponds with the expansion of stc2 
expression in mutant embryos. Other marker genes of sensory maculae patterning are 
also expanded in sox10 mutant embryos (Dutton et al., 2009). Thus loss of function 
studies of this gene might be expected to unearth an anterior and posterior sensory 
maculae phenotype. It is intriguing that a gene can be both up-regulated and down-
regulated in sox10 mutant embryos, although in different tissues. Indeed it is perhaps 
surprising that such a gene was detected by microarray analysis. This behaviour is unique 
amongst all the targets of sox10 identified during this screen. 
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Figure 43: Whole mount in situ hybridization pattern of stc2 expression. 
All images are of zebrafish embryos at 24 hpf (A-C) or 30 hpf (D-E’) treated. WT embryos 
are labelled with a letter alone, corresponding images of sox10 mutant embryos are 
labelled with a letter and an apostrophe. Images A and A’ are lateral views oriented 
anterior down and dorsal right, images D and D’ are dorsal views of embryos oriented 
anterior left, all remaining images are lateral views orientated anterior left and dorsal top. 
Images A, A’, D and D’ are of the otic vesicle, all other images are views of the trunk. 
Expression of stc2 in the otic vesicle is marked (arrowheads) and in cells outside of the 
otic vesicle (arrows), note expression on both the medial (B) and lateral (C) pathways. All 
scale bars = 50 µm. 
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4.2.6.2 sfrp5 
Affymetrix Probe Identifier Dr.21012.1.A1_at 
Affymetrix Gene Symbol sfrp5 
ZFIN Gene Symbol sfrp5 
Full Name secreted frizzled-related protein 5 
Orthology SFRP5 
Biological Process GO Term 
eye development 
multicellular organismal development 
Wnt receptor signalling pathway 
forebrain development 
Molecular Function GO Term Protein binding 
7.2sox10:GFP array 
results 
t-statistic 6.4778895378 
p-value 0.0029267701 
CLEAR result diff.expr 
Fold Change 1.38 
4.9sox10:GFP array 
results 
t-statistic 0.1465975344 
p-value 0.8968923688 
CLEAR result non.significant 
Fold Change 1.03 
7.2+4.9sox10:GFP 
array results 
t-statistic 1.1840668917 
p-value 0.2703716457 
CLEAR result non.significant 
Fold Change 1.19 
Table 43: Summary of information for sfrp5. 
The Affymetrix probe set Dr.21012.1.A1_at corresponds to the gene sfrp5. This gene was 
identified as differentially regulated in sox10 mutant embryos by both statistical tests 
applied to the 7.2 data set (Table 43). Sfrp5 was not identified as differentially regulated in 
the other two data sets by either statistical test. Thus it was necessary to validate the 7.2 
microarray data by in situ hybridization (Figure 44). Sfrp5 expression at 24 hpf was visible 
but very weak in the otic vesicle (data not shown), it was not possible to genotype 
embryos by sfrp5 expression at this stage. At 30 hpf, in WT embryos, sfrp5 expression 
was observed in the otic vesicle in a ventro-medial position (Figure 44A and B). This otic 
vesicle expression pattern is similar to that already published for sfrp5 on the ZFIN 
website (Thisse et al., 2004). The same pattern of expression was observed in sox10 
mutant embryos but expression levels were visibly increased in mutant embryos in 
comparison to WT embryos (Figure 44A’ and B’). In summary, sfrp5 is expressed in the 
otic vesicle and is up-regulated in sox10 mutant embryos. 
The sfrp family of genes code for secreted molecules that sequester Wnt signalling 
molecules in the extracellular space and thus are capable of antagonising both canonical 
(β-catenin dependent) and non-canonical (β-catenin independent) Wnt signalling (Kawano 
and Kypta, 2003, Li et al., 2008). Sfrp5 is known to play a role in modulating Wnt11 
signalling during Xenopus gut development (Li et al., 2008). This study identified that local 
Sfrp5 inhibition of canonical Wnt11 signalling in the endoderm was required to promote 
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foregut identity. In addition, Sfrp5 inhibition of non-canonical Wnt11 signalling was 
essential for correct foregut morphogenesis, Sfrp5 depleted embryos displayed a lack of 
gut cell apical-basal polarity and cells were only loosely adherent (Li et al., 2008). A role 
for sfrp5 during otic vesicle development has not yet been elucidated but it is plausible 
that sfrp5 modulates Wnt signalling in the otic epithelium to promote correct 
morphogenesis. 
Lateral View Dorsal View 
Figure 44: Whole mount in situ hybridization of sfrp5 expression. 
All images are of zebrafish embryos at 30 hpf showing the otic vesicle. WT embryos are 
labelled with a letter alone, corresponding images of sox10 mutant embryos are labelled 
with a letter and an apostrophe. Images A and A’ are lateral views of embryos oriented 
anterior down and dorsal left, images B and B’ are dorsal views of embryos oriented 
anterior left. Sfrp5 is expressed in a ventro-medial patch of the otic vesicle in WT and 
mutant embryos. All scale bars = 50 µm. 
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4.2.6.3 wnt11r displays possible NC expression 
Affymetrix Probe Identifier Dr.8297.1.S1_at 
Affymetrix Gene Symbol wnt11r 
ZFIN Gene Symbol wnt11r 
Full Name wingless-type MMTV integration site family, member 11, related 
Orthology WNT11 
Biological Process GO Term 
Wnt receptor signalling pathway, calcium 
modulating pathway 
multicellular organismal development 
heart development 
Wnt receptor signalling pathway 
cell migration involved in gastrulation 
Molecular Function GO Term signal transducer activity 
7.2sox10:GFP array 
results 
t-statistic 7.6103687286 
p-value 0.0016000068 
CLEAR result diff.expr 
Fold Change 1.59 
4.9sox10:GFP array 
results 
t-statistic 2.7982866764 
p-value 0.107503697 
CLEAR result diff.expr 
Fold Change 1.70 
7.2+4.9sox10:GFP 
array results 
t-statistic 3.7948172092 
p-value 0.0052754763 
CLEAR result 1.63 
Fold Change diff.expr 
Table 44: Summary of information for wnt11r. 
The Affymetrix probe set Dr.8297.1.S1_at corresponds to the gene wnt11r. This probe set 
was identified as up-regulated in all three data sets by both statistical tests except the t-
Test on the 4.9 data set (Table 44). To validate if this gene was up-regulated in sox10-/­
embryos, in situ hybridization was performed (Figure 45). Expression of wnt11r was 
observed in the dorsal neural tube (arrowheads in Figure 45) consistent with NCCs prior 
to delamination. Wnt11r expression was also observed in a position consistent with pre­
migratory NCCs post-delamination (arrows in Figure 45). Wnt11r is expressed in NCCs 
that contribute to the dorsal fin mesenchyme of Xenopus embryos (Garriock and Krieg, 
2007), the Xenopus expression pattern bears a striking resemblance to the pattern 
observed here (Garriock and Krieg, 2007). However, no clear difference in the expression 
level of wnt11r was visible between WT and mutant embryos as determined by in situ 
hybridization. Given that all down-regulated NC expressed genes identified during this 
screen have shown a clear expression difference by in situ hybridization this may indicate 
that this gene is not NC expressed. If the gene is not expressed in NCCs no difference in 
gene expression would be expected, the result could be a false positive. In line with this, 
zebrafish wnt11r expression has been visualised in the same locations shown in Figure 
45 but the sites of expression were identified as the neural tube and dorsomedial somite 
edge (Groves et al., 2005). Wnt11r is expressed in the dorsomedial region of somites in 
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Xenopus embryos as well (Garriock and Krieg, 2007). Consistent with this, the wnt11rfh224 
mutant has no obvious pigment defect although other NCC types may not have been 
assessed (C. Moens personal communication). It is possible that wnt11r is only expressed 
in NCCs in the dorsal neural tube prior to delamination. To resolve if wnt11r is expressed 
in zebrafish NCCs a double in situ could be performed with a sox10 probe to check for 
expression overlap. Alternatively embryos from one of the sox10:GFP lines could be 
antibody stained to visualise GFP and combined with an in situ for wnt11r expression, 
again to assess if expression overlaps with identified NCCs. Alongside these experiments 
it would be necessary to determine if wnt11r expression is up-regulated in sox10 mutant 
embryos using a more sensitive technique such as quantitative RT-PCR. This could be 
performed on FACS enriched NCCs from both WT and mutant embryos for comparison. 
To conclude, wnt11r is expressed in positions consistent with NCCs but differential 
regulation of this gene in sox10 mutant embryos could not be validated by in situ 
hybridization. Further work to validate if this gene is up-regulated in the NC should be a 
priority as wnt11r is the only candidate in this category. 
The expression pattern of wnt11r obtained here indicates that this gene is NC 
expressed. Interest in wnt11r, despite not being validated during this screen, has been 
sustained by research undertaken in Xenopus embryos. It was shown that wnt11r was 
expressed in NCCs that contributed to the dorsal fin mesenchyme (Garriock and Krieg, 
2007). The authors identified that wnt11r signalling, via a Ca2+ dependent non-canonical 
Wnt signalling pathway, was required cell autonomously for the delamination of NCCs. 
Although fin mesenchyme NC contribution is restricted to skeletogenic NC (therefore not 
Sox10 dependent NCCs), the detection of this gene as up-regulated in the microarray 
data presented in this study hinted at a role for wnt11r in non-skeletogenic NC. A study in 
Xenopus has demonstrated that wnt11r is essential for cranial NCC migration (Matthews 
et al., 2008). But the authors identified that wnt11r was not expressed in the NC but in 
ectodermal cells adjacent to the NC. Wnt11r functioned non-cell autonomously and was 
essential for NCC migration. NCCs in morphant embryos could not delaminate from the 
neural tube. Thus this study and the study from Garriock and Krieg, 2007 identified similar 
functions for wnt11r in NCC migration but via different mechanisms. The published data is 
therefore contradictory regarding the sites of wnt11r expression. Comparable studies have 
not been performed in zebrafish but it would be very interesting to examine derivates of 
the NC in wnt11r mutants, focusing primarily on a defect in cell migration. Cell 
transplantation studies, similar to those performed in Xenopus embryos (Garriock and 
Krieg, 2007, Matthews et al., 2008) would be required to address if wnt11r functions cell 
autonomously or not. In summary, wnt11r was an intriguing result in the microarray data 
and the only possible up-regulated gene in NCCs, therefore wnt11r should be considered 
for further study to shed light on a possible role in NC migration. 
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Figure 45: Gene Expression pattern for wnt11r. 
All images are of 30 hpf embryos treated by in situ hybridization. Images A and A’ are 
lateral views of trunk oriented anterior left and dorsal top, B-C’ are images of transverse 
sections through trunk regions oriented dorsal top. All images labelled with a letter alone 
are of WT embryos, images labelled with a letter and apostrophe are corresponding 
images of sox10 mutant embryos. Wnt11r expression was observed in putative NCCs in 
pre-migratory dorsal neural tube positions (arrowheads) and delaminated NCC pre­
migratory positions (arrows). 
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4.2.7 Summary of the probe sets that were not validated. 
During the in situ hybridization screen, a considerable number of genes expressed in the 
NC or otic vesicle were validated. However, the majority of genes screened were not 
expressed in these tissues. Many genes screened did not display obvious patterns of 
gene expression, displayed an expression pattern that was not spatially restricted or 
showed high levels of background that could not be resolved (Figure 46). Such genes 
were described as displaying non-specific expression. In both the down and up-regulated 
screens a large number of these genes were detected. In many cases these genes had 
also been described in a similar fashion on the ZFIN website. One example was the 
down-regulated gene mkks, no obvious expression pattern was determined for this gene 
and the same result had been published on ZFIN (Thisse et al., 2004). A minority of 
probes had a published expression on ZFIN that was not detected during this screen. For 
example, the up-regulated gene pvalb7 is expressed in several sites including the 
hypaxial part of the anterior somites (Thisse et al., 2004) but this was not detected during 
the screen. This suggests that on occasion probes generated by the pipeline implemented 
during this screen were of a poor quality. Ten of the genes with no obvious expression 
pattern were only annotated with an Affymetrix identifier. Therefore only a limited amount 
of sequence data (typically between 300 to 400 base pairs) was available for probe 
design. It is perhaps not surprising that these probes were typically unable to specifically 
detect the distribution of mRNA. 
During the screen it was observed that a large number of genes identified by the 
microarray were expressed in the central nervous system (CNS) or in the somites (Figure 
46). These are not sites of sox10 expression and these genes were not differentially 
regulated in sox10 mutant embryos. However, ectopic GFP expression is present in the 
CNS and somites for both of the sox10:GFP transgenic zebrafish lines used during this 
project. It is tempting therefore, to speculate that both somite and CNS cells were sorted 
by FACS and therefore genes expressed specifically at these locations would be identified 
as expressed on the microarrays. By chance alone, the expression levels could have 
varied between WT and mutant samples thus resulting in these genes being identified as 
differentially regulated and subsequently screened by in situ hybridization. However, some 
genes were identified as differentially regulated that when examined by in situ 
hybridization displayed expression in other sites, for example the hatching gland, mucous 
secreting cells or the pectoral fin buds. These tissues do not display GFP expression in 
sox10:GFP transgenic embryos. Thus these genes have been identified as differentially 
regulated by chance. 
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Figure 46: Pie charts summarising the sites of expression detected during the in 
situ hybridization screen. 
4.3 Discussion 
4.3.1 Further Work 
Most of the genes identified as differentially regulated in sox10 mutant embryos have 
clear expression patterns. This has enabled a strong prediction to be made about the cell 
type the gene was expressed in. This is not true in all cases and some genes show 
expression in cells not fully consistent with expression in a single cell type. For example, 
cx33.8 shows a strong xanthophore lineage expression pattern but rare cells on the 
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medial pathway expressing cx33.8 deviate from this. To clarify the cell types that each 
gene is expressed in, in situ hybridization could be performed comparing WT embryos 
with those of well known mutants. These mutant embryos lack or show defects in specific 
cell types, for example melanocytes (mitfanacre), xanthophores (pfeffer or csf1rpanther ), 
iridophores (ltkshady), glia (foxd3m188) and sensory neurons (neurog1hi1059 or sox10baz1). 
Thus if cx33.8 medial pathway expression was absent in ltk mutant this would point 
towards expression in the iridophore lineage alongside the clear xanthophore expression. 
The validated miscellaneous genes, in particular coro1c and Dr.3972.1.S1_at should be 
prioritised for this type of evaluation. It might also be interesting to examine expression of 
wnt11r in different NC mutant embryos. In addition, further analyses of temporal and 
spatial expression patterns would be informative. For example, a time course of gene 
expression patterns could be produced for each gene. This could be combined with 
double in situ hybridizations with key marker genes for comparison. This would clarify 
when and where a gene is expressed and might help to indicate a possible function. 
These analyses would comprehensively characterise the gene expression patterns for the 
genes identified during this project and would ensure their use as valuable marker genes. 
The majority of genes validated during the in situ hybridization screen have little or 
no function ascribed to them, particularly in regard to a role in NC or otic vesicle biology. 
Future work using morpholino mediated gene knock down or inhibitor studies should be 
focused on and would help to elucidate the function of these genes. Such a study could 
initially target genes with a very strong NC expression pattern, for example cx33.8, 
slc2a15b, zgc:110343 or zgc:100919. Alternatively genes known to play a role in key NCC 
processes taking place at around 24 hpf such as specification, differentiation, migration or 
proliferation but have only been associated with the NC through this study could be 
prioritised. For example, both degs1 and zgc:100919 have been implicated in regulation of 
cell motility and cell proliferation. Alternatively genes with known functions but no clear 
functional relationship to NC biology could be investigated, for example, aldh2b (aldehyde 
metabolism), zgc:110343 (reducing oxidative stress) or cx33.8 (cell to cell 
communication). Such functional studies in zebrafish would be very informative regarding 
NC biology. 
A large number of known NC expressed genes including gch, aox3 (xdh) and 
members of the IMP biosynthesis pathway such as gart have been identified as 
differentially regulated by the microarray data but have not been validated by in situ 
hybridization. Thus there is clearly scope to continue the blind in situ hybridization screen 
which will lead to further known and novel genes being validated. An alternative approach 
would be to focus on particular classes or families of genes or genes with known functions 
of interest that have been identified as differentially regulated, for example transcription 
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factors. A focused in situ hybridization screen approach would also be likely to identify 
new targets of interest but would exclude genes that currently have little or no annotation 
to suggest a link with NC biology (See Chapter 5). 
4.3.2 Regarding the Melanocyte Lineage Expressed Genes 
4.3.2.1 Summary of the Melanocyte Lineage Expressed Genes Identified 
The in situ hybridization screen has validated 8 genes that are expressed in the 
melanocyte lineage. Three of these genes, dct, mitfa and pah, are known marker genes of 
this lineage and thus their identification in the microarray analysis improved confidence 
that the screen has identified in vivo endogenous gene expression changes. The two V-
ATPase subunit genes validated have links to melanocyte biology through the phenotype 
of insertional mutants (Amsterdam et al., 2004) but no gene expression pattern has been 
published. Interestingly more V-ATPase genes have been identified as differentially 
regulated by the microarray analysis and are therefore attractive candidates for validation. 
The three remaining genes, zgc:100919, degs1 and zgc:110239 have published neural 
crest gene expression patterns although they were not specifically annotated as marking 
the melanocyte lineage (Thisse et al., 2004). However there is no published data 
regarding the role these genes play in melanocyte development thus making them 
interesting candidates for further analysis, for example morpholino mediated gene 
expression knock down. Additionally zgc:100919 has a very strong melanoblast 
expression pattern making it a valuable marker for this cell type. 
4.3.2.2 V-ATPases and Neural Crest Development 
Nine separate V-ATPase subunit genes were identified as differentially regulated in one or 
more of the microarray data sets (Table 22). Two of these genes, atp6v1a and atp6v1e1, 
were validated during the in situ hybridization screen. Both of the validated genes 
displayed a melanocyte lineage expression pattern with expression strongly reduced in 
pre-migratory NCCs and expression absent in migrating cells of mutant embryos. The 
validation of two V-ATPase genes makes the remaining candidates attractive genes for 
examination by in situ hybridization. 
V-ATPase genes have been linked to NC biology by other studies. As a result of 
the insertional mutagenesis screen performed to identify genes important in zebrafish 
development, seven V-ATPase mutants were identified (Table 45). All of these mutants 
have a pigment phenotype showing a strong reduction in melanised cells, some also 
display an ear phenotype (Amsterdam et al., 2004). Fortuitously a mutant for atp6v1e1, 
one of the validated genes identified here, exists; this mutant has both a melanocyte and 
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an otic vesicle phenotype. The melanocyte phenotype corresponds well with the 
expression pattern identified during the in situ hybridization screen. In contrast, no otic 
vesicle expression was detected despite the small otolith phenotype of this mutant. The 
gene expression pattern detected for atp6v1e1 was quite weak and had to be stained for 
an extended period of time. This led to the development of some background, particularly 
in the head, thus otic vesicle expression may have been obscured. Alternatively otic 
vesicle expression could be below detectable levels. This would correspond with the lack 
of otic vesicle expression detected not only for atp6v1a, but also for atp6v1e1. With these 
genes expressing subunits of the same proton transporter identical expression patterns 
would be expected. The majority of the V-ATPase mutants display a reduced head 
phenotype (Table 45) therefore it is feasible the otic vesicle phenotype of atp6v1e1 is a 
secondary consequence of this consistent defect. Indeed the atp6v1e1 mutant displays 
some very broad defects such as thin body, small head and underdeveloped gut that do 
not correspond with the expression pattern observed during this study. The mutant of 
atp6v0c has also been phenocopied by morpholino mediated gene knockdown (Pickart et 
al., 2004). The similarity of V-ATPase insertional mutants with the class VI.B pigmentation 
mutants landing, slow tan and touch-down has led to speculation that these mutants may 
have lesions in components of the V-ATPase complex (Kelsh et al., 1996, Pickart et al., 
2004). Five V-ATPase subunit proteins were identified as components of melanosomes in 
a study designed to elucidate the melanosome proteome (Basrur et al., 2003). Thus 
components of the V-ATPase complex have a strong connection to melanocyte 
pigmentation which has been reinforced by the prevalence of the V-ATPase genes in this 
microarray screen. 
The role of the V-ATPase complex in melanosome biology has yet to be fully 
understood. The V-ATPase complex is known to transport H+ into intracellular 
compartments in an ATP dependent manner. This process acidifies the intracellular 
compartment and thus helps to regulate pH dependent processes (Nishi and Forgac, 
2002). The pH of lightly melanised melanosomes (pH 4.6) and heavily melanised 
melanosomes was assayed (pH 3.0) and found to be acidic (Bhatnagar et al., 1993). This 
observation led to the assumption that a low pH was required for melanin biosynthesis. In 
this regard V-ATPases have an obvious role in ensuring the environmental conditions of 
the melanosome are suited to melanin biosynthesis. In contrast to this, the optimal pH for 
mammalian tyrosinase (the key enzyme in melanin biosynthesis) was suggested to be at 
an approximately neutral pH (Saeki and Oikawa, 1978, Ancans et al., 2001). Despite this, 
a mutation in a component of the V-ATPase complex leads to a reduction in pigmentation 
thus indicating a positive role in pigmentation during normal melanocyte development 
(Amsterdam et al., 2004). The application of V-ATPase inhibitors to melanoma cell lines 
increased tyrosinase activity and melanin production (Ancans and Thody, 2000). Thus the 
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role of the V-ATPase complex in melanocyte development is unclear, apparently having 
both positive and negative influences. This contradiction is reconciled if the insertion 
mutants actually up-regulate V-ATPase activity however this is unlikely as deletion of any 
gene that encodes a V-ATPase subunit in yeast leads to the entire complex failing to 
assemble (Nishi and Forgac, 2002). It is possible that during melanoblast development 
melanosomes require a low pH but at later stages during melanocyte differentiation, 
melanin biosynthesis is optimal at a neutral pH. Thus the difference in effects seen when 
knocking down V-ATPase function may be resolved by careful analysis of temporal 
function. Consistent with this, expression of atp6v1a was qualitatively stronger at 24 hpf 
than at 30 hpf. In line with this hypothesis it has been postulated that a switch in pH from 
acidic to neutral is required during melanosome maturation (Schallreuter et al., 2008). 
Gene Name Mutant Identifier Phenotype 
V-ATPase Ac45 or 
atp6ap1 hi112 
day 2: no/less body pigment; day 5: less 
body pigment, small head and eyes, 
underdeveloped liver/gut 
v-ATPase membrane 
sector associated 
protein M8-9 or 
atp6ap2 
hi3681 
day 2: no pigment, slightly smaller head and 
eyes; day 5: still no pigment, a little cns 
necrosis, slightly smaller head, eyes, and 
ears, a little pericardial oedema, 
underdeveloped liver/gut 
v-ATPase subunit e or 
atp6v1e1 hi577a 
day 2: little/no body pigment, day 3 spotty 
body pigment, small head, small otoliths, 
day 5: little/no body pigment, small head, 
eyes, and ears, underdeveloped gut, thin 
body 
v-ATPase SDF/54kD 
subunit or atp6v1h hi923 
day 2: no/less body pigment; day 5: less 
body pigment, small head and eyes, 
underdeveloped liver/gut, sometimes some 
pericardial oedema 
v-ATPase 16 kDa 
proteolipid subunit or 
atp6v0c 
hi1207 
day 2: no pigment and a little cns necrosis; 
d5: less pigment, also small head and eyes, 
underdeveloped liver/gut, sometimes bent 
and/or dying 
v-atpase subunit F or 
atp6v1f hi1988 
day 2: no body pigment, less eye pigment; 
d5: less pigment, small and blocky head 
with some necrosis, small eye, 
underdeveloped liver/gut, a little pericardial 
oedema 
v-atpase AC39 subunit 
or atp6v0d1 hi2188B 
day 2: no/less body pigment, head a little 
shorter/blockier; day 5: less body pigment, 
body a little thinner, gut slightly 
underdeveloped 
Table 45: V-ATPase subunit and V-ATPase associated genes with identified 
insertion mutants. 
All information is taken from data published regarding the insertional mutagenesis screen 
(Amsterdam et al., 2004). Phenotypes are described in comparison to WT embryos. 
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4.3.3 Regarding the Xanthophore Lineage Expressed Genes 
4.3.3.1 Summary of the Xanthophore lineage genes identified 
From the 100 most down-regulated genes, of which 89 were examined by in situ 
hybridization, 12 probe sets represented genes expressed in the xanthophore lineage. 
These 12 probe sets corresponded to 9 separate genes (Table 17). In comparison to 
melanocytes, xanthophores have been poorly studied and have fewer well known 
markers. The well known xanthophore markers gch and xdh have both been identified as 
down-regulated in the microarray screen but do not feature in the 100 most down-
regulated genes. The only well characterised xanthophore marker identified and validated 
in this screen was pax7 (Minchin and Hughes, 2008). This paper identified pax3 
(Affymetrix probe identifier Dr.579.1.S1_at) as a key transcription factor in xanthophore 
development. This probe set was not identified as differentially expressed in any of the 
microarray data sets suggesting pax3 expression is independent of Sox10. Six of the 
genes identified and validated (rbp4l, atic, adsl, paics, zgc:110343 and aldh2b) have 
already been characterised as NC expressed but have no known functional role. Three of 
these genes are involved in the de novo IMP biosynthesis pathway and are likely to be 
important in generating GTP for pteridine biosynthesis. The two remaining genes have not 
been shown to be expressed in the NC or associated with a role in NC biology and are 
thus novel targets. Slc2a15b functions as a transporter and cx33.8 may play a role in gap 
junction mediated cell to cell communication. Several of these genes, most noticeably 
slc2a15b, cx33.8, paics and zgc:110343, are highly expressed in the xanthophore lineage 
and therefore are likely to prove to be valuable markers in future studies of this cell type. 
4.3.3.2 Connexins, sox10 and the neural crest. 
The cx33.8 expression pattern and lack of published material on the role of cx33.8 in 
neural crest biology makes this an attractive target for further work. In addition there is a 
considerable amount of literature regarding the role of connexins; some research has 
linked them with both neural crest and sox10 biology. Connexins assemble into hexamers 
called connexons (hemichannels), these are inserted into the plasma membrane. When a 
connexon in the membrane of one cell comes into contact and interacts with a connexon 
in an adjacent cell a gap junction is formed. This intercellular channel connects the 
cytoplasm of two cells and allows the exchange of ions, secondary messengers and small 
metabolites thus allowing electrical and biochemical communication between cells (Meşe 
et al., 2007). Evidence is also starting to accrue to suggest that unpaired connexons are 
functional and also that connexins have a function independent of their channel activity 
(Goodenough and Paul, 2003, Stout et al., 2004). Connexins and gap junctions function in 
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processes important in NC development including cell differentiation and migration 
(Kojima et al., 2008, Xu et al., 2006). 
Connexins are known to play roles in NC biology. A zebrafish adult pigment 
patterning mutant, leopard, is caused by lesions in cx41.8 (Johnson et al., 1995, 
Watanabe et al., 2006). The leopard mutant has all pigment cell types but during adult 
pigment pattern formation, pigment cells become organised into spots rather than stripes 
(Johnson et al., 1995). The precise function of cx41.8 in pigment cell patterning has yet to 
be elucidated but the leotq270 mutant displays a strong phenotype and disrupted gap 
junction activity (Watanabe et al., 2006). In line with this, transplantation experiments 
identified that homotypic and heterotypic interactions between melanocytes and 
xanthophores are required to establish the adult zebrafish stripe pattern (Maderspacher 
and Nüsslein-Volhard, 2003). Thus cell to cell communication mediated by gap junctions 
is important during NC patterning. 
NCCs undergo extensive migration throughout the embryo to various locations, 
during this process connexins are up-regulated (Kuriyama and Mayor, 2008). The 
expression of Cx43 has been documented in mouse trunk NCCs by both in situ 
hybridization and through analysis of a transgenic mouse in which a LacZ reporter was 
under control of the Cx43 promoter (Lo et al., 1997). Experiments in vitro demonstrated 
that NCCs over expressing Cx43 migrated faster than cells from a Cx43 knock out mouse. 
This effect was also observed in vivo using the Cx43-LacZ transgenic mouse; more LacZ 
positive cells from embryos over expressing Cx43 migrated to their final destination in the 
heart than LacZ positive cells in Cx43 knock out embryos (Huang et al., 1998). Thus Cx43 
appears to play a role in the migration of cardiac NCCs. Further studies have indicated 
that this role may be independent of gap junction communication but dependent on 
interactions with the actin cytoskeleton (Xu et al., 2006, Xu et al., 2001). A further possible 
role of connexins in the NC was indicated by the inhibition of gap junction communication 
using chemical inhibitors (uncoupling agents). This reduced the survival of rat trunk NCCs 
in vitro with weaker inhibitors quantitatively inducing a weaker effect (Bannerman et al., 
2000). Thus connexins have been associated with several aspects of NC biology including 
pigment cell patterning, migration and cell survival. However no role for connexins and 
gap junctions has been identified in early embryonic pigment cells. Thus, cx33.8 identified 
in this study is so far unique by being clearly expressed in a pigment cell type and may 
function in one of the roles associated with connexins. The strong expression of cx33.8 in 
xanthophores suggests that this gene might regulate cell to cell communication between 
xanthophores. The alternative is that cx33.8 may have a function as a hemichannel in 
xanthophores or have a function independent of gap junction activity. 
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In addition to the roles that connexins play in the NC, this family of genes is also of 
interest because they are known to be regulated by Sox10. Co-transfection of the Cx32 
promoter up-stream of a reporter gene with a human SOX10 expression construct 
identified in vitro regulation by Sox10 of a connexin gene. The study also identified SOX10 
binding sites in the Cx32 promoter suggesting that this regulation may be direct 
(Bondurand et al., 2001). In a similar transient co-transfection experiment, SOX10 
regulation of Cx32 and Cx47 was identified (Schlierf et al., 2006). SOX10 binding sites 
were identified in the promoter sequence of Cx47, again showing that this regulation could 
be direct. While there is no evidence that cx33.8 is a direct target of Sox10 this could be 
investigated by assessing the promoter for Sox10 binding sites and through co­
transfection experiments. 
Study of connexin genes, particularly with regard to cx33.8, is likely to prove 
amenable in the zebrafish model organism. Single cell labelling can be performed in 
zebrafish embryos and is often used to trace the fates adopted by the progeny of a cell 
(Dutton et al., 2001a). To study cell to cell coupling mediated by gap junctions, a single 
NCC could be injected with neurobiotin or another low molecular weight marker. Such a 
dye can pass between coupled cells to demonstrate functional gap junction 
communication (Bannerman et al., 2000). It would be exciting to observe if this 
communication occurs between NCCs. Uncoupling agents, such as 18α-glycyrrhetinic 
acid, which inhibit the gap junction function of all connexins could also be used on 
zebrafish embryos (Bannerman et al., 2000). As these agents are not specific inhibitors of 
a particular connexin, they would need to be used with caution perhaps limiting application 
to a specific period of time. It would be relevant to determine the full complement of 
connexin genes expressed in NCCs during zebrafish development. Inhibition of a specific 
connexin could also be studied in zebrafish using a morpholino approach. A morpholino 
approach was adopted during this project to examine the function of cx33.8 in the 
zebrafish NC. This was a very preliminary experiment and as such has not been 
presented fully within this thesis. Briefly, cx33.8 morphant embryos (9.2 ng injected) 
appeared to have fewer gch positive cells than control (phenol red injected) embryos. 
Counts of gch positive cells migrating in morphologically normal 30 hpf WT (phenol red 
injected) and cx33.8 morphant embryos (n=15 for control group, n=18 for morphant group) 
were performed. Cells were counted migrating over the 8 somites anterior of the anus and 
only cells separate from the dorsal stripe were counted. This showed a statistically 
significant difference between the two groups as determined by a two tailed t-Test. 
Averages of the cells counted per embryos from the two groups are presented with 
standard deviation; control average = 22.9 ± 4.3, morphant average = 14.4 ± 5.3. It was 
not determined if the reduction in gch positive cells was the result of xanthophore 
migration failing, being delayed or as a result of a reduction in xanthophore numbers. 
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More comprehensive counts and more carefully controlled experiments, including using a 
mismatch and a second non-overlapping morpholino, are required to validate and further 
examine this observation. 
4.3.3.3 Regarding the de novo IMP biosynthesis pathway. 
Three genes encoding enzymes of the de novo IMP biosynthesis pathway were present in 
the 100 most down-regulated genes in the 7.2sox10:GFP microarray data set and were 
validated during the in situ hybridization screen. Several of the remaining genes in this 
pathway are also down-regulated according to the microarray data (Table 32) and have 
published NC expression patterns. These genes are therefore likely to be down-regulated 
in sox10-/- embryos. The identification of multiple components of this pathway by 
microarray analysis helps to both validate the screen and to suggest that this pathway 
functions during xanthophore development at around 24 hpf. 
The connection between this pathway and xanthophore development has not been 
elucidated. The starting point in the synthesis of pteridines, the yellow pigment of 
xanthophores, is the purine nucleotide guanosine triphosphate (GTP) (Ziegler, 2003). The 
initial step in pteridine biosynthesis involves GTP being converted into H2neopterin 
triphosphate by Gch. Thus a supply of purine nucleotides is likely to be important in 
pteridine synthesis and xanthophore development. To generate GTP from IMP requires 
the synthesis of xanthosine monophosphate (XMP) from IMP and this is catalysed by the 
enzyme IMP Dehydrogenase (IMPDH). The impdh (si:dkey-31f5.7 on ZFIN) gene is 
differentially expressed with high variability according to the CLEAR test on the 7.2 
microarray data and is down-regulated (fold change = -1.51). According to in situ 
hybridization data submitted to ZFIN, impdh is expressed in the NC (Thisse et al., 2004). 
The reaction to synthesise guanine monophosphate (GMP) from XMP is catalysed by the 
enzyme guanine monophosphate synthetase (GMPS). According to situ hybridization data 
submitted to ZFIN this gene is also NC expressed (Thisse et al., 2004) however no 
Affymetrix probe set corresponds to this gene. Phosphate groups can then be added to 
GMP by kinase enzymes to synthesise GTP, the starting molecule of pteridine synthesis. 
Thus a supply of IMP is likely to be required as a substrate for pteridine synthesis and 
therefore for xanthophore pigmentation. IMP biosynthesis enzymes have been strongly 
represented in the microarray data and in situ hybridization validation presented here. 
At later stages in development (2 dpf) many of the de novo IMP biosynthesis 
genes appeared to be expressed in scattered cells in the dorsal and ventral stripes. These 
positions are consistent with cells of the iridophore lineage. Thus it is possible that the de 
novo IMP biosynthesis pathway is required for both xanthophore and iridophore 
development. The iridescence of iridophores is a result of light reflecting plates within the 
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cell that are comprised of purine crystals (Ziegler et al., 2000, Rohrlich and Rubin, 1975). 
Thus the synthesis of purine nucleotides like IMP may be required to generate purine for 
crystallisation. It is interesting to note that adsl is expressed in rare medial pathway 
migrating cells, these could be iridoblasts. Consistent with this, only a few ltk expressing 
iridoblasts can be seen migrating on the medial pathway at 26 hpf (Lopes et al., 2008). As 
there are very few markers of the iridophores lineage available it would be worth 
examining adsl expression in ltk mutant embryos. 
A key gene in the specification of iridophores is the receptor tyrosine kinase ltk 
(Lopes et al., 2008). LTK is most closely related to another receptor tyrosine kinase, ALK 
(Morris et al., 1997). In ALK positive anaplastic large cell lymphoma tumours 
chromosomal translocations juxtapose ALK to other genes. This generates ALK fusion 
proteins that have constitutive kinase activity, this perturbs cell signalling leading to a 
neoplastic phenotype. One of the known fusions that occurs to activate ALK is with the de 
novo IMP biosynthesis pathway enzyme ATIC (Trinei et al., 2000). However recent 
evidence has also identified ATIC as a direct phosphorylation target of ALK (Boccalatte et 
al., 2009). The authors discovered that the enzymatic activity of ATIC was enhanced by 
ALK dependent phosphorylation. Considering the close relationship between ALK and 
LTK, it is conceivable that ltk may play a role in atic regulation and de novo IMP 
biosynthesis in iridophores. 
Cells that are rapidly proliferating require a supply of nucleotides, these can be 
supplied by either the de novo nucleotide biosynthesis pathways or by the nucleotide 
salvage pathways. Normal cells prefer the salvage pathway while cancer cells are known 
to rely heavily on the de novo purine biosynthesis pathway for ATP and GTP nucleotides 
(Li et al., 2007). As such a variety of inhibitors of enzymes in the de novo purine 
biosynthesis pathway have been developed, for a review see (Christopherson et al., 
2002). Cells of the xanthophore lineage express several enzymes from this pathway (this 
study and Thisse et al., 2004) and characterised mutants of these enzymes display 
xanthophore defects (Amsterdam et al., 2004). Thus it seems likely that de novo purine 
biosynthesis is important in xanthophore development. With xanthophores being an easily 
visualised cell type in zebrafish, this may provide an amenable model to test the efficacy 
of IMP biosyntheis inhibitors in an in vivo context. To progress this idea, the identified 
mutants of de novo IMP biosynthesis genes need to be fully characterised to identify at 
what stage in xanthophore development the defect occurs. For example, do these 
mutants fail to specify xanthophores, do the cells fail to differentiate or do they have a 
normal morphology but simply do not pigment? The increased number of xanthophore 
markers available as a result of this microarray study will be a valuable tool in achieving 
this. As the de novo IMP biosynthesis pathway is likely to produce a substrate for pteridine 
synthesis, these mutants are likely to only have a defect in xanthophore pigmentation. 
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Once the defect has been examined, suitable in situ hybridization markers will be 
available to complement the visual assessment of xanthophore yellow pigmentation. Thus 
the efficacy of de novo IMP biosynthesis pathway inhibitors could be accurately examined. 
It is encouraging to note that apart from lacking yellow pigment, mutants of enzymes in 
the de novo IMP biosynthesis pathway are grossly normal and therefore toxic side effects 
of inhibitors would generate striking phenotypes. It should also be noted that using 
zebrafish as a model organism will enable medium to high throughput analysis of potential 
inhibitors. 
4.3.4 Regarding the Differentially Regulated Otic Epithelium Expressed Genes 
Three otic epithelium expressed genes have been identified and validated as down-
regulated in sox10 mutant embryos during this project. This represents a hit rate of 3/89 
(3.4 %). Two of these genes (cldnj and otomp) have already been identified as otic 
epithelium expressed genes and analysis of mutant or morphant embryos has been 
conducted. As a result of functional studies it was determined that both cldnj and otomp 
knockdown results in otoliths forming but failing to grow properly. Thus both genes play a 
role in otolith development and loss of function experiments show that these genes are 
required for otoliths to grow at the correct rate. Despite the similar phenotype elicited by 
loss of function of these two genes, otomp and cldnj have different expression patterns. 
Both genes are expressed throughout the otic epithelium but cldnj expression is 
concentrated in the dorso-lateral region of the otic epithelium while cldnj expression is 
more intense in a ventro-posterior region. The other Affymetrix probe set validated 
(Dr.18158.1.A1_at) has not been assigned to any known transcript yet. The data 
presented here demonstrates that the portion of chromosome 21 that Dr.18158.1.A1_at 
corresponds to is transcribed. Again the pattern of expression of this gene is different to 
otomp and cldnj. Dr.18158.1.A1_at is chiefly expressed in a ventro-medial region with 
some expression extending to a ventro-lateral area. It would be very interesting to identify 
the gene at this chromosomal location and then to pursue functional studies. It would be 
fascinating to identify which characteristic of the complex sox10 mutant otic vesicle is 
phenocopied by knock down of Dr.18158.1.A1_at. This result will contribute to unravelling 
the molecular basis of the zebrafish sox10 mutant otic vesicle phenotype and may shed 
light on human deafness often associated with WS4 syndrome. 
Two otic epithelium expressed genes (2/47 or 4.3 % hit rate) have also been 
validated as up-regulated in sox10 mutant embryos, sfrp5 and stc2. Sfrp5 is expressed 
strongly in a ventro-medial region of sox10 mutant embryos with weaker expression at the 
same sites in WT embryos. Stc2 was expressed in two patches towards the ventro-medial 
region of the otic vesicle in WT embryos. Interestingly, expression of stc2 was up 
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regulated in sox10 mutant embryos at the endogenous WT sites but also displayed 
expression in ectopic sites. Careful examination of the phenotype of sox10 mutant 
embryos determined that sox10 mutant otic vesicles show morphological and patterning 
defects (Dutton et al., 2009). An examination of molecular markers of otic vesicle 
patterning such as sox9a, sox9b, pax2a, fgf8, fsta, bmp4 and wnt4a in WT and sox10 
mutant embryos was performed. It was discovered that these markers were up-regulated 
and often displayed ectopic expression, sometimes associated with a loss of expression 
at normal sites (Dutton et al., 2009). This could explain why the majority of these genes 
were not identified as differentially regulated in the microarray screen. It would be 
interesting to dissect how the altered regulation of all of these genes, including stc2 and 
sfrp5, has contributed to the sox10 mutant otic vesicle phenotype. This study has 
established that ear patterning genes show derepression and deregulation in sox10 
mutant embryos (Dutton et al., 2009). It is therefore not surprising that ear genes have 
been identified as up-regulated in the microarray screen. However it is not clear if Sox10 
directly or indirectly regulates these targets. 
4.3.5 Regarding the Down-Regulated Genes 
During the in situ hybridization screen, 89 down-regulated genes were assessed, of these 
25 were validated, a hit rate of 28 %. All genes that showed NC or otic vesicle expression 
were also down-regulated in sox10 mutant embryos. The majority of these genes (17/25) 
appeared to be expressed in melanocytes and xanthophores and 3/25 were otic vesicle 
expressed. The neural crest marker gene crestin was also validated. Only one gene 
(foxd3) was expressed in the peripheral nervous system and three genes require further 
work to further characterise their NC expression pattern. No clear markers of the 
iridophore lineage were identified. It has recently been shown that iridoblasts specify at 
around 24 hpf (Lopes et al., 2008), the time point being examined by the microarray 
experiment. Thus iridophore specific genes down-regulated in sox10 mutants were 
expected to be detected. Cells of the iridophore lineage only migrate on the medial 
pathway and their identification could be masked if a potential marker is also expressed in 
another medial pathway migrating cell type, melanocytes for example. Additionally, some 
xanthophore marker genes displayed rare cells on the medial pathway, for example 
cx33.8 and adsl, these cells may represent iridoblasts. The xanthophore expressed IMP 
biosynthesis pathway genes, particularly adsl, are of extreme interest in this regard as 
they appear to be expressed in iridophores at 2 dpf. Analysis of the expression pattern of 
potential iridophore genes in the ltkshady mutant would help to identify any iridophore 
lineage expression. 
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In regards to the scarcity of identified peripheral nervous expressed genes, 
neuronal and glial fated cells are migrating at around 24 hpf thus some degree of 
specification is likely to have occurred (Raible and Eisen, 1994). It is unclear to what 
degree these cells are specified and what molecular correlates of this are expressed at 
this stage. Therefore some neuronal and glial expressed genes might have been 
expected to be identified as down-regulated by microarray analysis. However these genes 
may not be dependent on Sox10 and thus would not be detected during this project. In 
addition, the mutant phenotype of neuronal cell types is less severe than for pigment cells 
in sox10 mutants as some cells differentiate correctly. For example neurog1 positive 
sensory neurons are only reduced in sox10 mutant embryos, unlike melanocytes which 
are almost completely absent (Carney et al., 2006). At 24 hpf neurons in the cranial 
ganglia appear normal in sox10 mutant embryos (Kelsh and Eisen, 2000) and may not 
display molecular differences between WT and mutant embryos at this stage. As a result, 
neuronal expressed genes may prove difficult to detect by microarray analysis. The 
enteric nervous system (Elworthy et al., 2005) and sensory neurons (Carney et al., 2006) 
are also specified later than 24 hpf therefore these cell types were not examined during 
this microarray screen. However, foxd3, which marks glial precursors, was detected as 
down-regulated by the microarray analysis, perhaps because the glial phenotype of sox10 
mutants is more severe than for sensory neurons (Carney et al., 2006). Therefore it would 
be expected that other glia expressed genes have been identified as down-regulated in 
the microarray screen and are awaiting validation by in situ hybridization. 
Of the validated genes, 7 were completely novel to NC biology, a further 8 genes 
had no known functional role in the NC and one gene was not known to be expressed in 
the NC but had a pigment mutant phenotype. Thus the screen has been successful in 
validating 16 genes identified as down-regulated by microarray analysis that are at least to 
some extent novel. This has identified many interesting targets for further investigation. In 
summary, the microarray screen appears to have mainly targeted pigment cell specific 
genes and the in situ hybridization approach has proved successful in elucidating 
temporal and spatial gene expression patterns and validating down-regulation in sox10 
mutant embryos. 
4.3.6 Regarding the Up-Regulated Genes 
Two otic vesicle expressed genes were validated as up-regulated by in situ hybridization. 
This represents a hit rate of 2/47 or approximately 4 %, similar to the 3 % hit rate of 
validated down-regulated otic vesicle expressed genes. No other genes were observed as 
NC or otic vesicle expressed. Sfrp5 displayed expression in a ventro-medial region of the 
otic vesicle that was stronger in sox10 mutants when compared to WT embryos. Stc2 was 
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expressed in two distinct patches in WT embryos, possibly marking two patches of 
sensory hair cells, in mutant embryos this expression was stronger and showed ectopic 
expression in the otic vesicle. Surprisingly stc2 was also expressed in rare NCCs and was 
down-regulated in these cells in mutant embryos. Thus up-regulation of two novel ear 
specific genes was identified in sox10 mutants and is likely a result of deregulation and 
derepression (see section 4.3.4) (Dutton et al., 2009). 
No clear example of a NC up-regulated gene was identified despite screening 47 
of the top 50 most up-regulated genes. The iridophore marker gene ltk has been shown 
by in situ hybridization to be strongly up-regulated with increased numbers of ltk positive 
NCCs in sox10 mutant embryos at around 24 hpf (Lopes et al., 2008). Thus up-regulation 
of gene expression does occur in sox10 mutant NCCs. The Affymetrix zebrafish chip lacks 
a probe set that detects transcripts from the ltk gene therefore no positive control for up-
regulated genes was available. This has made it difficult to interpret the lack of up-
regulated NCCs identified by the microarray approach. In sox10m618 mutant embryos, the 
supernumerary ltk positive cells also expressed sox10 (Lopes et al., 2008). This led to the 
hypothesis that these ltk positive cells, in line with the fate restriction model of NC 
development, represent NCCs trapped in a partially restricted progenitor phase. Cells are 
trapped because without functional sox10 they cannot become specified to individual 
derivative cell fates (Dutton et al., 2001a). It was predicted that such trapped cells would 
show up-regulated expression of genes that mark an intermediate phase in NC 
development, for example a chromatoblast precursor cell. A lack of such examples in the 
array data does not exclude their existence; it does raise the question why these 
examples were not identified. This can be viewed in contrast to the successful 
identification of up-regulated otic vesicle genes. Sox10 plays a key role in the specification 
of non-skeletogenic NC derivatives by regulating key transcription factors thereby 
activating a cascade of genes required for the development of a specific cell type (Dutton 
et al., 2001a, Carney et al., 2006, Elworthy et al., 2003, Elworthy et al., 2005). Thus 
without functional sox10, the expression of a large number of genes is defective as 
demonstrated during this project. In the otic vesicle, sox10 plays a role in regulating genes 
involved in patterning and morphology (Dutton et al., 2009). A loss of sox10 deregulates 
these processes leading to abnormal gene expression. As such up-regulation of otic 
vesicle genes in sox10 mutants could have been predicted and has been demonstrated 
(Dutton et al., 2009). However, the example of ltk demonstrates clear and strong up-
regulation of a NC gene in sox10 mutants. It would be interesting to see if this up-
regulation was maintained after FACS. It is possible that in sox10 mutants, the trapped 
NC progenitor cells represent a highly heterogeneous population of cells with variable 
gene expression profiles. A t-Test tends to select against genes that show variable gene 
expression across samples. Thus it is possible that no clear pattern of up-regulated gene 
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expression would be detected by microarray analysis using a t-Test. The in situ 
hybridization pattern of ltk in sox10 mutants shows that a large number of NCCs 
ectopically expressed ltk suggesting that this gene would have been identified as up-
regulated with a large fold change. This argues that the trapped NCC population, even if 
highly heterogeneous, still strongly express certain genes. Therefore the CLEAR test, 
which assesses fold change, may have been a more powerful test than the t-Test to 
detect this. It is also possible that there are only a few genes that mark these trapped 
populations of cells and these genes are poorly represented on the Affymetrix array. An 
alternative hypothesis is that the disaggregation of embryos for FACS has disrupted the 
expression profile of these unspecified cells, perhaps by denying them specific secreted 
signalling molecules. Thus the unstable progenitor state expression profile would be lost 
while a stable specified cell fate expression profile in WT cells might not be so disrupted. 
The genes expressed in trapped NCCs in sox10 mutants may represent examples of 
NCSC genes, markers of multipotency or receptors for instructive ligands and thus 
represent genes of extreme interest. It is therefore disappointing that such examples have 
yet to be characterised from the microarray data. However the value of this type of target 
ensures that further investigation of the data is worthwhile in an attempt to uncover them. 
4.3.7 General Discussion 
The in situ hybridization screen has validated 27/136 (20 %) of the assessed genes, in 
fact this hit rate increases to 30/136 (22 %) when duplicate probe sets are included. All 
the genes that showed clear expression in the cell types of interest were differentially 
expressed in sox10 mutant embryos compared to WT embryos. The hit rate for down-
regulated genes was 28 % and for up-regulated genes was 4 %. This represents a striking 
difference and it should also be noted that all the validated up-regulated genes were 
expressed in the otic vesicle. This suggests that sox10 has a primary function in the NC to 
activate gene expression but may play a different role in the otic vesicle. 
The in situ hybridization screen approach has the benefit of generating gene 
expression patterns often for genes with no published expression pattern. This has 
enabled genes to be characterised into groups based on gene expression pattern. A 
technique such as RT-PCR could not achieve this, indeed it could not easily distinguish 
between otic vesicle and NC expressed genes. Despite this advantage, an in situ 
hybridization screen which involved the cloning of most of the genes of interest has 
proved to be a labour intensive and costly process. These difficulties could be partly 
negated by collaboration with a group that has access to an extensive cDNA library for in 
situ hybridization probe generation. Examination of microarray data by RT-PCR tends to 
be able to validate more targets than an in situ hybridization approach, for example, Qian 
209

et al., 2005 examined 13 genes validated by RT-PCR as differentially regulated in cloche 
mutant microarray data. Only 8 of these target genes showed expression in cell types of 
interest by in situ hybridization. The remaining 5 genes did not display a specific 
expression pattern. Thus in situ hybridization may be a less sensitive technique but 
equally provides a more informative and stringent test. Genes that did not show specific 
expression patterns were deemed not to be NC or otic vesicle expressed during this 
screen. 
Analysis of the gene expression patterns of the validated genes determined that 
the majority of genes were expressed in melanocytes or xanthophores. This has greatly 
expanded the number of marker genes now available for these cell types. No clear 
markers of the iridophore lineage were discovered but several genes show potential in this 
regard and are worth investigating. Equally, only one well known glia marker and no clear 
neuronal markers were validated from the microarray data. With a paucity of markers 
available for the peripheral nervous system it would be worth investigating the potential 
PNS expressed genes coro1c and Dr.3972 to determine their expression pattern more 
fully. 
A number of known NC expressed genes have been identified as differentially 
regulated in the microarray data but were not assessed during the in situ hybridization 
screen. It would be expected that these genes show differential expression in sox10 
mutant embryos in comparison with WT embryos. This demonstrates that further 
discoveries are waiting to be made from the microarray data. This could be achieved by 
further blind screening or by targeting gene types of interest, for example transcription 
factors. Alternatively, published expression patterns could first be used to interrogate a list 
of genes identified by microarray analysis to eliminate genes not expressed in the cell 
type of interest. These ideas will be explored in more detail in Chapter 5. In summary, this 
combined microarray analysis of sox10 mutant embryos and in situ hybridization screen 
has been successful so far and retains the potential to facilitate further discoveries. 
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Chapter 5: Further Exploration of Microarray Data 
5.1 Introduction 
One challenge of a microarray project arises when selecting genes for validation. Typically 
a large number of candidates are designated as significantly differentially regulated. One 
option available to examine identified genes is to use published data, such as expression 
patterns on ZFIN. When well characterised expression patterns are available these could 
be used to identify if a gene is expressed in the tissue or cell type of interest or not. This 
approach will focus on genes that are already well characterised to reduce the number of 
genes requiring validation by eliminating false positives and to highlight likely true 
positives. 
A major advantage of microarray data is that novel candidates can be identified 
that have not previously been associated with a biological process. This can identify 
genes for study that have little or no prior publication history. However these candidates 
are unknown entities and are therefore only likely to be identified during validation by 
methods such as a blind in situ hybridization screen. The screen performed in Chapter 4 
was a blind screen that identified many interesting known and novel genes; unfortunately 
a large number of false positives were also assessed. This screen was based on the 
ranking of genes by t-statistic (with associated p-values used to determine significance). 
Alternatively, fold change has been a popular measure used to select genes of interest 
from microarray data. Fold change is the ratio of RNA quantities between two groups of 
samples in a microarray experiment (Cui and Churchill, 2003). Thus fold change is used 
as a measure of the change in gene expression levels between samples but is not 
associated with any level of statistical significance. Fold change was used to rank genes 
that were up-regulated during the induction of NCCs in vitro (Adams et al., 2008, Gammill 
and Bronner-Fraser, 2002). Thus this method may help to identify genes that are easily 
validated by a method such as in situ hybridization but without performing a statistical test 
there is no associated level of confidence in the designation of genes as differentially 
regulated or not differentially regulated (Cui and Churchill, 2003). 
During the statistical analysis of a microarray experiment a test is carried out on 
each gene leading to thousands of tests being performed. This results in the accumulation 
of false positives, when a gene is declared as differentially regulated when in fact it is not 
(type 1 error). Methods are available to correct for multiple testing (also see Chapter 3). 
One approach to multiple testing controls the family-wise error rate (FWER) or the 
probability of accumulating false positive errors. FWER criteria are very stringent therefore 
lists of genes significant after controlling FWER are associated with high confidence that 
they do not contain any false positives. The reality is that while FWER significant genes 
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are likely to be significantly differentially regulated, a large number of genes will falsely be 
rejected and identified as not differentially regulated, false negative (type 2 error) (Cui and 
Churchill, 2003). This method of controlling multiple testing may not be appropriate when 
attempting to conduct a screen to identify a large number of differentially regulated genes. 
Controlling the false-discovery rate (FDR) represents an alternative strategy and defines 
the proportion of false positives among all of the genes identified as being differentially 
expressed (Cui and Churchill, 2003). At a defined FDR significance level a known 
proportion of genes should be false positives; this approach should help to ensure that 
true positives are not rejected. Thus at a significance level of p<0.05, 5 % of identified 
candidates are likely to be false positives. This represents a more liberal approach to 
controlling for multiple testing and FDR provides a sensible balance between the number 
of true positives and false positives in a microarray study (Storey and Tibshirani, 2003). 
Therefore a range of options are available to rank these significantly differentially 
regulated genes to facilitate selecting genes for validation. The investigator would aim to 
select the method which maximised true positives and minimised false positive results. 
During this project two microarray data sets have been generated from the 
7.2sox10:GFP and 4.9sox10:GFP transgenic lines. These two sets of samples are derived 
from different biological sources but both examine differential gene regulation in sox10 
mutant embryos compared to WT embryos. Thus any gene identified as differentially 
regulated in both data sets has been identified twice independently. It would be expected 
that the false positives (identified as differentially regulated by chance) would not be 
common between the two differentially regulated lists of genes. This analysis may 
therefore present an opportunity to eliminate false positives. The caveat is that not all of 
the marker genes known to be down-regulated in sox10 mutants were identified as such 
in both data sets. In addition otic vesicle expressed genes may also be excluded as the 
4.9sox10:GFP transgenic line only weakly labels otic vesicle cells. As such this technique 
might also eliminate true positives that have been identified as differentially regulated 
during the in situ hybridization screen. These two samples generated from different 
transgenic lines have been treated as biological replicates by producing the combined 
data set to generate a set of 10 independent biological replicates (5 WT and 5 mutant 
samples). In doing so the number of microarray chips being evaluated has been 
increased. This increase in sample size may generate data that is more reliable than data 
from the two separate sets of arrays. 
Selecting genes of interest based on function represents a third option for cherry 
picking genes of interest from microarray data. For example, genes annotated with an 
interesting gene ontology (GO) term or genes that are part of a gene family of interest 
such as zinc finger transcription factors could be selected. Affymetrix probe annotation on 
the NetAffx website provides both the gene name and functional annotation in the form of 
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GO terms thus facilitating this form of analysis. While this approach will focus on genes 
that have been studied previously, at least to some extent, it would be capable of 
identifying genes that have not been previously associated with biological process of 
interest. Selected genes would require subsequent validation with a number of candidates 
likely to be false positives. 
Gene ontology or GO terms form a hierarchical structure of precisely defined, 
common and controlled vocabulary of terms for describing the normal roles of genes and 
gene products (Ashburner et al., 2000). GO terms have been split into three categories. A 
biological process GO term refers to the biological process to which the gene or gene 
product contributes. A molecular function GO term is defined as the biochemical activity of 
a gene product. The third category, cellular component, describes the cellular location 
where a gene product is active (Ashburner et al., 2000). GO terms are organised so that 
higher or parent terms describe a broad function, for example cell growth, but lower child 
terms are more specific, such as pyrimidine biosynthesis. All the genes annotated with a 
child GO term are also included within the broad parent term. Thus a balance exists 
between identifying from microarray data, a large number of genes involved with a broad 
GO term function and identifying very few or no genes from a more specific level of GO 
term. 
To facilitate the identification of genes by GO term a programme such as 
Babelomics can be used. Babelomics is a web based tool for the functional analysis of 
genome scale experiments, such as microarray experiments (Al-Shahrour et al., 2006). A 
variety of tools are available on the Babelomics website (http://babelomics.bioinfo.cipf.es) 
to help in the functional annotation and analysis of large scale experiments. For example, 
the FatiGO tool can be used to identify the functional terms of a list of genes and can 
compare two lists of genes to identify if certain functions have been enriched. For 
example, the functions of significantly differentially regulated genes identified during a 
microarray experiment could be compared to the functions of genes unaffected by the 
experimental parameters. The FatiGO tool can identify which functional terms are over or 
under represented in the experimental data set to try and elucidate the biological 
processes affected. Such functional studies are undertaken in an attempt to understand 
the global response of a biological system rather than the responses of individual genes. 
5.1.2 Aims 
Only a small portion of the genes identified as differentially regulated in the 7.2sox10:GFP 
data set were assessed by in situ hybridization. All genes that were validated by in situ 
hybridization as either NC or otic vesicle expressed displayed differential gene expression 
between WT and sox10 mutant embryos. As such it would be expected that genes 
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published as being expressed at these sites would also follow this pattern and display 
differential gene expression. A number of known NC expressed genes were identified as 
differentially regulated in the microarray data but were not assessed during the in situ 
hybridization screen as a result of time constraints. A selection of genes that display very 
strong NC expression in WT embryos are given in Table 46. This suggests that there are 
other genes differentially regulated in sox10 mutants that have been identified by 
microarray analysis that await validation. These genes could be identified from the 
7.2sox10:GFP data set. However two other data sets exist, the 4.9sox10:GFP data set 
and the 7.2+4.9 combined data set. These data sets could also be examined for 
interesting targets that are differentially regulated. The aim of this chapter is to assess 
which is the best microarray data set from which to identify further targets of sox10. In 
addition, methods to interrogate the microarray data sets for genes that are good 
candidates for validation will be explored. The aim of this chapter therefore is to maximise 
the value of the microarray data by identifying genes to prioritise for future validation. 
Affymetrix ID Gene Symbol 7.2 t-Test p-value 
Dr.21790.1.A1_at pcdh10a 0.046600606 
Dr.17217.1.S1_at rab32 0.032265697 
Dr.26358.1.A1_at ppat 0.007318902 
Dr.4801.1.S1_at gart 0.006213317 
Table 46: Examples of genes identified as differentially expressed but not assessed 
by in situ hybridization. 
All genes have been identified as NC expressed on the ZFIN website (Thisse et al., 2004). 
5.2 Results and Conclusions 
5.2.1 Analysing the Microarray Data Sets 
Three microarray data sets have been produced during this project. Two data sets were 
based on RNA from cells purified from two different transgenic lines. The 7.2sox10:GFP 
data set was comprised of three WT arrays versus three mutant arrays. These arrays 
were hybridised with RNA from NC and otic epithelium GFP positive cells from the 
7.2sox10:GFP transgenic zebrafish line. The 4.9sox10:GFP data set was comprised of 
two WT arrays versus two mutant arrays. These arrays were hybridised with RNA from 
the 4.9sox10:GFP transgenic line which labels NCCs strongly with GFP but otic 
epithelium cells only weakly. As both transgenic lines strongly marked NCCs, the two sets 
of arrays were combined for an analysis of five WT arrays versus five sox10 mutant 
arrays. This section aims to assess which of these data sets could be used most reliably 
to cherry pick interesting targets for validation. This will be performed by analysing the 
performance of known NC and otic vesicle marker genes expressed at approximately 24 
hpf, including those genes validated in Chapter 4, within the three data sets. 
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5.2.1.1 Performance of NC expressed genes 
The 7.2sox10:GFP data set was analysed for genes significantly differentially regulated 
using a t-Test. The genes were selected for validation by in situ hybridization based on 
ranking by t-statistic. This led to 22 NC expressed genes being identified as down-
regulated in sox10 mutant embryos. These genes were represented by 25 probe sets in 
the 100 most significantly down-regulated genes of the 7.2sox10:GFP data set. To assess 
whether these validated genes were also identified in the other data sets, the results (t-
Test derived p-value) were examined for these validated probe sets across all three 
microarray data sets (Table 47). Ten of these validated probe sets were not identified as 
down-regulated in the 4.9sox10:GFP data set. A single validated probe set for zgc:110239 
was not identified as down-regulated in the 7.2+4.9 combined data set (Table 47). Thus, 
in contrast to the combined data set, the 4.9sox10:GFP data set failed to identify many of 
these validated genes as differentially regulated. To assess the performance of the three 
microarray data sets without using results biased towards the 7.2sox10:GFP data set, a 
selection of well known NC marker genes were examined (Table 48). These 10 genes 
were represented by 11 separate probe sets on the zebrafish Affymetrix array as gch is 
represented by two probe sets. All these genes are known to be expressed in cells of the 
NC at approximately 24 hpf (Thisse et al., 2004). As all NC expressed genes evaluated 
during the in situ hybridization screen were validated, these genes are also likely to be 
down-regulated in sox10 mutant embryos. Indeed, crestin, dct, foxd3 and mitfa have been 
examined in sox10 mutant embryos and shown to be down-regulated (Dutton et al., 
2001a, Elworthy et al., 2003, Kelsh et al., 2000, Kelsh and Eisen, 2000, Lopes et al., 
2008). The combined data set was the only data set to identify all these NC markers as 
down-regulated in sox10 mutant embryos. The 7.2sox10:GFP data set identified 6 probe 
sets as down-regulated, surprisingly failing to identify gch in this category. The 
4.9sox10:GFP data set only identified 4 probe sets as down-regulated. The combined 
data set identified genes, such as kita and csf1r, which were not identified as down-
regulated in either of the individual data sets (Table 48). The combined data set thus 
appears to be the most reliable dataset to examine for genes to validate. 
Table 47: Summary of all NC expressed probe sets validated by in situ hybridization 
in Chapter 4. 
The t-Test derived p-values are given for all probe sets that correspond to NC expressed 
genes validated in Chapter 4. Gene names were determined, when available, by 
interrogating the NetAffx database with Affymetrix identifiers. Significantly down-regulated 
results are highlighted in green, non-significant results are highlighted in red. (See next 
page) 
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Affymetrix ID Gene Symbol 7.2 t-Test p-value 
4.9 t-Test 
p-value 
7.2+4.9 t-Test 
p-value 
Dr.1251.1.S1_at degs1 0.00330296 0.17091808 0.01819284 
Dr.7966.1.S1_at atp6v1e1 0.00267154 0.03115208 0.00001058 
Dr.7250.1.A1_at zgc:110239 0.00261661 0.62630892 0.30263367 
Dr.4751.2.A1_at aldh2b 0.00233465 0.01113994 0.00009979 
Dr.10336.1.S1_at dct 0.00220708 0.03181335 0.00005568 
Dr.13359.1.S1_at adsl 0.00209284 0.10092666 0.00037379 
Dr.20896.1.S1_at slc2a15b 0.00180482 0.02056247 0.00005038 
Dr.4171.1.A1_at pah 0.00173763 0.00474269 0.00002168 
Dr.10624.2.S1_a_at zgc:110343 0.00152714 0.00239700 0.00003745 
Dr.8124.1.S1_at crestin 0.00150991 0.08672696 0.00187139 
Dr.4751.1.S1_a_at aldh2b 0.00149498 0.03365096 0.00002157 
Dr.983.1.S1_at paics 0.00148799 0.02142708 0.00003690 
Dr.8594.1.S1_at zgc:100919 0.00135927 0.04615977 0.00000230 
Dr.8080.1.S1_at mitfa 0.00130524 0.06132047 0.00018682 
Dr.10624.2.S1_at zgc:110343 0.00119537 0.00416982 0.00016658 
Dr.3972.1.S1_at 0.00114965 0.00889788 0.00000121 
Dr.590.1.S1_at foxd3 0.00103716 0.08952936 0.01265310 
Dr.481.1.S1_at atic 0.00097499 0.09128246 0.00004416 
DrAffx.1.65.S1_at cx33.8 0.00096602 0.06422850 0.00053927 
Dr.2901.1.S1_at coro1c 0.00073671 0.19995388 0.00701491 
Dr.14747.1.A1_at slc2a15b 0.00056468 0.04337164 0.00001950 
Dr.23456.1.S1_at pax7 0.00044960 0.66678756 0.00174165 
Dr.10292.1.S1_at rbp4l 0.00008840 0.00056999 0.00000138 
Dr.2855.1.A1_a_at atp6v1a 0.00008356 0.00043360 0.00000078 
Dr.4612.1.A1_at wu:fc31e04 0.00005447 0.01980770 0.00000783 
Affymetrix ID Gene Symbol 7.2 t-Test p-value 
4.9 t-Test 
p-value 
7.2+4.9 t-Test 
p-value 
Dr.8096.1.S1_at kita 0.26101655 0.07901513 0.02429431 
Dr.14668.2.S1_at gch 0.12587915 0.03146349 0.00446180 
Dr.10333.1.S1_at csf1r 0.12376060 0.20075732 0.00621486 
Dr.14668.1.S1_at gch 0.09166294 0.02026650 0.00329152 
Dr.19561.1.S1_at tyr 0.07561973 0.14350338 0.01024735 
Dr.9225.1.A1_at aox3 (xdh) 0.01398500 0.00162993 0.00102245 
Dr.10456.1.S1_at ednrb1 0.00546011 0.11667577 0.00014209 
Dr.10336.1.S1_at dct 0.00220708 0.03181335 0.00005568 
Dr.8124.1.S1_at crestin 0.00150991 0.08672696 0.00187139 
Dr.8080.1.S1_at mitfa 0.00130524 0.06132047 0.00018682 
Dr.590.1.S1_at foxd3 0.00103716 0.08952936 0.01265310 
Table 48: Table of microarray data for probe sets of known NC marker genes. 
The t-Test derived p-values are given for probe sets representing known marker genes of 
the NC. Significantly down-regulated results are highlighted in green, non-significant 
results are highlighted in red. All these genes are expressed in NCCs at approximately 24 
hpf (Thisse et al., 2004). 
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This study was extended to include all genes on the ZFIN website that have been 
published as NC expressed (Table 49). NC expressed genes (including substructures) 
were selected by interrogating the anatomy section on the ZFIN website. The list of genes 
was then restricted to an appropriate time period, 22 to 30 hpf. This gave 130 expressed 
genes of which 92 had at least one corresponding Affymetrix probe set. These genes 
were represented by a total of 121 probe sets. This list of genes included genes 
expressed in skeletogenic NCCs and was therefore not restricted to NCCs dependent on 
sox10 expression for specification. The 7.2sox10:GFP data set identified 47 probe sets as 
differentially regulated, the 4.9sox10:GFP data set identified 29 probe sets and the 
combined data set identified 55 probe sets (Table 49). This indicated that the combined 
data set was the most promising data set to interrogate for genes of interest. Interestingly, 
while most genes were down-regulated, several NC expressed genes were identified as 
up-regulated. These genes are tempting candidates for in situ hybridization validation and 
may facilitate the identification of up-regulated NC genes in sox10 mutant embryos. 
Indeed all NC expressed genes on ZFIN that have been identified as differentially 
regulated in the microarray data are targets for validation. 
To refine this list of genes to sox10 dependent NCCs the same search was 
performed using the term “pigment cell” (Table 50). This list of genes will include those 
expressed in NC derived pigment cells but also those expressed in the melanocytes of the 
pigmented retinal epithelium, for example mitfb (Lister et al., 2001). 50 genes were 
expressed in pigment cells during the time period of interest. 40 probe sets on the array 
corresponded to 31 of these genes. The 7.2sox10:GFP data set identified 26 probe sets 
as differentially regulated, the 4.9sox10:GFP data set identified 15 probe sets and the 
combined data set identified 27 probe sets. Thus similar numbers of pigment cell 
expressed genes were identified in the 7.2sox10:GFP and combined data sets with the 
4.9sox10:GFP data set performing less well. It is interesting to note that of the 31 pigment 
cell genes represented on the Affymetrix array, 26 were identified as down-regulated in 
one or more of the microarray data sets. A large number of melanocyte or xanthophore 
expressed genes were validated by in situ hybridization in Chapter 4. These two 
observations both suggest that these sets of microarray data are powerful tools for 
identifying pigment cell expressed genes. In summary, the combined data set appears to 
be a more reliable indicator of differential gene regulation of NC expressed genes in 
sox10 mutant embryos. This could be a result of the increased sample size examined in 
this data set. To definitively test this, a blind in situ hybridization validation screen would 
need to be performed to examine the hit rate of NC and otic vesicle expressed genes 
compared to the 7.2sox10:GFP results presented in Chapter 4. 
The only PNS expressed gene successfully validated during the in situ 
hybridization screen was foxd3. This is consistent with the fact that there are very few 
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markers available for the PNS at 24 hpf. In an attempt to reveal PNS markers and to 
provide candidate genes to test for differential PNS gene expression in sox10 mutant 
embryos, ZFIN anatomy searches were performed as above. The anatomical search 
terms used were “neuron, neural crest derived” (Table 51) and “glial cell” (Table 52). On 
ZFIN, 79 genes have been identified as expressed in NC derived neurons and of these 27 
were expressed between 22 and 30 hpf. 16 of these genes were represented by 18 
Affymetrix probe sets. 6 of these genes were identified as up-regulated in one of the three 
microarray data sets, no genes were identified as down-regulated and no genes were 
identified as up-regulated in two or more data sets (Table 51). This is in stark contrast to 
the results for the pigment cell expressed genes, all of which were down-regulated but 
more importantly, all of which were identified as such in at least two of the data sets. Thus 
the results for these neuronal expressed genes may not be reliable. However, as only a 
few neuronal expressed genes are known to be differentially expressed in sox10 mutants, 
these genes are worth examining by in situ hybridization. 28 genes have been annotated 
as glial cell expressed on ZFIN, of these only 3 were expressed during the time period of 
interest (Table 52). From these genes, foxd3 was identified as down-regulated in two data 
sets and has been validated as down-regulated in glia previously (Kelsh et al., 2000). 
Neither of the other two genes were identified as differentially regulated. Mbp is not 
expressed at 24 hpf (Thisse et al., 2004) thus it is not surprising that this gene was not 
identified as differentially regulated in this microarray screen. Thus this approach has not 
helped to uncover more glial expressed genes that are likely to be down-regulated in 
sox10 mutant embryos. 
Affymetrix ID Gene Symbol 7.2 t-Test p-value 
4.9 t-Test 
p-value 
7.2+4.9 t-Test 
p-value 
No acbd7 
Dr.20912.1.S1_at alcam 0.44367251 0.18985467 0.65715164 
Dr.20912.1.S2_at alcam 0.94103247 0.18985467 0.65715164 
Dr.4751.1.S1_a_at aldh2b 0.00149498 0.03365096 0.00002157 Down 
Dr.4751.2.A1_at aldh2b 0.00233465 0.01113994 0.00009979 Down 
Dr.14515.1.A1_at aldh16a1 0.06206876 0.40363121 0.02175599 Down 
Dr.9225.1.A1_at aox3 (xdh) 0.01398500 0.00162993 0.00102245 Down 
Dr.24131.1.S1_at ap3b1 0.03986506 0.32664850 0.02191994 Down 
Dr.24201.1.A1_at ap3b1 0.12334988 0.29018345 0.09773549 
Dr.481.1.S1_at atic 0.00097499 0.09128246 0.00004416 Down 
Dr.19482.1.A1_at barx1 0.02183935 0.76380199 0.26302573 Down 
Dr.12383.2.S1_a_at bcmo1 0.75866866 0.14405601 0.20674919 
Dr.12376.1.A1_at bmper 0.76941806 0.21464749 0.69242579 
No c10orf11 
Dr.14422.1.A1_at cdon 0.06976867 0.67238581 0.26811984 
Dr.14422.3.A1_x_at cdon 0.04962551 0.02272565 0.00605113 UP 
Dr.14422.2.S1_at cdon 0.00608916 0.05217386 0.00024247 UP 
Dr.6570.1.S1_at cited3 0.09305646 0.48906589 0.42471692 
Dr.6570.1.S2_at cited3 0.18408886 0.50958717 0.26852319 
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Dr.6571.1.S1_at cndp2 0.07980923 0.10165119 0.05346033 
Dr.8124.1.S1_at crestin 0.00150991 0.08672696 0.00187139 Down 
No crestinl 
Dr.10333.1.S1_at csf1r 0.12376060 0.20075732 0.00621486 Down 
Dr.3374.2.S1_at ctsba 0.04551315 0.14553307 0.37332499 Down 
Dr.4782.1.S1_at ctsc 0.01052202 0.17543989 0.00098793 Down 
Dr.5040.1.S1_at cyb5a 0.02398859 0.03205880 0.00046595 Down 
Dr.1251.1.S1_at degs1 0.00330296 0.17091808 0.01819284 Down 
Dr.19211.1.S1_at dera 0.03396077 0.13432646 0.01961480 Down 
Dr.21797.1.S1_at dfna5 0.47294620 0.42051473 0.68788755 
Dr.7949.1.S1_at dlg1 0.12859283 0.73419821 0.30322888 
Dr.2.1.S1_at dlx2a 0.08324626 0.18918946 0.10120377 
Dr.17477.1.S1_at dtnbp1a 0.06309766 0.12429862 0.03482805 Down 
Dr.12576.1.S1_at ednra 0.51036042 0.30257273 0.78283429 
Dr.20789.1.A1_at erbb2 0.28649518 0.14815147 0.03358486 Down 
Dr.12366.1.S1_at ets1a 0.92823583 0.56444848 0.99816859 
Dr.12366.2.A1_at ets1a 0.19307689 0.43550211 0.12932420 
No evi1 
Dr.3713.1.A1_at flncb 0.25183645 0.66238552 0.45772052 
Dr.590.1.S1_at foxd3 0.00103716 0.08952936 0.01265310 Down 
Dr.13161.1.S1_at gadd45bl 0.43283209 0.47833639 0.14824764 
Dr.4801.1.S1_at gart 0.00621332 0.00762501 0.00086417 Down 
Dr.14668.1.S1_at gch2 0.09166294 0.02026650 0.00329152 Down 
Dr.14668.2.S1_at gch2 0.12587915 0.03146349 0.00446180 Down 
Dr.3275.1.A1_at gpd1b 0.03814965 0.12779483 0.00584716 Down 
No gpr143 
Dr.23788.1.S1_at gstp1 0.01244999 0.08942329 0.04036518 Down 
Dr.6382.1.A1_at hhip 0.11818337 0.07007825 0.01270617 UP 
Dr.5772.1.S1_at hoxa2b 0.17399095 0.40500796 0.65684378 
Dr.15717.1.S1_at hoxb1a 0.02427962 0.12227093 0.77110028 UP 
Dr.20962.1.S1_at hoxb2a 0.21660677 0.88262790 0.83758640 
Dr.10626.1.A1_at hoxb2a 0.55855376 0.29411480 0.08929119 
Dr.5779.1.S1_at hoxb3a 0.36674219 0.01520381 0.07713863 UP 
Dr.5428.1.S1_at id2a 0.16466472 0.38644043 0.18560024 
Dr.12583.1.S1_at igfbp3 0.67537624 0.94783461 0.43605354 
Dr.12583.2.A1_at igfbp3 0.52644509 0.45061094 0.85839808 
Dr.12379.1.S1_at il17rd 0.07022136 0.17281879 0.02638596 UP 
No im:7140212 
No im:7142864 
No si:ch211-222e23.2 
Dr.2855.2.S1_at atp6v1a 0.12184907 0.30382824 0.07631407 
Dr.2855.1.A1_a_at atp6v1a 0.00008356 0.00043360 0.00000078 Down 
Dr.8096.1.S1_at kita 0.26101655 0.07901513 0.02429431 Down 
No lratb 
No ltk 
Dr.608.1.A1_at mafba 0.18024163 0.72081417 0.48328298 
Dr.1680.1.S1_at meis3 0.04055930 0.04795788 0.00354967 UP 
Dr.8080.1.S1_at mitfa 0.00130524 0.06132047 0.00018682 Down 
Dr.2596.2.A1_a_at mpv17 0.11796077 0.10906474 0.01362077 UP 
Dr.2596.2.A1_x_at mpv17 0.14466071 0.04209826 0.00810471 UP 
Dr.2596.5.A1_x_at mpv17 0.37744278 0.41452524 0.05553884 
Dr.17843.1.A1_at mpv17 0.03258898 0.42932430 0.91304076 Down 
Dr.25316.1.S1_at nlcam 0.26748446 0.81812811 0.40730393 
Dr.4171.1.A1_at pah 0.00173763 0.00474269 0.00002168 Down 
Dr.983.1.S1_at paics 0.00148799 0.02142708 0.00003690 Down 
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Dr.579.1.S1_at pax3a 0.42822087 0.22187571 0.07897566 
No pax3b 
Dr.23456.1.S1_at pax7a (pax7e) 0.00044960 0.66678756 0.00174165 Down 
Dr.8033.1.S1_at pax7a (pax7d) 0.03809424 0.38300705 0.12114859 Down 
Dr.23455.1.S1_at pax7a (pax7c) 0.20390600 0.25540304 0.21863870 
Dr.1470.1.S1_at pax7a 0.82161093 0.92229867 0.95834744 
No pax7b 
Dr.21026.1.S1_at pcdh10a 0.59820735 0.06410612 0.70804060 
Dr.21790.1.A1_at pcdh10a 0.04660061 0.25406221 0.00684118 Down 
Dr.12.1.S1_at pdgfra 0.57346189 0.71522051 0.42611179 
Dr.12.1.S2_at pdgfra 0.06314114 0.11937556 0.05489326 
Dr.10257.1.A1_at pepd 0.19357376 0.33827218 0.11715376 
No plcb3 
Dr.26392.2.S1_at pold1 0.61816293 0.54821336 0.65618092 
Dr.9175.1.A1_at pold1 0.24453563 0.20382360 0.04444419 UP 
Dr.26358.1.A1_at ppat 0.00731890 0.03197975 0.00065635 Down 
Dr.14001.1.A1_at pttg1ip 0.01807404 0.02672966 0.00143626 Down 
Dr.14001.2.S1_at pttg1ip 0.04133245 0.03335282 0.00275114 Down 
Dr.12260.1.A1_at rab7 0.00403438 0.06317651 0.00093235 Down 
Dr.17217.1.S1_at rab32 0.03226570 0.01295175 0.00041274 Down 
Dr.193.1.S1_at raraa 0.14747715 0.67268211 0.05884251 
Dr.23544.1.S1_s_at rarga 0.83216679 0.37732565 0.67024988 
Dr.194.1.S1_at rarga 0.31954211 0.04755262 0.85664773 Down 
No rargb 
Dr.10292.1.S1_at rbp4l 0.00008840 0.00056999 0.00000138 Down 
Dr.15169.1.A1_at rgs14 0.90088600 0.10029853 0.16752151 
No rxraa 
Dr.348.1.S1_at rxrga 0.97731149 0.64712524 0.74930751 
No sb:cb429 
No sb:eu188 
No sb:eu233 
No sb:eu383 
No sb:eu823 
No sdc4 
No sdc4 
No selj 
Dr.8061.1.S1_at sema3d 0.01972223 0.06748841 0.00402466 UP 
No si:busm1­172d23.2 
Dr.19537.1.S1_a_at si:dkey-31f5.7 0.12623142 0.36014467 0.50056982 
Dr.25685.1.A1_at si:dkey-31f5.7 0.03678070 0.03715282 0.00512837 Down 
No si:dkey-251i10.2 
No slc39a1 
No slc45a2 
Dr.625.1.S1_at snai1b 0.93246692 0.32032564 0.40757066 
Dr.20.3.S1_x_at snai2 0.70444691 0.69350541 0.92420554 
Dr.20.1.S1_at snai2 0.04492790 0.04804532 0.01577159 Down 
Dr.20.3.S1_at snai2 0.80465686 0.81674427 0.54248405 
DrAffx.2.85.S1_at sox4b 0.11148241 0.02486156 0.98327315 Down 
Dr.12604.1.S1_at sox10 0.13209380 0.51710188 0.34151468 
Dr.10038.1.S1_at spry1 0.33454302 0.89178789 0.97663689 
Dr.923.1.A1_at sqstm1 0.10544427 0.11012185 0.00469088 Down 
Dr.15842.1.A1_at syngr1 0.02023073 0.00469429 0.00033034 Down 
No tbc1d5 
Dr.8506.1.S1_a_at tfap2a 0.93010110 0.47889030 0.98553759 
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Dr.9638.1.S1_a_at tnc 0.85379112 0.32953891 0.98698306 
Dr.9638.1.A1_a_at tnc 0.27302995 0.98284644 0.58994442 
Dr.8121.1.S1_at twist1a 0.14644158 0.64330959 0.08623191 
No twist1b 
Dr.8127.1.S1_at ube2i 0.13066502 0.05531247 0.01923041 UP 
Dr.389.1.S1_at wnt5b 0.64728123 0.16993344 0.17441466 
Dr.8822.1.A1_at zeb2a (sip1a) 0.00374613 0.14579193 0.00891323 Down 
DrAffx.2.73.S1_at zeb2a (sip1a) 0.55840504 0.30754045 0.59923309 
No zeb2b 
No zgc:63474 
Dr.4031.1.A1_at zgc:73134 0.08620743 0.49211428 0.06297540 
Dr.16684.1.S1_at zgc:77051 0.14692816 0.46021384 0.41851234 
Dr.890.1.S1_at zgc:77517 0.07359646 0.95719385 0.17930047 
Dr.16185.1.S1_at zgc:77775 0.00761450 0.11927229 0.00187873 Down 
No zgc:85942 
No zgc:91909 
Dr.9944.1.A1_at zgc:91968 0.01952465 0.01008070 0.00096157 Down 
No zgc:101606 
No zgc:103530 
No zgc:103749 
Dr.7250.1.A1_at zgc:110239 0.00261661 0.62630892 0.30263367 Down 
Dr.10624.2.S1_a_at zgc:110343 0.00152714 0.00239700 0.00003745 Down 
Dr.10624.2.S1_at zgc:110343 0.00119537 0.00416982 0.00016658 Down 
Dr.10624.1.S1_at zgc:110343 0.00851871 0.00023531 0.00020797 Down 
Dr.22923.1.A1_at zgc:110355 0.00404091 0.09509496 0.00240261 Down 
Dr.5081.1.A1_at zgc:110784 0.05444692 0.24116734 0.05048341 
Dr.12707.1.A1_at zgc:112072 0.00097298 0.04124477 0.00017576 Down 
No zgc:112101 
No zgc:113337 
No zgc:113456 
Dr.10102.2.S1_at zgc:136369 0.45216620 0.60071957 0.38222027 
Dr.10102.1.A1_at zgc:136369 0.91889745 0.19289894 0.60223079 
No zgc:162334 
Table 49: Microarray results for ZFIN NC expressed genes. 
A ZFIN anatomy search was performed using the term neural crest. All NC genes 
expressed between the 20-25 somite stage and Prim 15 stage (approximately 22 hpf to 30 
hpf) were selected and are presented alphabetically. Affymetrix IDs were determined from 
the NetAffx website and t-Test p-values are given for each microarray data set. The far 
right column indicates whether a probe set was up or down-regulated. (See previous 
page) 
Affymetrix ID Gene Symbol 7.2 t-Test p-value 
4.9 t-Test 
p-value 
7.2+4.9 t-Test 
p-value 
Dr.4751.1.S1_a_at aldh2b 0.0014950 0.0336510 0.0000216 
Dr.4751.2.A1_at aldh2b 0.0023346 0.0111399 0.0000998 
Dr.9225.1.A1_at aox3 0.0139850 0.0016299 0.0010225 
Dr.15693.1.S1_at atp6v0c 0.1971969 0.3194535 0.1264327 
Dr.1971.1.A1_at atp6v0c 0.0093238 0.1356747 0.0002904 
Dr.3514.1.S1_at cox4nb 0.0065779 0.7956251 0.1957595 
Dr.10333.1.S1_at csf1r 0.1237606 0.2007573 0.0062149 
Dr.10336.1.S1_at dct 0.0022071 0.0318134 0.0000557 
Dr.19211.1.S1_at dera 0.0339608 0.1343265 0.0196148 
Dr.17477.1.S1_at dtnbp1a 0.0630977 0.1242986 0.0348281 
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Dr.10456.1.S1_at ednrb1 0.0054601 0.1166758 0.0001421 
Dr.3713.1.A1_at flncb 0.2518364 0.6623855 0.4577205 
Dr.4801.1.S1_at gart 0.0062133 0.0076250 0.0008642 
Dr.14668.1.S1_at gch2 0.0916629 0.0202665 0.0032915 
Dr.14668.2.S1_at gch2 0.1258792 0.0314635 0.0044618 
No gmps 
No gpr143 
No gpr182 
Dr.23788.1.S1_at gstp1 0.0124500 0.0894233 0.0403652 
Dr.14058.1.A1_at gstt1a 0.9572253 0.3944546 0.6610474 
Dr.25191.1.S1_at idh1 0.0300042 0.6534362 0.4241687 
Dr.14555.1.S1_at ivns1abpa 0.0387004 0.4871136 0.0420197 
Dr.9512.1.A1_at ivns1abpa 0.0076884 0.1765334 0.0005903 
Dr.8096.1.S1_at kita 0.2610165 0.0790151 0.0242943 
Dr.729.1.S1_at ldhb 0.0222297 0.1858931 0.1338363 
No ltk 
Dr.8080.1.S1_at mitfa 0.0013052 0.0613205 0.0001868 
Dr.12631.1.S1_at mitfb 0.3067101 0.4362738 0.3427937 
Dr.24311.1.S1_at nme4 0.0451185 0.1693777 0.0442447 
Dr.4171.1.A1_at pah 0.0017376 0.0047427 0.0000217 
Dr.23456.1.S1_at pax7a (pax7e) 0.0004496 0.6667876 0.0017417 
Dr.8033.1.S1_at pax7a (pax7d) 0.0380942 0.3830070 0.1211486 
Dr.23455.1.S1_at pax7a (pax7c) 0.2039060 0.2554030 0.2186387 
Dr.1470.1.S1_at pax7a 0.8216109 0.9222987 0.9583474 
No pax7b 
Dr.11425.1.S1_at psat1 0.4161273 0.8670802 0.5461265 
Dr.14001.1.A1_at pttg1ip 0.0180740 0.0267297 0.0014363 
Dr.14001.2.S1_at pttg1ip 0.0413324 0.0333528 0.0027511 
Dr.17217.1.S1_at rab32 0.0322657 0.0129518 0.0004127 
No sb:eu188 
Dr.19537.1.S1_a_at si:dkey-31f5.7 0.1262314 0.3601447 0.5005698 
Dr.25685.1.A1_at si:dkey-31f5.7 0.0367807 0.0371528 0.0051284 
No silva 
No slc24a5 
No slc39a10 
No slc45a2 
No spra 
Dr.15842.1.A1_at syngr1 0.0202307 0.0046943 0.0003303 
No tyrp1b 
Dr.1368.4.A1_at wu:cegs2586 0.9591529 0.6867187 0.6530809 
No zgc:77375 
No zgc:86889 
Dr.9944.1.A1_at zgc:91968 0.0195247 0.0100807 0.0009616 
Dr.8594 zgc:100919 0.0013593 0.0461598 0.0000023 
No zgc:103530 
No zgc:110789 
No zgc:162334 
No zgc:162606 
Table 50: Microarray results for ZFIN pigment cell expressed genes. 
A ZFIN anatomy search was performed using the term pigment cell as performed for 
Table 4. All differentially regulated genes were down-regulated. 
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Affymetrix ID Gene Name 
7.2 t-Test p-
value 
4.9 t-Test p-
value 
7.2+4.9 t-Test p-
value 
Dr.15722.1.S1_at ache 0.408349216 0.636530876 0.865899742 
Dr.20912.1.S1_at alcam 0.443672508 0.281618953 0.998932274 
Dr.20912.1.S2_at alcam 0.941032469 0.189854667 0.65715164 
No chrna4 
Dr.6798.1.S1_at cxcr4b 0.047582835 0.985801399 0.411663681 
Dr.10492.1.S1_at dla 0.092713371 0.032959372 0.212765485 
No flot1a 
Dr.17863.1.S1_at flot2a 0.723339081 0.422459006 0.808896005 
Dr.15717.1.S1_at hoxb1a 0.024279619 0.122270934 0.771100283 
No insm1a 
Dr.19235.1.S1_at insm1b 0.047903273 0.73179245 0.126329988 
Dr.12208.1.S1_s_at isl1 0.355698913 0.430072218 0.684007704 
Dr.279.1.S1_at isl1 0.670866251 0.844222367 0.587054551 
Dr.281.1.S1_at isl2a 0.349266678 0.553344309 0.191186607 
Dr.570.1.S1_at lhx3 0.095309049 0.890643537 0.337820679 
No met 
No mnx1 
No nkx6.1 
Dr.26440.1.S1_at nrp1a 0.047821794 0.476297349 0.294988781 
Dr.10562.1.A1_at olfm2 0.341941446 0.551333189 0.439760268 
Dr.3920.1.S1_at olig2 0.821317732 0.486432523 0.481608063 
Dr.24244.2.S1_a_at pax6a 0.15213044 0.947506189 0.263120949 
No phox2a 
plxna3 
Dr.439.1.A1_at prickle1b 0.312992334 0.184240609 0.033645876 
Dr.12382.1.S1_at slc6a3 0.316994131 0.982832909 0.080466352 
No sp8 
Table 51: Microarray results for ZFIN NC derived neuron expressed genes. 
A ZFIN anatomy search was performed using the term neuron NC derived, as performed 
for Table 4. All differentially regulated genes were up-regulated. 
Affymetrix ID Gene Name 
7.2 t-Test p-
value 
4.9 t-Test p-
value 
7.2+4.9 t-Test p-
value 
Dr.590.1.S1_at foxd3 0.001037158 0.089529358 0.012653097 
Dr.7462.1.A1_at mbp 0.276803732 0.824697912 0.501458645 
Dr.3920.1.S1_at olig2 0.821317732 0.486432523 0.481608063 
Table 52: Microarray results for ZFIN glial cell expressed genes. 
A ZFIN anatomy search was performed using the term glial cell as performed for Table 4. 
Foxd3 was identified as down-regulated. 
5.2.1.2 Performance of otic vesicle expressed genes 
Five otic vesicle expressed genes were identified as differentially regulated in sox10 
mutant embryos from the 7.2sox10:GFP data and were subsequently validated. Results 
from the microarray analysis (t-Test derived p-value) were examined for these genes 
across all three microarray data sets (Table 53). It was expected that the otic vesicle 
expressed genes would not be readily identified as differentially regulated in the 
4.9sox10:GFP data set because otic epithelium cells are only weakly labelled with GFP in 
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this line. This appeared to be true as only otomp was identified as differentially regulated 
in the 4.9sox10:GFP line. Combining the two data sets also appeared to reduce the power 
of the screen when compared to the 7.2sox10:GFP data. Only two of the genes validated 
in Chapter 4 were identified as differentially regulated in the combined data set (Table 
53). However, a paucity of validated otic vesicle markers known to be differentially 
regulated in sox10 mutant embryos makes this analysis difficult. Recently a study 
examining the otic vesicle phenotype of sox10 mutant embryos was conducted (Dutton et 
al., 2009). The expression patterns of some otic vesicle marker genes were examined in 
WT and sox10 mutant embryos. The genes which were up-regulated in sox10 mutant 
embryos at 24 hpf are shown in Table 54; no genes were down-regulated. These up-
regulated genes were poorly detected in the three microarray data sets with only a few 
probe sets being identified as differentially regulated in one of the three microarray data 
sets. Two of these differentially regulated probe sets corresponded to sox9b and these 
showed conflicting results in the 4.9sox10:GFP data set, one being called up-regulated 
and one, against the published data, being called down-regulated (Table 54). Thus the 
results were not consistent across the three data sets and with the published data. Indeed 
it appears that otic vesicle expressed genes were not easily detected as differentially-
regulated in any data set. 
Affymetrix ID Gene Symbol 7.2 t-Test p-value 4.9 t-Test p-value 7.2+4.9 t-Test p-value 
Dr.21012.1.A1_at sfrp5 0.00292677 0.89689237 0.27037165 Up 
Dr.23461.1.A1_at stc2 0.00215093 0.25583288 0.00428666 Up 
Dr.19416.1.S1_at otomp 0.00267353 0.01195940 0.01608922 Down 
Dr.18158.1.A1_at 0.00152277 0.12411628 0.18378794 Down 
Dr.8680.1.S1_at cldnj 0.00008655 0.13460585 0.07455172 Down 
Table 53: Summary of all otic vesicle expressed genes validated in Chapter 4. 
The t-Test derived p-values are given for all probe sets that correspond to otic vesicle 
expressed genes validated in Chapter 4. Significantly differentially regulated results are 
highlighted in green, non-significant results are highlighted in red. Direction of change, up 
or down-regulation, is indicated in the far right column. 
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Affymetrix ID Gene Symbol 7.2 t-Test p-value 4.9 t-Test p-value 7.2+4.9 t-Test p-value 
Dr.198.1.S1_at fsta 0.917976379 0.988044858 0.848030746 
Dr.198.1.S2_at fsta 0.079166167 0.090070494 0.023546828 Up 
Dr.567.2.S1_a_at bmp4 0.738948643 0.284754723 0.831891239 
Dr.478.1.S1_at fgf8a 0.492221892 0.652610123 0.384049505 
Dr.11850.1.S2_at sox9b 0.260425121 0.024585784 0.020765815 Up 
Down Dr.11850.1.S1_at sox9b 0.827677131 0.047364879 0.218093172 
Dr.10460.1.S1_at sox9a 0.077197567 0.906565189 0.18403475 
Dr.385.1.S1_at wnt4a 0.035770889 0.699507535 0.30663532 Up 
Table 54: Summary of otic vesicle expressed genes known to be up-regulated in 
sox10 mutant embryos. 
The t-Test derived p-values are given for probe sets representing genes known to be up-
regulated in sox10 mutant embryos at approximately 24 hpf (Dutton et al., 2009). 
Significantly differentially regulated results are highlighted in green, non-significant results 
are highlighted in red. Direction of change, up or down-regulation, is indicated in the far 
right column. 
5.2.2 Identifying Good Candidates for Validation 
The aim of this section is to identify genes that are good candidates for further validation, 
including genes with no prior association to NC or otic vesicle biology. This will be done by 
applying new approaches to evaluate the existing microarray data thus generating gene 
lists of interesting candidates. These lists will be examined to identify known NC and otic 
vesicle expressed genes, known false positive genes and genes with no known 
expression pattern by integrating published expression data and the results obtained in 
Chapter 4. This information will be used to evaluate the success of each method to enable 
the selection of some high priority genes for future validation. Primarily the combined 
7.2+4.9 data set will be assessed for high priority genes as this data set appears to most 
reliably identify known differentially regulated genes. 
5.2.2.1 Identifying Candidates with a large fold change 
The combined 7.2+4.9 data set was ranked by fold change values generated from the 
GEPAS CLEAR test. The genes with the most negative fold change (down-regulated) 
(Table 55) and largest positive fold change (up-regulated) (Table 56) were selected using 
a fold change of 2 (> 2 or < -2) as an arbitrary cut off. 
For the down-regulated genes (Table 55), 55 probe sets corresponding to 52 
genes, had a fold change of < -2. Of these, 24 probe sets already had a strong expression 
pattern on the ZFIN website including 17 probe sets which displayed NC (13 probe sets) 
or otic vesicle (4 probe sets) expression. There were also 13 genes in this list that were 
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validated as NC (12 probe sets) or otic vesicle (1 probe set) expressed and down-
regulated in sox10 mutants during the in situ hybridization screen. In the list of genes 
shown in Table 55, 30 probe sets were examined during the in situ hybridization screen 
and as 13 were validated, 17 (57 %) of the probe sets were false positives. When the 
information from ZFIN and the in situ hybridization screen was combined, 20 of the 55 
identified probe sets were known to be NC or otic vesicle expressed. That a large number 
of known NC and otic vesicle expressed genes were present in this gene list increases 
confidence that unknown genes expressed in the cell types of interest are also present. 
The genes with a well characterised expression pattern that do not show expression in the 
NC or otic vesicle are unlikely to be of interest. 
The published data could be used to prioritise candidates for validation and to 
reduce the number of candidates for validation. Caution must be exercised with this 
technique, for example while slc3a2 was not annotated as being NC expressed (Thisse et 
al., 2004) the pattern on ZFIN does show some potential migratory NCCs and this gene is 
expressed in the dorsal neural tube (DNT), the site of NCCs prior to delamination. The 
use of published data can also highlight targets examined during the in situ hybridization 
screen that might be worth revisiting, for example zgc:112072 has been annotated as NC 
expressed on ZFIN but this was not observed during the screen (Thisse et al., 2004). 
Genes evaluated during the screen should only be revisited when there is a compelling 
reason, such as an expression pattern of interest, for doing so. There are 6 genes in 
Table 55 which have a poorly characterised expression pattern on ZFIN, described as not 
spatially restricted. This included the gene slc2a15b which was validated during the in situ 
hybridization screen as NC expressed and down-regulated in sox10 mutant embryos. 
Thus genes annotated in this way may be expressed in cell types of interest and could be 
examined. Throughout this chapter such annotated unclear expression patterns will be 
counted as lacking a defined expression pattern. There are 24 Affymetrix probe sets that 
correspond to targets that have no published gene expression data within this gene list. 
Some of these genes were analysed during the in situ hybridization screen, for example 
Dr.3972.1.S1_at was expressed in the neural crest while for some of these genes no NC 
or otic vesicle expression was observed (false positives). There remain 14 genes that 
lacked an expression pattern on ZFIN and that were not examined during the in situ 
hybridization screen. This group of genes could be prioritised for in situ hybridization 
validation to facilitate the discovery of novel NC or otic vesicle expressed genes. In 
summary, genes annotated as NC or otic vesicle expressed on ZFIN that were not 
examined during the in situ hybridization screen should be high priorities for future 
validation with genes without a published expression pattern prioritised next for 
examination. Genes with an unclear published expression pattern (not spatially restricted) 
should then be prioritised for validation. Finally genes with a well defined expression 
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pattern from published data that is not of interest should have the lowest priority for future 
validation studies. This order of priority should remain the same regardless of the method 
employed to select genes for validation in this chapter. Genes within each category should 
be prioritised by the fold change ranking displayed in Table 55. 
A large number of NC and otic vesicle marker genes were present in the down-
regulated genes that displayed large fold changes. This indicated that the same analysis 
could unearth up-regulated targets for validation. For the up-regulated genes, 23 probe 
sets had a fold change greater than 2. 13 of these genes had a published expression 
pattern on ZFIN, two of which were expressed in the NC. Neither of these genes were 
examined during the in situ hybridization screen, analysis of the expression pattern of 
mpv17 and sema3d should be a priority to facilitate the identification of up-regulated NC 
expressed genes. 4 of the genes in this list were examined during the in situ hybridization 
screen, all 4 were false positives. 10 up-regulated genes with large fold changes have no 
published expression pattern and this group of genes may contain some novel NC or otic 
vesicle expressed genes. However, in line with the up-regulated gene in situ hybridization 
screen, detection of up-regulated genes may be rare. 
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Affymetrix ID Gene Symbol Fold Change 
ZFIN Expression 
Pattern ISH Screen 
Dr.10336.1.S1_at dct -14.58 Yes, NC Yes, NC 
Dr.10292.1.S1_at rbp4l -11.03 Yes, NC Yes, NC 
Dr.25257.1.A1_at bhlhb3l -8.42 Yes 
Dr.518.1.A1_at sb:cb319 -3.88 Yes Yes 
Dr.13919.1.S1_at -3.85 Yes 
Dr.2268.1.A1_at wu:fc64c05 -3.49 No expression pattern 
Dr.14747.1.A1_at slc2a15b -3.46 Yes, not spatially restricted Yes, NC 
Dr.4612.1.A1_at wu:fc31e04 -3.41 No expression pattern Yes, NC 
Dr.3933.1.A1_at wu:fc46b01 -3.40 No expression pattern Yes 
Dr.3972.1.S1_at -3.36 Yes, NC 
Dr.22614.1.A1_at -3.35 
Dr.26101.1.A1_at -3.32 Yes 
Dr.4171.1.A1_at pah -3.30 Yes, NC Yes, NC 
Dr.10624.2.S1_a_at zgc:110343 -3.18 Yes, NC Yes, NC 
Dr.4751.2.A1_at aldh2b -3.15 Yes, NC Yes, NC 
Dr.14787.1.A1_at s100b -2.99 
Dr.6142.1.A1_at si:dkey-180p18.9 -2.90 Yes, not spatially restricted 
Dr.2788.1.S1_at si:dkeyp-86b9.2 -2.72 Yes, not spatially restricted Yes 
Dr.22360.1.A1_at zgc:85890 -2.71 Yes 
Dr.20850.1.S1_at fabp7a -2.69 Yes Yes 
Dr.18194.1.A1_at pik3c3 -2.67 Yes, not spatially restricted Yes 
Dr.4838.1.A1_at zgc:158673 -2.56 Yes Yes 
Dr.8124.1.S1_at crestin -2.53 Yes, NC Yes, NC 
Dr.10624.2.S1_at zgc:110343 -2.48 Yes, NC Yes, NC 
Dr.3991.1.A1_at wu:fd02h10 -2.45 No expression pattern Yes 
Dr.11035.1.A1_at wu:fj35f12 -2.44 No expression pattern 
Dr.9896.1.A1_at si:ch211-195b13.1 -2.41 No expression pattern 
Dr.9611.1.A1_at si:ch211-241e15.2 -2.38 No expression pattern Yes 
Dr.723.1.A1_at cno -2.37 Yes, not spatially restricted 
Dr.8680.1.S1_at claudin j -2.35 Yes, OV Yes, OV 
Dr.14326.1.A1_at -2.34 
Dr.4751.1.S1_a_at aldh2b -2.34 Yes, NC Yes, NC 
Dr.10941.1.A1_at -2.25 
Dr.22990.1.A1_at wu:fj82h06 -2.23 No expression pattern Yes 
Dr.17217.1.S1_at rab32 -2.22 Yes, NC 
Dr.5325.1.A1_at zgc:65870 -2.22 Yes Yes 
Dr.12707.1.A1_at zgc:112072 -2.20 Yes, NC Yes 
Dr.10624.1.S1_at zgc:110343 -2.18 Yes, NC Yes, NC 
Dr.23536.1.A1_at si:dkeyp-38g6.2 -2.18 No expression 
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pattern 
Dr.6806.1.S1_at keap1a -2.16 Yes Yes 
Dr.22923.1.A1_at zgc:110355 -2.16 Yes, NC 
Dr.5513.1.S1_at slc3a2 -2.13 Yes, DNT, possible NC 
Dr.17743.1.A1_at zgc:66482 -2.13 Yes, OV Yes 
Dr.12551.1.S1_at -2.13 
Dr.20434.1.A1_at -2.12 
Dr.3773.1.S1_at uap1 -2.11 Yes, OV 
Dr.14668.1.S1_at gch2 -2.11 Yes, NC 
Dr.11767.1.A1_at epo -2.10 Yes 
Dr.25465.1.A1_at si:dkey-15j16.2 -2.09 Yes, not spatially restricted 
Dr.10376.1.S1_at -2.06 
Dr.13952.1.A1_at zgc:63553 -2.04 No expression pattern 
Dr.19899.1.A1_at -2.04 
Dr.13145.1.A1_at -2.04 
Dr.12107.1.A1_at ndrg1 -2.03 Yes, OV Yes 
Dr.23838.1.S1_at wu:fc38f09 -2.00 No expression pattern 
Table 55: Table of the down-regulated genes ranked by fold change identified from 
the combined data set. 
The Affymetrix probe set identifier was used to obtain the corresponding gene symbol 
from the NetAffx website. Gene symbols were used to interrogate the ZFIN website for 
published expression patterns. Yes = a pattern was available, when this identified 
expression in the neural crest (NC), otic vesicle (OV) or dorsal neural tube (DNT) this has 
been noted, when no NC, OV or DNT was observed no sites of expression have been 
noted. No expression pattern = gene was present on ZFIN but no pattern was available. 
Yes, not spatially restricted = the expression pattern was unclear. Blank cells indicate that 
the gene was not present on the ZFIN website. The ISH screen column indicates if a gene 
was examined during the in situ hybridization screen. If expression was observed in the 
neural crest or otic vesicle this has been noted; Yes = a pattern was available, when this 
identified expression in the NC, OV or DNT this has been noted, when no NC, OV or DNT 
expression was observed, no sites of expression have been noted. Blank cells indicate 
the gene was not examined by in situ hybridization. Genes have been ranked by fold 
change. 
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Affymetrix ID Gene Symbol Fold Change ZFIN Expression Pattern ISH Screen 
Dr.2596.2.A1_a_at mpv17 3.14 Yes, NC 
Dr.23341.1.A1_at 2.73 
Dr.20391.1.A1_at LOC563577 2.60 
Dr.17625.1.A1_at si:rp71-69p9.2 2.58 No expression pattern 
Dr.10405.1.S1_at ca2 2.45 Yes 
Dr.11260.1.A1_at 2.35 
Dr.15195.1.A1_at 2.32 
Dr.10488.1.A1_at ngfr 2.28 No expression pattern 
Dr.12717.1.S1_at sulf2 2.27 Yes 
Dr.185.1.A1_at wu:fa04h02 2.22 No expression pattern 
Dr.13165.1.A1_at npr3 2.19 Yes Yes 
Dr.8061.1.S1_at sema3d 2.16 Yes, NC 
Dr.7441.1.A1_at wu:fi31c04 2.16 No expression pattern 
Dr.8617.1.A1_at id:ibd5023 2.14 Yes 
Dr.2967.1.A1_at hoxc8a 2.10 Yes Yes 
Dr.19844.1.A1_at CH211-173B8.2 2.09 No expression pattern 
Dr.6603.1.A1_at ehd2 2.08 Yes 
Dr.5129.1.S1_at sesn3 2.08 Yes 
Dr.26411.2.S1_s_at 
LOC792267 
Tnni2 
tnni2a.2 
tnni2a.4 
2.07 Yes 
Dr.13868.1.S1_at syt4 2.04 Yes, possible DNT 
Dr.14522.1.S1_at pvalb7 2.04 Yes Yes 
Dr.12963.1.A1_at 2.00 
Dr.18513.1.A1_at sccpdhb 2.00 Yes Yes 
Table 56: Table of the up-regulated genes in the combined data set, ranked by fold 
change. 
The Affymetrix probe set identifier was used to identify the gene symbol using the NetAffx 
website. Gene symbols were used to interrogate the ZFIN website for published 
expression patterns at 24 hpf. Table is presented in the same format as Table 55. 
5.2.2.2 Identifying candidates differentially regulated in both 7.2sox10:GFP and 
4.9sox10:GFP data sets. 
All Affymetrix probe sets identified as significantly down-regulated in sox10 mutants using 
the t-Test (p<0.05) from analysis of the two initial data sets were independently collected. 
Thus significantly differentially-regulated genes identified from both the 7.2sox10:GFP and 
4.9sox10:GFP lines were collected. In this section, the differentially regulated genes were 
compared to identify common down-regulated or up-regulated probe sets using the 
intersect function on the NetAffx website. 
89 down-regulated probe sets were identified as common between the two gene 
lists (Table 57). 30 of these probe sets were evaluated during the in situ hybridization 
screen, 19 of which were validated as NC or otic vesicle expressed and 11 probe sets (37 
%) were false positives. This low rate of false positives suggests that the list of genes 
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presented in Table 57 will provide a reliable set of genes to screen for N or otic vesicle 
expression. To examine this further, the list of probe sets was interrogated for expression 
patterns on ZFIN. This identified that 23 probe sets had a NC expression pattern and 4 
had an otic vesicle expression pattern. Three probe sets displayed an expression pattern 
on ZFIN that suggested NCCs were marked. 39 probe sets did not have a published 
expression pattern, 8 had no clear expression pattern and 12 had a clear expression 
pattern that was not of interest. Integrating the in situ hybridization data from Chapter 4 
and the published expression pattern data identified that 31 probe sets had a published 
NC or otic vesicle expression pattern. Therefore a large number of genes expressed in the 
cell types of interest were represented by the probe sets identified as down-regulated in 
both the 7.2sox10:GFP and 4.9sox10:GFP microarray data sets (Table 57). 4 genes 
expressed in the otic vesicle were present in Table 57, 3 of which were not assessed 
during the in situ hybridization screen. Thus otic vesicle expressed genes were identified 
by this method. Three genes had an expression pattern on ZFIN that suggested NCCs 
were marked but were not annotated as such, but this requires further investigation. This 
demonstrates the danger of assuming that the annotation of published gene expression 
data is comprehensive. 15 genes had a clear expression pattern determined from ZFIN or 
were assessed during the in situ hybridization screen and displayed no NC or otic vesicle 
expression. Thus the remaining 42 genes had no clear published expression pattern and 
could be investigated. The presence of a large number of genes with an expression 
pattern of interest contrasts with only a few genes that were false positives. This suggests 
the remaining candidates should be a priority for validation. 
The same analysis was performed with genes that were up-regulated in both of the 
independent microarray data sets (Table 58). This identified 51 probe sets of which 3 had 
a clear published NC expression pattern and 3 were expressed in the otic vesicle on 
ZFIN. None of these 6 genes were assessed during the in situ hybridization screen; all 
therefore should be examined to identify if these genes are up-regulated in sox10 mutant 
embryos. 20 genes had a clear published expression pattern but displayed no expression 
in the NC or otic vesicle. This suggested that the percentage of positive hits in the up-
regulated data set was low, as noted in Chapter 4. In addition, 9 genes that were 
assessed during the in situ hybridization screen appeared in Table 58. None of these 
were expressed in the NC or otic vesicle thus all are false positives. This suggested that a 
large number of false positive genes were present in the gene list. However, 25 genes 
had no clear published expression pattern and could be investigated despite the likelihood 
that many are false positives. 
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Probe Set ID Gene Symbol ZFIN Expression Pattern ISH Screen 
Dr.4751.1.S1_a_at aldh2b Yes, NC Yes, NC 
Dr.4751.2.A1_at aldh2b Yes, NC Yes, NC 
Dr.25417.1.A1_at ap3m2 No expression pattern 
Dr.2855.1.A1_a_at atp6v1a Yes Yes, NC 
Dr.186.1.S1_at atp6v1ba Yes, possible NC expression 
Dr.14783.1.S1_at atp6v1c1 Yes, not spatially restricted 
Dr.7966.1.S1_at atp6v1e1 No expression pattern Yes, NC 
Dr.370.1.S1_at atp6v1g1 Yes, possible NC expression 
Dr.25257.1.A1_at bhlhb3l No expression pattern Yes 
Dr.7400.1.A1_at csnk1e Yes, OV 
Dr.5040.1.S1_at cyb5a Yes, NC 
Dr.10336.1.S1_at dct Yes, NC Yes, NC 
Dr.6362.1.A1_at depdc6 No expression pattern 
Dr.20850.1.S1_at fabp7a Yes Yes 
Dr.4801.1.S1_at gart Yes, NC 
Dr.17596.1.A1_at LOC100000591 
Dr.10530.1.S1_at LOC100002236 
Dr.9225.1.A1_at LOC100148138 
Dr.2072.1.A1_at LOC553451 
Dr.14390.1.S1_at LOC557898 
Dr.752.1.A1_at LOC562425 
Dr.12107.1.A1_at ndrg1 Yes, OV Yes 
Dr.19416.1.S1_at otomp Yes, OV Yes, OV 
Dr.4171.1.A1_at pah Yes, NC Yes, NC 
Dr.983.1.S1_at paics Yes, NC Yes, NC 
Dr.360.1.A1_at pla2g15 No expression pattern 
Dr.26358.1.A1_at ppat Yes, NC 
Dr.8045.1.S1_at prtfdc1 Yes, not spatially restricted 
Dr.14001.1.A1_at pttg1ip Yes, NC 
Dr.14001.2.S1_at pttg1ip Yes, NC 
Dr.17217.1.S1_at rab32 Yes, NC 
Dr.10292.1.S1_at rbp4l Yes, NC Yes, NC 
Dr.518.1.A1_at sb:cb319 Yes Yes 
Dr.12651.1.S1_at sh3glb2 Yes 
Dr.1823.2.S1_at si:ch211-150c22.2 Yes, not spatially restricted 
Dr.6142.1.A1_at si:dkey-180p18.9 Yes, not spatially restricted 
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Dr.25685.1.A1_at si:dkey-31f5.7 Yes, NC 
Dr.21747.1.A1_at si:dkey-94n12.4 No expression pattern 
Dr.14747.1.A1_at slc2a15b Yes Yes, NC 
Dr.20896.1.S1_at slc2a15b Yes Yes, NC 
Dr.4885.1.S1_at slc34a2a Yes, not spatially restricted 
Dr.24728.1.S1_at slc37a2 No expression pattern 
Dr.5513.1.S1_at slc3a2 Yes, possible NC, DNT 
Dr.13477.1.A1_at slc9a8 Yes, not spatially restricted 
Dr.20.1.S1_at snai2 Yes, NC 
Dr.15842.1.A1_at syngr1 Yes, NC 
Dr.3773.1.S1_at uap1 Yes, OV 
Dr.14652.1.A1_at ube2k Yes 
Dr.18689.1.A1_at vac14 Yes, not spatially restricted 
Dr.18964.1.A1_at vac14 Yes, not spatially restricted 
Dr.4248.1.A1_at wu:fa98e08 No expression pattern Yes 
Dr.4612.1.A1_at wu:fc31e04 No expression pattern Yes, NC 
Dr.23838.1.S1_at wu:fc38f09 No expression pattern 
Dr.5170.2.A1_at wu:fc41e04 No expression pattern 
Dr.3933.1.A1_at wu:fc46b01 No expression pattern Yes 
Dr.9746.7.A1_at wu:fc51f04 No expression pattern 
Dr.2268.1.A1_at wu:fc64c05 No expression pattern 
Dr.22266.1.A1_at wu:fe48e11 No expression pattern 
Dr.8251.1.A1_at wu:fi05a09 Yes, NC Yes, NC 
Dr.11035.1.A1_at wu:fj35f12 No expression pattern 
Dr.7226.1.S1_at wu:fj65h10 No expression pattern 
Dr.14073.1.A1_at wu:fj78f01 Yes 
Dr.8594.1.S1_at zgc:100919 Yes, NC Yes, NC 
Dr.4057.1.S1_at zgc:101045 No expression pattern 
Dr.10145.1.A1_at zgc:110003 No expression pattern 
Dr.10624.1.S1_at zgc:110343 Yes, NC Yes, NC 
Dr.10624.2.S1_at zgc:110343 Yes, NC Yes, NC 
Dr.10624.2.S1_a_at zgc:110343 Yes, NC Yes, NC 
Dr.12707.1.A1_at zgc:112072 Yes, NC Yes 
Dr.13330.1.A1_at zgc:112153 No expression pattern 
Dr.9036.1.A1_at zgc:136982 No expression pattern 
Dr.4838.1.A1_at zgc:158673 Yes Yes 
Dr.4868.1.A1_at zgc:174888 Yes 
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Dr.5325.1.A1_at zgc:65870 Yes Yes 
Dr.9944.1.A1_at zgc:91968 Yes, NC 
Dr.14275.1.A1_at zgc:92185 No expression pattern 
Dr.10941.1.A1_at 
Dr.13919.1.S1_at No 
Dr.14838.1.A1_at 
Dr.16789.1.A1_at No 
Dr.17577.1.A1_at 
Dr.21407.1.A1_at No 
Dr.26012.1.A1_at 
Dr.26101.1.A1_at No 
Dr.26254.1.A1_at 
Dr.26522.1.A1_at 
Dr.3972.1.S1_at Yes, NC 
Dr.4836.1.A1_at 
Dr.8674.1.A1_at 
Table 57: Table of the probe sets identified as down-regulated in both the 
7.2sox10:GFP and 4.9sox10:GFP data sets. 
Probe set Affymetrix IDs were annotated using NetAffx. Table is presented as per Table 
55 except genes are ordered alphabetically. 
Probe Set ID Gene Symbol ZFIN Expression Pattern ISH Screen 
Dr.10405.1.S1_at ca2 Yes 
Dr.25673.2.S1_at cdc25 No expression pattern 
Dr.14422.3.A1_x_at cdon Yes, OV 
Dr.22283.1.S1_at cnn3a Yes, NC 
Dr.15055.1.S1_at cxcr4a Yes 
Dr.574.2.S1_at dlb Yes 
Dr.21809.1.S1_at fbxl14 
14 
Yes, not spatially restricted 
Dr.21414.1.A1_at hoxb9a Yes, not spatially restricted 
Dr.2967.1.A1_at hoxc8a Yes Yes 
Dr.8617.1.A1_at id:ibd5023 Yes 
Dr.17792.2.A1_at im:7163473 Yes, not spatially restricted 
Dr.23153.1.S1_at LOC100000500 Yes 
Dr.11563.1.A1_at LOC553231 
Dr.13854.1.S1_at LOC569855 
Dr.14994.1.A1_at mapk14b Yes, not spatially restricted 
Dr.24241.1.S1_at mdkb Yes, OV 
Dr.1680.1.S1_at meis3 Yes, NC 
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Dr.4771.1.S1_at ndufb9 Yes, not spatially restricted 
Dr.10488.1.A1_at ngfr No expression pattern 
Dr.13165.1.A1_at npr3 No Yes 
Dr.14203.1.S1_at ppp1r14a Yes 
Dr.14522.1.S1_at pvalb7 Yes Yes 
Dr.24815.1.S1_at rpl13 Yes, not spatially restricted 
Dr.1691.14.S1_at sb:cb8 Yes 
Dr.9438.1.A1_at si:dkey-218l8.1 No expression pattern 
Dr.7094.1.A1_at si:dkey-24l11.4 Yes, not spatially restricted 
Dr.4624.1.A1_at si:dkey-32e6.1 Yes, not spatially restricted 
Dr.6063.1.A1_at si:dkey-73n10.1 No expression pattern Yes 
Dr.25679.1.S1_at slc1a3 Yes, OV 
Dr.7855.2.S1_at sncb Yes 
Dr.12717.1.S1_at sulf2 Yes 
Dr.13868.1.S1_at syt4 Yes, possible DNT 
Dr.25500.1.S1_at vamp1 Yes, possible DNT Yes 
Dr.26450.1.S1_at vegfc No 
Dr.18141.2.S1_at wu:fa99c11 No expression pattern 
Dr.21543.1.A1_at wu:fc41f11 No expression pattern 
Dr.22087.1.A1_at wu:fd12f01 No expression pattern Yes 
Dr.1094.1.A1_at wu:fk49e12 No expression pattern Yes 
Dr.15362.1.S1_at zgc:110256 Yes, not spatially restricted 
Dr.25338.1.A1_at zgc:123165 Yes 
Dr.17582.1.A1_at zgc:152916 No expression pattern 
Dr.3936.1.A1_at zgc:162730 No expression pattern Yes 
Dr.23549.1.A1_at zgc:92231 Yes, OV 
Dr.13091.1.S1_at zgc:92878 Yes, not spatially restricted 
Dr.10689.1.S1_at zic2b Yes, possible DNT 
Dr.11232.1.A1_at 
Dr.12819.1.A1_at 
Dr.14210.1.A1_at 
Dr.14213.1.A1_at 
Dr.15195.1.A1_at 
Dr.2693.1.A1_at 
Table 58: Table of the probe sets identified as up-regulated in both the 
7.2sox10:GFP and 4.9sox10:GFP data sets. 
Probe set Affymetrix IDs were annotated using NetAffx. Table is presented as per Table 
55 except that genes are ordered alphabetically. 
5.2.2.3 Examining candidates significantly differentially regulated after methods to 
control for multiple testing were applied. 
A small number of genes were identified as significantly differentially regulated in the 
combined data set after controlling for multiple testing using the FDR method. In a list of 
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genes identified as differentially regulated under FDR criteria, it would be expected that a 
known number of genes are false positives (Cui and Churchill, 2003). 32 down-regulated 
genes were significant using the FDR method (p<0.05) (Table 59). 18 of these genes had 
a clear published NC or otic vesicle expression pattern on ZFIN or were validated during 
the in situ hybridization screen. 26 of the 32 genes were examined during the in situ 
hybridization screen, identifying 15 NC or otic vesicle expressed genes and 11 false 
positives (11/26 = 42 %). The false positive percentage is considerably higher than the 
expected 5 % rate (at p<0.05 significance level). This left 6 genes that had not been 
examined during the in situ hybridization screen and did not have a clear expression 
pattern on ZFIN. These genes present attractive targets for validation although it should 
be noted that s100b present in this list of genes could not be amplified by PCR from 24 
hpf cDNA. 
For the up-regulated genes significant after applying the FDR method (p<0.05), 7 
genes were identified. Of these, 6 had a clear expression pattern on ZFIN, 3 of which 
were also examined during the in situ hybridization screen. None of these genes had a 
NC or otic vesicle expression pattern. Thus all genes examined by in situ hybridization 
were false positives. One gene had no clear expression pattern on ZFIN but was 
examined during the in situ hybridization screen but was not validated. Thus this list of up-
regulated target genes contains no obvious candidates to prioritise for validation. 
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Affymetrix ID Gene Symbol FDR ZFIN Expression Pattern ISH Screen 
Dr.3933.1.A1_at wu:fc46b01 0.0028 No expression pattern Yes 
Dr.25257.1.A1_at bhlhb3l 0.0028 No expression pattern Yes 
Dr.2855.1.A1_a_at atp6v1a 0.0034 No expression pattern Yes, NC 
Dr.10292.1.S1_at rpb4l 0.0036 Yes, NC Yes, NC 
Dr.3972.1.S1_at 0.0036 Yes, NC 
Dr.8594.1.S1_at zgc:100919 0.0051 Yes, NC Yes, NC 
Dr.13919.1.S1_at 0.0100 Yes 
Dr.4612.1.A1_at wu:fc31e04 0.0111 No expression pattern Yes, NC 
Dr.518.1.A1_at sb:cb319 0.0122 Yes Yes 
Dr.18194.1.A1_at pik3c3 0.0125 Yes, not spatially restricted Yes 
Dr.7966.1.S1_at atp6v1e1 0.0125 No expression pattern Yes, NC 
Dr.12107.1.A1_at ndrg1 0.0153 Yes, OV Yes 
Dr.4171.1.A1_at pah 0.0174 Yes, NC Yes, NC 
Dr.4751.1.S1_a_at aldh2b 0.0174 Yes, NC Yes, NC 
Dr.6142.1.A1_at si:dkey-180p18.9 0.0174 Yes, not spatially restricted 
Dr.14747.1.A1_at slc2a15b 0.0174 Yes, not spatially restricted Yes, NC 
Dr.10624.2.S1_a_at zgc:110343 0.0244 Yes, NC Yes, NC 
Dr.983.1.S1_at paics 0.0244 Yes, NC Yes, NC 
Dr.8251.1.A1_at wu:fi05a09 0.0244 Yes, NC Yes 
Dr.17577.1.A1_at 0.0244 
Dr.370.1.S1_at atp6v1g1 0.0251 Yes 
Dr.481.1.S1_at atic 0.0251 Yes, NC Yes, NC 
Dr.16789.1.A1_at 0.0251 Yes 
Dr.20896.1.S1_at slc2a15b 0.0262 Yes, not spatially restricted Yes, NC 
Dr.10336.1.S1_at dct 0.0281 Yes, NC Yes, NC 
Dr.25465.1.A1_at si:dkey-15j16.2 0.0301 Yes, not spatially restricted 
Dr.17743.1.A1_at zgc:66482 0.0301 Yes, OV Yes 
Dr.2729.1.A1_at wu:fc54b10 0.0344 No expression pattern Yes 
Dr.14787.1.A1_at s100b 0.0344 
Dr.4751.2.A1_at aldh2b 0.0410 Yes, NC Yes, NC 
Dr.26522.1.A1_at 0.0410 
Dr.26101.1.A1_at 0.0434 Yes 
Table 59: Table of probe sets significantly down-regulated after controlling for 
multiple testing. 
The Affymetrix probe set identifiers significant by FDR were annotated using the NetAffx 
website. Gene symbols were used to interrogate the ZFIN website for published 
expression patterns. Data is presented as per Table 55 except genes are ranked by FDR 
adjusted p-value. 
Affymetrix ID Gene Symbol FDR ZFIN Expression Pattern ISH Screen 
Dr.13165.1.A1_at npr3 0.0034 Yes Yes 
Dr.6063.1.A1_at si:dkey-73n10.1 0.0054 No expression pattern Yes 
Dr.2967.1.A1_at hoxc8a 0.0088 Yes Yes 
Dr.10405.1.S1_at ca2 0.0174 Yes 
Dr.25673.2.S1_at cdc25 0.0251 Yes 
Dr.14522.1.S1_at pvalb7 0.0251 Yes Yes 
Dr.26450.1.S1_at vegfc 0.0410 Yes 
Table 60: Table of probe sets significantly up-regulated after controlling for multiple 
testing. 
The Affymetrix probe set identifiers significant by FDR were annotated using the NetAffx 
website. Gene symbols were used to interrogate the ZFIN website for published 
expression patterns. Data is presented as per Table 55 except genes are ranked by FDR 
adjusted p-value. 
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5.2.2.4 Comparing the methods used to identify high priority genes for validation. 
The results from the three methods utilised in this section to generate lists of genes are 
summarised in Table 61. This table includes the same results for the blind in situ screen 
performed on the 7.2sox10GFP t-Test data for comparison. In addition, the same data 
was gathered for the 7.2+4.9 combined data set. From these methods, the number of 
probe sets that were assessed during the in situ hybridization screen as true positives (NC 
or otic vesicle expressed and differentially regulated in sox10 mutant embryos) or false 
positives are given. This provides an indication of how an in situ hybridization screen 
might perform on the whole gene list. This data has also been combined with that of 
published expression patterns on the ZFIN website to indicate the total number of likely 
positive results that are present in a gene list. This also enabled the number of genes that 
lack any published expression data to be determined as these candidates would be 
targeted to yield novel NC and otic vesicle expressed genes when examined by in situ 
hybridization. 
For the down-regulated gene lists, all three methods appeared to identify a higher 
proportion of positive hits than were identified during the blind in situ hybridization screen 
and a smaller proportion of false positives were also identified (Table 61). Thus further 
investigation of the genes identified by these methods may be more valuable than 
continuing a blind screen on the 7.2sox10:GFP data set. Alternatively performing a blind 
screen on the combined data set (focusing on the most down-regulated genes not 
investigated in Chapter 4) is likely to reavel more genes of interest. For two of these 
analyses, fold change and FDR, the combined data set was examined rather than the 
7.2sox10:GFP which was the basis for the blind in situ hybridization screen. This may 
account for some of the differences detected in positive and false positive hit rates. A 
number of poorly characterised probe sets (only annotated with an Affymetrix identifier) 
have not been investigated in the data sets summarised in Table 61. When these probe 
sets were examined by in situ hybridization they typically had no clear or specific gene 
expression pattern (false positive) thus the hit rates predicted in Table 61 are likely to be 
slightly high. However it should also be noted that some poorly characterised probe sets, 
such as Dr.3972.1.S1_at, were expressed in the NC and validated as down-regulated in 
sox10 mutant embryos. Based on the results presented in Table 61, the method that 
produced the best true positive hit rate and the lowest false positive hit rate was the 
comparison of down-regulated genes in the two independent microarray data sets. This 
appears to be the gene list that should be prioritised for validation. For many studies a 
comparison of two different but similar sets of data will not be possible. Controlling for 
multiple testing (by the FDR method) also generated a list of genes that contained many 
true positives and a reduced number of false positives compared to the screen performed 
in Chapter 4. Thus this method could also be used to select genes for validation from 
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microarray data. While cross-referencing the in situ hybridization screen data with 
expression patterns on the ZFIN website it was noticed that 3 genes had an expression 
pattern of interest on ZFIN but were not validated during the screen. The published otic 
vesicle expression of ndrg1 and zgc:66482 and the NC expression pattern of zgc:112072 
were not detected. These genes should be re-evaluated to confirm the in situ hybridization 
screen result. 
For the up-regulated gene lists, neither of the two otic vesicle expressed genes 
validated during the in situ hybridization screen were identified by the three methods. The 
lack of known up-regulated markers on the Affymetrix microarray chip makes analysis of 
the information presented in this chapter difficult and no gene list can be prioritised for 
validation. However, several genes known to be NC or otic vesicle were highlighted during 
these analyses. To increase the range of known up-regulated marker genes available, 
these known genes should be prioritised for examination by in situ hybridization. This 
could facilitate the interpretation of the up-regulated data sets which has proved 
problematic at all stages of this project thus far. 
During the in situ hybridization screen only five ear expressed genes were 
identified and validated as differentially regulated from the genes examined. Very few 
known otic vesicle expressed genes were identified by the various methods utilised here 
to sort microarray data. This was despite a ZFIN anatomy search for the term “otic 
vesicle” returning 520 expressed genes at the same time point that 130 genes are NC 
expressed. Thus the screen has, up to this point, not proved as successful at identifying 
otic vesicle expressed genes when compared to NC expressed genes. 
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Method 
Number of 
ISH 
positives 
Number of 
ISH 
false 
positives 
Number of 
known NC 
or otic vesicle 
expressed 
genes 
Number of genes 
lacking a clear 
expression pattern 
Down-
regulated 
genes 
7.2 data set 
t-test 
28/92 
(30.4 %) 
64/92 
(69.6 %) 
31/92 
(33.7 %) -
Fold Change 13/30 (43.3 %) 
17/30 
(56.7 %) 
20/37 
(54.1 %) 18 
Identified in 
two 
independent 
data sets 
19/30 
(63.3 %) 
11/30 
(36. 7 %) 
31/46 
(67.4 %) 
40 (+ 3 possible 
NC 
expressed genes) 
FDR 15/26 (57.7 %) 
11/26 
(42.3 %) 
18/27 
(66.7 %) 5 
7.2+4.9 
Combined 
data set 
17/30 
(56.7 %) 
13/30 
(43.3 %) 
33/100 
(33.3 %) 47 
7.2 data set 
t-test 
2/47 
(4.3 %) 
45/47 
(95.7 %) 
2/47 
(4.3 %) -
Fold Change 0/4 (0 %) 
4/4 
(100 %) 
2/13 
(15.4 %) 10 
Up-
regulated 
genes 
Identified in 
two 
independent 
data sets 
0/9 
(0 %) 
9/9 
(100 %) 
6/26 
(23.1 %) 25 
FDR 0/4 (0 %) 
4/4 
(100 %) 
0/7 
(0 %) 0 
7.2+4.9 
Combined 
data set 
0/9 
(0 %) 
9/9 
(100 %) 
6/50 
(12 %) 34 
Table 61: Summary of the methods employed to identify genes for validation. 
Results from the three methods described in this section and the t-Test used to select 
genes for in situ hybridization validation in Chapter 4 are shown. From the probe sets 
identified by each method, the numbers of probe sets assessed by in situ hybridization in 
Chapter 4 are split into positive and negative (false positive) results. This data was 
combined with published ZFIN data to identify the number of probe sets identified by each 
method that are NC or otic vesicle expressed. The number of probe sets that were not 
assessed during the in situ hybridization screen and do not have a clear published 
expression pattern are also given. 
5.2.3 Identifying interesting genes from microarray data by function. 
5.2.3.1 Identifying Genes of interest by GO Term using Babelomics. 
To highlight genes with a function of interest identified as differentially regulated in the 
combined 7.2+4.9 microarray data set, the Babelomics FatiGO tool was used. A list of all 
significantly (t-Test p-value <0.05) down or up-regulated genes was loaded into the tool 
for analysis of GO biological process and molecular function terms. The genes 
represented by a GO term of interest were then evaluated. 
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5.2.3.1.1 Transcription Factors 
A key aim of this microarray project was to identify Sox10 dependent transcription factors 
that play important roles in NC development. All of the genes identified as down-regulated 
in the combined data set were sorted by GO term using Babelomics. Of the 640 down-
regulated genes, 190 were annotated with a molecular function GO term. Two level 5 GO 
terms appeared to be likely candidates to facilitate identifying transcription factor genes. 7 
genes were annotated by the GO term “Transcription factor activity” (GO:0003700), esr1, 
foxd3, mtx1, poll, rorab, runx2b and wu:fa05a04 (Table 62). All of these genes except 
runx2b were also annotated by the level 5 GO term “Sequence specific DNA binding” 
(GO:0043565). A parent (level 4) GO term) of both of these terms, “DNA binding” 
(GO:0003677), was associated with 19 genes including all the genes identified as 
potential transcription factor genes so far (Table 62). A number of genes at this annotation 
level were not transcription factors, for example, paics is an enzyme involved in purine 
biosynthesis (Li et al., 2007). Thus the level 4 GO term covers a very broad range of 
genes, not simply transcription factors. The level 5 GO term “Transcription factor activity” 
identified a number of transcription factor genes including foxd3. The majority of these 
genes had a published expression pattern and did not display NC or otic vesicle 
expression. However, the gene wu:fa05a04 had no expression pattern and is therefore a 
candidate for validation. By adopting a more specific GO term, some genes which were 
not transcription factors were excluded but some genes such as the two basic helix-loop­
helix domain containing genes (bhlhb2 and bhlhb3l) were excluded. The helix-loop-helix 
domain is a DNA binding domain found in proteins that function as transcription factors, 
including the melanocyte transcription factor Mitf (Hodgkinson et al., 1993). Thus bhlhb2 
and bhlhb3l are likely to function as transcription factors. Depending on which level of GO 
term was selected for analysis, some non-transcription factor genes were selected or with 
a more specific GO term some likely transcription factor genes were excluded. 
The key melanocyte transcription factor mitfa was surprisingly not annotated by 
the GO Terms examined so far. Thus to facilitate identifying potential transcription factor 
genes, the GO terms associated with mitfa were identified using Babelomics. The GO 
terms that appeared to be linked to the function of mitfa as a transcription factor were as 
follows: GO Molecular function level 5 “Transcriptional activator activity” (GO:0016563), 
GO Biological process level 5 “Transcription” (GO:0006350), GO biological process level 
7 “Transcription, DNA-dependent” (GO:0006351) and “Regulation of transcription” 
(GO:0045449). The combined down-regulated Babelomics data was examined for these 
GO terms (Table 63). Along with the key melanocyte transcription factor mitfa, the NC 
transcription factor foxd3 was also annotated with all of these GO terms. The other gene 
annotated with all of these GO terms was wu:fa05a04, which was also identified 
previously (Table 62 and Table 63). This again suggests that this gene represents an 
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interesting candidate for validation. As with the GO term analysis presented in Table 62, 
some genes annotated with a GO term of interest are not transcription factors. For 
example, from the 20 genes presented in Table 63, polr3f and polr2c both encode 
subunits of RNA polymerase. Manual selection of transcription factors from these 
generated gene lists would therefore be required to address the specific aim of identifying 
transcription factors for validation. 
Affymetrix ID Gene Symbol 
DNA 
Binding 
Transcription 
Factor 
Activity 
Sequence 
Specific 
DNA 
Binding 
NC or otic 
vesicle 
expressed 
ISH 
Result 
Dr.10717.1.S1_at esr1    No 
Dr.17137.1.S1_at rorab    No 
Dr.20.1.S1_at snai2  Yes, NC 
Dr.21045.1.S1_at rabgef1  
Not 
spatially 
restricted 
Dr.24983.1.S1_at polr3f  
Not 
spatially 
restricted 
Dr.25257.1.A1_at bhlhb3l  No 
Dr.2654.3.S1_a_at rfx2  No 
Dr.3180.1.A1_at bhlhb2  Yes, early NC No 
Dr.462.1.A1_at wu:fa05a04    
Dr.5094.2.A1_at  
Dr.5418.2.S1_at top2a  
Dr.5740.1.S1_at neurod2  
Dr.590.1.S1_at foxd3    Yes, NC Yes, NC 
Dr.6031.2.A1_at poll    
Not 
spatially 
restricted 
Dr.7734.1.S1_a_at mcm3l  
Not 
spatially 
restricted 
Dr.8324.1.S1_at mxtx1    No 
Dr.9758.1.S1_at polr2c  
Not 
spatially 
restricted 
Dr.983.1.S1_at paics  Yes, NC Yes, NC 
DrAffx.2.6.S1_s_at runx2b   No 
Table 62: Summary of potential transcription factor genes as identified by GO Term. 
All genes identified with appropriate GO Terms relating to possible transcription factor 
activity are listed. Where genes have a published expression pattern on ZFIN this has 
been noted, blank cells indicate that no pattern was available. If a gene was examined 
during the in situ hybridization screen this has been noted (No = not validated, Yes = 
validated). NC = neural crest expression was observed. 
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Probe Set ID 
Gene 
Symbol 
Tran­
scription 
Regulation 
of 
Tran­
scription 
Tran­
scription, 
DNA-
dependent 
Tran­
scriptional 
Activator 
NC or 
otic vesicle 
expressed 
ISH 
Result 
Dr.10717.1.S1_at esr1    No 
Dr.12260.1.A1_at rab7    Yes, NC 
Dr.14855.1.S1_a_at rab35    
Dr.17137.1.S1_at rorab    No 
Dr.20.1.S1_at snai2    Yes, NC 
Dr.24248.1.S1_at jmjd2al    
Dr.24983.1.S1_at polr3f    
Not spatially 
restricted 
Dr.25257.1.A1_at bhlhb3l    No 
Dr.2654.3.S1_a_at rfx2    No 
Dr.3148.2.A1_at   
Dr.3180.1.A1_at bhlhb2    Yes, early NC No 
Dr.462.1.A1_at wu:fa05a04     
Dr.4874.1.S1_at rab1a    
Not spatially 
restricted 
Dr.5094.2.A1_at    
Dr.5740.1.S1_at neurod2    
Dr.590.1.S1_at foxd3     Yes, NC Yes, NC 
Dr.8080.1.S1_at mitfa     Yes, NC Yes, NC 
Dr.8324.1.S1_at mxtx1    No 
Dr.9758.1.S1_at polr2c    
Not spatially 
restricted 
DrAffx.2.6.S1_s_at runx2b    No 
Table 63: Summary of potential transcription factor genes identified by GO Term. 
All genes identified with appropriate GO Terms relating to possible transcription factor 
activity are listed. Where genes have a published expression pattern on ZFIN this has 
been noted, blank cells indicate that no pattern was available. If a gene was examined 
during the in situ hybridization screen this has been noted (No = not validated, Yes = 
validated). NC = neural crest expression was observed. 
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5.3 Discussion 
5.3.1 Discussion on which data set presents the best list of genes for future 
validation. 
The microarray analysis results for genes known to be down-regulated in the NC of sox10 
mutant embryos identified from the in situ hybridization screen were compared across the 
three microarray data sets. This showed that the 4.9sox10:GFP data set often failed to 
correctly identify known down-regulated genes, this data set therefore generated a 
number of false negatives. As this screen has aimed to be inclusive to identify as many 
genes of interest as possible, false negatives are not desirable. The combined data set 
identified most of the known down-regulated NC expressed genes that were validated 
during the in situ hybridization screen (Table 47). In order to compare these data sets 
while not relying on genes picked from the 7.2sox10:GFP data set, the results for a 
number of key NC marker genes were compared across all three data sets (Table 48). 
Again the 4.9sox10:GFP data set performed worst, the 7.2sox10:GFP data set identified 
6/11 probe sets as down-regulated while the combined data set identified all genes as 
down-regulated. This suggested that the combined data identified down-regulated genes 
most efficiently with the lowest rate of false negative results. This conclusion is based on a 
limited number of NC expressed genes, not all of which are known to be down-regulated 
in sox10 mutant embryos but based on the timing of expression would be expected to be 
Sox10 dependent. To determine comprehensively the best data set to use when selecting 
interesting genes for future validation the 100 most down-regulated genes in the 
4.9sox10:GFP and combined data sets would need to be examined by in situ 
hybridization. Then the performance of the three data sets could be accurately compared. 
This would require a significant extension of the in situ hybridization screening project to 
examine a large number of genes not yet assessed. This approach would be likely to 
identify a number of novel NC and otic vesicle expressed genes that were not examined 
during the in situ hybridization screen to date. Despite this, the strong performance of the 
combined data set in all the above tests suggests that this data set is the most reliable. 
The combined data set is the data set that should be used to address if specific genes, 
gene families or genes with specific functions of interest, for example transcription factors, 
are likely to be differentially regulated in sox10 mutant embryos. 
It was expected that differentially regulated NC genes would be detected in all 
three data sets as NCCs are labelled equally with GFP in the 7.2sox10:GFP and 
4.9sox10:GFP transgenic lines. The identification of otic vesicle genes was expected to be 
less effective in the 4.9sox10:GFP data set because the otic epithelium is only weakly 
labelled with GFP in this line, and also therefore, to some extent in the combined data set, 
than the 7.2sox10:GFP data set. Comparing the otic vesicle expressed genes identified 
during the in situ hybridization screen across all three microarray data sets suggested that 
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this was true. Only a few of the otic vesicle expressed genes validated from the 
7.2sox10:GFP data set were also identified as differentially regulated in the other two data 
sets. Genes known to be up-regulated in the otic vesicle of sox10 mutant embryos were 
also examined (Dutton et al., 2009). All three data sets failed to identify the majority of 
these genes as up-regulated. This result suggested that otic vesicle expressed genes that 
are differentially regulated in sox10 mutants were not readily or consistently designated as 
such in any of the data sets. In contrast to this, a number of genes were validated during 
the in situ hybridization screen, thus otic vesicle expressed genes could be identified from 
the 7.2sox10:GFP data set. Otic vesicle expressed genes tend to only show small 
differences in gene expression between WT and sox10 mutant embryos by in situ 
hybridization (Dutton et al., 2009). As a result, otic vesicle expressed genes may still be 
detected as differentially expressed by microarray analysis but perhaps not within the 
statistically most differentially regulated genes. Alongside this, the paucity of otic vesicle 
markers known to be differentially regulated in sox10 mutants made it difficult to compare 
data sets and form a conclusion. Thus it was not clear which data set provided the best 
source to select otic vesicle expressed genes for validation. The original rationale for 
performing microarray analysis on the two transgenic lines was that genes differentially 
regulated in the 7.2sox10:GFP data set would include NC and otic vesicle expressed 
genes while the 4.9sox10:GFP data set would only include NC expressed genes. Thus 
subtracting the genes differentially regulated in the 4.9sox10:GFP data set from the 
7.2sox10:GFP data set would reveal otic epithelium expressed genes. In reality, the high 
rate of false positives identified as differentially regulated in the 7.2sox10:GFP data set 
and therefore probably also in the 4.9sox10:GFP data set rendered this impossible. 
5.3.2 Regarding the use of published expression data. 
A large amount of gene expression data is available to zebrafish researchers on the ZFIN 
website from both published papers and directly submitted data, chiefly from a large scale 
gene expression screen by Thisse et al., 2004. Such data, when available, can indicate if 
a gene identified by microarray analysis is expressed in the tissue or cell type of interest. 
Previous work has used this resource to validate candidates identified from microarray 
data (Cerda et al., 2009). This cannot show if gene expression in the tissue or cell type of 
interest shown in a WT embryo is altered in a mutant embryo. Thus for this project 
published data can only indicate if a gene is likely to be of interest; in situ hybridization 
would still be required to validate a gene. However, all genes identified as NC or otic 
vesicle expressed during the in situ hybridization screen were validated as differentially 
expressed (Chapter 4). As no up-regulated NC expressed genes were identified, it 
remains to be seen if up-regulated NC expressed genes are always up-regulated in sox10 
mutant embryos. However, it was deemed very likely during this chapter that all NC and 
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otic vesicle expressed genes at 24 hpf identified as differentially regulated by microarray 
analysis were differentially regulated in sox10 mutant embryos. 
The Thisse et el. expression pattern screens form a very useful collection as they 
typically show images of whole embryos over a range of embryonic stages so that 
expression or lack of expression in cells or tissues of interest can be observed. In addition 
sites of expression are usually annotated for clarity. In rare circumstances, an expression 
pattern that appears to be consistent with NC expression has not been annotated. Thus 
visual examination of the patterns online is preferable to relying on annotation. 
Occasionally the Thisse et el. expression pattern is not clear, often annotated as not 
spatially restricted or a similar term. This may refer to a gene ubiquitously expressed in 
the whole embryo. During the in situ hybridization screen one such gene was examined 
and NC expression was identified. Thus while these genes may in fact be ubiquitously 
expressed, on rare occasions a specific expression pattern that differs from the published 
pattern can be obtained. When no Thisse et el. pattern is available, but expression 
patterns have been published, focus is on the tissue or cell type of interest. It is therefore 
difficult to determine if the gene is also expressed elsewhere in the embryo. The published 
data may also not cover the embryonic stage of interest. Unless published data explicitly 
stated that genes were expressed or not expressed in the NC or otic vesicle at 
approximately 24 hpf then it was assumed this had not been assessed. Thus Thisse et el. 
patterns were the most useful source of expression pattern data. Therefore a researcher 
could use published data to refine and prioritise a list of genes identified by microarray 
analysis. Genes with a well defined expression pattern in the tissue of interest would be 
selected for validation while those with a clear pattern that does not display expression in 
the tissue of interest would be the lowest priority for validation. Genes with no known 
published expression pattern would also be prioritised as this could lead to the validation 
of genes not previously associated with the biological process under investigation. Genes 
with a published but unclear expression pattern would form a group prioritised behind 
those genes without an expression pattern. This use of published data would enable a 
researcher to focus their resources in the validation of microarray data. 
5.3.3 Examining the methods applied to refine the number of candidates generated 
from microarray data 
The simplest measure used to rank microarray data is fold change (Cui and Churchill, 
2003). Fold change is a measure of the change in the expression level of a gene between 
experimental samples. Thus in this project, genes with a large fold change should show a 
clear difference in expression patterns between WT and mutant embryos. To identify 
genes as differentially regulated or not, an arbitrary fold change cut off is selected. As no 
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statistical test is performed to generate fold change results, genes have no associated 
value that can indicate a level of confidence in the designation of differentially regulated or 
not differentially regulated (Cui and Churchill, 2003). For this chapter, a cut off of a twofold 
difference was selected without any prior examination of the data. A different cut off could 
be selected after examining the data for the performance of marker genes known to be 
differentially regulated or to include an appropriate number of genes for validation. Thus 
this method of ranking genes can be adapted to suit the data and the needs of the 
investigator. A large number of down-regulated NC and otic vesicle expressed genes 
were designated as differentially regulated using fold change (Table 55 and Table 56). 
Thirty of these genes were assessed during the in situ hybridization screen and 13 were 
validated. This represented a higher hit rate than was achieved during the blind in situ 
hybridization screen in Chapter 4. However the entire list of genes identified by fold 
change would need to be examined to verify this. Only one of the validated differentially 
regulated otic vesicle expressed genes, cldnj, was identified by fold change thus the 
majority of genes with the largest fold changes were NC expressed. This suggested that 
this method may preferentially identify NC expressed genes. Otic vesicle expressed 
genes tend to only show small differences in gene expression between WT and sox10 
mutant embryos by in situ hybridization (Dutton et al., 2009). Therefore these genes would 
have small fold changes. Although it should be noted that all analysis methods identified a 
greater number of NC expressed genes than otic vesicle expressed genes. There were 
still a large number of false positive genes identified after ranking by fold change. That so 
many genes (30/55) identified by fold change as down-regulated were assessed in the 
100 most down-regulated genes during the validation screen suggest that similar genes 
were identified by both methods. In contrast to the down-regulated genes, very few of the 
up-regulated genes identified by fold change were examined during the in situ 
hybridization screen. This suggests that very different results were obtained using fold 
change compared to the t-Test to rank genes. It should be noted that fold change was 
used to rank the combined data set but it was compared to the t-Test applied to rank the 
7.2sox10:GFP data set and this may account for some of the differences. 
As two separate transgenic lines were evaluated under the same experimental 
conditions, two independent sets of microarray data were available for comparison. Genes 
that were designated as differentially regulated in both data sets were examined (Table 
57 and Table 58). A large number of genes known to be NC or otic vesicle expressed and 
or validated as down-regulated during the in situ hybridization screen were identified by 
this method. In comparison to the other methods employed, this gene list had the highest 
true positive hit rate and the lowest false positive hit rate as far as could be determined. 
False positive genes have been designated as differentially regulated by chance and 
would therefore not be expected to appear in both data sets. Thus the genes identified by 
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this method represent attractive targets for future examination by in situ hybridization. A 
down side to this method is that a number of genes validated during the in situ 
hybridization screen were not designated as down-regulated in the 4.9sox10:GFP data 
set. Thus this comparison method will exclude a number of genes that are known to be 
differentially regulated in sox10 mutant embryos. This method will only be as reliable as 
the least reliable data set. To overcome this, the number of arrays hybridized with RNA 
from each transgenic line could be increased. By increasing array number the number of 
data points for each probe set is increased thereby improving the reliability of any 
statistical test performed on each probe set. Identifying genes identified as differentially 
regulated in two independent data sets would then potentially be a very effective way to 
eliminate false positive results. 
During the analysis of microarray data the chosen statistical test is carried out on 
each gene, leading to thousands of tests being performed. During this process it is likely 
that a large number of false positives will accumulate (Cui and Churchill, 2003). To 
address this problem, methods to control for multiple testing can be applied. There are 
two commonly used methods FWER and FDR. FWER criteria are very strict and designed 
to eliminate false positive results (Cui and Churchill, 2003). This can result in the 
exclusion of truly differentially regulated genes; the power of the test is reduced. During 
the process of a microarray screen a proportion of false positives may be accepted to 
ensure that a large number of differentially regulated genes can be detected. The FDR or 
false discovery rate is the proportion of false positives amongst all the genes initially 
identified as differentially regulated (Cui and Churchill, 2003). The FDR provides a 
measure of the proportion of false positives that are likely to be present in a data set. As 
such the FDR method of controlling for multiple testing may be more appropriate. By 
allowing for a higher rate of false positives to occur this is a more inclusive test that can 
achieve more power than the FWER method and therefore designate more genes as 
differentially regulated. The FDR method was applied to the combined data set and the 
genes detected as differentially regulated were examined (Table 59 and Table 60). 32 
genes were designated as down-regulated at p<0.05 (5 % of genes are predicted to be 
false positives). Of these genes, 26 had been assessed during the in situ hybridization 
screen and 15 showed NC or otic vesicle expression. Thus 11/26 genes were false 
positives (42 %) which was considerably higher than expected. Thus while this method 
when applied to the combined data set increased the positive hit rate and reduced the 
false positive hit rate obtained during the 7.2sox10:GFP validation screen, this method 
was not as successful as expected. It is unclear why the false positive hit rate was much 
higher than 5 %, but multiple testing correction methods only identified differentially 
regulated genes in the combined data set. When FDR methods were applied to the two 
independent data sets, no genes were identified as differentially regulated (see Chapter 
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3). Thus an increase in sample size may improve the results of such methods. It may be 
that this result also highlights the gap between the theoretical result of a statistical test 
and the actual performance of a test when applied to biological data evaluated by 
experimental techniques. It should be noted that a large number of biologically relevant 
results were obtained by screening the 7.2sox10:GFP data set in which no genes were 
designated as differentially regulated after controlling for multiple testing. Thus while 
correcting for multiple testing is the accepted best practise (Cui and Churchill, 2003) in 
analysing microarray data, successful results can be generated when these controls are 
not applied. 
While no method of ranking genes applied during this project could eliminate false 
positives, all methods did identify a large number of validated genes. Thus all methods 
could have been used to select a number of genes for a successful in situ hybridization 
screen. The method chosen and its implementation would depend on the nature of the 
subsequent in situ hybridization validation screen. If the investigator has access to a 
cDNA library and perhaps an automated in situ hybridization machine then a high through 
put screen is possible. The investigator could then select a large number of genes for 
validation by relaxing arbitrary criteria for selecting a method that identifies a large number 
of genes as differentially regulated. This would be done with the aim of validating the 
greatest number of novel targets and known targets possible. Similarly, if targets were to 
be validated through a PCR approach then a greater number of genes could be 
investigated. An investigator lacking access to these resources might consider reducing 
the number of genes requiring validation using published data, all genes with a clear 
expression pattern lacking expression in the cell type or tissue of interest could be 
excluded from the in situ hybridization screen. 
Published studies that perform a microarray based screen do not publish data 
comparing different methods of identifying or ranking differentially regulated genes. 
Perhaps because groups that perform these experiments and validate the biological 
relevance of the microarray data are not experts in the mechanics of different statistical 
tests. Equally, when different statistical tests are compared on published data sets by 
experts in microarray analysis, for example the t-Test and the CLEAR test (Valls et al., 
2008), the biological relevance of the different results obtained by each method are not 
investigated. Thus while according to statistical measures the CLEAR test may perform 
best in identifying supposed differentially regulated genes, no validation of this is 
performed via methods such as QRT-PCR or in situ hybridization. To some extent this 
chapter has attempted to assess the effects of different methods that can be applied to 
identify differentially regulated genes by combining in situ hybridization data from this 
project and published data on ZFIN. However, such an approach cannot allow fair 
comparisons to be made as well annotated and characterised genes are always 
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preferentially represented in the published literature while poorly annotated genes 
investigated during a blind in situ hybridization screen often display unclear expression 
patterns. As such the chief focus of this chapter was not to compare different methods but 
to use them to draw out key genes of interest for future validation. 
5.3.4 Selecting Genes by Function. 
An aim of microarray expression studies can be to understand the biological functions that 
are altered between experimental conditions to gain a global view of the biological 
processes or pathways that are differentially regulated (Al-Shahrour et al., 2008). The web 
based tool Babelomics can, for example, evaluate if certain GO terms are significantly 
enriched in the genes identified as up or down-regulated when compared to genes whose 
expression level is not significantly changed. This could indicate if genes that play a role 
in, for example, apoptosis or cell division are enriched amongst the differentially regulated 
genes. This type of analysis could be misleading when a large number of genes 
designated as differentially regulated are false positives. For this reason, this type of 
analysis performed on the microarray data sets generated during this project was not 
presented here. It should be noted that this analysis did highlight the large number of 
vATPase and IMP biosynthesis pathway genes that were identified as differentially 
regulated, something that was also shown during the in situ hybridization screen. 
To identify genes by function, all up or down-regulated genes were categorised by 
GO term; GO biological process and GO molecular function terms were examined. From 
these identified GO terms, terms likely to contain transcription factor genes were selected. 
It proved difficult to select a GO term that covered all transcription factor genes. For 
example, the GO Term “Transcription factor activity” represented a number of 
transcription factors but not the key melanocyte transcription factor mitfa. Thus the 
selection of genes by this method is dependent on accurate annotation. This was 
complicated by having two or more similar GO terms at the same level that, for example 
GO molecular function level 5 “Transcription factor activity” and “Transcriptional activator”. 
These two terms covered slightly different sets of genes. GO terms are organised into 
levels with more specific functional information at higher numbered levels and more 
general GO terms contained in the lower levels. Thus there is a balance between 
selecting a very general GO term that includes all transcription factors and a large number 
of genes that are not transcription factors and selecting a more specific GO term that 
actually excludes some transcription factors. In addition more specific GO terms are only 
applied to well characterised genes so some genes of interest are excluded by examining 
a more specific GO term. Indeed a large number of the differentially regulated genes had 
no associated GO term. Therefore GO term analysis will favour genes that are well 
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characterised. All of these factors made GO term analyses very difficult to apply and then 
interpret, even without considering that a number of the identified genes were likely to be 
false positives. Therefore even when trying to address a very specific biological question 
by examining transcription factors, GO term analyses proved, in this case, to not be very 
informative. However other types of types of target could be investigated through GO 
terms, for example genes with “receptor activity” GO term: GO:0004872. Other strategies 
could be considered for the functional analysis of microarray data. Genes of interest could 
be selected manually based on name, gene family, a literature search or functional 
annotation. Such manual strategies would be time consuming but would enable the 
investigator to make informed choices. Essentially, all these methods could be used to 
interrogate existing microarray data to address a specific biological question of interest 
with the best approach likely to vary from case to case. 
5.3.5 Interesting candidates for future validation 
While all the validation of all the genes highlighted during this chapter is of interest, those 
genes that have been shown to be NC and otic vesicle expressed are of particular 
interest. The work presented in this chapter has also highlighted some additional genes 
that have no clear published expression pattern that are also of interest and should be 
prioritised for validation; these genes are summarised in Table 64. For the down-
regulated genes, bhlhb3l is of interest as this gene was identified as differentially 
regulated by all three different methods applied in this chapter, in addition this gene is a 
TF. Bhlhb3l expression was assessed during the in situ hybridization screen and had no 
clear expression pattern but the results presented here suggest this gene is worth 
revisiting. Two other genes are of interest as they were identified as differentially 
regulated by two methods, wu:fc64c05 and atp6v1g1. The wu:fc64c05 gene has no 
published expression pattern thus elucidating this is of interest. Atp6v1g1 along with 
atp6v1ba and slc3a2 are of interest as they display potential NC expression patterns on 
ZFIN, in addition similar genes to these were validated during the in situ hybridization 
screen. The bhlhb2 gene has been highlighted as this gene is not only a TF but is also NC 
expressed, according to ZFIN, albeit restricted to an earlier stage than was assessed by 
this microarray project. Bhlhb2 was examined during the in situ hybridization screen but 
may also be worth revisiting. 
For the up-regulated genes, all of the genes presented in Table 64 were 
highlighted as differentially regulated by at least one of the methods utilised during this 
chapter. The genes mpv17, meis3 and sema3d have all been highlighted as these genes 
have been annotated as NC expressed on ZFIN thus validating these genes may help to 
identify more NC expressed genes up-regulated in sox10 mutant embryos. The genes 
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syt4, vamp1 and zic2b are all expressed in the dorsal NT according to ZFIN and as such 
may be expressed in NCCs prior to delamination. The Zic family of genes are considered 
to be a constituent of the network of genes that specify early NCCs (Steventon et al., 
2005). The genes ngfr and si:dkey-73n10.1 were selected as these were highlighted by 
two of the methods used during this chapter and have no published expression pattern on 
ZFIN. In addition, ngfr was selected as according to the model of Sox10 function 
presented in Chapter 1, NC expressed receptors are strong candidates to be up-regulated 
in sox10 mutant embryos. 
In addition to the genes prioritised for validation that are presented in Table 64, a 
large number of NC and otic vesicle expressed genes that were not examined during the 
in situ hybridization screen have been highlighted in this chapter. These genes also 
represent strong candidates for future validation studies. 
Down-Regulated 
Affymetrix ID Gene Name Fold Change 
Differentially 
expressed in 
7.2 and 4.9 
data sets 
FDR p-value 
Dr.25257.1.A1_at bhlhb3l -8.42  0.0028 
Dr.2268.1.A1_at wu:fc64c05 -2.13  
Dr.5513.1.S1_at slc3a2  
Dr.186.1.S1_at atp6v1ba  
Dr.370.1.S1_at atp6v1g1  0.0251 
Dr.3180.1.A1_at bhlhb2 
Up-Regulated 
Affymetrix ID Gene Name Fold Change 
Differentially 
expressed in 
7.2 and 4.9 
data sets 
FDR p-value 
Dr.17843.1.A1_at mpv17 +3.14 
Dr.8061.1.S1_at sema3d +2.16 
Dr.1680.1.S1_at meis3  
Dr.13868.1.S1_at syt4 +2.04  
Dr.25500.1.S1_at vamp1  
Dr.10689.1.S1_at zic2b  
Dr.10488.1.A1_at ngfr +2.28  
Dr.6063.1.A1_at si:dkey-73n10.1  0.0054 
Table 64: Summary of genes to prioritise for validation. 
Genes in this table have been identified as priorities for validation by the methods applied 
during this chapter. 
5.3.6 Regarding the combined dataset 
The combined data set was generated in order to appreciate what effect an increase in 
array number would have on the experiment, particularly on the results of key differentially 
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regulated marker genes. This data set was unique in that genes were still designated as 
differentially regulated after controlling for multiple testing. This gave the first indication of 
a positive effect. Examining the p-values of a range of key NC marker genes across all 
three data sets also indicated that the combined data set performed the best at identifying 
these genes as differentially regulated (Table 48). The combined data set designated 
almost all of the NC expressed genes validated during the in situ hybridization as 
differentially regulated (Table 47). This held true for NC expressed genes but the 
performance of otic vesicle expressed genes in this data set was unclear due to the 
paucity of validated marker genes. 
Despite NC marker genes being consistently identified as differentially regulated in 
the combined data set, the question remained if this was a valid experimental data set. 
The data suggested that otic vesicle expressed genes were not reliably designated as 
differentially regulated in this data set. While the key marker gene otomp was down-
regulated in the combined data set, the strongly down-regulated gene cldnj was not 
identified as differentially regulated (Table 53). This was the consequence of combining 
two data sets in which this gene was designated as down-regulated in one and not 
significantly changed in the other. The unreliable designation of ear genes in the 
combined data set stems from combining data from two different transgenic lines that 
label the otic vesicle differently. The 7.2sox10:GFP line labels the otic vesicle cells 
strongly with GFP while the in 4.9sox10:GFP line the otic vesicle cells are weakly labelled 
with GFP. As such it was expected that otic vesicle expressed genes would not be 
identified as differentially regulated in the 4.9sox10:GFP samples because fewer otic 
vesicle cells would be sorted by FACS in these samples. The consequence of this would 
be an apparent reduction of otic vesicle gene expression in the 4.9sox10:GFP samples in 
comparison to the 7.2sox10:GFP samples. This variability across samples when the data 
sets were combined was likely to result in these genes not being identified as differentially 
regulated. The t-Test will not designate a gene as differentially regulated if it displays 
variability in gene expression across samples. Therefore it seemed the best data set to 
identify otic vesicle expressed genes in was the 7.2sox10:GFP data set. It has not been 
possible to examine enough otic vesicle markers to fully confirm this. However both 
transgenic lines label NCCs in an almost identical fashion (Carney, 2003, Carney et al., 
2006, Dutton et al., 2008). Therefore for NCCs both transgenic lines were effectively 
equivalent so combining data sets simply increases the number of replicates. This was 
supported by the results of the key NC marker genes in this data set. To back this up, the 
greatest number of ZFIN annotated NC expressed genes were identified as differentially 
regulated in the combined data set. Therefore, for NC expressed genes this data set 
provides the most reliable list of differentially regulated genes to interrogate with specific 
biological questions and to source genes for validation from. 
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Chapter 6: Final Discussion 
The initially multipotent cells of the neural crest produce a wide range of different 
derivatives that migrate to various locations within the developing embryo. Thus this cell 
population undergoes a number of key processes including cell specification, cell 
differentiation and the acquisition of migratory properties. These processes have been 
shown to fail in zebrafish sox10 mutant embryos as a result of the primary failure in non­
skeletogenic NCC specification (Dutton et al., 2001a). Thus the TF Sox10 directly or 
indirectly regulates a large number of cellular processes. The molecular players and 
correlates of these processes are poorly understood therefore this project was undertaken 
in an attempt to identify these genes. The rationale behind this experiment is that direct 
and indirect targets of Sox10 will show differential expression in sox10 mutant embryos 
compared to WT embryos. Thus a comparison of the transcriptome of WT and sox10 
mutant embryos would identify genes whose expression is enhanced by Sox10 function 
(down-regulated in mutant embryos) or inhibited by Sox10 function (up-regulated in 
mutant embryos). To specifically target the transcriptome of cells in which sox10 is 
expressed, sox10 expressing cells were enriched, by FACS, from sox10:GFP transgenic 
zebrafish embryos. This was performed on 24 hpf embryos as NC derivatives are 
undergoing specification, differentiation and migration at this developmental stage. The 
cell populations that express sox10 are the neural crest and the otic epithelium. Cells 
were enriched from both WT and sox10 mutant embryos and RNA purified from these 
cells was hybridized to Affymetrix zebrafish microarrays (by the UCI DNA and Protein 
Microarray Facility, CA, USA). By comparing WT and mutant RNA hybridized microarrays, 
genes that were differentially regulated were identified. Subsequently these candidates 
were examined by in situ hybridization to validate differential gene expression in the cell 
types of interest. 27 individual genes were identified and validated in this way. 
The in situ hybridization screen presented in Chapter 4 validated 23 NC and 3 otic 
vesicle expressed down-regulated genes and 2 up-regulated otic vesicle expressed 
genes. The majority of the NC genes were expressed in pigment cells, particularly the 
xanthophore and melanocyte lineages. This strongly suggests that at 24 hpf, NCCs are 
chiefly undergoing specification to the pigment cell lineages. Of these validated genes, 9 
had not previously been shown to be NC or otic vesicle expressed and 17 had no 
identified functional link to NC or otic vesicle biology. Thus this project has identified novel 
marker genes for NCC lineages, genes that previously had no functional association with 
NC or otic vesicle biology and marker genes known to play roles in NC and otic vesicle 
biology. This presents a number of opportunities to evaluate the function of these novel 
genes, chiefly through morpholino mediated gene knock down. Such functional studies 
could open new avenues of research for NC and otic vesicle biology. In particular, no 
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function for a connexin gene in early NCCs has been described yet, thus the function of 
cx33.8 in the NC is of great interest. 
Sox10 functions to specifiy non-skeletogenic NC derivatives, the failure of NCCs to 
differentiate, migrate and their subsequent apoptosis in sox10 mutant embryos are 
secondary defects (Dutton et al., 2001a). Despite the majority of genes having no known 
functional link to NC biology, it is important to consider how the validated genes identified 
are likely to fit into this model of Sox10 function. The only validated gene known to be 
involved in the specification of a specific cell lineage was mitfa, the melanocyte lineage 
master switch TF (Elworthy et al., 2003). Several of the known marker genes validated 
during the in situ hybridization screen are involved in the differentiation of NCC lineages, 
these include the TF Pax7 (Minchin and Hughes, 2008) and the enzymes Dct and Pah 
(Ludwig et al., 2004, Schallreuter et al., 2008). The TF Foxd3 is down-regulated in the glia 
of sox10 mutant embryos, but the role of Foxd3 in these cells may be to promote cell 
survival but this is unclear (Stewart et al., 2006). Despite the lack of functional information 
pertaining to the remaining genes, possible functions in the NC can be hypothesised 
based on the expression pattern of the gene and current published literature regarding 
their function in other cell types. The enzymes Atic, Paics and Adsl are all involved in the 
IMP biosynthesis pathway. It is likely this pathway supplies GTP as a substrate for 
xanthophore pigmentation therefore these enzymes are involved in differentiation. The v-
ATPase subunit genes may play a role in melanosome development and therefore 
melanocyte differentiation. The enzyme degs1 may be involved in cell migration or cell 
proliferation (Cadena et al., 1997, Zhou et al., 2009, García-López et al., 2005). The 
putative tetraspanin zgc:100919, coro1c and rbp4l may all be involved in cell migration 
(García-López et al., 2005, Rosentreter et al., 2007, Matsukawa et al., 2004). The 
published data that is available for several genes has no obvious connection to NC 
biology, for example aldh2b is an enzyme involved in aldehyde metabolism, slc2a15b is 
likely to encode a sugar transporter of some kind, zgc:110343 may have a role as an 
antioxidant and zgc:110239 may function in proteolysis. For other genes, Dr.4612.1.A1_at 
and Dr.3972.1.S1_at, a lack of functional information means it is impossible to speculate 
on the role of these genes in the NC. It would be intriguing to identify the function of all the 
genes validated during the in situ hybridization screen in the NC to further confirm the 
function of Sox10 as an activator of key genes involved in NC biology. A wide range of 
different genes have been identified as down-regulated in sox10 mutant NCCs. It seems 
likely that these genes function in a number of different roles. The simplest explanation for 
this is that Sox10 functions to specify non-skeletogenic NCCs and when this fails, a large 
number of cellular processes are not initiated. 
The model of Sox10 function put forward in Chapter 1 includes a prediction of the 
properties of NCCs in sox10 mutant embryos. These cells cannot specify correctly and as 
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such might maintain the properties of early NCCs, perhaps even NCSCs. Therefore genes 
that mark an intermediate cell type, for example ltk marking chromatoblasts (Lopes et al., 
2008), markers of NCSCs and receptors for extrinsic signals required to promote NC fate 
specification might be up-regulated in sox10 mutant NCCs. NCSCs have not yet been 
identified in zebrafish therefore any markers of these cells would be extremely valuable. 
As no such targets were identified during this study, the validity of this part of the model 
remains untested. The unspecified mutant cell population might express a range of 
different molecular markers, perhaps for short periods of time. This chaotic molecular 
situation would ensure these genes could not be detected as up-regulated by microarray 
analysis. However, ltk is strongly up-regulated in sox10 mutant NCCs arguing against this 
hypothesis and suggesting that other up-regulated targets do exist. 
Down-regulated and up-regulated otic vesicle expressed genes were identified in 
sox10 mutant embryos during this project. This included otomp which was already known 
to be down-regulated in sox10 mutant embryos. A number of otic vesicle expressed genes 
known to be up-regulated in sox10 mutant embryos such as pax2a and fgf8 (Dutton et al., 
2009) were not identified. It was proposed by Dutton et al., 2009 that the loss of Sox10 
function in the ear results in a loss of regulation of key patterning genes with gene 
expression up-regulated in mutants and occurring in ectopic locations. Without functional 
information for the two up-regulated otic vesicle expressed genes stc2 and sfrp5 it is 
impossible to tell if these two genes fit into this model but their distinct expression patterns 
in WT embryos certainly support this. Morpholino knock down of the down-regulated gene 
cldnj results in reduced otoliths formation (Hardison et al., 2005). This correlates with the 
small otoliths seen in sox10 mutant embryos and loss of cldnj expression is likely to 
contribute to this phenotype. Thus again the otic vesicle expressed genes identified during 
this study seem to fit with current data. 
Throughout this project the performance of a number of key marker genes, for 
example mitfa and dct, was assessed. These genes were known to be down-regulated in 
sox10 mutant embryos. Given that our group had very little experience with FACS and 
had no prior experience of microarray experiments, these genes served as markers at 
vital checkpoints. Expression levels of these key marker genes in purified GFP positive 
populations of WT and mutant cells were evaluated by RT-PCR to substantiate differential 
gene expression prior to sending samples for microarray analysis. RT-PCR was also used 
to assess the expression of these genes between GFP positive and GFP negative cell 
populations after FACS. Thus without these marker genes the efficacy of the FACS 
protocol would have been difficult to evaluate. The use of these marker genes also 
extended into the microarray section of the project. Not only was the performance of these 
genes in the raw microarray data examined but the performance of these genes was used 
to evaluate different GEPAS Expresso normalization methods in combination with 
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different methods applied using the T-Rex tool to identify differentially regulated genes. 
This led to, in conjunction with published literature, selecting the RMA normalization 
method and t-Test to process and analyse the raw microarray data. Thus throughout the 
project these marker genes provided results that not only confirmed the success of each 
step but also enabled important choices to be made. These marker genes were therefore 
invaluable. 
While the project has identified a large number interesting targets of Sox10, the 
majority of genes (nearly 80 %) examined during the in situ hybridization screen were 
false positives. This high false positive hit rate could not be resolved through changing the 
method by which differentially regulated genes were identified. Thus a large amount of 
validation work was performed on false positive microarray results. The false positive hit 
rate for microarray experiments, when published, seems to vary greatly from study to 
study. A microarray study was performed to identify genes whose expression was 
restricted to either deep or superficial ectodermal cells in Xenopus embryos (Chalmers et 
al., 2006). When the differentially expressed genes (twofold cut off) identified by 
microarray analysis were examined by in situ hybridization, 32/98 (33 %) genes were 
validated. Thus 67 % of genes were false positives. This screen also adopted a blind in 
situ hybridization approach to validate target genes. However, many aspects of this 
experiment were different; the microarray platform used was different being a two colour 
array, the model organism and biological question being examined were different, the 
cells were treated differently prior to RNA extraction and fold change was used to identify 
differentially expressed genes rather than a t-Test. These are only a few selected 
differences from the project presented here. A study in Drosophila used FACS to select 
proneural cluster cells prior to RNA extraction for hybridization to Affymetrix microarrays 
(Reeves and Posakony, 2005). Microarray analysis was performed to identify genes 
expressed preferentially in the proneural cluster cells (twofold increase). This identified 
204 candidate genes including 23 genes known to be expressed in the proneural cluster 
cells. 43 genes not known to be expressed in the cells of interest were selected and 27 
(63 %) were validated by in situ hybridization. Thus this study purified cells in a similar 
way to the project presented here but had a false positive hit rate of 37 % despite 
excluding known proneural cluster expressed genes from their study. This could to some 
extent stem from only a portion of the differentially regulated genes being selected for 
validation. Two microarray projects identified genes differentially regulated in cloche 
mutants in comparison to WT embryos (Sumanas et al., 2005, Qian et al., 2005). Thus 
these studies are interested in examining a similar biological question to this project. Both 
studies differed in microarray platforms, examining zebrafish embryos at slightly different 
embryonic stages, differentially expressed genes were defined by fold change in both 
studies but with different cut off values and both studies used different methods of 
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validation. Despite investigating the same biological question, only 12 validated genes 
were common between both screens. Thus differences exist between studies that 
investigate the same biological question but use slightly different methods. While trying to 
investigate published literature for true positive and false positive hit rates it became clear 
that direct comparisons between microarray studies is difficult. Not only are the biological 
questions and model organisms being studied different but so are the microarray 
platforms, experimental methods, analytical methods and validation methods. In addition, 
the exact protocol of each step can vary between labs, even if the same method is used. 
This can lead to striking differences between the genes validated in quite similar studies 
(Sumanas et al., 2005, Qian et al., 2005). Therefore while the false positive hit rate of the 
study presented here does seem to be high, it is difficult to relate this to other studies. The 
high false positive error rate of this study may result from variation in gene expression in 
each of the pooled samples of cells from which RNA was extracted. It cannot be 
determined if this is caused by natural variation between samples or if it is a result of 
experimental manipulation. It is certainly possible that by performing FACS the extensive 
manipulation of the embryos and cells prior to RNA extraction has had an effect on gene 
expression. Alternatively, the use of an RNA amplification step may have had an effect. 
While it has been shown that microarray data from unamplified and amplified sources of 
RNA are capable of identifying a large number of the same genes (Qian et al., 2005), it is 
possible that amplification could increase the false positive hit rate. However, as a number 
of biologically relevant results were identified in the microarray data and subsequently 
validated, such manipulations did not affect endogenous gene expression detrimentally. 
If this project was to be repeated, a number of factors could be changed. During 
the FACS purification of GFP positive cells it would be sensible to introduce pulse width to 
the sorting characteristics to distinguish carefully between single cells and clumps of cells. 
This would help to ensure only single cells were collected and therefore if GFP positive 
cells were clumped with GFP negative cells, prevent these GFP negative cells 
contaminating the samples. By improving the homogeneity of the collected cell 
populations the microarray data might become more consistent between each array and 
prevent some false positives being identified as differentially regulated. At the microarray 
normalization stage it might be worth investigating whether the RMA normalization 
method which excludes the mismatch probe sets does perform better, as was shown in 
the literature (Irizarry et al., 2003b), than the Affymetrix normalization method which 
includes mismatch probe set data. Also it might be worth investigating alternative methods 
to the t-Test to identify differentially regulated genes, such as the CLEAR test as different 
methods do produce differing results (Millenaar et al., 2006). However, as a good number 
of true positive genes were validated from the microarray data the methods utilised during 
this project were effective. The best way to improve the identification of genes as 
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differentially regulated or not is likely to be by increasing the number of microarrays used. 
The effects of this was demonstrated by the improved reliability of the data generated 
from analysing the combined data set (5 WT versus 5 mutant arrays) than the 
7.2sox10:GFP (3 WT versus 3 mutant arrays) or 4.9sox10:GFP (2 WT versus 2 mutant 
arrays) data sets. 
The in situ hybridization screen could also have been streamlined to save both 
time and resources from investigating false positives. As was examined in Chapter 5, 
published expression data on the ZFIN website could have been used to initially screen 
the microarray data in silico to eliminate likely false positive genes with clear published 
expression patterns. This would lead to genes known to be expressed in the cell types of 
interest and genes with no published expression pattern that are potentially novel being 
prioritised. Such an approach would certainly benefit a lab that does not have access to a 
cDNA library to facilitate the generation of in situ hybridization probes. In addition, a 
number of genes from interesting gene families identified as differentially regulated were 
selected for in situ hybridization analysis prior to commencing the unbiased screen 
presented in Chapter 4. The hope was that investigating a few additional targets quickly 
using in situ probes kindly donated by other labs would validate differential gene 
expression and increase confidence that the microarray data analysis had been effective. 
In reality, selecting a few genes did not shed any light on this, particularly given that such 
a large percentage of genes identified as differentially regulated were false positives. It 
would have been more beneficial to start the screen and examine the 10 most down-
regulated genes immediately. This set of genes contained 4 differentially regulated true 
positives. 
Given that a number of very interesting targets of Sox10 have been identified 
during this study, the project could be extended. One obvious extension would be to 
change the time point of the embryos being examined. This study was performed at the 
earliest point when WT and sox10 mutant embryos could be distinguished by GFP pattern 
in sox10:GFP transgenic embryos. Thus to extend this study to an earlier time point 
morpholino injection that knocks down sox10 expression would be required (Dutton et al., 
2001b). Morphant embryo and WT embryo RNA from GFP positive cells could then be 
compared by microarray analysis. Alternatively the microarray analysis could be extended 
to a later time point. Given that this project mostly identified pigment cell expressed 
genes, the study could focus on the change of gene expression in PNS cells in sox10 
mutant embryos by selecting time points, for example 48 hpf, when cells of the enteric 
nervous system or dorsal root ganglia are being specified. This could help to address the 
paucity of marker genes for these cell types and help to dissect the role that Sox10 plays 
in these cell types. 
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To summarise, the first project of this type to be carried out by our group has 
identified a large number of genes that are differentially regulated in sox10 mutant NC and 
otic vesicle cells. These genes are direct or indirect targets of Sox10. Not only has the 
identification of these genes opened up a number of new avenues for research but has 
also unearthed a number of marker genes that will prove useful in future research. Further 
in situ hybridization screening will validate yet more genes that are differentially regulated 
in sox10 mutant embryos. The genes discovered by this approach include both known NC 
and otic vesicle genes and those with no prior association to these cell types. Such 
identification of novel genes would be extremely difficult to achieve through a different 
approach. The range of genes that have been validated during the in situ hybridization 
screen appear to fit within the model of Sox10 specifying non-skeletogenic NCCs. 
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Appendix 
Affymetrix GeneChip® Definitions
Definitions were taken or adapted from the Affymetrix GeneChip® Expression Analysis 
Data Analysis Fundamentals handbook on the Affymetrix website (www.Affymetrix.com). 
Array (or Chip): A collection of probes on glass encased in a plastic cartridge. 
Background: A measurement of signal intensity caused by auto-fluorescence of the array 
surface and non-specifically bound target or stain molecules. 
Change: A qualitative call indicating an increase (I), marginal increase (MI), no change 
(NC), marginal decrease (MD) or decrease (D) in transcript level between a control array 
and an experimental array. 
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Detection call: A qualitative measurement indicating if as transcript has been detected 
(Present), not detected (Absent) or marginally detected (Marginal). 
Hybridization Controls: Controls added to the samples before hybridization to the array, 
eg: bioB. 
Noise (Raw Q): The result of small variations in digitized signals in the scanner as it 
samples the probe array surface and is measured by examining the pixel to pixel 
variations in signal intensities. 
Probe: A 25-mer oligonucleotide on the surface of an array. Hybridization of a target to the 
probe is used to generate intensity data for measuring levels of gene expression. 
Probe Cell: A square shaped area of the array containing probes of a unique sequence. 
Probe pair: MM and PM 
Probe Set: A collection of probe cells that interrogates the same sequence. 
Signal: A quantitative measurement of the relative abundance of a transcript. 
Target: The labeled (biotinylated) and fragmented sample applied to an array for 
hybridization to a matching probe. 
Sectioning Protocol 
Embryos fixed in 4 % PFA were dehydrated in 70 % ethanol for 2 hours, 96 % ethanol for

2 hours and 100 % ethanol for 1 hour at room temperature. Pre-infiltration was performed

using a 1:1 ratio of 100 % ethanol to infiltration solution A for 2 hours at room temperature.

For infiltration, embryos were incubated in infiltration solution A for up to 24 hours at room

temperature. Embedding and polymerization were performed by positioning the embryos

in embedding solution B in a Histoform mould recess and then incubating for 2 hours at

room temperature. To mount the embryo, Histobloc holders were placed into the

Histoform mould recess, Technovit 3040 liquid was then poured into the Histobloc holder

and allowed to polymerize for 10 minutes.Tissue blocks were then sectioned using a

microtome. Cut sections were placed on a glass slide to dry and a cover slip glued on top.

Infiltration Solution A:

Technovit 7100 (100 ml)

Hardener 1 (1 g)

Mix well for 1 minute and then store for up to 4 weeks at 4 °C

Embedding Solution B:

Infiltration solution A (15 parts)

Hardener 2 (1 part)

Mix well for 1 minute
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Folder Name File Name Description 
Thesis Files ThesisWord.docx Word 2007 document 
ThesisWord.doc Word 2003 document 
Thesis.pdf 
Figures (folder) .jpg images used in thesis 
Excel Spreadsheets 7.2Ttest.xlsx Excel 2007 7.2sox10:GFP analysis 
7.2Ttest.xls Excel 2003 7.2sox10:GFP analysis 
4.9Ttest.xlsx Excel 2007 4.9sox10:GFP analysis 
4.9Ttest.xls Excel 2003 4.9sox10:GFP analysis 
7.2and4.9analysis.xlsx Excel 2007 combined data set 
analysis 
7.2and4.9analysis.xls Excel 2003 combined data set 
analysis 
MIAMI files (folder) Minimum information about a 
microarray experiment files 
Original Array Data Original Array Data 
(folder) 
Raw microarray data from GCOS, 
.cel, .dat and .chp files 
GEPAS Files (folder) GEPAS notepad files generated from 
expresso and t-rex. 
Table 65: Table of electronic files provided on the accompanying CD. 
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